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Abstract 
Interleukin-10 (IL-10) is an immunoregulatory cytokine that has a vital role in 
maintaining a balanced and appropriate immune response. CD4+ T helper (Th) cells are 
important in regulating an effective immune response, and are a dominant source of IL-
10. Despite the different signalling pathways that result in the polarisation of each Th 
subset and lead to the expression of their hallmark cytokines, IL-10 is expressed by all 
of the different Th subsets. We show that Th1 cells cultured with IL-12 produce IFNγ 
and small amounts of IL-10, while Th1 cells cultured with IL-12 and IL-27 produce 
large amounts of IL-10 and IFNγ. Furthermore, we show that Th17 cells can produce 
IL-10, or not, depending on the presence of IL-2. However, these Th cell populations 
are phenotypically heterogeneous, particularly with respect production of IL-10 protein. 
Less than half of each of these in vitro cultured Th cell populations expresses IL-10 or 
the hallmark cytokine, and co-expression of IL-10 and the hallmark cytokine is also 
heterogeneous. Therefore we devised and implemented an innovative new technique 
that enables RNA-Seq analysis of different intracellular cytokine producing cell 
subpopulations from within Th subsets. We find that it is possible to extract high quality 
mRNA from Th samples, even though they have been fixed and stained for intracellular 
cytokines, and that the data from these samples is replicable. Using this technique we 
have identified potential molecules and pathways by which (I) IL-27 drives IFNγ and 
IL-10 production by Th1 cells, and (II) IL-2 drives IL-10 production by Th17 cells. 
Furthermore, by separating different intracellular cytokine producing subpopulations 
within different Th1 and Th17 cell subsets we have found that cytokine producing and 
non-cytokine producing subpopulations within heterogeneous Th subsets have 
significantly different transcriptional profiles and that some pathways and molecules are 
enriched in IL-10 producing cells.   
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1.1 A overview of the immune response 
The immune system has evolved many mechanisms with which to respond to the 
constant assault of potentially pathogenic organisms and promote normal health of the 
host. In jawed vertebrates these mechanisms involve cells that can be broadly 
categorised into the innate and adaptive immune systems, which act in a co-ordinated 
way to protect the host against infection. The innate immune system is thought to be 
evolutionarily older than the adaptive and is the first line of defence against invading 
pathogens. It controls the initial infection, activates the adaptive immune response and 
dictates the course the following immune response will take. However, unlike the 
adaptive immune system, the innate has restricted specificity and cannot prevent re-
infection, as it has limited immunological memory (Sun et al., 2009). The adaptive 
immune system is more evolutionarily advanced, and it can recognise pathogens 
specifically and mount robust memory responses. The different receptor types these 
cells use to recognise pathogens dictate the difference in specificity of these two 
branches of the immune system. Innate immune cells express germ line encoded, 
invariant receptors that have broad specificities for pathogens; while adaptive immune 
cells express receptors encoded by various genes which are recombined resulting in a 
diverse repertoire of receptors (Medzhitov, 2007).  
 
The innate immune system is comprised of many different cell types including dendritic 
cells (DCs), macrophages, natural killer cells, basophils, eosinophils and mast cells. 
DCs and macrophages recognise infection via ligation of the germ-line encoded pattern 
recognition receptors (PRRs), expressed on their surface, by conserved protein motifs 
expressed by microorganisms. When infection is detected by the innate immune system 
an inflammatory response is initiated, resulting in the recruitment of other immune cells 
to the site of infection and the production of the soluble factors chemokines and 
cytokines (Medzhitov, 2007).  
 
DCs and macrophages are also known as antigen presenting cells (APCs) as they alert 
cells of the adaptive immune system to infection by migrating to the lymphoid organs of 
the host and stimulating T cells. APCs take up pathogens, process them and present the 
peptide antigen on their surface in the context of major histocompatibility complexes 
(MHC) to T cells. These will ligate the T cell receptor (TCR) and alongside ligation of 
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co-stimulatory molecules, the T cells will become activated (Guermonprez et al., 2002); 
they will clonally expand and differentiate into effector cells. There are two main types 
of effector T cells; the CD8+ cytotoxic T cells recognise antigen presented on MHC 
class I and directly kill infected cells (Harty et al., 2000), therefore they mainly 
recognise intracellular pathogens; and the CD4+ helper T cells that recognise antigen 
presented on MHC class II, and can activate other cells of the immune response 
including innate cell types and B cells (Abbas et al., 1996). Innate cells produce 
cytokines, which alongside the activation of CD4+ T cells by the ligation of the TCR, 
influence the expansion of CD4+ T cells and direct their differentiation into distinct 
subsets of T helper (Th) cell that are specialized to eradicate different pathogens 
through differing effector functions (Figure 1.1) (Murphy et al., 2000). 
 
Another arm of the adaptive immune response is formed by the B cells, which produce 
antibodies and have many crucial immunological functions. Like T cells, B cells can be 
separated into many lineages, which have various roles in the immune response. The 
terminally differentiated effector lineage of plasma B cells are activated by ligation of 
the B cell receptor (BCR) by antigen and respond by secreting pathogen specific 
antibodies to neutralise pathogens (Kurosaki et al., 2010). However, other B cell subsets 
exist that can express multiple cytokines and present antigen, which is internalised upon 
BCR ligation, and expressed in the context of MHC class II (Mauri and Bosma, 2012). 
After the elimination of an antigen most immune cells undergo programmed cell death, 
however a few remain to form the pool of memory T and B cells. These ensure a faster 
and more effective immune response upon secondary invasion by the pathogen, and 
therefore provide long lasting immune protection. 
 
Alongside the eradication of pathogens, however, is the risk of over-exuberant immune 
responses that can cause more damage to the host than the invading pathogen. Therefore 
parallel mechanisms within the immune response are in place to limit host damage and 
prevent reactivity to self. One important way in which the immune system does this is 
via the soluble factor Interleukin-10 (IL-10). This cytokine is crucial in maintaining a 
balanced immune response (Jankovic et al., 2010), it is produced by multiple cell types 
and has immunoregulatory functions on a broad range of targets (Figure 1.2) (Moore et 
al., 2001; Saraiva and O'Garra, 2010).  
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1.2 The role of T helper cells in the immune response 
For over fifty years we have known that the thymus is crucial in immune system 
development; neonatal thymectomy in mammals leads to impaired immune responses 
(Kay, 1970). In fact the thymus is the environment in which thymus (T) cells develop 
from haematopoietic stem cells. The thymus has four discrete areas, which have 
different microenvironments with specific functions that guide T cells through the 
stages of development. The T cells can be traced through their development by 
alterations in the expression of markers on their cell surface; these include the TCR, 
CD3, CD4, CD8, CD25 and CD44. The expression of CD4 and CD8 enables the 
separation of T cells into the early stage double negative (CD4-CD8-), intermediate 
stage double positive (CD4+CD8+) and final stage single positive (CD4+ or CD8+) 
cells. The differential expression of CD25 and CD44 allows the separation of the four 
main double negative sub-stages (Koch and Radtke, 2011). Within the thymus the genes 
encoding the TCR are randomly rearranged and the T cells undergo a process of 
selection where cells with TCRs that have a high affinity for self peptide-MHC 
complexes are eliminated by apoptosis and those with potentially useful TCR 
specificities are allowed to mature (Mingueneau et al., 2013; Yamane and Paul, 2012). 
This entire developmental process results in the removal of self-reactive cells and the 
existence of a diverse pool of defensive T cells. 
 
In the 1960s the first functional roles were discovered for T cells. A series of papers 
were published showing that thymus-derived cells were necessary for antibody 
production, but that these cells themselves were not making the antibodies. In fact they 
were somehow supporting the production of antibodies from bone marrow (B) -derived 
cells, and therefore these cells acquired the name T helper cells (Reviewed in (Crotty, 
2015). Twenty years later, in 1986 two distinct CD4+ Th clones were identified, IFNγ 
producing Th1 cells and IL-4 producing Th2 cells (Mosmann et al., 1986). Since then 
different Th cells, such as Th17, Treg and T follicular helper (Tfh) cells, have been 
reported based on their transcription factor expression and cytokine secretion profile.  
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1.2.1 The differentiation of functionally heterogeneous T helper cell subsets  
The differentiation of Th subsets from the homogenous naïve CD4+ T cell pool requires 
three signals. The first involves the presentation of peptide antigen on MHC class II 
molecules by APCs to the TCR of the T cell. The second involves the interaction of 
ligands on the APCs surface, such as CD80/86, with TCR costimulatory molecules 
found on the surface of T cells, such as CD28 (Yamane and Paul, 2013). The third 
signal involves the presence of polarising cytokines within the microenvironment of the 
Th cell; signals from these cytokines lead to the expression of signal transducer and 
activator of transcription protein (STATs) and transcription factors that direct the 
effector function of that cell (O'Garra, 1998). The culmination of these three signals 
leads to the activation and initiation of differentiation of the Th cell into a specific Th 
cell subset that can coordinate the eradication of the invading pathogen (Figure 1.1).  
 
1.2.1.1 An overview of the T helper cell subsets 
Each T helper subset has a specific differentiation profile; polarising cytokines instruct 
the cell along a certain differentiation pathway; STATs and transcription factors are 
activated in accordance with the polarising cytokines and act on genes within the T cell 
to dictate which cytokines are produced upon infection. The different Th subsets have 
been rigorously studied and they are now characterised by the ‘hallmark’ cytokines that 
they produce, and their ‘master’ transcription factors that dictate their differentiation. 
Different Th subsets have different phenotypic characteristics as they participate in 
different types of immune and inflammatory responses. The profiles of these subsets are 
outlined in Figure 1.3. 
 
A hallmark cytokine is considered to be a cytokine that is produced by a specific subset 
of Th cell that drives a specific immune response. IFNγ is the hallmark cytokine of Th1 
cells that acts on macrophages leading to their accumulation at the site of infection and 
the clearance of intracellular pathogens (O'Garra, 1998). IL-4, alongside IL-5 and IL-13, 
are the hallmark cytokines of Th2 cells (Sher and Coffman, 1992), which act to clear 
helminths by activating mast cells (IL-4) and eosinophils (IL-5), and elevating class 
switching and IgE production by B cells (IL-4 & IL-13) (Zhu, 2010). IL-17 is the 
hallmark cytokine of Th17 cells (Harrington et al., 2005), which is involved in the 
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defence of mucosal barriers (Ciofani et al., 2012; Korn et al., 2009). Alongside these 
hallmark cytokines these cells also produce other cytokines. In particular, all Th subsets 
produce IL-10, alongside other pro-inflammatory cytokines, which acts to feedback 
negatively on the immune response (Jankovic et al., 2010; Saraiva and O'Garra, 2010). 
A master transcription factor is defined by its expression being necessary and sufficient 
for the differentiation and acquisition of specific characteristics of a certain cell type 
(Josefowicz, 2013). T-bet is considered the master transcription factor for Th1 cells 
(Szabo et al., 2000), GATA3 for Th2 cells (Zheng and Flavell, 1997), RORγt for Th17 
cells (Ivanov et al., 2006), FoxP3 for Treg cells (Josefowicz et al., 2012) and BCL6 for 
Tfh cells (Johnston et al., 2009); however recent evidence suggests that the role of these 
factors may be more limited than initially thought and they may need to act 
collaboratively with other factors (Josefowicz, 2013). This will be discussed in greater 
detail later in the chapter. 
 
1.2.1.2 The early signalling events that underlie T helper cell differentiation 
The affinity of ligation of the TCR and its costimulatory molecules, and the dose of 
antigen, determine the strength of stimulation of naive CD4+ T cells and is a major 
checkpoint in their differentiation. The strength of stimulation can also be regulated by 
serial triggering, where a few MHC-antigen complexes trigger multiple TCRs (Valitutti 
et al., 1995), and by the duration of TCR-MHC interactions (Iezzi et al., 1998). The 
required duration of TCR signalling for T cell activation varies between naïve and 
effector T cells; naïve T cells need as much as 20 hours of signalling to initiate 
proliferation, while effector T cells need only 1 hour for initiation of commitment with 
prolonged TCR stimulation of effector T cells resulting in cell death (Iezzi et al., 1998). 
This can be circumvented by CD28 costimulation, which facilitates greater signalling in 
reduced periods of TCR-MHC interaction (Iezzi et al., 1998). The strength of TCR 
signalling can regulate the Th1-Th2 and Th17-Treg cell balance in vitro. Strong 
signalling leads to Th1 differentiation (Nembrini et al., 2006) and weak favours Th2; 
strong TCR stimulation leads to high levels of extracellular signal-regulated kinase 
(ERK) activation that restricts the early production of GATA3 and the activation of 
STAT5 by IL-2 is blocked, therefore blocking the induction of Th2 cells and supporting 
Th1 development (Yamane and Paul, 2013). In the presence of TGFβ weak TCR 
Chapter 1: Introduction 
 -32- 
 
signalling leads to FoxP3 expression and failure of T cells to differentiate into Th17 
cells (Gabrysova et al., 2011).  
 
Antigen dose can similarly have a fundamental impact on the differentiation of Th cells. 
Low levels of antigen dose, as with weak TCR signalling, lead to the development of 
Th2 cells while high levels of antigen presented by DCs leads to the development of 
Th1 cells (Constant et al., 1995; Hosken et al., 1995). In mice high levels of TCR 
occupancy by large amounts of antigen lead to greater ERK phosphorylation and the 
downregulation of GATA3 (O'Garra et al., 2011). A similar effect has been seen in 
human cells; DCs cultured with LPS and pulsed with high levels of antigen drove Th1 
cell differentiation, while those that were pulsed with low doses of antigen drove Th2 
cell differentiation (Langenkamp et al., 2000). There is some evidence that at very high 
antigen doses Th2 cell differentiation is favoured again, the mechanism driving this is 
unknown, though it has been shown to be IL-4 dependent (Hosken et al., 1995). High 
concentrations of antigen have also been associated with Th17 cell differentiation; this 
is via a feedback mechanism where high antigenic stimulation leads to increased cell 
surface expression of CD40L which cross-talks with CD40 on DCs to increase their IL-
6 production, which further promotes Th17 polarisation (Iezzi et al., 2009). 
Additionally it has been suggested for Th1 cells that abundant and repeated antigenic 
stimulation may result in IL-10 production from these cells, and reduced IL-2 
production and anergy (Gabrysova et al., 2009; Saraiva et al., 2009). The signalling 
strength from the TCR controls downstream expression of cytokine receptors (van 
Panhuys et al., 2014), which is the next step in determining the polarisation of naïve 
CD4+ T cells. 
 
The dominant signals that orchestrate naïve CD4+ T cell specification are cytokines. 
These are soluble proteins released by various cell types in response to infection, that 
initiate and direct the immune response. Cytokines in the microenvironment 
surrounding the naïve CD4+ T cells bind receptors on their surface and promote or 
repress certain signalling cascades that drive different differentiation pathways. IL-12 is 
a cytokine produced predominantly by macrophages and DCs upon encounter with 
microbial products, and is the main factor in directing Th1 cell differentiation and IFNγ 
production (Hsieh et al., 1993b). Ligation of the IL-12 receptor leads to a signalling 
cascade that activates STAT4 and drives Th1 cell development; mice where the IL-12 
gene or STAT4 gene has been deleted (knockout mice) have markedly reduced levels of 
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Th1 responses (O'Garra, 1998). IL-4 is the crucial cytokine in the initiation of Th2 cell 
development (Le Gros et al., 1990; Seder et al., 1992; Swain et al., 1990). Ligation of 
the IL-4 receptor leads to a signalling cascade that activates STAT6 and drives Th2 cell 
development (Hou et al., 1994). The source of this IL-4 remains elusive, with many cell 
types being suggested, but no consensus having been reached; many cell types produce 
IL-4 but the relevance of this in the context of driving Th2 cells is unknown and is 
probably context depenedent. Other than autocrine T cell derived IL-4, which is known 
to propitiate Th2 cell differentiation (Abbas et al., 1996), basophils have centrally been 
discussed as having a role in driving Th2 cells, with studies advocating their promotion 
of Th2 cell development (Sokol et al., 2008; Sullivan et al., 2011). The cytokines 
required to drive Th17 cell differentiation are numerous and thought to act in a certain 
order; with TGFβ, activating SMADs, and IL-6, activating STAT3, to induce initial 
differentiation, IL-21 subsequently driving amplification via STAT3 and finally IL-23 
maintaining stability via STAT3 and STAT4 (Yamane and Paul, 2013). Alongside the 
‘driving’ cytokines, IL-2 plays a fundamental role in the differentiation of all the Th 
subsets. IL-2 signals through the IL-2 receptor and activates STAT5. IL-2 acts on all 
known Th subsets, but in different ways. It has been shown to be essential for Th1 and 
Th2 differentiation, and to block Th17 and Tfh differentiation, via different mechanisms 
(Yamane and Paul, 2012). 
 
1.2.1.3 The role of pioneer transcription factors and STATs in T helper cell 
differentiation 
The differentiation of T helper cells can be considered as a two-step process; the first 
step being the ligation of the TCR and initial activation of the cells, and the second 
being the distinction of the Th subset phenotype by the cytokines present in the 
microenvironment. The initial TCR signals seem to result in pioneer transcription 
factors initiating an initial phase of gene regulation by altering the enhancer landscape 
of the cell’s chromatin (Vahedi et al., 2013b). In Th17 cells BATF and IRF4 are thought 
to act as pioneer factors by cooperating to control chromatin accessibility and enable 
subsequent RORγt binding and the binding of other transcription factors that are 
activated by cytokine stimulation (Ciofani et al., 2012; Glasmacher et al., 2012; Li et al., 
2012a). BATF is part of the activator protein 1 (AP-1) family of proteins, other 
members of which have been shown to have a role in pre-patterning of chromatin in 
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other cell types (Biddie et al., 2011). IRF4 has been shown to contribute to the 
development of multiple Th subsets and therefore may collaborate with other AP-1 
family members to act as a pioneer in different Th subsets (Ahyi et al., 2009; Li et al., 
2014), though this is still unknown. Pioneer factors in Th1 and Th2 cells remain elusive, 
this is likely to be due to the fact that unlike RORyt, T-bet and GATA3 have direct 
effects on the epigenetic landscapes of cells (Vahedi et al., 2013a). In fact GATA3 is 
expressed at varying levels throughout T cell development, and GATA3 binding can 
precede enhancer activation during thymocyte development. This suggests that 
alongside being a master transcription factor for Th2 cells, GATA3 may also be a 
pioneer factor (Wei et al., 2011; Zhang et al., 2012).  
 
Most specifying cytokines exert their actions through STATs, which can alter the 
enhancer landscape of the chromatin and bind directly to genes as transcription factors. 
Unlike master transcription factors, whose activity is regulated by the level of 
expression, STATs are mostly regulated by cytokine-mediated post-translational 
modifications (Zhu et al., 2010). STATs not only induce and collaborate with master 
transcription factors to drive cytokine expression, but they also play an important role in 
the induction of other transcription factors (Zhu et al., 2010). STATs play a crucial role 
in altering the chromatin landscape; STAT3, STAT4 and STAT6 have all been shown 
to recruit and regulate the binding of the acetyltransferase p300 to specific genes 
(Ciofani et al., 2012; Vahedi et al., 2012), and in the absence of these STATs the master 
transcription factors cannot recover the enhancer landscapes of the cells (Wei et al., 
2010). However, cytokines often activate more than one STAT family member and 
multiple cytokines usually act on a cell; therefore the role of STAT signalling within 
differentiating Th cells is multifaceted, where they can act in complex or opposition 
with one another (O'Shea et al., 2011). Recently the negative regulatory role of STATs 
has become more apparent; for instance STAT4 can inhibit Th2 differentiation while 
promoting Th1, and STAT6 can inhibit Th1 differentiation while promoting Th2 (Zhu 
et al., 2010). Interestingly, the Il10 gene is positively regulated by both STAT4 and 
STAT6 (Saraiva and O'Garra, 2010). STATs can also act competitively, such as in Th17 
cells where STAT3 and STAT5 compete for multiple common binding sites, and where 
it is a balance of the two signals that determines the lineage specification of the cell 
rather than the magnitude of each signal (Yang et al., 2011). 
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1.2.2 The role of different T helper cell subsets in the immune response 
1.2.2.1 T helper 1 cells (Th1) 
Invasion by intracellular pathogens causes DCs and macrophages to produce IL-12 
(Hsieh et al., 1993b), which activates STAT4 in naïve T cells (O'Shea et al., 2011) and, 
via IFNγ, induces the expression of the transcription factor T-bet (Lighvani et al., 2001) 
and the reprograming of chromatin structure to activate the Ifng gene (Szabo et al., 
2000). IFNγ is the hallmark cytokine of Th1 cells and acts on macrophages, leading to 
their accumulation at the site of infection and the clearance of intracellular pathogens, 
such as Mycobacterium tuberculosis (O'Garra, 1998). However alongside this protective 
role of Th1 cells can be dysregulation, leading to immunopathology and autoimmune or 
inflammatory diseases (Gabrysova et al., 2009). 
 
1.2.2.1.1 The role of Th1 cells in the immune response 
It has been known for many years that Th1 cells are predominantly induced by bacteria, 
such as during B. abortus (Scott and Kaufmann, 1991) and M. tuberculosis (Redford et 
al., 2011) infection. However, Th1 cells are also found in large numbers in the initial 
stages of malaria infection with Plasmodium parasite (Langhorne et al., 1989), and in 
other parasitic infections such as Trichinella and Leishmania (Scott and Kaufmann, 
1991). Additionally, Th1 cells have been found to be induced during viral infections 
such as Hepititis C virus (Brady et al., 2003) and HIV (Clerici and Shearer, 1993). Th1 
activation is often time dependent, as seen in Malaria, and location dependent, as seen 
in the compartmentalisation of Th responses to different organs in Trichinella infection 
(Scott and Kaufmann, 1991). Infection of the host by these pathogens will lead to IL-12 
secretion by DCs and macrophages that will drive the differentiation of Th1 cells, as 
described above. These activated Th1 cells will then release IFNγ, which then drives 
specific immune responses to eradicate the invading pathogen. The IFNγ receptor is 
expressed by almost all cells within the body, however Th1 cell mediated IFNγ is 
mainly thought to act on DCs and macrophages. It leads to the enhanced expression of 
the MHC class II receptors on the surface of DCs and macrophages, leading to more 
effective antigen presentation to CD4+ T cells (Billiau et al., 1998). Furthermore, IFNγ 
increases the production of iNOS and other anti-microbial factors by macrophages that 
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aid in the killing of pathogens (Stuehr and Marletta, 1987). Additionally Th1 IFNγ 
inhibits Th2 cell development (O'Garra, 1998).  
 
1.2.2.1.2 Transcriptional regulation of Th1 cell differentiation and cytokine production 
IL-12 and IFNγ activate STAT4 and STAT1, respectively, which in turn drive the 
expression of Tbx21, the gene encoding the T-box protein T-bet (Zhu et al., 2010). 
Studies have shown that though IFNγ activates STAT1 during Th1 cells differentiation, 
it is not crucial for Th1 development and functioning. Nevertheless, it is thought that 
when the Th1 response is sub-optimally stimulated, the activation of STAT1 becomes 
more important (Zhu et al., 2010). The important role IFNγ signalling plays in Th1 
responses is highlighted by findings that mutations in humans in the IFNγ receptor and 
STAT1 lead to susceptibility to mycobacterial disease (Fortin et al., 2007). Unlike 
STAT1, STAT4 has been shown to have a vital role in Th1 development, with STAT4 
deficiencies leading to a discrete phenotype of decreased IFNγ production. STAT4 has 
been shown to have an important role in epigenetically modifying the chromatin 
landscape of cells and a core set of genes that are highly dependent on direct STAT4 
binding have been described, including Ifng and Tbx21 (Wei et al., 2010). STAT4 has 
also been found to actively repress STAT6 target genes in Th1 cells, therefore 
repressing Th2 lineage genes (O'Shea et al., 2011). 
 
T-bet is considered to be the master regulator of Th1 cells (Szabo et al., 2000). It drives 
the Th1 differentiation programme by initiating IFNγ and IL-12 receptor expression, 
creating a positive feedback loop. T-bet also maintains the Th1 lineage and antagonises 
the differentiation of Th2 and Th17 cells by inhibiting GATA3 and RORγt (Li et al., 
2014). However, T-bet is not alone in driving the Th1 lineage, it acts in complex with 
other transcription factors; including runt-related transcription factor 3 (RUNX3), 
enabling the induction of Ifng and repressing the expression of Il4 (Djuretic et al., 2007). 
T-bet can also cooperate with BCL6 to form repressive complexes that silence certain 
genes to promote Th1 development (Oestreich et al., 2011). In fact it has been shown 
that a deficiency in Blimp-1, a transcription factor that negatively regulates BCL6, leads 
to increased Th1 cell numbers (Lin et al., 2014); supporting the role for BCL6 in Th1 
differentiation.  
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1.2.2.2 T helper 2 cells (Th2) 
Parasitic invasion will result in the release of the polarising cytokine IL-4 which acts on 
naïve CD4+ T cells (Maggi et al., 1992; Swain et al., 1990) to activate STAT6 (Hou et 
al., 1994), inducing the expression of the transcription factor GATA3 (Scheinman and 
Avni, 2009; Zhu et al., 2001), which goes on to reprogram the chromatin structure of 
the cell activating the genes for Il4, Il5 and Il13 (Lee et al., 2000; Maier et al., 2012). 
These interleukins are the Th2 hallmark cytokines, which act to clear helminths by 
activating mast cells and eosinophils, and elevating class switching and IgE production 
by B cells (Zhu, 2010). The adverse side of this response is when it is mounted against 
otherwise innocuous environmental ‘allergens’, resulting in atopy and allergy (Akdis et 
al., 2004). 
 
1.2.2.2.1 The role of Th2 cells in the immune response 
Extracellular parasites, particularly gastrointestinal helminths, are the main stimuli of 
Th2 cell responses (Finkelman et al., 1991; Locksley, 1994; Scott and Kaufmann, 1991; 
Sher and Coffman, 1992). Helminth parasites such as H. polygyrus and N. brasiliensis 
are often used as mouse models of parasitic worm infection and are strong drivers of the 
Type 2 response (Mowen and Glimcher, 2004). Ligation of the TCR in combination 
with IL-4 leads to STAT6 signalling and initiation of the Th2 phenotype. However 
alongside IL-4, IL-2 signalling has been shown to be important in Th2 cell 
differentiation; IL-2 regulates IL-4 expression alongside promoting cell growth and 
survival (Ansel et al., 2006; Le Gros et al., 1990). After the initial stimulation of Th2 
cells, the cells enter a state of rest during which they do not actively express Th2 
cytokines. However, the chromatin is remodelled and Th2 specific genes become 
transcriptionally accessible. This enables further stimulation to drive Th2 cell cytokine 
secretion (Zeng, 2013). Activated Th2 cells release the cytokines IL-4, IL-5 and IL-13, 
which have specific and overlapping roles in driving Type 2 immunity. The genes for 
these cytokines are all clustered together on the same chromosome (chromosome 11 in 
mouse, and chromosome 5 in human) in an area known as the Th2 cytokine locus. The 
Th2 cytokines, IL-4, IL-5 and IL-13, act on epithelial cells, goblet cells and mast cells 
to drive mastocytosis, mucus production and eosinophilia, and on B cells to drive IgE 
production and MHC class II upregulation. IL-4 aids in B cell class switching of IgG 
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and IgE production, IL-4 and IL-13 affect macrophage activation, and IL-5 recruits 
eosinophils (Zhu, 2010). IL-4 is fundamental to the Th2 immune response; in vivo 
studies reveal that IL-4 knockout mice have impaired, but not absent, responses to 
helminth infection (Kopf et al., 1993), and IL-4 can compensate for the triple knockout 
of IL-5, IL-9 and IL-13 (Fallon et al., 2002). The activation of the Type 2 response 
leads to immunological actions that are pathogen specific, for instance expulsion of N. 
brasiliensis requires increased mucus production while expulsion of T. spiralis requires 
mast cell activation (Mowen and Glimcher, 2004). Th2 cells also make substantial 
amounts of IL-10 alongside their hallmark cytokines; explaining why IL-10 was 
initially described as a Th2 specific cytokine (Fiorentino et al., 1989). 
 
1.2.2.2.2 Transcriptional regulation of Th2 cell differentiation and cytokine production 
An initial round of low-antigen dose TCR stimulation leads to the upregualtion of 
GATA3 and IL-2 expression (Yamane et al., 2005), this IL-2 feeds back onto the cells 
and activates STAT5, which alongside GATA3 alters the accessibility of the IL-4 locus 
(Zhu et al., 2003). Paracrine and autocrine IL-4 act on the T cells to drive the 
differentiation of Th2 cells by activating STAT6. STAT6 is thought to be a crucial 
switch signal in the initiation of Th2 differentiation, and it has been shown to facilitate 
the expression of over half of the IL-4 regulated genes (O'Shea et al., 2011). STAT6 
acts on both promoters of the Gata3 gene to drive its expression; redundantly on the 
distal promoter and non-redundantly on the proximal promoter (Scheinman and Avni, 
2009). TCR signalling leads to activation of nuclear factor of activated T cells 1 
(NFAT1), which cooperates with STAT6 at the Gata3 promoters to drive GATA3 
expression (Scheinman and Avni, 2009). The IL-4/STAT6 signalling pathway also 
induces growth factor independent 1 (GFI-1) (Zhu et al., 2002), which promotes the 
proliferation of GATA3 high cells and suppresses the differentiation of other Th subsets 
(Zhu et al., 2006). Independently of the STAT6 signalling pathway, DCs and 
macrophages express Jagged proteins on their surfaces that ligate the Notch 1 and 2 
proteins on CD4+ T cells and may induce Th2 cell differentiation by enhancing GATA3 
transcription (Zeng, 2013).  
 
GATA3 is considered to be the Th2 master regulator, however it is present at various 
levels through haematopoiesis and is expressed at low levels in naïve CD4+ T cells 
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(Wei et al., 2011). However, upon Th2 cell polarisation its levels are dramatically 
upregulated and it goes on to further activate its own expression (Lee et al., 2000; 
Ouyang et al., 2000). GATA3 over-expression can drive Th2 cell differentiation even 
under Th1 polarising conditions (Zheng and Flavell, 1997) or in STAT6 deficient cells 
(Ouyang et al., 2000), and down-regulation of GATA3 impairs the expression of all Th2 
cell associated cytokines (Zheng and Flavell, 1997). GATA3 has been shown to be able 
to remodel chromatin and it directly binds to the promoters of Il5 and Il13 (Kishikawa 
et al., 2001; Lee et al., 1998); which are both highly responsive to GATA3. The Il4 
promoter, however, is less responsive to GATA3 (Lee et al., 2001). GATA3 has also 
been shown to act on various enhancers of the Th2 cytokine locus (Zeng, 2013). 
GATA3 also induces the transcription factor c-Maf, which cooperates with JUNB to 
drive expression of the Il4 gene (Li et al., 1999a), and synergises with Kruppel-like 
factor 13 (KLF13) at the Il4 promoter to regulate IL-4 expression (Kwon et al., 2014). 
Finally, alongside promoting various aspects of Th2 differentiation, GATA3 can 
suppress Th1 differentiation by attenuating the IL-12/STAT4 signalling axis (Ferber et 
al., 1999; Ouyang et al., 1998; Usui et al., 2003; Zeng, 2013).  
 
Independently of the IL-4/STAT6 signalling pathway, TCR signalling leads to the 
activation of NFAT, AP-1 and nuclear factor-κB (NF-κB); all of which contribute to 
Th2 cytokine gene activation. NFAT and AP-1 together bind the NFAT/AP-1 
composite site at the Il4 promoter to activate it (Rooney et al., 1995), while NF-κB 
synergises with NFAT1 and nuclear factor of IL-6 (NFIL6) to activate the Il4 promoter 
(Li-Weber et al., 2004). There is also overlap between the TCR signalling and IL-
4/STAT6 signalling pathways, mostly through interactions with c-Maf. Interferon 
regulatory factor 4 (IRF4) physically interacts with NFATc2 to activate the Il4 promoter, 
and these together synergise with c-Maf to drive IL-4 expression (Rengarajan et al., 
2002). Furthermore, NOD-like receptor family, pyrin domain containing 3 (NLRP3), 
the expression of which in Th2 cells is regulated by STAT5 via IL-2 signalling, directly 
interacts with IRF4 to facilitate optimal IRF4-dependent Il4 expression (Bruchard et al., 
2015). The NFAT interacting protein NIP45 has also been shown to interact with 
NFATc2 and c-Maf to activate the Il4 promoter (Hodge et al., 1996). 
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1.2.2.3 T helper 17 cells (Th17) 
Bacterial or fungal invasion will lead to IL-6 and TGFβ acting on naïve CD4+ T cells to 
drive the activation of STAT3 and SMADs, respectively, (Bettelli et al., 2006; 
Veldhoen et al., 2006; Yamane and Paul, 2013) that induce the transcription factor 
RORγt which in turn drives the hallmark cytokine IL-17 and IL-22 expression (Awasthi 
and Kuchroo, 2009). However, IL-1, IL-21 and IL-23 have all also been implicated in 
playing important accessory roles in Th17 differentiation, and Th17 cells can also 
produce IL-6, IL-21 (Korn et al., 2009), and IL-10 (McGeachy et al., 2007), depending 
on the stimulatory conditions. Initially most of the effector functions of Th17 cells were 
described in the context of autoimmunity, however more recent data suggests a vital 
role for Th17 cells in immunity, particularly in the defence of mucosal barriers (Ciofani 
et al., 2012; Korn et al., 2009; Puel et al., 2010). 
 
1.2.2.3.1 The role of Th17 cells in the immune response 
Th17 cells were initially established as a separate lineage of Th cells in the context of 
the autoimmune disease EAE, where Th17 cells specific for autoantigens induce severe 
tissue inflammation (Awasthi and Kuchroo, 2009; Langrish et al., 2005). Nevertheless, 
the evolutionary function of Th17 cells is not to cause autoimmunity and therefore there 
must be situations in which the massive inflammation driven by Th17 cells is necessary. 
There is now a wealth of evidence to show that Th17 cells are involved in mounting 
immune responses to bacterial and fungal infections, and they are thought to be 
particularly important in the defence of mucosal barriers (Aujla et al., 2007). 
Neutralisation of the IL-23/IL-17 axis prevents mice for clearing Pneumocystis 
infection, highlighting their important role in anti-fungal responses (Rudner et al., 2007). 
Mice deficient in IL-17 and IL-23 are also susceptible to gram-negative bacteria such as 
K. pneumonia, and IL-17 and IL-22 have been shown to increase proliferation of lung 
epithelial cells and resistance to injury by this bacterium (Aujla et al., 2008). IL-17 has 
also been shown to have important anti-microbial functions, for example during 
infection with M. tuberculosis (Mtb); Th17 cells have been implicated in the early 
response to Mtb and are thought to be crucial in recruiting Th1 cells to the site of 
infection (Awasthi and Kuchroo, 2009; Khader et al., 2007).  
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The cytokines that Th17 cells release have different wide-spread roles in controlling and 
recruiting cells to maintain immune responses to bacterial and fungal infection. Overall 
Th17 cells are implicated in upregulating certain chemokines, pro-inflammatory 
cytokines and colony-stimulating factors (CSFs) to induce neutrophils and recruit 
myeloid cells to the site of infection. As mentioned above the IL-23/IL-17 axis is 
important in many Th17 cell actions; IL-23 acts to feedback on Th17 cells to drive 
greater IL-17 expression and has been suggested to repress the expression of 
immunoregulatory cytokines such as IL-10 (McGeachy et al., 2007). Furthermore, IL-
23 driven Th17 cells have a greater ability to express IFNγ and behave in a pathogenic 
manner (Ghoreschi et al., 2010; Langrish et al., 2005; Lee et al., 2009b). IL-17, 
alongside IL-22, acts on many different cell types and has a broad range of 
proinflammatory effects. IL-21, however, has more targeted actions on certain immune 
cells, such as B cells to drive their expansion and isotype class-switching, and on Th17 
cell themselves to initiate further amplification of the Th17 response (Korn et al., 2009). 
However, the actions of IL-21 are complicated by findings that it has 
immunosuppressive roles; it is thought to regulate immune responses by inducing IL-10 
production by CD4+ and CD8+ T cells (Spolski et al., 2009).   
 
1.2.2.3.2 Transcriptional regulation of Th17 cell differentiation and cytokine 
production 
IL-6, IL-21 and IL-23 all signal through STAT3 to drive Th17 differentiation. Deletion 
of STAT3 in CD4+ T cells leads to detrimental effects on IL-17 and IL-21 expression, 
and STAT3 has been shown to directly bind the Il17 and Il21 genes. Additionally, 
STAT3 has been shown to bind multiple genes implicated in Th17 differentiation, 
including Rorc which encodes the Th17 master transcription factor RORγt, alongside 
genes for the transcription factors BATF and c-Maf, and the receptors for IL-23 and IL-
6 (O'Shea et al., 2011). 
 
Unlike GATA3 and T-bet, RORγt alone is not sufficient to drive Th17 cell 
differentiation. Alongside STAT3, which has been shown to be critical for IL-17 and 
IL-21 expression, other transcription factors have been shown to regulate IL-17 and 
RORγt, including BATF and IRF4. In fact an absence in BATF leads to defective Th17 
polarisation (Li et al., 2014). Recent ChIP-Seq studies have revealed that it is actually 
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likely that a large complex of transcription factors co-localise at the promoters of Il17 
and Il21 to act competitively or cooperatively to drive gene expression. The 
transcription factors suggested to be involved thus far include STAT3, RORγt, BATF, 
IRF4, c-Maf, JUN/JUNB/JUND and FOSL2 (Ciofani et al., 2012; Li et al., 2012a). 
 
Both paracrine and autocrine TGFβ are thought to be important in Th17 cell 
differentiation, though the role of TGFβ in driving Th17 differentiation is complex for 
two main reasons. Firstly the concentration of TGFβ in the environment is crucial in 
dictating Th cell differentiation; low doses of TGFβ can synergise with IL-6 and IL-21 
to initiate the development of Th17 responses, however high doses of TGFβ lead to the 
inhibition of IL-23 receptor expression and the induction of regulatory T cells 
expressing the transcription factor FoxP3 (Awasthi and Kuchroo, 2009). Secondly, it 
has been shown that Th17 cells can be polarised in the absence of TGFβ; if the cells are 
driven with IL-1β together with STAT3 activation then the IL-23 receptor can be 
upregulated, and this IL-23 responsiveness enables the generation of pathogenic Th17 
cells in the absence of TGFβ (Ghoreschi et al., 2010). Nevertheless, TGFβ is generally 
considered to be required for Th17 induction. Unlike other Th17 driving cytokines, 
TGFβ signals through the SMAD family of proteins; activation of the TGFβRI leads to 
phosphorylation of SMAD2 and 3 which complex with SMAD4 to translocate to the 
nucleus and transcribe genes. Deletion of SMAD2 prevents Th17 cell differentiation, 
and studies suggest that SMAD2 may control the cross-talk between TGFβ and IL-6 
(Malhotra et al., 2010). While the deletion of SMAD3 leads to an increase in Th17 
differentiation, the double knockout of SMAD2/3 leads to reduced Th17 differentiation 
but no effect on RORγt; suggesting the upregulation of RORγt by TGFβ is not via 
SMAD2/3 (Takimoto et al., 2010). Recent studies have found that though TGFβ signals 
through both SMAD2 and SMAD3, these proteins actually have differential effects on 
STAT3 driven transcription of IL-17. In support of previous findings, SMAD2 
promotes STAT3 transactivation of Rorc and Il17a while SMAD3 promotes inhibition 
of STAT3 (Yoon et al., 2015). TGFβ has also been shown to interact with NFAT and 
IRF4 to drive the transcription of IL-23 (Hermann-Kleiter and Baier, 2010). SOCS3 is 
activated by IL-6 and IL-21 signalling, but feeds back as a negative regulator of STAT3 
signalling, and the deletion of this factor leads to increased Th17 numbers; TGFβ 
inhibits SOCS3 to prolong STAT3 activation in Th17 cells (Qin et al., 2009). 
Additionally, TGFβ may also aid Th17 differentiation by inhibiting the differentiation 
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of both Th1 and Th2 cells (Gorelik et al., 2002; Gorelik et al., 2000; Zhu and Paul, 
2010).  
 
Finally, IL-1β has also been shown to promote the proliferation and maintenance of 
antigenically stimulated Th17 cells in the context of some inflammatory conditions. In 
particular it has been shown that in the absence of TGFβ, IL-1β is crucial in aiding IL-6 
and IL-23 driven differentiation of Th17 cells (Ghoreschi et al., 2010; Zielinski et al., 
2012). It acts through the Akt-mammalian target of rapamycin (Akt-mTor) pathway via 
glycogen synthase 3 (GSK3) and IRF4 to regulate IL-21 expression (Muranski and 
Restifo, 2013). 
 
1.2.3 T helper cell lineage commitment  
1.2.3.1 Heterogeneity of cytokine production within T helper cell populations 
Initial studies of Th1 and Th2 cell populations established that the cells making up these 
subsets express cytokines in a heterogeneous manner (Bucy et al., 1994; Murphy et al., 
1996; Openshaw et al., 1995). By looking at single cells within each subset using 
double labelling of cytokines with in situ hybridisation (ISH) it was ascertained that 
certain cytokines are more or less likely to be coexpressed. In IL-4 driven Th2 cells, IL-
4 and IL-5 are highly coexpressed at all stages of stimulation, while IL-4 and IL-10 are 
increasingly coexpresssed with multiple rounds of cell stimulation (Bucy et al., 1995). It 
is now well established that heterogeneity exists within all Th cell subsets, and this can 
be visualised by their patterns of cytokine production; as each lineage is able to express 
multiple cytokines. This heterogeneity in cytokine secretion is likely to be due to 
differences in epigenetic modifications, temporal and stochastic signalling events and 
the variable expression of transcription factors (O'Garra et al., 2011; Zhu et al., 2010).  
 
However, the origins and factors controlling the heterogeneity within Th cell subset 
populations remain unclear. The heterogeneity in Th2 cells has in part been associated 
with the ETS family transcription factor PU.1, which has been shown to prevent 
GATA3 binding the Il4 locus resulting in lower levels of IL-4 expression. When PU.1 
expression is attenuated the homogeneity of the Th2 population is increased (Chang et 
al., 2005). In Th17 cells it has been shown that activation of the aryl hydrocarbon 
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receptor (AhR) may dictate the expression of IL-17 and IL-22; in the absence of the 
AhR IL-22 expression by Th17 cells is lost while IL-17 expression is only mildly 
affected (Veldhoen et al., 2008a). Nevertheless establishing the factors that underlie Th 
subset cytokine expression heterogeneity remains a problem. However, new 
technologies, including single cell RNA-Sequencing, are being applied to finds answers 
to questions such as these; a topic that will be discussed in greater detail later in this 
chapter.  
 
1.2.3.2 Feedback and cross-regulation between T helper cell subsets 
Each Th subset has a set of molecular feedback mechanisms instilled within it to 
maintain the differentiation of that specific lineage. In most Th subsets, the master 
transcription factor, often in concert with other transcription factors, drives increased 
expression of cytokine receptors that leads to positive feedback loops; promoting cell 
fate determination (Zhu et al., 2010). As already mentioned, in Th1 cells IFNγ 
activation of STAT1 drives T-bet expression, which then initiates further IFNγ 
production (Lighvani et al., 2001). Additionally, in human T cells T-bet feeds back to 
directly activate its own expression and re-enforce the Th1 lineage (Kanhere et al., 
2012). With regard to Th2 cells, the hallmark cytokine IL-4, which is expressed by Th2 
cells, is also the critical driving cytokine of Th2 cells, and therefore the actions of IL-4 
on Th2 cells drives further IL-4 expression and reinforcement of this lineage. Dec2 is a 
transcription factor that has been shown to directly bind Junb and Gata3 and drives 
their expression, and GATA3 has been shown to regulate Dec2 expression, creating a 
positive feedback circuit that drives expression of GATA3 and enhancement of Th2 
differentiation (Yang et al., 2009). Additionally Dec2 has been shown to upregulate IL-
2 receptor expression, which could further boost Th2 responses (Liu et al., 2009). In 
Th17 cells RORγt induces the expression of IL-21, which then acts on the Th17 cells to 
initiate further STAT3 signalling and maintenance of RORγt expression (Murphy and 
Stockinger, 2010). However, alongside these positive feedback mechanisms that further 
drive Th subset differentiation, there are circumstances in which Th cells will feedback 
negatively on themselves or each other to reduce differentiation and proliferation. One 
of the main mechanisms by which Th cells do this is via the production of the 
immunosuppressive factor IL-10 (O'Garra and Vieira, 2007). 
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While maintaining certain Th lineages, cytokines can also suppress the differentiation of 
other lineages. IL-4 suppresses Th1, Th17 and Treg differentiation via the upregulation 
of GFI-1, and IL-2 suppresses the Th17 lineage while promoting Th1, Th2 and Treg 
cells in appropriate contexts. TGFβ promotes Th17 and Treg development and prevents 
Th1 and Th2 cell differentiation (Gorelik et al., 2002; Gorelik et al., 2000; Zhu and Paul, 
2010). Transcription factors also play a crucial role in cross-regulation of Th cell subset 
differentiation at both transcriptional and post-transcriptional levels. For instance, T-bet 
inhibits GATA3 and RORγt function and therefore antagonises the differentiation of 
Th2 and Th17 cells. One of the mechanisms by which it does this is by associating with 
RUNX1 and therefore preventing RUNX1 and RORγt cooperation in Th17 
differentiation (Li et al., 2014). Additionally, T-bet in Th1 cells induces RUNX3, which 
directly binds Il4 and represses its expression, and can repress GATA3 function (Zhu 
and Paul, 2010). However in Th2 cells, GATA3 can interact with RUNX3 to prevent its 
upregulation of IFNγ expression (Yagi et al., 2010) and GATA3 can downregulate 
STAT4 expression (Usui et al., 2003). At the post-transcriptional level, phosphorylated 
T-bet can interact with GATA3 to suppress its capacity to drive IL-5 expression 
(Hwang et al., 2005). Enforced STAT5 signalling in Th1 cells can drive Th2 
differentiation in the absence of GATA3 upregulation (Zhu et al., 2003), and STAT5 
has been shown to suppress RORγt and IL-17 upregulation (Laurence et al., 2007). 
Overexpression of RORγt can prevent STAT4 activation and T-bet upregulation 
(Mukasa et al., 2010), and it can bind Foxp3 to repress its expression (Burgler et al., 
2010). IL-6 can also suppress FoxP3 function in Tregs through STAT3, while 
conversely FoxP3 can interact with RORγt to prevent IL-17 expression (Zhou et al., 
2008). The mechanisms by which cytokines and transcription factors repress certain 
genes expressed in different Th subsets to reinforce the differentiation of that subset are 
complex and diverse, but are fundamental in maintaining certain types immune 
responses.  
 
1.2.3.3 T helper cell subset plasticity 
Once a naïve CD4+ T cell has differentiated into a specific Th subset, can that effector 
phenotype be changed to better control infection? There are two mechanisms by which 
the phenotype of CD4+ T cells can be changed during infection: cellular plasticity and 
population plasticity. Cellular plasticity refers to individual cells changing their 
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phenotype and cytokine secretion profile, while population plasticity refers to changes 
in the size of different Th populations due to proliferation or cell death (Magombedze et 
al., 2013). Population plasticity is a generally accepted phenomenon, and though all the 
processes behind driving the changes in Th cell numbers are not understood, it is clear 
that during infections, particularly chronic infections, the ratios of different Th subsets 
shift (Zhang et al., 1997). However, the concept of cellular plasticity is still an area of 
contention. 
 
It has been shown in vitro (Murphy et al., 1996) and in vivo, with N. brasiliensis 
infection (Panzer et al., 2012), that Th1 cells can acquire the characteristics of Th2 cells. 
However, in vitro it has been shown that the more ‘terminally’ differentiated a cell 
becomes, after multiple rounds of antigenic stimulation, the harder it is to reprogram 
(Murphy et al., 1996). This model may be reflected in vivo during chronic infections, 
such as with the CRTh2+ pool of Th2 effector memory cells described by Messi et al 
(Messi et al., 2003) which have no flexibility and are not capable of reverting to the Th1 
profile under any conditions tested. At least some plasticity can be attributed to Th2 
cells differentiating from naïve T cells still present within the Th1 cell populations. 
However, even Th2 cells that are considered stably committed, that have lost the 
expression of the IL-12Rβ2, can be reprogrammed to re-express the IL-12Rβ2 and 
produce both IL-4 and IFNγ (Hegazy et al., 2010; Murphy and Stockinger, 2010) and 
some Th2 populations can express both GATA3 and T-bet (Zhu and Paul, 2010). The 
potential for plasticity in IFNγ expression may be due to the bivalent histone 
modifications of H3K4me3 and H3K27me3 found at the Tbx21 locus (Wei et al., 2009). 
Bivalent modifications at master transcription factor gene loci may be one of the key 
factors in enabling Th cell subset plasticity. Another example of the reprogramming of a 
Th cells is in the presence of TGFβ Th2 cells can acquire the capacity to produce IL-9 
(Veldhoen et al., 2008b), while IL-9 can also be expressed by Th17 cells. In vivo Th17 
cells are commonly found to acquire the potential to express IFNγ (Bending et al., 2009; 
Hirota et al., 2011; Lee et al., 2009b), and in some cases they even lose the ability to 
express IL-17 (O'Shea and Paul, 2010). These examples argue for plasticity in Th cell 
cytokine expression and the blurring of lines between the different Th subsets, but the 
actual frequency of Th cells that alter their cytokine profiles at the single cell level in 
vivo remains uncertain, and with current technologies it is not possible to test. 
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1.3 The role of IL-10 in the immune response 
IL-10 was initially named cytokine synthesis inhibitory factor when it was discovered in 
1989 (Fiorentino et al., 1989) and it was described as a product of Th2 cells which acted 
on Th1 cells to suppress their differentiation and effector functions. The wider role of 
IL-10 was suggested 2 years later with the finding that IL-10 could inhibit many 
macrophage functions, including the release of proinflammatory cytokines, to indirectly 
reduce the actions of CD4+ T cells (Bogdan et al., 1991; Fiorentino et al., 1991a; 
Fiorentino et al., 1991b). IL-10 was also found to inhibit DC IL-12 production, 
preventing them from driving Interferon-γ (IFNγ) production by CD4+ and CD8+ T 
cells (Hsieh et al., 1993a; Macatonia et al., 1993). IL-10 is produced by most cells of 
the immune system (Figure 1.2) and is now considered to be a crucial 
immunoregulatory cytokine with various actions (Saraiva and O'Garra, 2010). IL-10 
deletion in mice can lead to inflammatory bowel disease and other exaggerated 
inflammatory disorders, highlighting its importance in limiting inflammation (Moore et 
al., 2001). Though this phenotype is not seen in germ free mice, emphasising the 
importance of IL-10 in the balance between the immune system and commensal 
bacteria.  
 
IL-10 is a homodimeric protein and part of the IL-10 family of cytokines that includes 
IL-9, IL-20, IL-22, IL-24, IL-26, IL-28A, IL-28B and IL-29 (Ouyang et al., 2011). 
These can be subgrouped based on their chromosomal location, structure, receptor 
usage and biological functions. However, this family has very diverse biological 
functions and only IL-10 has been clearly associated with an anti-inflammatory role 
(Ouyang et al., 2011). Additionally, in Epstein-Barr virus (EBV) and in human 
cytomegalovirus (CMV), viral homologues of the Il10 gene have been described, these 
are now known as ebvIL-10 (Moore et al., 1990) and cmvIL-10 respectively (Kotenko 
et al., 2000). The existence of viral IL-10 suggests there is a beneficial role of 
mimicking the actions of IL-10 for viruses. This is supported by that fact that though 
ebvIL-10 mimics the immunosuppressive actions of IL-10 (Hsu et al., 1990), it does not 
result in the immunostimulatory actions (Vieira et al., 1991). 
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1.3.1 Cellular sources of IL-10  
It has been established that IL-10 is produced by a range of cells in both the innate and 
adaptive immune systems (Maynard and Weaver, 2008; Moore et al., 2001). Within the 
innate system DCs, macrophages, mast cells, natural killer (NK) cells, eosinophils and 
neutrophils have all been shown to express IL-10 (O'Garra and Vieira, 2007). 
Recognition of microbe-derived products by pattern recognition receptors (PRRs) 
causes DCs and macrophages to become activated and express cytokines, including IL-
10. IL-10 is produced rapidly by these cells upon toll-like receptor (TLR) and other 
PRR ligation and is therefore thought to be important in controlling early responses to 
pathogens and acute inflammation (Murray, 2006b). IL-10 production by mDCs and 
macrophages can be induced downstream of TLR2, TLR3, TLR4 and TLR9 (Kaiser et 
al., 2009; Saraiva and O'Garra, 2010). Furthermore, other PRRs can be potent inducers 
of IL-10, such as Dectin-1 in mDCs (Slack et al., 2007). The amount of IL-10 
expression by DCs and macrophages does differ, with macrophages producing high 
levels of IL-10, myeloid DCs producing intermediate amounts and plasmacytoid DCs 
producing none (Boonstra et al., 2006). Independently of TLRs, ligation of Dectin-1 
leads to potent induction of IL-10 in myeloid DCs but not macrophages (Reviewed in 
(Saraiva and O'Garra, 2010), suggesting that innate cells may not have the same 
intrinsic capacity to make IL-10. 
 
Alongside their role as positive regulators of the immune response, B cells do also have 
suppressive roles in the immune response, chiefly through their production of IL-10. IL-
10 production by B cells as part of their normal immune response was first shown in 
1990 (O'Garra et al., 1990), and this was followed by a series of publications 
highlighting Ly-1+ CD5+ B-1 cells, which are the main producers of natural antibodies, 
as the major B cell source of IL-10 (O'Garra et al., 1992). Since then our understanding 
of B cell IL-10 expression has greatly improved (Fillatreau et al., 2002; Hilgenberg et 
al., 2014) and there is now a B cell subset specifically attributed to IL-10 production 
and immune system downregulation, known as Bregs (Mizoguchi et al., 2002). This 
initial paper found that in a spontaneous colitis model, CD1d hi CD5+ B cell derived 
IL-10 could suppress Th2 mediated immunity. So far no marker has been found to 
define Bregs, however various subtypes of Breg have now been proposed, with different 
phenotypes depending on environmental stimuli, which are thought to all stem from a 
common progenitor (Mauri and Bosma, 2012). 




The concept of T cell mediated immunosuppression is an old one, and the mechanisms 
by which CD8+ T cells facilitate this are varied, though mostly they are considered to 
function via the cytolytic killing of other immune cells harbouring the pathogen. 
However, the expression of IL-10 and immune repression via this mechanism has not 
been greatly explored. Nevertheless, there is evidence that both human and mouse 
CD8+ T cells do express IL-10 and can downregulate the immune response. In mice, 
tolerant CD8+ T cells, which did not proliferate in response to PMA and ionomycin or 
IL-2, constitutively expressed IL-10 (Tanchot et al., 1998). Furthermore, in mice, MHC 
class I restricted CD8+ T cells can be activated to develop a regulatory phenotype that 
is mediated by contact-dependent suppression of other T cells in combination with IL-
10 expression (Noble et al., 2006). In humans, monocyte-derived DCs can induce CD8+ 
T cell differentiation into non-cytolytic IL-10 producing T cells that can inhibit APC 
induced CD8+ T cell proliferation (Gilliet and Liu, 2002). IL-10 expressing CD8+ T 
cells are thought to be most common intestinal epithelial lymphocytes found in the 
small intestine of naïve mice (Maynard and Weaver, 2008). 
 
Unlike CD8+ T cells, the production of IL-10 by CD4+ T cells has been extensively 
studied, as they are considered the major source of IL-10 in inflammation and infection; 
conditional deletion of IL-10 production in CD4+ T cells closely resembles the 
phenotype with T. gondii infection seen in non-conditional IL-10 deficient animals 
(Roers et al., 2004). As mentioned, IL-10 was initially thought to be a Th2 subset 
specific cytokine, produced alongside IL-4, IL-5 and IL-13 (Fiorentino et al., 1989). 
However, it is now known to be expressed by a wide variety of Th cells. This includes 
Th1 cells that express IL-10 alongside IFNγ; these cells often have a strong effector 
phenotype suggesting they produce IL-10 as a regulatory feedback mechanism to 
control their own actions (Jankovic et al., 2007; O'Garra and Vieira, 2007; Svetic et al., 
1993; Trinchieri, 2001). Additionally, Th17 cells have been shown to conditionally 
express IL-10 (McGeachy et al., 2007; Stumhofer et al., 2007), and IL-9 producing Th 
cells (Th9 cells) also produce IL-10 (Veldhoen et al., 2008b). Regulatory CD4+ T cell 
(Treg) populations, distinguished by the expression of the transcription factor FoxP3, 
can either be derived in the thymus or induced from naive T cells in the periphery (Hori 
et al., 2003; Sakaguchi, 2005; Uhlig et al., 2006). These cells are regarded as an 
immunosuppressive CD4+ T cell subset that make IL-10 as part of their multiple 
suppressive mechanisms (Josefowicz et al., 2012). Tregs release IL-10, which can 
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promote their survival whilst downregulating other immune responses; maintaining an 
optimum balance between pathogen removal and host-mediated inflammatory 
pathology (Trinchieri, 2001). Additionally, it has been suggested that there is a 
population of FoxP3 negative Tregs which are derived in the periphery that only 
produce the cytokine IL-10, often referred to a Tr1 cells (Gregori et al., 2010; Maynard 
et al., 2007; Roncarolo and Gregori, 2008; Vieira et al., 2004); making them distinct 
from the other Th cell subsets such as Th1, Th2 and Th17, which secrete IL-10 and 
have regulatory roles, but also may secrete other effector cytokines.  
 
1.3.2 Cellular targets of IL-10 
The IL-10 receptor is expressed on most haematopoietic cells and is composed of two 
receptor chains, IL-10R1 and IL-10R2 that are members of the IFN receptor family 
(Moore et al., 2001). IL-10R1 is important for the binding of IL-10, while the accessory 
subunit IL-10R2 is critical for signal transduction. IL-10R2 is also used in signalling for 
other IL-10 family cytokines, highlighting that the IL-10R1 chain is the important 
portion for IL-10 specificity (Ouyang et al., 2011). DCs and macrophages express the 
highest levels of the IL-10R, supporting evidence that these are the main targets of IL-
10 activity (Murray, 2006b). 
 
Upon ligation of the IL-10 receptor Janus kinase (JAK) 1 and tyrosine kinase (TyK) 2 
are activated, JAK1 in turn phosphorylates the IL-10R1 chain and TyK2 phosphorylates 
the IL-10R2 chain (Ouyang et al., 2011), enabling docking with the SH2 domains of 
signal transducer and activator of transcription (STAT) 3 (Finbloom and Winestock, 
1995). The IL-10 receptor can also activate other STATs and initiate other signalling 
pathways, however STAT3 is thought to be the most important in the anti-inflammatory 
effects of IL-10 (Murray, 2006b). However, IL-10 is not the only receptor to signal via 
STAT3; IL-6 also signals via STAT3, but IL-6 cannot initiate the anti-inflammatory 
response that IL-10 does. It has been proposed that this may be due to temporal 
differences in the signalling pathways, with SOCS3 terminating IL-6 signalling before it 
can initiate the anti-inflammatory pathway (Murray, 2006a).  
 
IL-10 is thought to signal via STAT3 to induce the expression of inhibitory factors, 
which in turn limit proinflammatory cytokine and chemokine production (Murray, 
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2005). The actions of these inhibitory factors are thought to act mainly via 
transcriptional inhibition, such as in human macrophages where IL-10 signalling leads 
to the inhibition of elongation of the tumour necrosis factor (TNF) transcript (Smallie et 
al., 2010). IL-10 may also have post-transcriptional actions; it has been shown to 
negatively regulate TNFα production by mediating the expression of microRNA-187 
(Rossato et al., 2012). Additionally, IL-10 has been shown to inhibit IL-12p40 
production by inhibiting Il12b transcription in myeloid cells and this has been proposed 
to be via the expression of the STAT3-dependent transcription factor nuclear factor of 
interleukin 3 (NFIL3) that mediates Il12b transcription inhibition (Smith et al., 2011). 
Further genome-wide studies have proposed other IL-10 signalling targets, the 
relevance of which are yet to be confirmed (Hutchins et al., 2012b). 
 
In the 1990s it was suggested that IL-10 also has direct immunomodulatory effects on 
CD4+ T cells, reducing Th1 and Th2 proliferation and cytokine production (De Waal 
Malefyt et al., 1993). However these effects were variable and controversial, as it has 
been shown that IL-10R1 is downregulated on T cells upon activation (Moore et al., 
2001), and may have been explained by the effects of contaminating DCs or 
macrophages in the culture. It is now generally accepted that IL-10 has no direct effect 
on Th1 cells, but instead limits the ability of DCs and macrophages to promote their 
differentiation and proliferation. It does this by downregulating the expression of the 
following DC and macrophage surface molecules: MHC, intracellular adhesion 
molecule-1 and the costimulatory molecules CD80 and 86 (Maynard and Weaver, 2008; 
Moore et al., 2001). Additionally, as discussed above, IL-10 reduces the transcription of 
pro-inflammatory cytokines from DCs and macrophages; such as IL-12, which drives 
Th1 cell differentiation (Moore et al., 2001). More recent studies, however, have shown 
that Th17 cells express the IL-10 receptor, and that when the activity of this receptor is 
specifically blocked on these cells there is an increase in Th17 cell numbers during 
intestinal inflammation (Huber et al., 2011). Additionally it has been shown that IL-10 
acts directly on Treg cells; (I) to maintain their FoxP3 expression and hence suppressive 
functions (Murai et al., 2009); (II) to enhance their suppression of Th17 cells via 
STAT3 (Chaudhry et al., 2011); (III) to increase their own IL-10 production which goes 
on to act at IL-10 receptors on Th17 cells (Huber et al., 2011). IL-10, therefore, reduces 
the inflammatory actions of Th cells, in both an indirect and a direct manner. 
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Paradoxically, alongside the suppressive effects of IL-10 described above, IL-10 can 
also have certain stimulatory effects on the immune system; such as the enhancement of 
NK cell proliferation and IFNγ production (Moore et al., 2001) and the activation of 
mast cells (O'Garra et al., 2008). It can also enhance the activation of polyclonal B cells, 
which can have a protective role or a pathogenic role; such as in systemic lupus 
erythematosus (O'Garra et al., 2008). IL-10 has been shown to upregulate MHC class II 
expression on the surface of naïve mouse B cells, and to enhance their survival (Go et 
al., 1990). In humans IL-10 can also promote B cell survival by rescuing them from 
apoptosis, though this effect is dependent upon the activation state of the cells (Itoh and 
Hirohata, 1995). IL-10 has also been attributed to a role in B cell differentiation and 
isotype class switching (Moore et al., 2001). Originally a factor secreted by B cells was 
described to promote the proliferation of thymocytes in the presence of IL-2 and IL-4, 
this was found to be IL-10 (MacNeil et al., 1990), and further studies support the role of 
IL-10 in promoting the proliferation and cytotoxic activity of activated CD8+ T cells 
when in combination with low doses of IL-2 (Groux et al., 1998). As with B cells the 
effects of IL-10 on CD8+ T cells can be either enhancing or inhibitory, depending on 
the activation state of the cells. 
 
1.3.3 Regulation of the immune response by IL-10 
A proinflammatory immune response is critical for the protection against infection, but 
it can become pathogenic and cause damage to the host if it is over exuberant. 
Additionally inappropriate immune responses, such as against self antigens and non-
harmful commensal or innocuous antigens, can also cause damage to the host. IL-10, 
with its immunosuppressive actions, plays a crucial role in preventing this excessive 
inflammation and autoimmunity. However, inappropriate IL-10 production when 
inflammation poses no threat to the host can prevent effective clearance of pathogens, 
and potential onset of chronic infections. Therefore the maintenance of a balanced 
immune response is crucial for normal functioning of the host, with the optimal amount 
of IL-10 ensuring protection from immunopathology but not inhibiting appropriate 
immune responses (Gabrysova et al., 2014; Moore et al., 2001). 
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1.3.3.1 The role of IL-10 in the protection against immunopathology 
IL-10 knockout (KO) mice suffer from severe alterations in intestinal homeostasis and 
inflammatory bowel disorders such as chronic enterocolitis (Kuhn et al., 1993).  
However, germ-free mice do not develop this phenotype (Sellon et al., 1998), 
suggesting that this colitis formation is due to commensal bacteria in the gut activating 
the immune system; in IL-10 deficient mice there is no suppression of this immune 
response and therefore there is excessive immunopathology. There are multiple 
lymphocyte populations that regulate intestinal inflammation, however CD4+ T cell 
derived IL-10 is considered to be one of the key mediators of gut homeostasis (Roers et 
al., 2004). The important role for IL-10 in steady state intestinal immunity is reflected 
in humans, where coeliac disease and inflammatory bowel disease (IBD), which are the 
most common forms of non-infectious intestinal inflammation in humans, have been 
linked to single nucleotide polymorphisms (SNPs) flanking the Il10 gene (Franke et al., 
2008). Nevertheless, though IL-10 plays a non-redundant role in intestinal homeostasis, 
it is not critical to steady state systemic immune regulation. However when not in the 
steady state, such as in the context of infection, IL-10 plays a fundamental part in 
immunoregulation.  
 
In the setting of infection, IL-10 is essential in limiting tissue damage resulting from 
unrestricted inflammation; it acts at different stages of the immune response and at 
various locations within the host. Endotoxic shock, which is characterised by an over-
exuberant inflammatory response, multi-organ failure and possible death, can develop 
in response to lipopolysaccharide (LPS), which is found in the cell walls of gram-
negative bacteria. The role of IL-10 in regulating this response is highlighted by the 
findings that disruption of the Il10 gene in mice greatly reduced the amount of LPS 
required for a lethal dose, part of which was attributable to enhanced TNFα and IFNγ 
production (Berg et al., 1995). Subsequently, macrophages have been shown to be a 
crucial source of protective IL-10 in this model (Roers et al., 2004). 
 
Much additional in vivo evidence supports the important role of IL-10 in immunity; IL-
10 deficiency leads to lethal autoimmune responses as a reaction to certain parasite and 
bacterial infections such as T. gondii (Gazzinelli et al., 1996), P. chabaudi chabaudi (Li 
et al., 1999b) and T. muris (Schopf et al., 2002). In these infections a strong Th1 
immune response, characterised by IFNγ production, is mounted in reaction to the 
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pathogen, and in the absence of IL-10 this response is not controlled and therefore there 
is enhanced mortality. In fact depletion of CD4+ T cells with anti-CD4 antibodies 
protects IL-10 deficient mice from mortality induced by T. gondii (Gazzinelli et al., 
1996). This protection against excessive Th1 immune responses is also seen during 
murine cytomegalovirus infection, where lacking IL-10 leads to immunopathology 
related to excessive Th1 driven inflammation during infection (Oakley et al., 2008). 
Interestingly, in these infections where there is a highly polarised Th1 response, and 
therefore IL-10 producing Th2 cells are not present, the source of IL-10 seems to be the 
Th1 cells themselves (Jankovic et al., 2010; Jankovic et al., 2007). Therefore it is 
thought that these cells are in fact feeding back to regulate their proinflammatory 
immune responses and prevent immunopathology (O'Garra and Vieira, 2007). 
 
Allergic diseases are complex conditions resulting from IL-4 driven Th2 cells mounting 
inappropriate inflammatory responses to innocuous antigens (Kay et al., 1991; 
Robinson et al., 1992; Till et al., 1997), such as pollen, which lead to high levels of IgE 
production and eosinophilia (Durham et al., 1992; Hawrylowicz and O'Garra, 2005; 
Kemeny et al., 1989). Recent evidence also suggests that IL-10 may play a protective 
role in allergy (Faith et al., 2009; Faith et al., 2012), and that these diseases may be 
caused by an imbalance between inflammatory Th2 cells and suppressive IL-10 
producing Th cells (Ling et al., 2004). Healthy individuals have a shift towards IL-10 
expressing Th cells, while allergic individuals have higher numbers of inflammatory 
allergen-specific Th2 cells (Akdis et al., 2004). Furthermore it has been demonstrated 
that Treg cells prevent allergen-specific Th2 cytokine responses in healthy (non-atopic) 
individuals (Cavani et al., 2003; Taams et al., 2002), in an IL-10 dependent manner 
(Xystrakis et al., 2006b). This supports the notion that allergic individuals may have 
impaired or altered Treg function (Hawrylowicz, 2005). The beneficial role of IL-10 in 
allergy is also supported by the findings that glucocorticoids, that are the main treatment 
for asthma, induce IL-10 synthesis by human T cells (Barrat et al., 2002; O'Garra and 
Barrat, 2003; O'Garra et al., 2008). Furthermore, the addition of 1,25(OH)2-vitamin D3 
(VitD3) alongside glucocorticoids enhances human Th cell IL-10 synthesis and restores 
responsiveness to glucocorticoids in steroid resistant individuals, enhancing therapeutic 
responses (Xystrakis et al., 2006b). The role of glucocorticoids and VitD3 in regulating 
IL-10 will be discussed in greater detail later in this Chapter.  
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Based on the broad anti-inflammatory effects of IL-10 there have been multiple studies 
in animals to see if the administration of IL-10 could be beneficial in the context of 
inflammation. In the model of endotoxic shock, the administration of IL-10 protects 
mice from the LPS induced shock, at least in part by decreasing TNFα production 
(Howard et al., 1993), though this has not been reproduced in humans. IL-10 treatment 
has also been shown to be beneficial in experimental autoimmune encephalitis (EAE), 
though in other models it has been shown to exacerbate the disease (Asadullah et al., 
2003). In colitis IL-10 treatment was successful in ameliorating the disease, but only if 
administered prior to disease onset; it could not reverse established inflammation 
(Herfarth and Scholmerich, 2002). These results have led to an interest in the potential 
clinical applications of IL-10. A variety of clinical trials on healthy volunteers have 
been undertaken with the aim of treating immune mediated inflammatory diseases with 
recombinant IL-10. Though initial results were encouraging, the ensuing larger blinded 
trials showed little therapeutic benefit with multiple side effects (O'Garra et al., 2008).  
This highlights again the complex role IL-10 plays in the immune response and that it 
has both suppressive and stimulatory actions. 
 
1.3.3.2 The role of IL-10 in the inhibition of protective immune responses 
Contrary to the beneficial role of IL-10 in preventing over exuberant proinflammatory 
responses, in some circumstances the anti-inflammatory actions of IL-10 can hinder 
protective immune responses. Inappropriate amounts of IL-10 can enable certain 
pathogens to persist in the host as it suppresses the immune responses required to clear 
them. For example, during M. tuberculosis infection, where mice deficient in IL-10 
mount elevated Th1 responses and expel the pathogen more effectively, resulting in 
lower bacterial loads than wild type mice (Redford et al., 2011). Similarly, infection 
with the protozoan L. major can lead to long-term persistence of the pathogen in the 
host that is not seen in IL-10 deficient mice (Belkaid et al., 2002). These mice can 
completely clear the infection, though this loss in IL-10 activity is also associated with 
the loss in immunity to reinfection (Belkaid et al., 2002); reinforcing the idea that the 
immune system needs equilibrium between effector and regulatory mechanisms. Further 
to this, high levels of IL-10 have been correlated with sever visceral leischmaniasis in 
humans; Th cells that are FoxP3 negative have been found as the main source of IL-10 
in this instance (Nylen et al., 2007). In the context of viral infection IL-10 can also 
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inhibit protective immunity; persistent infection with lymphocytic choriomeningitis 
virus (LCMV) leads to increased IL-10 production and impaired T cell responses in 
mice (Brooks et al., 2006), whereas mice lacking the IL-10 gene or IL-10 receptor 
blockade results in robust effector responses and clearance of the virus (Brooks et al., 
2006; Ejrnaes et al., 2006). Recent data suggests that Type I IFNs may drive IL-10 
production from DCs during LCMV infection, which results in suppressed antiviral T 
cell responses, and that interfering with type I IFN signalling can restore protective 
immunity to LMCV (Wilson et al., 2013). Similarly, negative regulation of Type I IFN 
signalling protects against intracellular bacterial infections including Mtb and L. 
monocytogenes (McNab et al., 2014; McNab et al., 2013). 
 
Not only is the generation of a robust immune response desirable in infection, it is also 
necessary for effective vaccination regimes, and therefore theoretically IL-10 could 
have a detrimental effect on vaccination efficacy (O'Garra et al., 2008). In fact the 
neutralisation of IL-10 using antibodies, in the presence of soluble antigen leads to more 
effective priming of Th1 responses and these cells mount an enhanced response upon 
rechallenge (Castro et al., 2000). Further to this, a recent study has shown that if IL-10 
is blocked at the time of vaccination with BCG, then the vaccination efficacy is 
enhanced and there is a reduction in bacterial load after rechallenge with M. 
tuberculosis (Pitt et al., 2012).  
 
1.3.3.3 The role of IL-10 in autoimmune disease 
Damaging immune responses to self antigens can occur in the absence of foreign 
antigens, such as in autoimmunity. Multiple sclerosis (MS) is a disease characterised by 
central nervous system (CNS) inflammation and is associated with Th1 and Th17 cell 
driven inflammation at the myelin sheath that surrounds nerve fibres and EAE is a 
mouse model of MS (Zamvil and Steinman, 1990). The role of IL-10 in EAE has been 
suggested to be protective, as IL-10 deficient mice develop an accelerated, more severe 
form of EAE and recovery is also impaired as compared to wild type mice (Bettelli et 
al., 1998). However treatment with IL-10 has led to contradictory results, depending on 
the timing and level of administration (O'Garra et al., 2008). Rheumatoid arthritis (RA) 
is a chronic inflammatory disease characterised by inflammation affecting the joints. 
TNFα has been shown to be a pathological factor in RA, as the treatment of RA 
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patient’s cells with anti-TNFα antibodies leads to reduced proinflammatory cytokine 
production (Brennan et al., 1989) and TNFα inhibitors are now used clinically as an RA 
therapy (Feldmann and Maini, 2003). IL-10 has been suggested to be protective in this 
condition, as the neutralisation of IL-10 leads to increased proinflammatory cytokine 
levels (Katsikis et al., 1994). Conversely, a number of studies have looked at the serum 
and synovial fluid of RA patients and found a positive correlation between RA and IL-
10 (Asadullah et al., 2003). These two diseases highlight the dual role of IL-10 in 
autoimmunity and the difficulty with targeting it therapeutically. IL-10 is associated 
with increased B cell activity and autoantibody production, and has stimulatory effects 
on B cell activation, differentiation and proliferation. In systemic lupus erythematosus 
(SLE), an autoimmune disease associated with autoantibodies recognising nuclear 
proteins, it has been suggested that IL-10 has an important role in pathogenesis of the 
disease (Iyer and Cheng, 2012). In fact IL-10 levels in SLE patients have been found to 
be higher than those in healthy controls and high levels of IL-10 correlated with clinical 
score (Park et al., 1998), and polymorphisms in the Il10 gene have been associated with 
SLE development (Reviewed in (Beebe et al., 2002). Furthermore, the treatment of SLE 
blood mononuclear cells with anti-IL-10 antibodies leads to a reduction in the 
production of autoantibodies (Llorente et al., 1995). 
 
1.3.3.4 The role of IL-10 in cancer 
Multiple studies have looked at IL-10 in anti-tumour immune responses and its role is 
thought to be highly contextual. Firstly, STAT3, the molecule through which IL-10 
signals, has been associated with tumour growth and function as it has been found to be 
highly expressed in many solid tumours and when constitutively activated STAT3 can 
have oncogenic effects (Murray, 2006b). On the other hand IL-10 has been shown to 
facilitate antitumor effects via stimulating cytotoxic CD8+ T cells in the tumour 
microenvironment, though contrastingly IL-10 conditioned DCs are thought to anergise 
CD8+ T cells towards melanoma antigens (Mocellin et al., 2005). There are many 
examples in which IL-10 has immunosuppressive effects in cancer models, however 
there are also many other studies suggesting it has an immunostimulatory effect 
(O'Garra et al., 2008). These contradictory effects are likely to be due to a combination 
of the complexity of actions IL-10 exerts on the immune response and the 
heterogeneous nature of cancer as a disease.  




The vast array of immunological systems and diseases IL-10 has been found to play a 
role in verifies its importance in regulating the immune response. 
 
 
1.4 Transcriptional regulation of genes 
DNA is negatively charged and therefore the ensuing electrostatic repulsion prevents 
strands of DNA interacting closely enough to fit into the nucleus. To solve this problem 
DNA is coiled around highly basic histone proteins, to form chromatin. The 
fundamental component of eukaryotic chromatin are the nucleosomes, these are 
comprised of eight histone proteins with approximately 147 bases of DNA wrapped 
around them. These nucleosomes are then further compacted into fibres (Jiang and Pugh, 
2009). The position of the nucleosome within the DNA and chemical modifications of 
the histones is key to gene regulation. The wrapping of DNA around the nucleosomes 
controls the access of transcription factors and enzymes to the genetic code, leading to a 
regulated process of gene expression. Additionally polypeptide chains from the histones, 
known as ‘tails’, extrude from the nucleosome core and can undergo a wide range of 
covalent modifications, such as acetylation or methylation. These post-translational 
histone modifications can act as markers indicating the regulatory state of the chromatin 
(Winter and Amit, 2014) and can be associated with different functional elements 
(Lenhard et al., 2012). Chromatin state varies across different cell types and can be 
altered by environmental conditions. The digestion of nuclear DNA with DNaseI allows 
for mapping of the chromatin landscape; it creates a distinctive map of cleavage 
alluding to the nucleosome depleted regions, which are indicative of accessible 
chromatin where transcription factors can interact with the DNA (Winter and Amit, 
2014). Chromatin immunoprecipitation (ChIP) can be used to profile histone 
modifications; using specific antibodies, regions enriched with the histone modification 
of interest can be sequenced (Barski et al., 2007).  
 
The spacing of nucleosomes, the presence of histone modifications and the alterations 
of DNA methylation are known as ‘epigenetic marks’ (Rothenberg, 2013). These make 
up the chromatin landscape and dictate the transcription of genes by regulating the 
binding of transcription factors. The first layer to the chromatin landscape is the 
accessibility of the chromatin. For transcription factors to bind, chromatin needs to be in 
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an ‘open’ state; the chromatin is unwrapped and not closely associated with 
nucleosomes, and the regulatory sites, which are revealed as DNase hypersensitive sites 
(HSS), are exposed (Winter and Amit, 2014). The second layer to the chromatin 
landscape is the histone modifications; the type and location of these modifications are 
indicative of different regulatory states. The presence of multiple modifications, and the 
ratio between them, can be used to predict a wide variety of different functional 
elements. For example, acetylation, as a general rule, is associated with activation. 
H3K4me is usually associated with the transcriptional start sites (TSS) of transcribed 
genes (Zhou et al., 2011) and active genes (Santos-Rosa et al., 2002). On the other hand 
H3K27me3 is usually associated with inactive chromatin regions and repressed genes 
(Zhou et al., 2011). Further complexity is added by the presence of multiple histone 
marks at one site (Wang et al., 2008), such as the bivalent modification of both 
H3K4me3 and H3K4me27 suggesting that the gene is in a poised state, waiting for 
either activation or repression as the cell differentiates (Bernstein et al., 2006). The final 
component of the landscape is DNA methylation at the cytosine residues of CpG 
(cytosine-phosphate-guanine) dinucleotides, which is associated with gene repression. 
Evidence suggests an intimate link between histone modifications and DNA 
methylation; with histone modifications establishing the basic DNA methylation profile 
in cells and DNA methylation feeding back to maintain histone modifications 
throughout cell division (Cedar and Bergman, 2009). 
 
Each gene is encoded by an area of DNA, known as the gene locus, which is transcribed 
by RNA polymerase II resulting in the production of mRNA. Genes consist of introns, 
which are removed from the RNA by splicing, and exons, which remain present in 
mature RNA. Transcription is initiated at the TSS, which is immediately downstream of 
the promoter, and contains a large portion of regulatory information for transcriptional 
initiation of that gene (Lenhard et al., 2012). Most promoters are associated with high 
GC base content and are known as CpG islands, and unlike most CpG dinucleotides, 
CpG islands are not methylated (Cedar and Bergman, 2009). The 3’ un-translated 
region (UTR), which is found immediately after the translated region of the gene, also 
often contains regulatory information (Lenhard et al., 2012). DNaseI HSS are areas via 
which gene expression can be regulated, and are often associated with particular genes. 
Furthermore, distal regulatory elements, such as enhancers, can be connected with 
genes; these are areas that regulate the transcription of a gene regardless of their 
location relative to the promoter (Bulger and Groudine, 2011). 




Cells are directed to become different cell types by the complex regulation of gene 
transcription, resulting in each cell type having a unique transcriptional programme. 
This programme is dependent on the binding of transcription factor proteins to specific 
‘consensus’ DNA regions that regulate the mRNA transcription of a gene by RNA 
polymerase II. Gain or loss of function studies highlight that transcription factors are 
crucial in the determination of cellular phenotype, and that mutations in transcription 
factors can lead to disease (Villar et al., 2014). These transcription factors fine-tune the 
transcriptional programme of a cell in a spatial and temporal manner (Magnani et al., 
2011). However, at a given time each transcription factor only occupies a small portion 
of its consensus regions (Zaret and Carroll, 2011). Therefore, there must also be factors 
in place that dictate the binding of transcription factors to their target sequences. These 
factors include the presence and distribution of epigenetic modifications, and the 
accessibility of promoters and gene transcription enhancers (Bulger and Groudine, 
2011; Magnani et al., 2011). However, not only do epigenetic modifications and 
enhancers regulate transcription factor binding, but transcription factors can regulate the 
fate of a cell by remodeling the chromatin and establishing a new set of enhancers. 
Some transcription factors can alter nucleosome position and recruit histone modifying 
enzymes, without leading to any transcriptional effects on gene expression; these factors 
are known as pioneer transcription factors (Rothenberg, 2013; Samstein et al., 2012). 
These factors refine the chromatin landscape and direct the binding of future 
transcription factors and therefore dictate the transcriptional programme of the cell 
(Zaret and Carroll, 2011). 
 
Although the chromatin landscape can regulate the binding of transcription factors, once 
bound the transcription factors can also feed back to change the properties of the 
surrounding chromatin. As mentioned, pioneer factors can recruit histone modifying 
enzymes that can prevent or promote the binding of further transcription factors. 
Additionally, the binding of a transcription factor can be key in the recruitment of other 
transcription factors to that site; transcription factors often bind regions of DNA in 
combination with other transcription factors (Villar et al., 2014). Conversely, 
transcription factors can act competitively by binding specific regions of DNA and 
blocking the binding of other factors that would have initiated transcription, resulting in 
the repression of gene expression (Yang et al., 2011). Therefore, transcription factors 
not only enhance gene transcription, but can also repress it. 
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1.5 The molecular mechanisms of IL-10 regulation 
It is crucial for the immune response to maintain the balance between the inflammatory 
responses required to eradicate a pathogen and preventing excessive inflammation, 
which could harm the host. Many publications have highlighted the importance of the 
regulatory cytokine IL-10 in this balance and have published findings into the 
mechanisms by which its production is regulated in immune cells (Saraiva and O'Garra, 
2010). However, the molecular mechanisms, transcription factors and epigenetic 
modifications involved in IL-10 regulation are still incompletely understood, and 
though many transcription factors have been reported to enhance IL-10 production in 
Th cells, the molecular mechanisms regulating Il10 transcription in different immune 
cells, and the existence of common mechanisms between all IL-10 producing cells, 
remains unclear (O'Garra and Vieira, 2007; Saraiva and O'Garra, 2010). 
 
1.5.1 The structure of the Il10 gene locus 
The gene encoding the IL-10 protein is found on chromosome 1 in both humans and 
mice, and it is found within the Il10 gene family cluster (Kim et al., 1992). Upstream of 
Il10 this cluster contains the genes for Il19, Il20 and Il24, which are all members of the 
IL-10 gene family of cytokines. The Il10 gene has a well-defined TSS and consists of 5 
exons and 4 introns followed by a 3’ UTR. Within the core promoter are TATA and 
CCAT (A or G in mice) elements, which are characteristic of a focused promoter that 
has been associated with transcription in an environmentally responsive, tissue specific 
manner (Lenhard et al., 2012). The Il10 gene is highly conserved between humans and 
mice with many homologous conserved non-coding sequences (CNS), suggesting that 
these regions have high levels of functional relevance and are therefore evolutionarily 
constrained. Many recent studies have highlighted some of these CNS as enhancers of 
Il10 gene expression (Ahyi et al., 2009; Jones and Flavell, 2005; Li et al., 2012a; Wang 
et al., 2005). 
 
Important for the regulation of Il10 gene expression is the capacity to change the 
structure of the gene locus. In macrophages, IL-10 can be expressed almost immediately 
upon stimulation with certain stimuli; this is reflected in the structure of the Il10 locus. 
The HSS in the Il10 gene of macrophages are somewhat sensitive to DNaseI digestion 
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even in the resting state. When stimulated with the PRR ligands LPS, CpG or zymosan 
A, five HSS were found in bone marrow (BM)-derived macrophages and one in BM-
derived DCs (Saraiva et al., 2005). Unlike macrophages, in T helper cells the Il10 locus 
requires large amounts of remodelling during differentiation before it becomes active. 
In naïve T cells only one HSS is found while differentiated Th1 and Th2 cells have 
many more HSS (Im et al., 2004; Jones and Flavell, 2005; Saraiva et al., 2005; Wang et 
al., 2005). Many, but not all, of these HSS are common between Th cells and 
macrophages. 
 
The accessibility of the Il10 locus has also been studied in the context of histone 
modifications. In macrophages that express IL-10, hyperacetlyation of histone H4, 
which is considered to be an active mark, can be detected at two HSS (Saraiva et al., 
2005). In Th1 and Th2 cells the Il10 locus has been shown to be bivalently marked with 
H3K4me3 and H3K27me3, which are active and repressive markers, respectively (Wei 
et al., 2010). The factors involved in altering the structure of the Il10 gene locus and 
regulating these epigenetic modifications will be discussed in detail in this chapter. 
 
1.5.2 Regulation of IL-10 production in T helper cells 
T helper cells are vital in controlling and maintaining an appropriate immune response, 
balancing between inflammatory responses required to eradicate a pathogen and the 
regulation of excessive inflammatory responses which would harm the host. 
Interestingly, despite the different signalling pathways that result in the polarisation of 
each Th subset and to the expression of their hallmark cytokines, IL-10 is expressed by 
all the different Th subsets. However, in each subset different factors may be associated 
with the expression of IL-10, and therefore it is likely that there are both common and 
dissimilar processes involved in the regulation of IL-10 expression in Th cells. In fact 
IL-10 expression in each subset is thought to be tightly linked to the differentiation of 
that unique subset, for instance in Th1 cells STAT4 is needed of IL-10 expression, 
while in Th2 cells STAT6 is needed and in Th17 cells STAT3 is required (Saraiva and 
O'Garra, 2010). As IL-10 regulation seems to be highly intertwined with the 
differentiation of each Th subset, the model of hallmark cytokine gene regulation; 
where TCR ligation and STAT activation leads to pioneer factors altering the epigenetic 
landscape, allowing for the expression of lineage specific factors, is likely to apply to 
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IL-10 gene regulation as well (Gabrysova et al., 2014). The specific signalling cascades 
and transcription factor complexes that regulate IL-10 gene expression in each Th 
subset are still being established.  
 
1.5.2.1 External factors that regulate IL-10 production in T helper cells 
IL-10 expression is initiated in Th cells via multiple external factors, which result in 
signalling cascades of proteins and transcription factors. The two main ways by which 
IL-10 expression is instigated is via ligation of the TCR and cytokine receptors, which 
consequently leads to complex signalling pathways that drive IL-10 transcription; these 
will be discussed in greater detail later in this chapter. With regard to the TCR, the type 
of antigen and the strength of the stimuli can both regulate IL-10 production by Th cells. 
For instance in Th1 cells, it has been shown that when naïve T cells are cultured in the 
presence of IL-12 and low levels of antigen the cells produce IFNγ but not IL-10. 
However when the cells are cultured with IL-12 and increasing doses of antigen, the 
number of IL-10 expressing cells increases with the antigen dose while IFNγ expression 
is not affected. Therefore Th1 cells require IL-12 in conjunction with high levels of 
TCR stimulation to express IL-10 (Saraiva et al., 2009). It is possible that high antigen 
dose causes the Th1 cells to feedback to the APC to induce factors, such as Type I IFN 
and IL-27, which then go on to enhance Th1 cell production of IL-10 together with 
IFNγ. Indeed, other extracellular factors produced by APCs, alongside antigen and 
cytokines, have also been associated with IL-10 expression. 
 
Direct cell-cell interactions have been associated with the induction of IL-10 in Th cells. 
In humans it has been shown that immature myeloid DCs (mDCs) (Jonuleit et al., 2000) 
and mature plasmacytoid DCs (pDCs) (Moseman et al., 2004) can drive the 
differentiation of IL-10 producing regulatory CD4+ T cells. pDCs express high levels of 
inducible costimulator ligand (ICOS-L) on their cell surface, and it has now been 
identified that a direct interaction of pDCs with naïve T cells via ICOS-L ligation of 
ICOS on the T cells drives the differentiation of IL-10 producing Treg cells (Ito et al., 
2007). Furthermore, it has been suggested that IFNγ may promote the expression of 
ICOS-L on accessory cells, which in turn acts on the Th1 cells to drive IL-10 expression 
(Shaw et al., 2006). The interaction of Notch ligands, expressed on APCs, with Notch 
on CD4+ T cells has also been shown to impact Th cell differentiation. With regard to 
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IL-10 production, Delta-like Notch ligands (DLL) 1 and 4 have been shown to induce 
IL-10 in Th1 cells without much effect on IFNγ production (Kassner et al., 2010; Rutz 
et al., 2008). Recently, liver sinusoidal endothelial cells (LSECs), which express all 4 
Notch ligands; DLL1 and 4, and Jagged 1 and 2, have also been shown to induce IL-10 
expression in Th1 cells (Neumann et al., 2015). Additionally, the Notch ligand Jagged1, 
which has been associated with IL-4 production and Th2 differentiation, has been 
linked to driving IL-10 expression in IFNγ secreting human T cells (Kemper et al., 
2003). 
 
Immunosuppressive drugs, including Dexamethasone and 1,25(OH)2-vitamin D3 
(VitD3), have also been implicated in regulating inflammatory cytokine genes and 
enabling the development of IL-10 expressing Th cells (O'Garra and Barrat, 2003; 
Xystrakis et al., 2006a). Glucocorticoids (GCs), including Dexamethasone, have been 
associated with gene regulation for many years. GCs bind a specific receptor (GR), 
which upon ligation can translocate into the nucleus and bind GC response elements 
(GREs) to regulate gene expression both positively and negatively. In addition, GR can 
also regulate gene transcription without binding DNA by directly interacting with other 
transcription factors and preventing their transcriptional activities (Karin, 1998). GCs 
have been shown to interfere with AP-1 and inhibit NF-κB (De Bosscher et al., 1997), 
both of which are important in Th cell cytokine gene expression. VitD3 has also been 
shown to inhibit the formation of AP-1/NFAT complexes, which results in the 
repression of Il2 gene transcription (Alroy et al., 1995), and Dexamethasone signalling 
results in GR synergising with NFAT to prevent it binding to the Il4 promoter (Chen et 
al., 2000b). In combination with APCs, Dexamethasone can induce CD8+ and CD4+ T 
cells to produce high levels of IL-10 and reduced amounts of IL-4 and IL-5 (Richards et 
al., 2000). VitD3 has been shown to promote IL-10 production and increase Treg 
differentiation, while suppressing effector cell proliferation and inflammatory cytokine 
production (Chambers ES, 2011; Chambers et al., 2014; Jeffery et al., 2009). Together, 
Dexamethasone and VitD3 can be used to drive a homogenous population of IL-10 
producing Th cells that have a regulatory function in vivo (Barrat et al., 2002; Xystrakis 
et al., 2006b).  
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1.5.2.1.1 T Cell Receptor signalling and regulation of IL-10  
Upon TCR ligation a series of signalling cascades are initiated that lead to the activation, 
translocation or induction of transcription factors. AP-1, NFAT and NF-κB are the main 
factors that TCR activation induces. AP-1 is downstream of the MAP kinase ERK, 
which is activated via RAS downstream of the TCR. ERK is thought to be a common 
factor in different Th subsets that positively regulates IL-10 (Saraiva et al., 2009). AP-1 
is a heterodimeric transcription factor composed of dimers of the FOS, JUN, JUN 
dimerising protein (JDP) and activating transcription factor (ATF) family members 
(Karin et al., 1997). AP-1, in the form of JUNB and c-JUN, binds at a HSS site within 
the Il10 locus in Th2 cells to enhance IL-10 expression. Retroviral expression of this 
AP-1 complex into naïve CD4+ T cells leads to increased IL-10 expression, and the 
expression of a dominant negative form of c-JUN decreases IL-10 production (Wang et 
al., 2005). When Th2 and Th17 cells are stimulated in the presence of IL-21, BATF 
(another AP-1 family member) can cooperatively bind with IRF4 at CNS-9 in the Il10 
locus (Li et al., 2012a). Furthermore, in the absence of BATF3, BATF can positively 
regulate IL-10 expression in Th2 cells (Tussiwand et al., 2012). However, BATF3 
BATF double knockout Th2 cells also have a defect in IL-4 production, suggesting that 
BATF3 and BATF may be involved in regulating Th2 differentiation rather that 
specifically IL-10 expression (Tussiwand et al., 2012). IRF4 has also been shown to 
positively regulate IL-10 by binding the Il10 promoter and a CNS within the locus 
(Ahyi et al., 2009). However, similarly to BATF, IRF4 also regulates IL-4 production 
and therefore may be involved in Th2 differentiation as a whole and therefore by 
association IL-10 expression.  
 
TCR activation leads to NFAT1 translocation to the nucleus from the cytoplasm, where 
it interacts with AP-1 and other partners to promote gene transcription. In Th2 cells 
NFAT1 has been shown to bind the Il10 promoter, while in Th1 cells it has been shown 
to bind in intron 4 of the Il10 locus (Im et al., 2004). NFAT1 has also been shown to 
synergise with IRF4 in Th2 cells and bind at CNS-9 to enhance IL-10 expression (Lee 
et al., 2009a). NFAT blockade reduces IL-10 mRNA in Th1 and Th2 cells, though this 
also affects the expression of hallmark cytokines, suggesting it may not be an IL-10 
specific regulator (Lee et al., 2009a). Though NF-κB is known to be activated 
downstream of the TCR, and has been shown to be involved in the production of 
hallmark cytokines from Th1, Th2 and Th17 cells, little is known about its role in IL-10 
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gene regulation, although it has been reported to bind at the Il10 gene locus in human T 
lymphoma cells (Mori and Prager, 1997).  
 
1.5.2.1.2 The effect of cytokines on Th1 cell IL-10 expression 
In order to express IL-10 alongside IFNγ, Th1 cells require high levels of antigen 
stimulation in the presence of IL-12 (Saraiva et al., 2009). IL-12 has also been shown to 
be important in IL-10 expression in memory Th1 responses, though it has no capacity to 
induce epigenetic modifications at the Il10 locus (Chang et al., 2007). Alongside IL-12, 
much recent evidence has arisen for the role of IL-27 in driving IL-10 expression by 
Th1 cells. The role of IL-27 in T helper cell differentiation was first noted in 2000, 
when it was found that IL-27 receptor deficient mice had deficient Th1 IFNγ production 
when challenged in vivo (Chen et al., 2000a), IL-10 production was not measured in this 
paper. IL-27 augments IL-12 driven IFNγ expression by CD4+ T cells and stimulates 
the induction of T-bet in a STAT1 dependent manner (Takeda et al., 2003). IL-27 can 
also signal through STAT3 to drive an IFNγ+ IL-10+ population of Th1 cells 
(Stumhofer et al., 2007). In vivo it has now been shown that IL-27 reduces the severity 
of EAE by inducing IL-10 expression in CD4+ T-bet+ cells, which in turn 
downregulates IL-17 expression (Fitzgerald et al., 2007). These IL-27 induced, IL-10 
expressing Th1 cells are distinct from Treg cells and do not express FoxP3 (Batten et al., 
2008). This year the pathway by which IL-27 drives IL-10 in Th1 cells has been further 
elucidated. It is now understood that IL-27 triggers two distinct non-redundant 
pathways in Th1 cells; a STAT1/T-bet pathway and a STAT3/NFIL3 pathway. T-bet 
and NFIL3 were found to cooperate to drive IL-10 expression alongside Tim-3 
expression, a factor associated with T cell exhaustion. These Th1 cells were found to be 
dysfunctional in the context of gut inflammation and cancer (Zhu et al., 2015). There is 
some additional evidence that IL-21 can drive IL-10 expression in Th1 cells via a 
STAT3 dependent manner (Spolski et al., 2009). IL-27 can drive IL-21 expression in Th 
cells, and therefore it has been suggested that part of the induction of IL-10 by IL-27 
may be via IL-21 upregulation.  
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1.5.2.1.3 The effect of cytokines on Th17 cell IL-10 expression 
Th17 cells driven with TGFβ and IL-6, rather than TGFβ, IL-1β, IL-6 and IL-23 have 
higher levels of IL-10 expression as seen by microarray (Ghoreschi et al., 2010). This is 
reflected in the phenotypic behaviour of these cells; when driven with TGFβ and IL-6 
alone Th17 cells express IL-17 and IL-10 and drive less CNS inflammation. However, 
IL-10 production by Th17 cells is variable and the cells are heterogeneous. When 
stimulated with IL-23 the cells express IL-17 and proinflammatory cytokines but not 
IL-10, leading to a pathogenic function (McGeachy et al., 2007).  
 
Th17 cells cultured with IL-6 and TGFβ in vitro can produce large amounts of IL-10, 
although this is variable. These cultures are heterogeneous and contain three cytokine 
producing cell types: IL-17+ IL-10-, IL-17- IL-10+ and IL-17+ IL-10+ (Stumhofer et 
al., 2007). When these cells are cultured with the additional presence of IL-27 the total 
number of IL-10+ cells is not affected, however the number of IL-17+ cells decreases 
and the number of IL-10+ IL-17- cells increases (Stumhofer et al., 2007).  IL-27 is not 
reducing IL-17+ cells by initiating IL-10 expression, as even in IL-10 deficient mice IL-
27 leads to a decrease in IL-17+ cells. In fact IL-27 and IL-6 can act synergistically 
with TGFβ to drive IL-10 expression in Th17 cells, and this does not affect FoxP3 
expression but does increase IFNγ expression (Stumhofer et al., 2007). IL-27 driven IL-
10 depends on STAT1 and STAT3, IL-6 driven IL-10 depends on only STAT3 
(Fitzgerald et al., 2007; Stumhofer et al., 2007). It has been suggested that this synergy 
between TGFβ and IL-27 may initiate the expression of IL-10 via c-Maf, in a STAT1 
independent manner (Xu et al., 2009). These findings are reflected in vivo where IL-27 
deficient mice succumb to excessive inflammation in the autoimmune model of EAE. 
Furthermore, when adoptively transferring myelin oligodendrocyte glycoprotein (MOG) 
activated T cells into mice, the transfer of cells cultured in the presence of IL-27 results 
in reduced disease severity (Fitzgerald et al., 2007). Finally, TGFβ signalling, in the 
presence of AhR activation has been shown to promote the conversion of IL-17 
expressing Th17 cells into IL-10 expressing FoxP3 negative regulatory cells (Gagliani 
et al., 2015). In summary, the role of IL-27 in the induction of IL-10 by Th cells is 
complex and remains unclear. 
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1.5.2.1.4 Cytokine signalling in the regulation of IL-10 in T helper cells 
There has been a lot of research into the role of cytokine signalling in IL-10 regulation; 
with STAT and SMAD proteins downstream of multiple cytokine receptors having been 
shown to affect IL-10 expression. However, as with TCR signalling, this is closely 
intertwined with the regulation of Th cell differentiation in general. IL-27 signalling 
through STAT1 and STAT3 (Batten et al., 2008; Fitzgerald et al., 2007; Stumhofer et 
al., 2007), IL-21 or IL-6 signalling through STAT3 (Spolski et al., 2009; Stumhofer et 
al., 2007), IL-12 signalling through STAT4, and IL-4 signalling through STAT6 
(Saraiva et al., 2009) have all been implicated in IL-10 regulation in Th cells. STAT4 
has been shown to directly bind within the intron 4 of the Il10 locus in Th1 cells, while 
STAT6 binds within the promoter region in Th2 cells. STAT4 is thought to promote 
accessible histone modifications such as H3K4me3 at the Il10 locus, while STAT6 is 
thought to antagonise repressive histone modifications such as H3K27me3. Both of 
these mechanisms increase the accessibility of the locus to transcription factors (Wei et 
al., 2010). In Th17 cells STAT3 has been shown to bind at intron 4, through its role in 
IL-10 regulation via chromatin remodelling is yet to be determined (Li et al., 2012a). 
The role of IL-10 in regulating IL-10 expression, via STAT3, or other mechanisms 
remains a possibility (Chaudhry et al., 2011). It has been shown that DCs that express 
high levels of IL-10 can drive Th1 cells to produce IL-10 and take on a regulatory 
phenotype (Wakkach et al., 2003). Additionally, in the presence of Dexamethasone and 
VitD3, and in the absence of APCs, T cell secreted IL-10 can act as an autocrine factor 
to drive further IL-10 expression by these T cells (Barrat et al., 2002; O'Garra and 
Barrat, 2003). 
 
TGFβ signalling via SMADs can also regulate IL-10 gene expression, though it inhibits 
Th1 and Th2 differentiation, but not Th17 differentiation (Saraiva et al., 2009). In Th1 
cells SMAD4 can bind and transactivate the Il10 promoter (Kitani et al., 2003). In Th2 
cells, GATA3 and SMAD3 can cooperate in response to TGFβ to positively regulate 
IL-10 expression (Blokzijl et al., 2002). Additionally, as mentioned previously, TGFβ 
and IL-6 alone can drive Th17 cells to express IL-17 and IL-10 but not proinflammatory 
cytokines, although this is variable and the cells are heterogeneous (McGeachy et al., 
2007). 
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1.5.2.2 The regulation of IL-10 in T helper cells by Transcription Factors 
T helper cell differentiation and IL-10 production are complexly linked; given the 
important role master transcription factors play in Th cell differentiation, it is possible 
that these factors may also be involved in regulating IL-10 expression. GATA3 has 
been shown to bind and remodel the Il10 gene locus, but alone it cannot transactivate 
the promoter (Chang et al., 2007; Shoemaker et al., 2006). In differentiated Th2 cells 
GATA3 is not required for IL-10 production (Zhu et al., 2004), therefore suggesting a 
role for additional factors in promoting IL-10 expression. The study of STAT deficient 
Th cells has highlighted a handful of enhancers that are directly regulated by GATA3 or 
T-bet (Vahedi et al., 2012), or RORγt (Ciofani et al., 2012) in the absence of STATs. 
Since GATA3 has been shown to directly bind the Il10 locus, it is possible that T-bet 
and RORγt may have similar roles in binding and/or altering the accessibility of the Il10 
locus alongside the hallmark cytokine gene loci in Th1 and Th17 cells, respectively. 
ChIP assays have shown that FoxP3 does not bind directly to the Il10 locus in Treg cells, 
but that it does directly target the MAP kinase signalling pathway, which, via AP-1, 
drives IL-10 expression (Marson et al., 2007; Morikawa and Sakaguchi, 2014). 
 
Data suggests that c-Maf has a role in regulating IL-10 expression in all Th subsets, 
though the mechanisms by which it does this and the factors that it cooperates with 
remain elusive and may vary between different cell types. c-Maf is present in all Th cell 
subsets, albeit at different levels, and its expression has been shown to correlate with 
IL-10 gene expression. For example, in Th1 cells abrogation of ERK activation leads to 
a decrease in both c-Maf and IL-10 expression (Saraiva et al., 2009). Furthermore, in 
Th1 cells that co-secrete IFNγ and IL-10, knockout of c-Maf or AhR correlates with a 
decrease in IL-10 expression, and both c-Maf and AhR have been shown to bind the 
Il10 locus and cooperatively transactivate the promoter (Apetoh et al., 2010). In Th2 
cells c-Maf is not thought to be able to transactivate the Il10 promoter (Kim et al., 1999). 
However, c-Maf may act in combination with other factors such as AP-1 or NFAT, as it 
does when driving IL-4 expression (Rengarajan et al., 2002), to regulate IL-10 
expression. As mentioned earlier in this chapter both NFAT and AP-1 have been shown 
to bind the Il10 gene. In Th17 cells c-Maf, downstream of TGFβ signalling, can induce 
genes involved in repressing inflammation, such as Il10 (Ciofani et al., 2012). In fact, in 
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Th17 cells c-Maf has been shown to bind the Il10 promoter and transactivate it, to 
regulate IL-10 expression in vitro (Xu et al., 2009).  
 
The E4 promoter-binding protein 4 (E4BP4) is a transcriptional repressor that is 
encoded by the gene Nfil3. E4BP4 has been shown to have a positive regulatory role on 
IL-10 expression in Th1 and Th2 cells without affecting IFNγ or IL-4 production. The 
signalling pathway leading to the induction of Nfil3 in T cells is unknown, however this 
effect on IL-10 production does not require GATA3, as it is seen in Gata3 knockout 
cells (Motomura et al., 2011). In Th2 cells E4BP4 binds the Il10 gene locus at intron 4 
and at the 3’ UTR, and may regulate activation state of the Il10 gene; as in Nfil3 
deficient Th2 cells there is a decrease in histone acetylation of the Il10 gene locus 
(Motomura et al., 2011). In Th17 cells, however, overexpression of E4BP4 prevents 
Th17 differentiation, and therefore there must be different mechanisms regulating IL-10 
production in Th17 cells (Ciofani et al., 2012). 
 
TCR signalling can lead to the induction of the Prdm1 gene, which encodes the PR 
domain zinc finger protein 1 (known as B lymphocyte induced maturation protein 1; 
Blimp-1). Blimp-1 is a transcriptional repressor, though it has been shown to positively 
regulate IL-10 expression in Th cells; conditional deletion of Prdm1 in T cells leads to 
pathology and inflammation in vivo and decreased IL-10 production by CD4+ T cells 
(Martins et al., 2006). IL-12 can induce Blimp-1 regulation of IL-10 in Th1 cells in 
vitro and in vivo, via STAT4 signalling (Neumann et al., 2014). In this study IL-10 
expression in IL-12 driven Th1 cells was dependent on Blimp-1 and additionally 
enhanced by c-Maf. However, in the presence of TGFβ, IL-10 regulation was shifted to 
a Blimp-1 independent mechanism that was responsive to IL-27 (Neumann et al., 2014). 
Nonetheless, IL-27 can also lead to Blimp-1 mediated expression of IL-10 in CD4+ T 
cells via STAT3 and early growth response 2 (EGR-2). In Egr-2 deficient cells, IL-27 
induction of Blimp-1 and IL-10 expression is impaired alongside dysregulation of IFNγ 
and IL-17 production (Iwasaki et al., 2013); suggesting EGR-2 may play a role in 
balancing pro- and anti-inflammatory cytokines. IL-27 has also been seen to drive IL-10 
expression via Blimp-1 in CD8+ T cells (Sun et al., 2011). In Treg cells, Blimp-1 
synergises with IRF4 to regulate histone acetylation at the Il10 gene promoter (Cretney 
et al., 2011). Blimp-1 represses BCL-6, which in turn represses GATA3 (Sawant et al., 
2012), so the regulation of IL-10 production by Blimp-1 may be indirect via the 
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upregulation of GATA3 due to Blimp-1 repressing of BCL-6 (Kusam et al., 2003). 
However, the processes and mechanisms regulating Il10 gene regulation remain unclear.  
 
1.5.2.3 Negative regulation of IL-10 in T helper cells 
As mentioned above, BCL-6 has been shown to repress GATA3 (Sawant et al., 2012) 
and therefore may suppress IL-10 via this mechanism. However, BCL-6 has also been 
shown to suppress IL-10 expression in a GATA3 independent manner; in CD4+ T cells 
conditionally deficient in BCL-6 there is a dramatic increase in IL-10 expression, but a 
reduction in Tfh and Th2 cell differentiation, and no effect on Th1 and Th17 
differentiation (Hollister et al., 2013). This suppression of IL-10 by BCL-6 is thought to 
be one mechanism by which it promotes Tfh differentiation. However, as BCL-6 and 
Blimp-1 reciprocally regulate one another (Johnston et al., 2009), it is possible that 
BCL-6 suppresses IL-10 expression by suppressing the action of Blimp-1. A final 
mechanism by which BCL-6 may regulate IL-10 is via the repression of microRNA-21, 
which has been shown to promote IL-10 expression and is discussed later in this chapter 
(Sawant et al., 2013). However, the deletion of BCL-6 also leads to increased 
proinflammatory cytokines, therefore the role of BCL-6 and Blimp-1 in regulating IL-
10 and proinflammatory cytokine gene expression in T cells is as yet unclear.  
 
The knockout of the E26 transformation-specific 1 (ETS-1) gene Ets1 leads to enhanced 
levels of IL-10 expression in Th cells when cultured in Th1 or Th2 polarising conditions. 
In Th1 cells, this downregulation of IL-10 by ETS-1 is thought to be via its capacity to 
maintain the Il10 locus in a closed confirmation; ETS -1 has been shown to interact 
with and recruit the histone deacetylase 1 (HDAC1) at the Il10 gene locus (Lee et al., 
2012). However, the role of ETS -1 in Th cell subset differentiation as a whole and its 
effect on hallmark cytokine expression has not been investigated in detail. It may, 
however, be essential in Th1 hallmark cytokine expression, as ETS -1 has been shown 
to synergise with T-bet to positively regulate IFNγ; ETS -1 deletion results in Th1 cells 
producing less IFNγ and increased amounts of IL-10 (Grenningloh et al., 2005). 
Another ETS family member, PU.1, has been shown to interfere with GATA3 (Chang 
et al., 2005) and IRF4 (Ahyi et al., 2009) DNA binding and therefore inhibit production 
of Th2 hallmark cytokines including IL-10. A direct effect of PU.1 at the Il10 locus 
however has not been reported. 
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1.5.3 The regulation of IL-10 in Macrophages and Dendritic Cells 
The combination of several molecular signals determines the production of IL-10 by 
mDCs and macrophages. Generally stimulation via PRRs is required to express IL-10 
(Saraiva and O'Garra, 2010), and co-stimulation of DCs can also enhance their IL-10 
production. Additionally, paracrine and autocrine cytokines can drive other signals that 
modulate IL-10 production by macrophages and mDCs (Gabrysova et al., 2014). The 
best studied PRRs are the TLRs, of which 2, 4, 5, 7 and 9 have all been shown to induce 
IL-10 expression in human and mouse macrophages and mDCs (Boonstra et al., 2006; 
Gabrysova et al., 2014; Kaiser et al., 2009). TLR ligation leads to signalling cascades 
that are activated through adaptor molecules including myeloid differentiation primary-
response protein 88 (MyD88) and Toll/IL-1 receptor (TIR)-domain-containing adaptor 
protein inducing IFNβ (TRIF). These TLR signalling pathways regulate the expression 
of TLR-induced cytokines, including IL-10 (Saraiva and O'Garra, 2010).  
 
Signalling through MyD88 activates MAP kinases, such as ERK, and NF-κB; the 
activation of ERK is thought to be critical to IL-10 production in macrophages and 
mDCs (Kaiser et al., 2009; McNab et al., 2013). In the absence of ERK, either via 
chemical inhibitors (Kaiser et al., 2009; Yi et al., 2002) or knockout (Agrawal et al., 
2006), TLR activated DCs produce less IL-10. Additionally, the differential levels of 
ERK activation in innate cells correlates with IL-10 expression; macrophages have the 
highest levels of ERK activation and have the highest production of IL-10, while pDCs 
produce no IL-10 and have low levels of ERK activation, mDCs have intermediate 
levels of ERK activation and produce intermediate amounts of IL-10 (Kaiser et al., 
2009). The complexity of IL-10 gene regulation is however paramount; Type I IFN 
(IFNβ) upregulates IL-10 production in macrophages, whereas TPL2/ERK activation 
negatively regulated IFNβ whilst upregulating IL-10 (McNab et al., 2015).  
 
When in complex with NF-κB, the tumour progression locus 2 (TPL2) is protected from 
degradation. Upon TLR activation, TPL2 dissociates from NF-κB and activates ERK. 
In the absence of NF-κB TPL2 is rapidly degraded and ERK activation is reduced 
(Beinke and Ley, 2004). TPL2 or NF-κB (Banerjee et al., 2006; Kaiser et al., 2009) 
deficient macrophages have lower amounts of TLR induced IL-10 production, owing to 
compromised ERK signalling. However, in NF-κB deficient cells, ERK rescue only 
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partially restored IL-10 signalling, suggesting ERK-dependent and independent roles 
for NF-κB in IL-10 regulation (Banerjee et al., 2006). This is supported by evidence 
that NF-κB can bind directly to the Il10 gene locus; there is a binding site at a HSS 
upstream of the TSS where the NF-κB p65 subunit can bind (Saraiva et al., 2005), and 
NF-κB p50 homodimers have been shown to bind at a site proximal to the TSS (Cao et 
al., 2006).  
 
Like ERK, the MAP kinase p38 has also been shown to have a role in regulating IL-10 
expression in TLR activated macrophages and mDCs. Removal of the dual-specificity 
protein phosphatase 1 (DUSP1), which negatively regulates p38, leads to prolonged p38 
signalling and increased IL-10 production (Hammer et al., 2006). Conversely, chemical 
inhibition of p38 leads to reduced IL-10 production (Chi et al., 2006). ERK and p38 are 
also thought to cooperate in their regulation of IL-10, as abrogation of either reduces 
but does not abolish IL-10 production, whereas abrogation of both completely stops IL-
10 expression in TLR stimulated macrophages (Saraiva and O'Garra, 2010). 
Additionally, the mitogen- and stress-activated protein kinases MSK1 and MSK2, 
which are activated by a contribution of both ERK and p38, can promote IL-10 
expression in TLR stimulated macrophages (Ananieva et al., 2008). The kinase p38 has 
also been shown to activate mammalian target of rapamycin (mTOR), which is 
downstream of the PI(3)K-AKT pathway and can promote IL-10 production (Katholnig 
et al., 2013).  
 
1.5.4 Post-transcriptional regulation of IL-10 
There is increasing evidence that in immune cells, IL-10 production is highly controlled 
at the post-transcriptional level. This regulation is important in ensuring rapid 
upregulation of cytokine production in response to pathogen invasion, and also in 
turning off cytokine production to prevent excessive and potentially pathological 
responses. Many cell types express Il10 mRNA, however not all of them have 
detectable amounts of IL-10 protein suggesting that post-transcriptional regulation of 
IL-10 may be important in many cells (Powell et al., 2000). Most studies looking at Il10 
mRNA stability and post-transcriptional regulation have been done in TLR-stimulated 
macrophages, therefore other potential mechanisms in different cell types, such as in 
CD4+ T cells, are still mostly unknown. 




The Il10 gene has a long 3’ UTR that contains class II adenosine-uridine-rich elements 
(ARE) and many potential mRNA destabilising motifs; the half-life of Il10 mRNA 
lacking the 3’ UTR is significantly longer than that of mRNA with the intact 3’ UTR 
(Powell et al., 2000). These AREs recruit proteins, such as tristetraprolin (TTP), that 
alter mRNA stability and therefore tend to be a marker of short-lived mRNA (Anderson, 
2008). Genome wide analysis has revealed that TTP targets Il10 mRNA (Stoecklin et al., 
2004), and initiates the assembly of RNA decay machinery (Franks and Lykke-
Andersen, 2007). Therefore, in TTP deficient macrophages there is a reduced rate of 
Il10 mRNA decay and increased IL-10 expression (Gaba et al., 2012; Stoecklin et al., 
2004). Furthermore, p38 has been shown to inhibit the action of TTP and therefore 
stabilise Il10 mRNA; p38 inhibition enhances TTP activity and its induction of mRNA 
decay (Tudor et al., 2009). The ARE/poly(U) binding degradation factor 1 (AUF1) 
binds the 3’ UTR of Il10 mRNA and a reduction in AUF1 levels leads to an increase in 
Il10 mRNA half-life (Brewer et al., 2003). In TLR stimulated macrophages AUF1 
translocation to the cytosol from the nucleus is thought to be regulated by DUSP1; 
which explains why in the absence of DUSP1 Il10 mRNA stability and IL-10 secretion 
are increased (Yu et al., 2011), although DUSP1 can negatively regulate p38, and 
therefore may also decrease IL-10 production via this mechanism (Hammer et al., 2006). 
Alongside being a TTP target, IL-10 can also activate TTP, by binding the TTP 
promoter and increasing its expression (Gaba et al., 2012), and by reducing p38-
mediated inhibition of TTP by acting on p38 to decrease its activity (Schaljo et al., 
2009). This suggests there is a feedback mechanism in which IL-10 can limit its own 
production and therefore maintain an appropriate by balanced immune response. 
 
MicroRNAs (miRNA) have also been implicated in post-transcriptional regulation of 
cytokines, including IL-10, that are downstream of TLR signalling. The human 
miRNA-106a has been shown to bind the Il10 mRNA 3’ UTR and induce its 
degradation (Sharma et al., 2009). In TLR activated macrophages miRNA-466L can 
upregulate IL-10 production and extend the half-life of Il10 mRNA by competitively 
binding at the Il10 mRNA ARE to prevent TTP binding and therefore preventing TTP-
mediated degradation of Il10 mRNA (Ma et al., 2010). In LPS stimulated macrophages, 
miRNA-21 has been shown to promote IL-10 production (Sheedy et al., 2010), and 
recently in Tregs it has been shown that STAT3 upregulates miRNA-21 and in turn 
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promotes Il10 expression. However it was suggested that it is possible that this is 
indirectly via the upregulation of Gata3 and Foxp3 (Sawant et al., 2013). 
 
 
1.6 Using RNA-Sequencing to determine the molecular mechanisms 
involved in gene expression 
The link between the genotype and phenotype of a cell is the result of gene expression. 
If a molecule of mRNA is present in a cell then the gene for that mRNA must have been 
transcribed; therefore by looking at what molecules of mRNA are present in a cell one 
can deduce which genes are being expressed, and depending on the number of mRNA 
molecules, to what extent. RNA synthesis and maturation are tightly controlled; as it is 
these RNAs or the proteins encoded by them that drive biological processes. The 
‘complete complement of mRNA molecules generated by a cell or population of cells’ 
was first termed the transcriptome by Charles Auffary in 1996 (McGettigan, 2013; Pietu 
et al., 1999). By understanding the transcriptome one can interpret the functional 
elements of the genome and the molecular constituents of cells and tissues can be 
revealed. 
 
Transcriptomics is the study of the transcriptome, with the aim of; logging all forms of 
transcript (including mRNA, non-coding RNA and small RNA), determining the 
transcriptional structure of genes, and quantifying changes in transcript expression 
levels in different cell types and under different conditions (Wang et al., 2009). 
Transcriptome profiling of mammalian cells was first attempted in the early 1990’s 
using automated Sanger sequencing technologies (Adams et al., 1991). Not long after, 
microarray started being used to deduce the transcriptome (Schena et al., 1995). 
Microarray is a hybridisation-based technology, in which fluorescent complementary 
probes of cDNA are used to detect specific mRNA transcripts. This approach is high-
throughput and relatively cheap, and dominated the field of transcriptomics for over 10 
years. However, as with all technologies, microarray has limitations, including; the 
reliance on existing knowledge about the genome of interest, high background noise 
due to cross-hybridisation, and a limited range of detection due to saturation of the 
probes (Wang et al., 2009). Additionally, to be able to compare across different 
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experiments the employment of complicated normalisation methods are required. Using 
sequencing technologies, which directly determine the cDNA sequence, to elucidate the 
transcriptome were developed at a similar time to microarray (Boguski et al., 1994), but 
these approaches were low throughput, expensive and not really quantitative. Tagged-
based (also known as read-based) sequencing approaches were developed to overcome 
these limitations as they provide accurate gene expression levels and are high 
throughput, but this technique was expensive and only a portion of transcripts were 
analysed (Wang et al., 2009). Now, with the development of new high-throughput DNA 
sequencing methods, RNA sequencing (RNA-Seq) is supplanting microarray as the 
choice of technology for gene expression analysis. RNA Sequencing involves the 
sequencing of complementary DNAs (cDNA) using high throughput DNA sequencing, 
followed by mapping of these sequence reads to the genome. 
 
1.6.1 RNA Sequencing technology 
1.6.1.1 RNA-Seq data generation and analysis 
RNA is extracted from a population of cells or tissue, and sheared into smaller 
molecules that are compatible with sequencing platforms (usually <500 base pairs). 
These are converted into a library of cDNA fragments, to which DNA adaptors are 
attached at one or both ends. These adaptors allow the cDNA fragments to be singled 
out either on beads or on a slide (Marguerat and Bahler, 2010). Each cDNA molecule is 
then sequenced in parallel in a high-throughput manner, resulting in a series of short 
sequences that are assimilated into large amounts of data that can be computationally 
analysed. These resulting short sequence reads, or transcripts, are then aligned to a 
reference genome or transcripts, or are assembled in a de novo manner without a 
reference genome (Nagalakshmi et al., 2008). For studies of organisms where the 
reference genome is complete and of high quality, RNA-Seq reads can be directly 
mapped to the genome, and annotations of that genome can guide analysis and resulting 
conclusions. Other methods are required when working with organisms that have an 
absent or incomplete reference genome. From here on I will mainly focus of RNA-Seq 
data analysis in the context of a model organism, where reads are mapped to a known 
genome. 
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Read alignment to the reference genome is the first crucial step in RNA-Seq data 
analysis, there are many algorithms in circulation that do this (Wang et al., 2009). Prior 
to alignment, the number of mismatches allowed per transcript and the exclusion of 
reads that match to multiple regions, must be considered. Reads may not map uniquely 
for multiple reasons, including; the presence of point mutations, sequencing errors in 
the transcript, or the read may be from a repetitive sequence (Marioni et al., 2008). 
Therefore, all of the reads from an RNA-Seq experiment never map uniquely to the 
reference genome. Once mapped one can computationally generate an expression score 
for each base that is sequenced, and when comparing that to the reference genome one 
can establish a high-resolution transcriptome map (Marguerat and Bahler, 2010). From 
this the overall expression for each gene can be estimated by summing the number of 
reads that map to exons within that gene. If a change in read count is statistically 
different between two conditions then the gene can be considered differentially 
expressed (Chen et al., 2011). Therefore, with RNA-Seq, one can not only quantify 
gene, and gene isoform, expression, but one can also analyse differentially expressed 
genes or differential expression between samples. This allows the reconstruction of the 
whole transcriptome and therefore the transcriptional landscape of a sample at a specific 
time (Chen et al., 2011). Alongside this, sequencing data can also be used to find novel 
transcripts and exons within a genome, and it can be used to study alternative splicing 
(Marioni et al., 2008).  
 
1.6.1.2 The benefits of using RNA-Seq for gene expression analysis studies 
RNA-Seq offers advantages and has many benefits over traditional hybridisation based 
approaches, such as microarray. Firstly, RNA-Seq requires less RNA than microarray, 
as there are no cloning steps (Wang et al., 2009). RNA-Seq also has lower background 
noise and higher sensitivity, because sequences of DNA can be mapped to unique 
genomic locations (Chen et al., 2011). Unlike microarray, RNA-Seq does not saturate, 
so there is no upper limit for the number of obtainable sequences; it has been estimated 
for 40 million reads of mouse sequence there is a range of five orders of magnitude over 
which transcripts can be detected (Marioni et al., 2008). This is close to the estimated 
range of transcripts found in a cell (Marguerat and Bahler, 2010). Additionally, it has 
been shown that RNA-Seq produces highly reproducible results with little technical 
variation (Chen et al., 2011; Marioni et al., 2008; Wang et al., 2009). 




RNA-Seq also has a very broad range of applications, with many more on the horizon; 
it is a technology that is still under development and has not been fully exploited. 
Unlike microarray, RNA-Seq data can be used to detect novel transcripts and enables 
the analysis of non-coding regions, as it does not require prior knowledge of the 
genome. It generates information about what genes are being expressed, and to what 
level, and about which isoforms of genes are being used by a cell. By knowing the 
transcripts expressed under certain conditions, studies are aiming to determine the 
regulatory networks underlying cellular phenotypes. The use of RNA-Seq has already 
revealed that the complexity of the transcriptome has been hugely underestimated 
(Marguerat and Bahler, 2010). RNA-Seq is the first technology that enables charting of 
the entire transcriptome in a quantitative and high-throughput manner. It allows single 
base resolution and quantification of gene expression on a whole genomic scale, at 
comparatively low costs (Wang et al., 2010). 
 
1.6.1.3 The limitations and challenges for RNA-Seq 
Though RNA-Seq has brought huge benefits to studies and has driven many important 
discoveries to the field of transcriptomics, it still faces many challenges from both the 
technological side and the data analysis side. The main technological aspect that limits 
high quality sequencing data is at the cDNA library construction step. This is a key step 
as the cDNA library directly mirrors the RNA from the original population, and 
therefore errors or bias here will be carried through to the rest of the sequencing and 
analysis process. A robust approach has been developed in which double-stranded 
cDNA is synthesised from the RNA, to which adaptors are ligated. However, though 
this approach introduces few errors, it is not ideal for some studies as information about 
transcriptional direction and transcript orientation are lost (Chen et al., 2011; Marguerat 
and Bahler, 2010). Methods are now being developed to overcome this drawback, 
however they are still in initial testing stages and are likely to introduce different biases 
into the data (Marguerat and Bahler, 2010). Additionally, either the RNA or the cDNA 
must be fragmented before sequencing can be performed. RNA fragmentation leads to 
the depletion of fragments ends, while cDNA fragmentation biases for fragments from 
the 3’ end of a transcript (Wang et al., 2009). Additionally, amplification can lead to 
polymerase chain reaction (PCR) artefacts, where many copies of certain reads are 
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found to be present in the library; to overcome this biological replicates are needed to 
determine if this is an artefact or biologically relevant (Wang et al., 2009). The shotgun 
process of RNA-Seq, where RNA molecules are randomly fragmented into short 
sequences, also leads to bias introduction. The number of short reads coming from a 
transcript is directly related to the length of the RNA molecule; longer molecules break 
up into more fragments. Therefore the comparison between samples is more efficient 
for longer transcripts (Oshlack and Wakefield, 2009). Biases in sequences obtained 
from transcripts have also been found to do with GC content, 3’ and 5’ end depletion 
and 3’ end bias (Fang and Cui, 2011). Increased samples size or sequence depth is 
therefore required to overcome these biases, though choosing appropriate protocols and 
analysis methods can also be very beneficial. 
 
Once samples have been sequenced there are challenges in alignment of the transcripts 
to the genome. The quality of the output and analysis relies on high quality mapping, 
and therefore on a high quality reference genome; in non-model organisms this can 
seriously affect analysis and final conclusions (Chen et al., 2011). Another facet of 
alignment is that reads can be misaligned if the transcript matches to related genes or 
other locations within the genome (McGettigan, 2013). Paired end sequencing can help 
overcome this as it extends the length of the read making it more likely to be specific. 
Additionally, the introduction of errors means that non-perfect matches may need to be 
considered when mapping reads. Most algorithms allow for one or two bases 
mismatching in a read, but deeper sequencing may be needed to resolve larger 
differences (Wang et al., 2009), particularly if the study is interested in distinguishing 
SNPs from sequencing errors (Marguerat and Bahler, 2010). Another analysis step that 
has not been fully eradicated in the transition form microarray to RNA-Seq is 
normalisation. Though sequencing data needs less normalisation than microarray data, 
some normalisation and bias correction is still required; at a minimum normalisation for 
the differences in sequencing depth between each library must be performed 
(McGettigan, 2013). For differential expression analysis, biases in sequencing depth, 
distribution of read counts between samples, and the length of genes and transcripts 
need to be taken into account (Chen et al., 2011). 
 
There are many challenges that still face RNA-Seq at the sample preparation and 
bioinformatics level. However, this technique has facilitated a huge new area of 
research and enabled questions to be answered in new and exciting ways. Now lie ahead 
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not only the refinement of methodologies and analysis, but the application of RNA-Seq 
to resolve new problems. One exciting feature of RNA-Seq data, that has so far not 
been applied, is how to use it to identify post-transcriptionally modified or rearranged 
(and therefore un-mappable) reads (Marguerat and Bahler, 2010). This would greatly 
increase our understanding of the transcriptome, and therefore the signalling networks 
and phenotypes, of cells. 
 
1.6.1.4 The application of RNA-Seq to better understand T helper cells  
RNA-Seq is a powerful tool to give an overview of the transcriptional profile of 
different T helper subsets after different treatments or at different stages of 
differentiation. RNA-Seq can also be used to further refine our understanding of the 
transcriptional landscape of a cell type; for instance it has been used to discover 
previously uncharacterised transcripts in mouse naïve and TCR stimulated CD4+ T 
cells (Hutchins et al., 2012a). However, RNA-Seq can also be used, particularly if in 
combination with other sequencing techniques, to give a very detailed map of the 
transcriptional and regulatory networks acting within a cell. Below I discuss three 
different systems biology approaches that emphasise how RNA-Seq can be and has 
been used to further our understanding of T helper cell differentiation and 
transcriptional regulation.  
 
RNA-Seq or microarray provide a temporal snapshot of the transcriptome of a cell. A 
recent study has used RNA-Seq to look at gene expression dynamics in human Th17 
cells over a differentiation time-course (Aijo et al., 2014); with the aim of gaining 
insight into the differentiation process, and understanding the temporal signatures and 
dependencies on different factors. They found that IL17A expression started to increase 
above naïve levels after 48hours of culture and continued to increase in a linear manner, 
while RORc took on a more bi-modal expression pattern. Additionally, using this 
method novel Th17 specific genes were identified. This paper illustrates that RNA-Seq 
can be used to look at Th cells as they develop and allow one to see how different 
signalling pathways and regulatory networks are used as differentiation progresses. 
 
However, it is argued that RNA-Seq data alone is not sufficient to fully elucidate the 
regulatory networks involved in T helper cell differentiation, and that a combination of 
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techniques are required to establish the transcriptional pathways of these cells. Various 
studies have tried to combine chromatin immunoprecipitation (ChIP)-Seq with RNA-
Seq to give a more comprehensive overview of the regulatory processes within different 
cell types. Vahedi et al., (Vahedi et al., 2012) used both ChIP-Seq and RNA-Seq of Th 
cells to link differential patterns of active enhancers, as characterised by the histone 
modification H3K4me3 and the presence of the acetyltransferase p300, with Th subset 
specific gene expression. To do this they transcriptionally profiled Th1 and Th2 cells 
using RNA-Seq, and identified the top 100 differentially expressed genes within each 
subset. Alongside this they chose to look at 100 housekeeping genes, which were 
chosen from the literature. Using antibodies to p300 or H3K4me3, they ChIP-Seq’d 
these cells and compared gene expression to the presence of p300 or H3K4me3 in the 
gene’s promoters. They found very little difference in H3K4me3 enrichment between 
housekeeping genes and Th subset specific genes. However, p300 was found to be 
enriched across the whole gene loci of Th subset specific genes compared to 
housekeeping genes; suggesting that housekeeping genes may be distinctly regulated 
compared to cell-type-specific genes. Furthermore, they found that expression of genes 
that were specifically upregulated in one Th subset over the other had significantly 
higher p300 enrichment. Therefore they concluded that lineage specific p300 binding 
correlates with cell-type-specific gene expression.  
 
Ciofani et al., published another example of a study comprehensively combining ChIP-
Seq and RNA-Seq (Ciofani et al., 2012). In this study they performed ChIP-Seq 
experiments in Th0 and Th17 cells with antibodies directed against transcription factors 
known to have a role in Th17 differentiation, to find transcription factor-DNA 
interactions. They then complemented this data with RNA-Seq on Th17 cells 
differentiated from naive T cells deficient in the same transcription factors of interest. 
This resulted in a comprehensive map of where key transcription factors are binding 
within the genome of Th17 cells and the effects they are having on gene expression. 
Using an integrated approach they then furthered the study with data from RNA-Seq 
experiments on 155 T helper cells, and from a public microarray of 167 different 
immune cell types. The two additional datasets provide regulatory information and 
further support to the interactions found by the first two datasets. From this they built up 
a network transcriptional model for mouse Th17 cell differentiation.  
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1.6.2 RNA-Seq of single cells 
RNA-Seq has been a revolutionary step in helping us understand whole transcriptomes 
and has been used extensively to profile gene expression. However, until the last few 
years all of these studies have been performed on bulk cell populations or tissues. An 
average of gene expression is drawn by pooling the RNA from thousands to millions of 
cells, which can be strongly biased by a few individual cells with very high expression 
of certain genes; however it may not be reflective of individual cells from within that 
population (Wu et al., 2014). Even cells with identical genomes have fluctuations in 
regulatory molecules and gene expression, which can result in significant deviations 
between cells within a population (Junker and van Oudenaarden, 2014). With recent 
advances in high-throughput technology, there is now the opportunity to obtain 
information about the transcriptomes and gene expression profiles of single cells using 
high resolution RNA-Seq (Tang et al., 2010a; Tang et al., 2010b; Tang et al., 2009).  
 
1.6.2.1 The benefits and limitations of single cell RNA-Seq 
Looking at the transcriptome of single-cells is not a new phenomenon. In 1990 a 
method was developed for the extraction and exponential amplification of cDNA from 
individual cells (Brady, 1990). Though findings with this technology were very 
informative, the resolution was limited. Until recently the most viable method for 
studying single cell gene expression was multiplexed quantitative real-time polymerase 
chain reaction (qRT-PCR), but the throughput of this technique is limited and biased 
towards a specific set of genes chosen by the researchers (Saliba et al., 2014). In the 
2000s high-density microarray chips paved the way for single cell microarrays, but as 
mentioned this is hampered by limited dynamic range and sensitivity, and the constraint 
of only detecting known genes (Tang et al., 2011). Additionally, microarray needs 
comparatively large amounts of starting RNA, micrograms versus the nanograms 
needed for RNA-Seq (Saliba et al., 2014). Single cell RNA-Seq overcomes these issues 
and greatly improves the scope and depth of transcriptome analysis. 
 
Demand for single cell RNA-Seq comes from two viewpoints; firstly for studying 
populations of rare cells, where the large numbers needed for traditional RNA-Seq are 
not available; secondly for the analysis of individual cells from heterogeneous 
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populations. Even in very similar cell types gene expression has been shown to be very 
heterogeneous and stochastic (Huang, 2009). To evaluate the importance of and to 
unravel the basis of this heterogeneity, it is necessary to study the transcriptomes of 
individual cells. Alongside the analysis of differential gene expression, single cell 
RNA-Seq has highlighted that splicing patterns and differences in allelic expression are 
highly variable between cells of the same population (Saliba et al., 2014). 
 
However for RNA-Seq of single cells to be successful, various technical and analysis 
challenges must be overcome. From the technical standpoint; individual cells need to be 
effectively isolated, minute amounts of cellular RNA need to be converted into cDNA, 
and this cDNA must be amplified into libraries and sequenced – and all of these 
techniques need to be successfully combined. Though the amount of starting material 
required for RNA-Seq is less than that needed for microarray, the material from a single 
cell still needs to be amplified to create enough for sequencing. This can lead to the 
accumulation of non-specific by-products and errors during amplification (Kalisky et al., 
2011; Tang et al., 2011). From the analysis standpoint; alongside the same challenges 
faced when analysing all RNA-Seq data there is the additional issue that for statistical 
significance, many individual cells from a sample must be sequenced (hundreds to 
thousands) (Saliba et al., 2014). This leads to vast amounts of data, which requires 
storing, and leads to questions about how to combine the analysis of all these samples 
efficiently without losing the individual resolution. It is still difficult to distinguish 
between biological variability and technical noise for low abundance transcripts due to 
the limited sensitivity of single cell RNA-Seq, which can result in the loss of 
information about individual transcriptomes (Saliba et al., 2014).  Nevertheless this can 
been overcome (Brennecke et al., 2013) and single cell RNA-Seq on a large number of 
cells can recapitulate both the bulk transcriptome complexity seen when performing 
traditional RNA-Seq and the gene expression distributions found in single cells (Wu et 
al., 2014). 
 
1.6.2.2 Single cell RNA-Seq applications on immune cells 
Single cell RNA-Seq can be used to investigate regulatory circuits within cells and 
explore the heterogeneity in response to stimuli. A recent study from the Regev 
laboratory (Shalek et al., 2013) investigated the differences between genetically 
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identical cells at the single cell level by looking at: 1) differences in gene expression 
between individual cells, 2) differences in expression levels of different transcripts 
within cells, 3) the splice variants present in the population. They studied in vitro 
generated mouse bone marrow derived DCs (BMDCs) activated with LPS, for two 
reasons; first they are post-mitotic and therefore lack cell cycle dependent 
transcriptional differences, and secondly because LPS synchronises cellular responses 
causing temporal phasing and robust transcriptional responses. The responses of 
BMDCs to LPS have been studied in detail at the population level and are therefore a 
good candidate to study at the single cell level. Comparing RNA-Seq data from 18 
single BMDCs to data from 3 samples of 10,000 pooled BMDCs, they found that 
between the 3 pooled samples there was a Pearson’s coefficient for gene expression of 
R2 > 0.98, while for the single cells the average R2 was 0.48; suggesting extensive cell-
to-cell variation. Additionally, splicing patterns were very heterogeneous between the 
different cells, and generally skewed towards one specific splice variant in each cell. 
Many of the most highly expressed genes across the single cells showed bimodal 
expression patterns; being highly expressed in most, but not all, cells. Performing 
principle component analysis (PCA) on the cells revealed two obvious subpopulations 
of DC; those with extremely high expression of inflammatory cytokines, and those with 
weaker expression.  
 
The following year this group published another paper that looked at single cell 
transcriptomics of 1,700 individual BMDCs (Shalek et al., 2014). Here they found that 
preventing cell-to-cell communication greatly reduced the heterogeneity of the 
population, suggesting there is a role for paracrine control in cellular variation. They 
found that, based on gene expression, a few cells clustered separately from the majority 
and were in the later stages of maturation. This small subset of cells express a specific 
set of antiviral genes very rapidly upon stimulation, and produce interferon, which acts 
in a paracrine manner on the other cells within the population to initiate the expression 
of the same set of antiviral genes. These studies highlight how looking at covariance 
between transcripts in individual cells can reveal regulatory circuits that may not be 
obvious at the population level, and demonstrate the potential role of single cell RNA-
Seq in helping to decipher the transcriptome. 
 
A recently study utilised single cell RNA-Seq to elucidate the mechanism of immune 
suppression by Th2 cells (Mahata et al., 2014). Whole Th1 and Th2 RNA-Seq data 
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revealed that upon TCR and IL-4 activation, Th2 cells express genes that encode all the 
factors involved in steroid synthesis. Steroids are known to have immunoregulatory 
roles (Sakiani et al., 2013), but their de novo production by immune cells has not been 
investigated. Using single cell RNA-Seq on Th2 cells at different stages of maturation, 
they found that Cyp11a1, which is the key enzyme in controlling the steroid synthesis 
pathway, is upregulated as they cells mature. At the single cell level Cyp11a1 
expression correlated with many genes involved in Type 2 immune responses, such as 
Nfil3, Gata3 and Il4, and with numerous factors that have been associated with 
immunosuppression, including Il10 and Tgfb1. Performing RNA-Seq on the bulk Th2 
cell population could not reveal that it is a small subset of the total Th2 cell population 
that produced these immunosuppressive cytokines along with the steroid pregnenolone. 
Therefore using single cell RNA-Seq they have demonstrated heterogeneity in the Th2 
population, with a previously unidentified subset capable of de novo steroid synthesis 
and immunosuppression in vitro and in vivo.   
 
Hematopoietic cells can be used as a model to push the boundaries of single cell RNA-
Seq and answer fundamental questions that have so far been restricted due to technical 
limitations. A key example of this is the massively parallel RNA single cell framework 
developed in the Amit laboratory (Jaitin et al., 2014). This method has been developed 
to enable the sampling and transcriptome analysis of thousands of individual in vivo 
cells. As a proof of principle they analysed the in vivo transcriptional states of 
thousands of DCs, a population of cells that is becoming increasingly difficult to 
characterise into refined cell types based on surface markers. Based on the expression of 
CD11c they sequenced over 4000 splenic cells, and then classified them firstly on low-
depth RNA sampling and secondly on their high resolution transcriptional profiles. A 
high level of cellular variance was observed, particularly of characteristic cell surface 
markers, supporting evidence of the high degree of heterogeneity within this population 
of cells. By pooling the single cell transcriptional profiles they were able to define these 
cells into splenic subpopulations at a high level of detail, finding significant 
compatibility with the traditional marker based definitions. Therefore they propose that 
this method can be used to characterise previously uninvestigated subpopulations of 
cells within heterogeneous tissues. 
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1.6.3 The limitations of RNA-Seq of low-quality or low-quantity RNA samples 
Single cell RNA-Seq has become more and more viable for analysing the 
transcriptomes of samples with low RNA quantity, however it is still expensive, and 
technically and bioinformatically challenging. Therefore several other methods have 
been devised for overcoming the challenge of low-quantity; two of note are the Ovation 
RNA-Seq system ‘NuGEN’ (Head et al., 2011) and the ‘SMART’ system that switches 
the 5’ end of the RNA template (Islam et al., 2011). Nevertheless, though these have 
distinct strengths, they also both have weaknesses, and single-cell RNA-Seq is currently 
overtaking them as a favoured method. Performing high resolution RNA-Seq on low-
quality RNA samples, however, is still proving to be a huge challenge. Resolving this 
issue would be of great importance, particularly for formalin-fixed samples, such as 
clinical samples that are formalin-fixed paraffin-embedded (FFPE). RNA is a fragile 
molecule and many biological processes, including ribonuclease digestion, and the 
fixation of samples can lead to RNA degradation (Opitz et al., 2010), which in turn can 
prevent efficient ribosomal (r)RNA depletion, reduce library complexity, decrease even 
transcript coverage of the genome (Adiconis et al., 2013), and lead to biases, such as 3’ 
bias; where transcripts are increasingly degraded from the 5’ end (Auer et al., 2003). 
Loss of 5’ ends can inhibit the ability of algorithms to correctly align reads and 
assemble novel transcripts. Some methods to overcome these issues can alter GC 
content and transcript length, which in turn create bias, with preferential sequencing of 
some transcripts over others (Gao et al., 2011; Oshlack and Wakefield, 2009).  
 
Certain assays have been developed to look at partially degraded RNA, such as the 
Illumina cDNA-mediated Annealing, Selection, extension, and Ligation (DASL) assay 
(Fan et al., 2004). This is a probe-based assay, where the probes only span 50 
nucleotide bases, meaning very short RNA fragments can be assessed. Though this is 
highly valuable in the clinical setting and can shed light on otherwise un-usable RNA 
samples (Haller et al., 2006), as with all hybridisation methods it relies on prior 
knowledge of the genome. Additionally this method doesn’t compensate for any bias 
introduced by the degradation of RNA. Standard microarray has also been used to 
assess the RNA profiles of FFPE samples, and it has been concluded that the resulting 
data is comparable to the gene expression profiles seen for identical fresh samples. 
However, as most microarray probes are designed to ligate the 3’ end of a transcript 
(Opitz et al., 2010), any loss of the 5’ end, as expected with 3’ bias, will not be seen. 
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Therefore, though microarray of fresh and FFPE samples may seem equivalent, it is 
possible information is being lost. In fact it has been shown that when a sample is 
degraded the likelihood of false positives in differential gene expression is increased 
(Auer et al., 2003). As RNA-Seq is not probe based, and all transcripts are aligned to 
the genome, this 3’ bias becomes obvious and severely disrupts differential expression 
analysis (Sigurgeirsson et al., 2014). Therefore RNA-Seq, unlike microarray, can reveal 
that the RNA of FFPE samples is of low quality. This can be overcome at the analysis 
stage by computational approaches such as 3’ tag counting (Sigurgeirsson et al., 2014), 
however this only reduces the issue of false positives in differential gene expression. 
This is still an area that needs much investigation and improvement before RNA-Seq 
data from low-quality samples can be comparable to results from fresh RNA. 
 
 
1.7 Project perspective: Using RNA-Seq to elucidate the molecular 
mechanisms involved in the regulation of Il10 gene expression  
The O’Garra laboratory is interested in understanding the transcriptional networks 
involved in the regulation of IL-10. Within the laboratory whole populations of multiple 
T helper cell subsets have been analysed by RNA-Seq and potential factors involved in 
IL-10 regulation have been discovered, and are now being studied. However, the T 
helper cell populations are phenotypically heterogeneous, particularly with respect to 
IL-10 protein production. Usually less than 30% of an in vitro cultured T helper cell 
population will express IL-10, and often less than half will express the hallmark 
cytokine, and co-expression of IL-10 and the hallmark cytokine is also heterogeneous. 
Therefore we wanted to devise and implement an innovative new technique that enables 
RNA-Seq analysis of different cell subpopulations within bulk Th1 / Th2 / Th17 
populations based on cytokine protein as seen by intracellular cytokine staining. This 
technique has never been applied to immune cells and will be greatly beneficial within 
the field for both in vitro and in vivo studies. In this thesis I show that it is possible to 
extract high quality RNA from intracellular cytokine stained subpopulations within Th1 
and Th17 bulk populations, even though they are fixed and stained for intracellular 
cytokines, and that the data from these samples is of high quality and is highly 
replicable. By separating the subpopulations of different T helper cell subsets according 
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to their IL-10 expression we have elucidated factors that may be involved in the 
regulation of IL-10 over those regulating differentiation and hallmark cytokine 
expression. 
  




Figure 1.1 Activation and differentiation of T helper cell subsets 
Peptides from invading pathogens are presented by APCs to naïve CD4+ T cells in the 
context of MHC class II. Ligation of the TCR alongside co-stimulatory molecule 
signaling leads to activation of the naïve CD4+ T cells, resulting in IL-2 production and 
proliferation. Cytokines in the microenvironment influence the activation of the CD4+ 
T cells and direct their differentiation into distinct subsets of T helper cell that promote 








Figure 1.2 The cellular sources and targets of IL-10 
IL-10 is produced by many cell of both the innate and adaptive immune systems, and 
acts predominantly to repress immune responses. IL-10 represses the proliferation and 
actions of APCs, which in turn indirectly reduces the activation of Th1 and Th2 cells. It 
also acts directly on Th17 cells to reduce their proliferation and cytokine production. 
However, IL-10 does also have stimulatory roles; of note it acts directly on Treg cells to 
promote their development and further IL-10 production. MΦ represents macrophages.  
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Figure 1.3 Differentiation pathways and IL-10 expression of different Th cell 
subsets 
In accordance with the polarising cytokines, which vary depending on the pathogen 
invasion, signal transducer and activator of transcription (STATs) and transcription 
factors are activated in naïve CD4+ T, and act on genes to dictate which cytokines the 
Th cell produces. IL-10 expression by Th1 cells requires strong antigen dose, conveyed 
by T cell receptor triggering, and the presence IL-12. Th1, Th2 and Th17 cells require 
the same factors that are used to polarise them for IL-10 expression. FoxP3+ Treg cells 
require TGFβ in vivo to produce IL-10, but other signalling pathways are still unknown. 
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C57BL/6 wild type, TCR7(Neighbors et al., 2006), TCR7 Rag KO, FoxP3 KO(Fontenot 
et al., 2003) TCR7 Rag, GATA3 fl/fl dLck-Cre(Zhang et al., 2005), GATA3 fl/fl(Zhu et 
al., 2004) mice were bred at the NIMR and maintained under specific pathogen free 
(SPF) conditions in accordance with the Home Office, UK, Animals (Scientific 
Procedures) Act 1986. 
 
 
2.2 In vitro differentiation of Th cells 
2.2.1 Cell Culture Mediums 
RPMI medium: RPMI 1640; 10% heat-inactivated FCS; 0.05mM 2-ME (Sigma-
Aldrich); 10mM HEPES buffer; 100U/ml penicillin; 100U/ml streptomycin; 2mM L-
glutamine; 1mM sodium pyruvate. Unless stated all reagents purchased from 
BioWhittaker, Lonza. IMDM medium: Iscove's Modified Dulbecco's Media (Sigma-
Aldrich); 5% heat-inactivated FCS; 0.05mM 2-Mercaptoethanol (Sigma-Aldrich); 
100U/ml penicillin; 100U/ml streptomycin; 2mM L-glutamine. Unless stated all 
reagents purchased from BioWhittaker, Lonza. Sort buffer: DPBS with no Ca2+ or Mg2+ 
(Gibco); 5% heat-inactivated FCS; 100U/ml penicillin; 100U/ml streptomycin. Unless 
stated all reagents purchased from BioWhittaker, Lonza. 
 
2.2.2 Isolation of naïve CD4+ T cells 
Disaggregated spleens were red blood cell lysed (0.83% ammonium-chloride) and 
incubated with depletion antibodies against B220 (RA3.6B2 DNAX), MHC class II 
(M5/114 eBio) and CD8 (C291.2.43 DNAX), T cells were isolated using Goat-anti-rat-
IgG heavy chain BioMag beads (Qiagen). Naïve (CD4+CD62L+CD44loCD25-) T cells 
were isolated by cell sorting with a MoFlo XDP (Beckman Coulter, Inc.) or a 
FACSAria (BD Biosciences) (Figure 2.1). 
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2.2.3 APC-independent generation of naive activated, Th0, Th1, Th2 cells 
Cells were plated at 500,000 cells in 48 well plates and stimulated with plate-bound 
anti-CD3 (5ug/ml; 2C11 Harlan or 10ug/ml; 2C11 DNAX) and soluble anti-CD28 
(2ug/ml; 37.51 Harlan or DNAX). Cells were plated at 500,000 cells per well in 1ml in 
48 well plates. Naïve activated cells were stimulated in medium alone. For Th0 
induction, cells were stimulated in the presence of anti-IL-4, anti-IL-12, anti-IFNγ, anti-
IL-6 and anti-TGFβ (all 10ug/ml). For Th1 induction cells were stimulated in the 
presence of mouse IL-12 (5ng/ml) and anti-IL-4 (10ug/ml) and in some cases with the 
addition of IL-27 (2ng/ml). For Th2 induction, cells were stimulated in the presence of 
IL-4 (10ng/ml) alone or in most cases with the addition of IL-2 (5ng/ml), anti-IL-12 and 
anti-IFNγ (both 10ug/ml). Cells were cultured at 37oC, 5% CO2 in RPMI medium. After 
3 days of culture cells were removed from the coated wells and split into three. These 
were then re-plated and given fresh medium and driving cytokines and antibodies as 
listed above. 
 
2.2.4 APC-independent generation of Th17 cells 
For Th17 cell induction, cells were stimulated with plate-bound anti-CD3 (2ug/ml 2C11 
Harlan) and plate-bound anti-CD28 (10ug/ml 37.51 Harlan) in the presence of mouse 
TGFβ (2ng/ml), human IL-6 (50ng/ml) anti-IL-4, anti-IL-12 and anti-IFNγ all at 
(10ug/ml) and in some cases with the addition of IL-2 (10ng/ml) or anti-IL-2 (10ug/ml). 
Cells were plated at 500,000 cells per well in 1ml in 48 well plates. Cells were cultured 
at 37oC, 7% CO2 in IMDM medium. 
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2.3 Quantification of cytokine production by ICS of in vitro 
differentiated Th cells 
2.3.1 Restimulation of APC-independently generated naive activated, Th0, Th1, Th2 
cells 
Cells were removed from culture wells, washed with fresh medium and re-plated at 
500,000 cells per well in 48 well plates. Cells were restimulated at 37oC for 4h with 
plate-bound anti-CD3 (2ug/ml) and soluble anti-CD28 (2ug/ml), in the presence of 
Brefeldin A (10ug/ml Sigma-Aldrich) for the second 2h. 
 
2.3.2 Restimulation of APC-independently generated Th17 cells 
Half of the culture medium was removed from the wells, avoiding disturbance of the 
cells, and an equivalent amount of medium containing PDBu (500ng/ml; Sigma-
Aldrich), ionomycin (500ng/ml; Calbiochem) and Brefeldin A (10ug/ml Sigma-
Aldrich). Cells were cultured for a further 4h at 37oC. 
 
2.3.3 Preparation of cells for intracellular cytokine stained 
After restimulation cells were stained for surface proteins and dead cells using UV 
LIVE/DEAD fixable dead cell stain (Invitrogen) in PBS with no Ca2+ or Mg2+ (Gibco); 
for 30mins at 4oC. Cells were then fixed with 2% formaldehyde (Sigma-Aldrich; diluted 
from 37-38% in PBS) for cytokine staining for 20mins or with FoxP3 staining buffer set 
(eBio) for transcription factor staining for 30mins at room temperature. This was 
followed by permeablisation of cells with permeablisation buffer (eBio) for 30mins at 
room temperature. Cells were then stained with anti-cytokine or anti-transcription factor 
antibodies (Table 2.1) for 30mins at room temperature in sort buffer. Cells were 
washed, resuspended in sort buffer and run on the BD LSR II flow cytometer. Data was 
analysed using FlowJo software (Treestar). Compensation controls were either single 
colour stained cells from the culture or compensation beads (BD). 
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Specificity Function Cellular 
Expression 









IL-4 Th2 Cytokine Th2 cells & B 
cells 
PE 11B11 eBio 200 






IL-17 Th17 Cytokine Th17 cells FITC 17B7 eBio 300 
IFNγ Th1 Cytokine Th1 cells PE-Cy7 XMG1.2 BD 800 




E450 RM4-5 eBio 200 
V500 RM4-5 eBio 400 
CD8 MHCII co-receptor Thymocytes, T 
cells, NK cells, 
DCs 
FITC 53-6.7 eBio 100 
CD62L Adhesion, binds 
CD34 
T & B cells, 
monocytes, 
NK cells 
PE-Cy7 MEL-14 eBio 400 
CD44 Adhesion T cells, B cells, 
erythrocytes 
PE IM7 eBio 400 
CD25 IL-2Ra chain  Activated T 
cells and B 
cells, 
monocytes 
APC PC61.5 eBio 100 
Table 2.1 Antibody details for FACS 
 
 
2.4 Quantification of cytokine production by ELISA of in vitro 
differentiated cells 
2.4.1 Restimulation of APC-independently generated naive activated, Th0, Th1, Th2 
and Th17 cells 
Naive activated, Th0, Th1 and Th2 cells were removed from culture wells, washed with 
fresh medium and re-plated at 500,000 cells per well in 48 well plates. Cells were 
restimulated at 37oC for 48h with plate-bound anti-CD3 (2ug/ml) and soluble anti-
CD28 (2ug/ml). The supernatant was then removed from the wells, avoiding 
disturbance of the pellet, and stored at -80oC for later analysis. For Th17 cells half of 
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the culture medium was removed from the wells, after differentiation but before 
restimulation, avoiding disturbance of the cells, and stored at -80oC for later analysis. 
 
2.4.2 Quantification of cytokine production by ELISA 
Maxisorp 96-well plates (Nunc, Thermo Scientific) were used for the assay. 
Commercially available kits were used according to the manufacturer’s instructions to 
quantify the concentration of IL-17 (eBio). Matched-pair sandwich Sandwich ELISAs 
were used to measure IL-10, IL-4, IFNγ, IL-2 and IL-5 (with antibodies listed in Table 
2.2). The assay details are summarised in Table 2.2. ELISA plates were read on Safire2 
microplate reader (Tecan). Standard curve calculations and cytokine concentrations 
were determined using Magellan software (Tecan). 
 
  
































































































IL-17 10ng/ml (eBio kit) (eBio kit) (eBio kit) TMB 
Table 2.2 Assay details for ELISA 
 
 
2.5 Quantification of cytokine production by qPCR of in vitro 
differentiated cells 
2.5.1 Restimulation of naive activated, Th0, Th1, Th2 cells 
Cells were removed from culture wells, washed with fresh medium and re-plated at 
500,000 cells per well in 48 well plates. Cells were restimulated at 37oC for the 
indicated time-points (0, 2, 4, 6, 8, 10, 12 or 24 hours) with plate-bound anti-CD3 
(2ug/ml) and soluble anti-CD28 (2ug/ml). Cells were removed from culture wells, 
washed with PBS and lysed immediately with RLT buffer (Qiagen) containing 1% 2-
Mercaptoethanol (Sigma-Aldirch) and lysates were stored at -80oC.  
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2.5.2 RNA isolation and purification 
RNA was isolated according to the manufacturer’s instructions using the RNeasy Mini 
or Micro kit (Qiagen) with an on-column DNase digestion step to remove 
contaminating DNA (RNase-Free DNase kit, Qiagen). Purified RNA concentration was 
determined with a Nanodrop spectrophotometer (Nanodrop1000, ThermoScientific).  
 
2.5.3 cDNA preparation and real-time quantitative PCR (qPCR) analysis 
cDNA was synthesised from purified RNA using a High Capacity cRNA Reverse 
Transcription kit (Applied Biosystems). The reaction mixture is summarised in Table 
2.3. The following PCR protocol was used to convert RNA to cDNA (Veriti Thermo 
Cycler, Applied Biosystems): 10mins 25oC, 2h 37oC, 5min 85oC. This was followed by 
an RNA degradation step in which aDNA was incubated with RNase H (final 
concentration 0.03U/ul, Invitrogen) at 37oC for 30mins. cDNA was then diluted to 
5ng/ul in Nuclease-free H2O (Preomega). qPCR was conducted using TaqMan Assay 
system (Applied Biosystems). Reaction mixtures, summarised in Table 2.4, were made 
up in 96-well plates (optical reaction plates, Applied Biosystems), including a no-cDNA 
template control and a water only control to ensure reagents were not contaminated. The 
primer-probes used are summarised in Table 2.5. 
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Reagent Volume Final Concentration Source 
Primer-Probe 0.5ul 900nM Applied Biosystems 
TaqMan Universal 
Master Mix 5ul n/a Applied Biosystems 
cDNA 4.5ul 2.25ng/ul n/a 
Table 2.3 qPCR reaction mixture (per well) 
 
Reagent Volume Final Concentration Source 
Cellular RNA 10ul n/a n/a 
Reverse transcriptase 
buffer 2ul n/a 
Applied 
Biosystems 
dNTPs 0.8ul 4mM 
Applied 
Biosystems 








Inhibitor) 0.5ul 1U/ul Promega 
Nuclease-free Water 3.7ul n/a Promega 
Table 2.4 Reaction mixture for cDNA synthesis 
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Table 2.5 TaqMan primer-probes for aPCR 
 
 
2.6 Preparation of unfixed samples for RNA-Sequencing 
2.6.1 In vitro differentiation, restimulation, RNA isolation and purification 
Naïve CD4+ T cells were prepared as described in 2.2.2. Th1 and Th2 cells were 
differentiated as described in 2.2.3 and were harvested on day 7 of culture. Cells were 
removed from culture wells, washed with fresh medium. 4ml of cells, at ~2.5M cells per 
ml, were gently layered on top of 3ml of room temperature Ficoll and centrifuged for 45 
minutes at 400xg with no braking (Ficoll-Paque Premium 1.084, GE Healthcare). The 
cell suspension was then taken off the top of the Ficoll and washed with fresh medium. 
Th1 and Th2 cells were restimulated as described in 2.5.1. RNA was isolated and 
purified as described in 2.5.2. 
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2.7 Preparation of cells for Intracellular cytokine staining and 
Sorting for analysis by RNA-Sequencing 
2.7.1 In vitro differentiation and restimulation 
Naïve CD4+ T cells were prepared as described in 2.2.2. Th1 cells, Th1 + IL-27 and 
Th2 were differentiated as described in 2.2.3 and were harvested on day 7 of culture. 
Th17 + IL-2 and Th17 + anti-IL-2 cells were differentiated as described in 2.2.4 and 
were harvested on day 3 of culture. Th1 cells were restimulated as described in 2.3.1. 
Th17 were restimulated as described in 2.3.2.  
 
2.7.2 Fixation, Intracellular cytokine staining and Sorting 
After incubation cells were stained for the surface protein CD4 and dead cells using 
e450 LIVE/DEAD fixable dead cell stain (Invitrogen) in PBS with no Ca2+ or Mg2+ 
(Gibco);  for 30mins at 4oC. Cells were then fixed with 4% formaldehyde (Sigma-
Aldrich; diluted from 37-38% in PBS) containing 0.4U/ul RNasin Plus (Promega) for 
30mins at 4oC. Cells were then washed with PBS containing 20% sort buffer and 
0.4U/ul RNasin Plus. This was followed by permeablisation of cells with 
permeablisation buffer (eBio) containing 1.6U/ul for 15mins at 4oC. Cells were then 
stained with anti-cytokine antibodies (Table 2.1) in permeablisation buffer (eBio) 
containing 1.6U/ul for 30mins at 4oC. Cells were then washed with PBS containing 
20% sort buffer and 0.4U/ul RNasin Plus. Cells were then resuspended in PBS 
containing 10% sort buffer and 1.6U/ul RNasin Plus. Samples were then run through 
the FACSAria cell sorter (BD Biosecinces) using FACSDiva software, and collected 
into FACS tubes with 500ul of PBS containing 10% sort buffer and enough RNasin 
Plus to result in a concentration of 1U/ul when the tube was filled to 5ml. Compensation 
controls were single colour stained cells.  
 
Four subsets of Th cells were sorted, each with 3 biological repeat experiments; Th1, 
Th1 + IL-27, Th17 + IL-2 and Th17 + anti-IL-2. These subsets were sorted as live 
CD4+, to collect the ‘bulk’ population of cells, and into their different intracellular 
cytokine producing subpopulations (Figure 2.1). The 3 biological repeat experiments 
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had similar percentages of live CD4+ cells in each intracellular cytokine producing 
subpopulation (See Chapter 5 & 6). 
 
2.7.3 RNA isolation and purification 
After sorting, cells were pelleted by centrifugation at 3000 g for 5mins at 4oC. The 
supernatant was discarded. Total RNA was isolated from the pellet using the FFPE 
RNeasy Kit (Qiagen), starting at the protease digestion stage of manufacturer-
recommended protocol. The following modification to the isolation procedure was 
made: instead of incubating cells in digestion buffer for 15 minutes at 50oC and 15 
minutes at 80oC, we carried out the incubation for 3 hours at 50oC. Cell lysates were 
frozen at -80oC overnight before continuing the RNA isolation by the manufacturer’s 
instructions. Purified RNA concentration was determined with a Nanodrop 
spectrophotometer (Nanodrop1000, ThermoScientific).  
 
2.8 RNA-Sequencing 
2.8.1 Verification of RNA Quality 
The quality of RNA was determined using an Agilent 2100 Bioanalyser (Agilent 
Technologies). All RNA samples that were not part of the optimisation steps had a 
RNA integrity number (RIN) over 7, meaning RNA was not degraded and of high 
quality (Schroeder et al., 2006). 
 
2.8.2 Preparation of samples for RNA-Sequencing 
RNA was obtained from 3 biological replicates of differentiated T helper cells. The 
samples were processed for RNA-Seq by the Francis Crick Institute Mill Hill 
laboratory’s HTS facility. Samples were poly-A purified and converted to cDNA 
libraries using the Illumina TruSeq Library preparation kit v2. 10-12pM of samples 
were multiplexed 6 to 7-per-lane for sequencing using the Illumina HiSeq 2500 
platform with single-end read lengths of 50bp, resulting in 27M to 65M reads per 
sample, and an average biological fragment length of 301-328 nt.  




2.8.3 Analysis of RNA-Sequencing data 
2.8.3.1 Pre-analysis processing and normalisation 
Reads were aligned to the mouse transcriptome and genome (GRCm38 / mm10, 
2014.10.08) using Strand NGS (Version 2.0) guided by RefSeq annotations 
(2013.04.01) (Pruitt et al., 2014; Tatusova et al., 2014), with 95% identity, max 5% 
gaps, 1 read only if duplicated. Samples were normalised using the count based 
technique DeSeq (Anders and Huber, 2010); with no normalisation to the baseline in 
Chapter 3 and initial quality controls in Chapter 5 & 6; with normalisation to the 
baseline median of the samples, for further analysis in Chapter 5 & 6. Results are 
outputted as a Log2 value.  
 
2.8.3.2 Relative gene coverage 
Aligned BAM files were exported from Strand NGS, in bash these were sorted and 
indexed using SAMtools (Li et al., 2009). The output was analysed for relative gene 
coverage over the mouse transcriptome (RefSeq, mm10) using the python module 
geneBody_coverage.py, which was imported from the RSeQC package (Wang et al., 
2012). This module is used to check if reads coverage was uniform and if there was any 
5’ or 3’ bias.  
 
2.8.3.3 Hierarchical clustering 
All hierarchically clustered according to conditions or conditions and entities used 
Pearson’s centred distance metric with Average linkage rule, in Strand NGS software. 
Hierarchical clustering constructs a dendrogram in which entities are represented in a 
relationship tree that allows the visualisation of the data within one heat map. This 
groups samples based on their similarity, and therefore similar samples should cluster 
together. Gene expression was shown as a red-blue heat map, with red indicating 
upregulation, blue indicating downregulation and yellow no change. The Pearson 
centred distance metric was used as this clusters genes based in the expression profile of 
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the entities over the different samples rather than by the magnitude of gene expression 
which is used by Euclidean-based distance metric. We were more interested in genes 
that had similar expression patterns as they are more likely to be co-regulated, 
regardless of the magnitude of induction. Groups of genes were manually curated based 
on dendrogram and experimental hypotheses. 
 
2.8.3.4 Fold change  
For all fold change the data from the three repeats of each sample was pooled. 
Differentially regulated genes were obtained by taking those that were at least 2 or 3-
fold up- or downregulated in at least 1 of the samples vs. the baseline (median of all the 
samples). Log fold change is the difference between two Log values; which is equal to 
the fold change difference between two raw read values.  
 
2.8.3.5 Pathway and network analysis with IPA 
Pathway and network analyses were conducted using Ingenuity Pathway analysis (IPA) 
(Ingenuity® Systems, www.ingenuity.com). Ingenuity relies on information from the 
manually curated database Ingenuity Knowledge Base (Calvano et al., 2005). 
Significant association to a gene list was determined by Fisher’s Exact Test. IPA was 
used to determine signalling pathways and gene netwroks associated with clusters of 
differentially expressed genes. Interactions were considered significant if p<0.01.  
 
2.8.3.6 Functional analysis with GO 
Functional analysis was carried out using gene ontology (GO) analysis in Strand NGS. 
In the GO database genes are assigned ontologies relating to their molecular functions, 
associated biological processes and cellular locations (Harris et al., 2004). Lists of 
genes can be analysed regarding their associated GO ontologies and significant 
associations with particular terms can be calculated.  




Figure 2.1 Gating strategy for separation of naive CD4+ CD62L + CD44 Low 
CD25- cells 
Single cell suspensions from mouse spleens were generated as described in section 2.2.2. 
Naïve (CD4+CD62L+CD44loCD25-) T cells were isolated by cell sorting with a MoFlo 
XDP or a FACSAria. Gates indicate the percentages of parent. Data shown are from one 
experiment. FSC = forward scatter; SSC = side scatter. Other information relating to 
fluorochrome-conjugated antibodies may be found in Table 2.1. 




Figure 2.2 Gating strategies for separation of live CD4+ Th1 and Th17 cells for 
RNA-Seq analysis 
A. Th1 cells and Th1 + IL-27 cells and B. Th17 + IL-2 cells and Th17 + anti-IL-2 cells 
were prepared for fixation, intracellular cytokine staining and sorting as describes in 
section 2.7.2. Gates indicate the percentages of parent. Data shown are from one 
experiment. FSC = forward scatter; SSC = side scatter. Other information relating to 
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IL-10 is an immunoregulatory cytokine that has a vital role in maintaining a balanced 
and appropriate immune response. It is fundamental that this balance between 
inflammatory responses required to eradicate a pathogen, and excessive inflammation 
which would harm the host, is maintained. CD4+ T helper cells are important in 
regulating an effective immune response, and are a dominant source of IL-10 that is 
crucial in regulating T cell responses (Roers et al., 2004). Despite the different 
signalling pathways that result in the polarisation of each Th subset and lead to the 
expression of their hallmark cytokines, IL-10 is expressed by all of the different Th 
subsets (Saraiva and O'Garra, 2010). Current studies suggest that the differentiation 
pathway of each T helper subset, governed by a set of distinct master transcription 
factors, is tightly linked to IL-10 expression (Gabrysova et al., 2014). It is therefore 
likely that there are disparate, but potentially overlapping, mechanisms by which IL-10 
expression is regulated in each Th subset.  
 
CD4+ T cells require TCR stimulation and signalling from cytokine receptors to fully 
differentiate and they will only express cytokines, other than IL-2, once they have 
differentiated (Yamane and Paul, 2013). In the absence of cytokine signalling CD4+ T 
cells will become activated and express IL-2, which acts in an autocrine manner to 
promote proliferation, but will not differentiate into a Th cell subset (Murphy et al., 
1996; Shoemaker et al., 2006). Once Th cells have differentiated they express their 
hallmark cytokines, in addition to IL-10. Each Th subset requires different types of 
TCR and cytokine signalling to drive differentiation and IL-10 expression. Th1 cell 
differentiation is driven by IL-12. However, it has been shown that strong TCR ligation 
is required to initiate IL-10 expression in this cell type (Saraiva et al., 2009). 
Additionally, IL-27 has been shown to boost IL-10 expression in Th1 cells (Stumhofer 
and Hunter, 2008). Th2 cells require IL-4 to drive the production of their hallmark 
cytokines and IL-10 (Fiorentino et al., 1989). Th17 cells, primarily driven by TGFβ and 
IL-6, express IL-10 transiently and variably, via mechanisms that are still unclear. 
Though IL-23 has been shown to suppress IL-10 expression (Ghoreschi et al., 2010; 
McGeachy et al., 2007). Therefore, for optimal IL-10 expression alongside hallmark 
cytokine expression, different Th subsets appear to require different specific signals and 




alterations in dose of TCR ligation or cytokine signalling can have profound effects on 
T cell differentiation and cytokine expression (Constant et al., 1995; Gabrysova et al., 
2011; Gabrysova and Wraith, 2010; Hosken et al., 1995; O'Garra et al., 2011). 
Therefore, we optimised our in vitro systems to study hallmark cytokine and IL-10 co-
expression in Th1, Th2 and Th17 cells subsets. 
 
Within the O’Garra laboratory a protocol for differentiating Th cells in vitro in an APC 
independent manner has been optimised. This involves the antibody anti-CD3, which 
stimulates the TCR by binding the protein CD3, and anti-CD28, which binds to CD28 
and costimulates the T cell resulting in additional signals for T cell activation. This 
method of T cell stimulation benefits from being able to stimulate TCRs of any 
specificity, and therefore transcription factor knockout mice can be used without the 
need to be crossed with a TCR transgenic line. Furthermore it is the only form of 
stimulation that can be used on human T cells. Using this system one can determine 
direct effects on T cells without the involvement of additional factors from APCs.  
 
The duration of CD4+ T cell culture in vitro and the number of times a cell is stimulated 
via the TCR and cytokine receptors can profoundly affect the concentration of cytokines 
produced (Aijo et al., 2014; O'Garra et al., 2011). Furthermore, it has been highlighted 
that once stimulated in vitro, Th cells only produce small amounts of their hallmark 
cytokines unless they are restimulated (Murphy et al., 1996). This restimulation can be 
induced with either TCR activation, such as with anti-CD3 and anti-CD28, or with a 
mix of a protein kinase C (PKC) activator, such as phorbol 12,13-dibutyrate (PDBu) or 
phorbol 12-myristate 13-acetate (PMA), and a calcium mobiliser, such as Ionomycin 
(Iono). Therefore to study cytokine production from Th cells, one must restimulate the 
cells after culture; no doubt the kinetics of this restimulation are also important in 
capturing optimal cytokine expression. 
 
To study optimal cytokine production from Th cells they must be differentiated and 
restimulated after culture. The kinetics of both differentiation and restimulation are 
important in capturing maximal cytokine expression. Thus, the conditions under which 
naïve CD4+ T cells are polarised into different Th subsets have a fundamental impact 
on cytokine expression. The type of TCR stimulation, the cocktail and dose of 




important role in determining IL-10 and hallmark cytokine production, and were 




3.2 The optimisation of in vitro differentiation of IL-10 secreting T 
helper cells: Study Aims 
To better characterise the regulation of IL-10 gene expression in Th cells, we needed to 
be able to differentiate Th cells that express their hallmark cytokines and IL-10. 
Therefore it was fundamental for future experiments that a system for differentiating IL-
10 producing Th cell subsets in vitro was optimised. With this intention, we set out to 
answer the following questions: 
 
1. How long do Th cells need to be cultured in vitro for optimal IL-10 expression 
alongside expression of hallmark cytokines? 
2. What is the optimal restimulation duration for analysis of IL-10 mRNA from 





3.3.1 Determining the optimal duration of in vitro culture of Th cells for hallmark 
cytokine and IL-10 production 
We wanted to assess the kinetics of hallmark cytokine and IL-10 production from Th1, 
Th2 and Th17 cells stimulated in vitro with anti-CD3 and anti-CD28, to evaluate the 
best duration of culture for each Th subset. 
 
3.3.1.1 Different Th cell subsets produce optimal amounts of hallmark cytokines 
and IL-10 after different durations of differentiation 
Naïve CD4+ T cells were stimulated with anti-CD3 and anti-CD28 in the presence of 
Th1, Th2 or Th17 driving cytokines and blocking antibodies as described in the 
Materials and Methods. Th1 and Th2 cells were cultured for 1, 2, 3, 5 or 7 days. Th17 
cells were cultured for 1, 2, 3, or 5 days, as Th17 cells were not split during culture, 
they do not survive beyond 5 days. Samples were stained for intracellular IL-2, IL-10 
and their associated hallmark cytokine (Figure 3.1). During the 7-day time course of 
Th1 cell differentiation IL-2, IL-10 and IFNγ production increased. Between day 3 and 
day 5 there was a dramatic increase in production of all three cytokines, and between 
day 5 and day 7 the amount of each cytokine produced almost doubled; with maximal 
amounts of IL-10 and IFNγ being produced at day 7 (Figure 3.1). A similar kinetic of 
IL-2, IL-10 and IL-4 cytokine production was seen for Th2 cells; with maximal 
amounts of IL-10 and IL-4 being produced at day 7 (Figure 3.1). In contrast Th17 cells 
showed a very different cytokine production profile. Th17 cells produced large amounts 
of IL-2 at day 1, which dramatically decreased by day 2, and then gradually increased 
again until day 5; this profile was mirrored in levels of IL-2 mRNA (data not shown). 
IL-17 production gradually increased over the time-course, while IL-10 production 
peaked at day 3 and then decreased again by day 5 (Figure 3.1). Therefore, unlike in 
Th1 and Th2 cells, IL-10 production by Th17 cells does not increase in parallel with 





Alongside intracellular cytokine staining, IL-10 and hallmark cytokine mRNA 
expression was assessed (Figure 3.2). In Th1 and Th2 cells Il10 mRNA expression 
steadily increased over the 7-day period. In contrast Th17 Il10 mRNA expression 
peaked at day 2 and then decreased again by day 5. As IL-10 protein is translated from 
mRNA, it is not surprising that in Th17 cells Il10 mRNA peaked the day before the 
protein levels peaked (Figure 3.1). Th2 cells had the highest levels of Il10 mRNA at 
day 7, while the day 2 levels of Il10 mRNA expressed by Th17 cells were greater than 
the maximum Il10 mRNA levels seen for Th1 cells at day 7 (Figure 3.2). Ifng 
expression in Th1 cells peaked at day 3; this does not mirror the increasing IFNγ protein 
levels seen over the 7 days (Figure 3.1 & 3.2). This may explained by the fact that 
when analysing intracellular cytokines the cells are restimulated, and Ifng mRNA in 
Th1 cells may not be constitutively expressed, but upon TCR signalling it may be 
dramatically upregulated. In Th2 cells Il4 mRNA expression peaked at day 5 and stayed 
high at day 7 (Figure 3.3). In Th17 cells Il17 mRNA reflected the protein by gradually 
increasing to a peak at day 5 (Figure 3.1 & 3.2). 
 
To further analyse the kinetics of the Th cell subset differentiation, the kinetics of 
master transcription factor mRNA expression were assessed (Figure 3.3). In all three 
Th cell subsets the levels of master transcription factor expression increased over the 
culture period. In Th1 cells T-bet mRNA (Tbx21) expression was very low at day 0 in 
naïve cells, with a gradual increase to day 7 (Figure 3.3). Gata3 expression in day 0 
naïve T cells was relatively high, which is not surprising as GATA3 is expressed 
throughout T cell development (Wei et al., 2011). In Th2 polarising conditions Gata3 
mRNA expression gradually increased to day 5 (Figure 3.3). In naïve T cells Rorc 
mRNA is almost undetectable, however upon stimulation in Th17 driving conditions 
Rorc levels were dramatically increased and peaked at day 3 where levels plateau 
(Figure 3.3). 
 
Therefore the day at which optimal concentrations of IL-10 and hallmark cytokines are 
produced differs between the different Th cell subsets. Additionally the mRNA profiles 
and protein profiles do not always follow the same trend, often, as expected, with 
mRNA peaking before protein. For future experiments we were interested in looking at 
both mRNA and protein and therefore a balanced time-point was chosen for the optimal 





Il10 mRNA and intracellular protein production by Th1 and Th2 cells was optimal at 
day 7 (Figure 3.1 & 3.2). Il4 and Gata3 mRNA in Th2 cells peaked earlier than 
intracellular IL-4 protein, but mRNA levels remained high at day 7 (Figure 3.1, 3.2 & 
3.3). Though Ifng mRNA expression decreased  by half after day 3 of Th1 culture, 
Tbx21 mRNA expression and IFNγ protein production peaked at day 7 (Figure 3.1, 3.2 
& 3.3). Il10 mRNA and intracellular protein in Th17 cells peaked at day 2 during the 
cell’s differentiation, while Il17 mRNA and intracellular protein and Rorc mRNA 
production were optimal at day 5 (Figure 3.1, 3.2 & 3.3). Taking all this information 
into account, and with importance placed on the further study of IL-10 expression 
alongside the expression of hallmark cytokines, the optimal duration for Th1 and Th2 
cell culture was chosen as 7 days, while for Th17 cells as 3 days.  
 
3.3.1.2 Differentiated Th1, Th2 and Th17 cells are distinctive from naïve 
activated and Th0 cells and do not produce reciprocal hallmark cytokines 
To further define Th1 and Th2 cells differentiated for 7 days, and establish their 
cytokine expression profiles, we compared them to in vitro cultured ‘naïve’ cells. As 
previously described, in the absence of cytokine signalling CD4+ T cells become 
activated and express IL-2, but do not differentiate into a Th cell subset (Murphy et al., 
1996; Shoemaker et al., 2006). Our in vitro cultured ‘naïve’ cells mimic this phenotype 
and were differentiated in culture via two methods; naïve activated cells represent naive 
CD4+ T cells that are stimulated with anti-CD3 and anti-CD28 but are not driven with 
any polarising cytokines or blocking antibodies; Th0 cells represent naïve CD4+ T cells 
that are stimulated with anti-CD3 and anti-CD28 and cultured in the presence of 
blocking antibodies for IL-4, IL-6, IL-12, IFNγ and TGFβ.  
 
Naive activated cells, as expected, only produced IL-2 intracellular protein (Figure 3.4) 
and mRNA (Figure 3.5). Interestingly, naive activated cells, which are not repressed by 
any blocking antibodies, also made minimal amounts of IFNγ protein alongside IL-2 
(Figure 3.4 & 3.5) suggesting the population may have contained some Th1 cells under 
these conditions, though the amounts were minimal compared to those seen from Th1 
cells. Th0 cells also produced very large amounts of IL-2 and no IL-10, IL-17 or 
IFNγ (Figure 3.5). However, they made small amounts of IL-4 at the protein level 




conditions, though the amounts were again insignificant compared to those seen from 
Th2 cells. 
 
Th1 cells produced large amounts of their hallmark cytokine IFNγ and there was a 
robust Th1 population producing IL-10 (Figure 3.4 & 3.5). Of note, IL-10 production 
was only seen in the IFNγ positive population of cells (Figure 3.4). This is supported by 
the literature that suggests Th1 cells make IL-10 to feedback and inhibit production of 
IL-12 by APCs to control themselves and promote anergy (O'Garra and Vieira, 2007; 
Saraiva et al., 2009). Therefore, in this APC free culture system this IL-10 will not be 
having an effect on the Th1 cells. Th1 cells did not produce IL-4 or IL-17 protein 
(Figure 3.4 & 3.5). This highlights that they are distinctive from the Th2 and Th17 cells 
and behave as characteristic in vitro cultured Th1 cells. Th2 cells made large amounts of 
the hallmark cytokine IL-4 and substantial amounts of IL-10 (Figure 3.4 & 3.5). Unlike 
the Th1 cells, Th2 cells produced IL-10 alongside IL-4 and there was a distinct 
population of IL-10+ IL-4- cells within the Th2 subset (Figure 3.4). Th2 cells did not 
produce IFNγ or IL-17 protein (Figure 3.4 & 3.5). Th17 cells produced large amount of 
the hallmark cytokine IL-17, as seen by ICS (Figure 3.4), however the amount of IL-17 
as seen by ELISA (Figure 3.5) was much less than the amount of IFNγ produced by 
Th1s or IL-4 produced by Th2s; possibly because Th17 supernatants were taken prior to 
restimulation. Like Th2 cells, Th17 cells produced IL-10 alongside IL-17 and there was 
a distinct population of IL-10+ IL-17- cells within the Th17 subset (Figure 3.4). This 
may be due to the fact that, unlike Th1 cells, Th2 and Th17 cells can respond to 
extracellular IL-10 (Coomes, In Press. ; Huber et al., 2011). Th17 cells did not produce 
IFNγ or IL-4 protein (Figure 3.4 & 3.5). Furthermore, none of the naive activated, Th0, 
Th1, Th2 or Th17 cell populations expressed the Treg master transcription factor FoxP3 
(data not shown). Therefore, after 7 days of in vitro culture of CD4+ T cells in Th1 or 
Th2 driving conditions, or after 3 days in Th17 driving conditions, we are confident that 
these cells have differentiated from naïve cells. They have robust hallmark cytokine 
expression phenotypes that are distinctive from each other, and yet the Th1, Th2 and 





3.3.2 Determining the optimal restimulation duration of differentiated Th cells for 
hallmark cytokine and IL-10 production 
We have established that stimulating naïve CD4+ T cells with anti-CD3 and anti-CD28, 
and differentiating them for 3 days for Th17 cells and 7 days for Th1 and Th2 cells, is 
the best method for optimal hallmark cytokine and IL-10 production. Now we sought to 
assess the kinetics of hallmark cytokine and Il10 mRNA expression after restimulation 
of differentiated Th1 and Th2 cells to evaluate the best restimulation time for analysis. 
This analysis was not performed on Th17 cells as the different differentiation timings 
meant the analysis could not be run in parallel. However, a microarray analysis run in 
the O’Garra lab of mRNA kinetics from Th1, Th2 and Th17 cells (Gabrysova, 
Unpublished) supported the data seen here and found similar Th17 hallmark cytokine 
and Il10 kinetics as those seen for Th1 and Th2 cells.  
 
3.3.2.1 Th1 and Th2 cells express optimal amounts of mRNA of IL-10 and 
hallmark cytokines after 4 to 6 hours of restimulation 
As we were fundamentally interested in gene expression, not only did we need to 
choose an optimal time for analysing Th cells based on intracellular protein production, 
but also on mRNA expression, as this is the best representation we have for gene 
expression. To determine the time points at which Il10 and hallmark cytokine mRNA 
expression peaked, we performed a kinetic of restimulation of differentiated Th1 and 
Th2 cells over a 24 hour period (Figure 3.6). Th1 cells expressed Ifng, Il10 and IL2 
mRNA and Th2 cells expressed Il4, Il10 and Il2 mRNA, while naive activated and Th0 
cells only expressed Il2 mRNA. In all the cell types Il2 dramatically increased to a peak 
at 4 hours, and then sharply decreased again to minimal amounts by 8 hours (Figure 
3.6).  
 
In Th1 cells, Il10 peaked at 4 hours and is maintained until 6 hours of restimulation, 
from which point it gradually decreased. Ifng was not expressed at substantial levels 
until 2 hours post restimulation, at which point it was rapidly expressed, peaking at 6 
hours, from which point expression considerably decreased again (Figure 3.6). Of note, 




levels seen before when Th1 cells were not restimulated after 7 days of differentiation 
(Figure 3.2), suggesting Th1 cells need restimulation to drive maximal Ifng production. 
 
In Th2 cells, Il10 mRNA expression gradually increased from 0 to 6 hours post 
restimulation, at which point it peaked. Over the next four hours, from 6 to 10 hours 
post restimulation, Il10 expression decreased to levels similar to those seen in Th1 cells, 
where it was maintained for the remainder of the time-course. The expression of Il4 
mRNA peaked at 6 hours post restimulation. Il4 mRNA levels then decreased and were 
maintained at about half the maximal amount for the remainder of the time-course 
(Figure 3.6). Therefore, for differentiated Th1 and Th2 cells, Il10 mRNA expression 
peaked between 4 to 6 hours, Il2 expression peaked at 4 hours, and the hallmark 





The anti-inflammatory roles of IL-10 are fundamental in regulating and maintaining a 
balanced immune response (Moore et al., 2001). CD4+ T cells are thought to be one of 
the major sources of IL-10 (Roers et al., 2004). However, owing to the complex nature 
of Th cell in vitro differentiation, a full understanding of the factors regulating IL-10 
expression is incomplete. To further our understanding of IL-10 regulation in Th cells, 
we first needed to optimise the differentiation of different Th subsets in vitro, for both 
hallmark cytokine production and IL-10 production at the protein and mRNA level. 
Therefore, with the aim of finding the optimal in vitro differentiation conditions for Th1, 
Th2 and Th17 cells, we set out to test the effect of different culture conditions including 
TCR stimuli, culture durations, restimulation kinetics, and cytokine stimuli.  
 
It is important to note that CD4+ T cells differentiated in vitro may not always be 
comparable to those that occur in vivo (Zhu et al., 2010). The study of in vivo 
specification of Th cells is important for understanding the factors involved in 
controlling infection, and crucial for identifying potential therapeutic interventions. It 
has been suggested that Th cells differentiated in vitro may represent the highly 
polarised cells that are found in unusual cases in vivo, such as during chronically 
infected or diseased tissue (Messi et al., 2003; O'Garra et al., 2011; Zhu et al., 2010). 
Nevertheless, the reductionist approaches of studying Th cells in vitro are central for 
investigating cells that are typically found in low numbers in vivo, and for in-depth 
molecular analysis of cytokine gene expression and regulation.  
 
3.4.1 Different durations of differentiation are required for optimal hallmark cytokine 
and IL-10 production by different Th cell subsets  
3.4.1.1 Robust Th1 and Th2 cell populations can be differentiated in vitro after 7 
days 
Analysis of Th1 and Th2 hallmark cytokines, IFNγ and IL-4, respectively, at the 
intracellular protein level revealed that the highest concentrations were produced after 7 




mRNA level, peaked at day 7. Th2 cell IL-4 mRNA peaked at day 5 which fits with the 
fact that mRNA is translated into protein and therefore there is likely to be a delay in 
the detectability of protein. Furthermore, GATA3 in Th2 cells increased over the 7-day 
period. Th1 cell IFNγ mRNA peaked at day 3 and then decreased again, which did not 
reflect the intracellular protein profile of IFNγ, which peaked at day 5. This is not 
surprising, however, as it has been shown that Th cells often need restimulation to 
maintain high levels of cytokines, and that after initial stimulation cytokine expression 
is not maximal (O'Garra et al., 2011; Saraiva et al., 2009; Zeng, 2013). In these 
experiments, samples taken for mRNA analysis were not restimulated, whereas samples 
taken for intracellular protein analysis were restimulated. T-bet, the Th1 master 
regulator, increased over the 7 day period to a peak at day 7. Therefore, for hallmark 
cytokine and IL-10 production by Th1 and Th2 cells, 7 days is the optimal duration of 
culture. 
 
The fact that IL-10 expression in Th1 and Th2 cells follows a similar expression pattern 
to the hallmark cytokines is not unexpected, as the factors that drive IL-10 in these cells 
are intertwined with those coordinating differentiation. In Th2 cells IL-4, STAT6 and 
GATA3 regulate IL-10 expression (Saraiva and O'Garra, 2010), and IL-10 is expressed 
constitutively. In Th1 cells IL-12, alongside strong TCR triggering, are required for 
maximal IL-10 expression (Saraiva et al., 2009). Furthermore, in Th1 cells IL-10 is 
thought to be expressed as the cells terminally differentiate, acting as negative feedback 
on APCs to control their IL-12 and proinflammatory cytokine production (O'Garra and 
Vieira, 2007; Trinchieri, 2007), and potentially causing Th1 anergy (O'Garra et al., 
2011; Saraiva et al., 2009).  
 
We also compared the cytokine expression profiles of differentiated Th1 and Th2 cells 
to in vitro cultured ‘naïve’ cells. Analysis of mRNA, protein and intracellular cytokine 
production of naive activated, Th0, Th1 and Th2 cells showed that we can differentiate 
naïve T cells into these fours subsets and they have the characteristics one would 
expect; naive activated and Th0 cells did not produce meaningful amounts of any 
cytokines other than IL-2; Th1 cells produced high levels of IFNγ and intermediate 
amounts of IL-10; Th2 cells produce high levels of IL-4 and IL-10. The differentiation 
of Th cells under these optimised conditions provided good representations and controls 




(Saraiva et al., 2009; Shoemaker et al., 2006), different T helper cell subsets have 
distinct cytokine profiles, and that they are in agreement with the proposed roles for 
these cells within the immune response. Th1 cells produce IFNγ to aid clearing of 
intracellular pathogens (O'Garra, 1998), while Th2 cells produce IL-4 to promote the 
removal of helminths (Zhu, 2010), they both produce IL-10 to downregulate excessive 
pathological responses (Jankovic et al., 2010; Saraiva and O'Garra, 2010).  
 
Th0 cells are an in vitro subset driven in conditions designed to maintain them in an 
active naïve state. When Th cells are initially activated, before they encounter polarising 
cytokines, they produce IL-2 to drive their own proliferation but as they have not yet 
differentiated they do not express hallmark cytokines. Naive activated cells are also an 
in vitro subset, however unlike Th0 cells they are not suppressed with antibodies, and 
unlike Th1 and Th2 cells they are not driven in the presence of polarising cytokines. 
Therefore their lack of production of hallmark cytokines indicates that our conditions 
did not drive Th cells to differentiate into a specific subset unless polarising cytokines 
were added. Their lack of differentiation also indicates that we are stimulating with an 
optimal levels of anti-CD3 and anti-CD28, as work from our lab reveals that when 
naive activated cells are stimulated with too high or too low a dose they may 
spontaneously differentiate down a Th1 or Th2 like pathway, respectively (Saraiva et al., 
2009). In addition, if the stimulation dose is too low naive activated cells may, under 
certain conditions, express FoxP3 (Gabrysova et al., 2011), which was not detectable in 
our naive activated population (data not shown). Therefore we are confident that our in 
vitro cultured Th1 or Th2 cells differentiated from naïve cells and have robust cytokine 
expression phenotypes that are distinct from each other. 
 
3.4.1.2 Th17 cells produce optimal IL-10 after 3 days and optimal IL-17 after 5 
days of differentiation in vitro 
Our study of the Th17 cell hallmark cytokine, IL-17, at the intracellular protein and 
mRNA levels revealed that the largest amounts were produced after 5 days of culture. 
Furthermore, RORγt expression increased over the time-course to a plateau at day 3. 
However, IL-10 did not follow the same profile as IL-17. IL-10 mRNA expression 
peaked at day 2 and intracellular IL-10 protein peaked at day 3. By day 5, IL-10 mRNA 




differentiation. Therefore the optimal duration for culture of Th17 cells is complex as 
IL-17 and IL-10 peak on different days. Unlike IL-10 production by Th1 and Th2 cells, 
in Th17 cells IL-10 production is highly variable and inconsistent. This is likely to be 
due to the fact that Th17 cells are highly plastic, and it has been suggested they are 
constantly balancing between becoming ‘pathogenic’ or ‘regulatory’ (Bettelli et al., 
2006). Pathogenic Th17 cells, which are promoted by IL-23 and IL-1β, begin to express 
IFNγ; regulatory Th17 cells, which are promoted by TGFβ, lose IL-17 expression and 
can begin to express FoxP3 and/or IL-10 (Beriou et al., 2009; Bettelli et al., 2006; 
Gagliani et al., 2015; Ghoreschi et al., 2010; Hirota et al., 2011; McGeachy et al., 2007; 
Zhou et al., 2008; Zielinski et al., 2012). Nevertheless, after 3 days of culture we 
managed to differentiate IL-17 and IL-10 producing Th17 cells that did not express 
IFNγ or FoxP3. Though at day 3 IL-17 expression was not at its peak, it was robust at 
both the mRNA and intracellular protein level, and RORγt expression had plateaued. 
Therefore we considered these cells to be differentiated Th17 cells that have not yet 
turned off IL-10 expression. 
 
3.4.2 Th1, Th2 and Th17 cells are heterogeneous with regard to hallmark cytokine 
and IL-10 production 
Intracellular cytokine staining of the hallmark cytokines and IL-10 in Th1, Th2 and 
Th17 cells revealed that cytokine production is highly heterogeneous within these 
populations of cells (Figure 3.7). Within the Th1 subset you have three distinct 
cytokine producing subpopulations: IFNγ- IL-10-, IFNγ+ IL-10- and IFNγ+ IL-10+. 
Within the Th2 subset you have four distinct cytokine producing subpopulations: IL-4- 
IL-10-, IL-4+ IL-10-, IL-4- IL-10+ and IL-4+ IL-10+. Within the Th17 subset you also 
have four distinct cytokine producing subpopulations: IL-17- IL-10-, IL-17+ IL-10-, IL-
17- IL-10+ and IL-17+ IL-10+. 
 
Interestingly, in the Th1 subset only the cells that produceed high levels of IFNγ also 
produceed IL-10. None of the Th1 cells that were negative for IFNγ produced IL-10, in 
contrast to what was seen for Th2 and Th17 cells, where IL-4 or IL-17 negative cells 
could make IL-10. This phenomenon supports concepts found in the literature. Highly 




pathogenicity via an intercellular, paracrine feedback mechanism (O'Garra and Vieira, 
2007; Trinchieri, 2007). APCs produce IL-12 in response to pathogens, which initiates 
the differentiation of Th1 cells that promote eradication of the pathogen (Hsieh et al., 
1993b). However, to control this process the Th1 cells also make IL-10, which then 
suppresses the APC IL-12 production to reduce the Th1 response (Murray, 2006b). Th2 
cells and Th17 cells, conversely, both produce their own driving cytokines, IL-4 and IL-
6/TGFβ respectively (Fiorentino et al., 1989; Gutcher et al., 2011; Korn et al., 2009; 
Mosmann et al., 1986), and therefore this intercellular, paracrine feedback mechanism 
does not exist. However, the IL-10 Th2 and Th17 cells produce may feedback on the 
cells themselves in an autocrine manner to prevent IL-4 and IL-6/TGFβ production 
(Coomes, In Press. ; Huber et al., 2011; Murai et al., 2009). This may explain why we 
can see Th2 and Th17 cells that only produce IL-10 without their hallmark cytokine. 
 
3.4.3 4 hours of restimulation is optimal for production of IL-10 and hallmark 
cytokines by Th cells  
We have observed, and previous publications concur, that Th cells require restimulation 
to produce maximal amounts of cytokines (Helmstetter et al., 2015; O'Garra et al., 
2011; Prussin and Metcalfe, 1995; Saraiva et al., 2009). Therefore we set out to 
investigate the best timings for restimulation of differentiated Th cells for mRNA 
expression of hallmark cytokines and importantly IL-10.  
 
To address this we performed a time-course of restimulation of Th1 and Th2 cell 
cytokine mRNA expression. This analysis was not performed on Th17 cells, however, a 
microarray analysis run of mRNA kinetics from Th1, Th2 and Th17 cells (Gabrysova, 
Unpublished) found similar Th17 hallmark cytokine and Il10 kinetics as those seen for 
Th1 and Th2 cells. mRNA levels for Il10 and hallmark cytokines mostly peaked at 6 
hours post restimulation. After 6 hours, Il10, Ifng and Il4 levels dramatically decreased. 
This lead to the concern that mRNA levels may begin to decrease before cells could be 
fixed or lysed, as the process of removing cells from the culture plates and cell surface 
protein staining takes a considerable amount of time. Therefore, for future experiments, 





3.4.4 Conclusions and future plans for studying the regulation of IL-10 in in vitro 
differentiated Th1, Th2 and Th17 cells 
We have optimised the conditions in which Th1, Th2 and Th17 cells can be 
differentiated in vitro for hallmark cytokine and IL-10 production. Th1 and Th2 cells 
are cultured for 7 days, while Th17 cells are cultured for 3 days. All cells are 
restimulated for 4 hours after differentiation, before samples are taken. With these 
protocols in place, we can study the regulation of IL-10 within these Th cell subsets. 
However, as highlighted in Figure 3.7, these subsets are highly heterogeneous with 
regard to cytokine production. All of the Th cell subsets contain subpopulations of cells 
that express different combinations of cytokines. Therefore to fully elucidate what 
factors may be involved in the regulation of IL-10 in Th cells, in the following chapters, 
we have developed methods to separate these subpopulations and investigate the 






Figure 3.1 Intracellular IL-10 and hallmark cytokine production by Th1, Th2 and 
Th17 cells driven with anti-CD3 and anti-CD28 at different days after 
differentiation from naïve cells 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with anti-CD3 and anti-
CD28, and polarised to Th1 cells with IL-12 and anti-IL-4 or Th2 cells with IL-4, IL-2, 
anti-IL-12 and anti-IFNγ or Th17 cells with TGFβ, IL-6, anti-IL-4, anti-IL-12 and anti-
IFNγ. Plots of flow cytometric analysis of intracellular cytokine staining, cells were 
assessed after 1, 2, 3, 5 or 7 days of polarization in vitro and restimulated for ICS as 
described in Materials and Methods. Numbers show percentage of live CD4+ cells. 







Figure 3.2 mRNA of cytokine production by Th1, Th2 and Th17 cells driven with 
anti-CD3 and anti-CD28 at different days after differentiation from naïve cells 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with anti-CD3 and anti-
CD28, and polarised to Th1 cells with IL-12 and anti-IL-4 or Th2 cells with IL-4, IL-2, 
anti-IL-12 and anti-IFNγ or Th17 cells with TGFβ, IL-6, anti-IL-4, anti-IL-12 and anti-
IFNγ. Graphs of transcription factor mRNA measured by qPCR relative to HPRT. Cells 
were harvested and mRNA was extracted with no restimulation after 1, 2, 3, 5 or 7 days of 
polarization in vitro. Graphs show means ± SD of triplicates. Representative of one 
experiment. 
  











































































































































Figure 3.3 mRNA of master transcription factor expression by Th1, Th2 and Th17 
cells driven with anti-CD3 and anti-CD28 at different days after differentiation 
from naïve cells 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with anti-CD3 and anti-
CD28, and polarised to Th1 cells with IL-12 and anti-IL-4 or Th2 cells with IL-4, IL-2, 
anti-IL-12 and anti-IFNγ or Th17 cells with TGFβ, IL-6, anti-IL-4, anti-IL-12 and anti-
IFNγ. Graphs of transcription factor mRNA measured by qPCR relative to HPRT. Cells 
were harvested and mRNA was extracted with no restimulation after 1, 2, 3, 5 or 7 days of 
polarization in vitro. Graphs show means ± SD of triplicates. Representative of one 
experiment.  













































































Figure 3.4 Intracellular cytokine production by naïve activated, Th0, Th1, Th2 and 
Th17 cells after optimal days of differentiation for peak cytokine production 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-CD3 
and soluble anti-CD28, and polarised to naïve activated cells with medium alone; Th0 cells 
with anti-IL-4, anti-IL-12, anti-IFNγ, anti-IL-6 and anti-TGFβ; Th1 cells with IL-12 and 
anti-IL-4; Th2 cells with IL-4, IL-2, anti-IL-12 and anti-IFNγ; Th17 cells with TGFβ, IL-6, 
anti-IL-4, anti-IL-12 and anti-IFNγ. Plots of flow cytometric analysis of intracellular 
cytokine staining, naïve activated, Th0, Th1 and Th2 cells were assessed after 7 days of 
polarization in vitro, Th17 cells were assessed after 3 days of polarization in vitro. Cells 
were restimulated for ICS as described in Materials and Methods. Numbers show 







Figure 3.5 ELISA of IL-10 and hallmark cytokine protein production by naïve 
activated, Th0, Th1, Th2 and Th17 cells after optimal days of differentiation  
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-
CD3 and soluble anti-CD28, and polarised. Naïve activated cells with medium alone; 
Th0 cells with anti-IL-4, anti-IL-12, anti-IFNg, anti-IL-6 and anti-TGFb; Th1 cells with 
IL-12 and anti-IL-4; Th2 cells with IL-4, IL-2, anti-IL-12 and anti-IFNγ; Th17 cells 
with TGFβ, IL-6, anti-IL-4, anti-IL-12 and anti-IFNγ. Graphs of enzyme-linked 
immunosorbent assay of cytokines in supernatants. Naïve activated, Th0, Th1 and Th2 
cells were assessed after 7 days of polarization in vitro, Th17 cells were assessed after 3 
days of polarization in vitro. Cells were restimulated for ELISA as described in 




















































































Figure 3.6 mRNA of cytokines expressed upon restimulation of naïve activated, 
Th0, Th1 and Th2 cells driven with anti-CD3 and anti-CD28 after 7 days of 
differentiation from naïve cells 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-CD3 
and soluble anti-CD28, and polarised to NIL cells with medium alone, Th0 cells with anti-
IL-4, anti-IL-12, anti-IFNγ, anti-IL-6 and anti-TGFβ, Th2 cells with IL-4, IL-2, anti-IL-12 
and anti-IFNγ or Th1 cells with IL-12 and anti-IL-4.  Graphs of cytokine mRNA measured 
by qPCR relative to HPRT. Cells were harvested after 7 days of polarization in vitro and 
restimulated for the specified time with plate-bound anti-CD3 and soluble anti-CD28. Cells 
were restimulated for mRNA extraction as described in Materials and Methods. 
Representative of one to two experiments.  
  
































































































Figure 3.7 Summary of the heterogeneity in IL-10 and hallmark cytokine 
production by Th1, Th2 and Th17 cells when differentiated after optimal days of 
differentiation  
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-
CD3 and soluble anti-CD28, and polarised to Th2 cells with IL-4, IL-2, anti-IL-12 and 
anti-IFNγ, or Th1 cells with IL-12 and anti-IL-4, or Th17 cells with TGFb, IL-6, anti-
IL-4, anti-IL-12 and anti-IFNγ. Plots of flow cytometric analysis of intracellular 
cytokine staining, cells restimulated as described in Materials and Methods, 3 days for 
Th17 cells and 7 days for Th1 and Th2 cells of polarization in vitro. Numbers show 










Chapter 4. The optimisation of RNA extraction 
and RNA-Sequencing analysis of intracellular 






CD4+ T cells are fundamental to a balanced and effective immune response. The 
different Th subsets secrete particular proinflammatory cytokines that drive specific 
immune responses to eradicate the invading pathogens (Zhu et al., 2010). However, 
these proinflammatory actions can also be harmful to the host if excessive and 
unregulated or inappropriate. Therefore, Th cells also secrete the regulatory cytokine 
IL-10 (Maynard and Weaver, 2008; Saraiva and O'Garra, 2010), that feeds back directly 
and indirectly to reduce CD4+ T cell proinflammatory cytokine secretion and 
proliferation (Ouyang et al., 2011). Each Th subset secretes a repertoire of different 
cytokines, but as shown in Chapter 3 (Figure 3.7), within that Th population the cells 
have heterogeneous cytokine secretion profiles. It is increasingly understood that genes 
associated with subpopulations of cells within a heterogeneous population cannot be 
revealed unless these cells are separated from the bulk population (Mahata et al., 2014) 
(Kuchroo VK, International Congress of Immunology, 2013). Therefore, to better 
understand the common and disparate mechanisms involved in regulating hallmark 
cytokine and IL-10 expression, we want to separate the Th subsets into subpopulations 
and analyse the differential gene expression patterns within these populations using 
RNA-Seq. By doing this we hope to glean information from different cytokine secreting 
subpopulations, particularly IL-10 producers, which could be difficult to detect when 
analysing only the bulk population of a Th subset. 
 
Four approaches could be used to separate these Th cell subpopulations: 1) using a 
cytokine secretion assay, 2) using transgenically modified cytokine reporter mice, 3) 
using single cell RNA-Seq, 4) using intracellular cytokine staining (ICS). These three 
approaches all have pros and cons, which I will now discuss. 
 
Cytokine secretion assays can be used to detect cytokines secreted by cells. With these 
assays, cells are labelled with cytokine specific ‘catch-reagents’ that then bind the 
specific cytokine when it is secreted by that cell. These cytokines are subsequently 
labelled with specific detection fluorescent antibodies, which can then be detected by 
FACS (Kaufmann and Kabelitz, 2002). Unlike ICS, cells selected with the cytokine 
secretion assay can continued to be cultured (Chang et al., 2007) or used for other 
downstream analysis, such as the analysis of RNA (Ahyi et al., 2009). However, these 




therefore production can be underrepresented (Helmstetter et al., 2015; Kaufmann and 
Kabelitz, 2002). Furthermore, diffuse cytokine molecules accumulate in the culture and 
other cells can catch low amounts of the cytokine and are subsequently labelled 
(Kaufmann and Kabelitz, 2002); resulting in non-cytokine producing cells being 
labelled as cytokine producing. This technique is further limited by the availability of 
specific cytokine assays, which are only produced for a small selection of cytokines in a 
limited selection of fluorochromes.  
 
In the last 15 years multiple mouse strains have been developed that are transgenically 
modified to express a reporter, such as a fluorescent molecule, whenever a gene is 
expressed. For example the ‘4get’ mouse, where green fluorescent protein (GFP)(Tsien, 
1998) has been incorporated into the Il4 locus such that a fluorochrome molecule is 
expressed whenever the IL-4 gene is transcribed (Mohrs et al., 2001). However, one can 
only look at one specific cytokine with these reporter mice. Therefore, dual reporter 
mice have been developed that can report on two cytokines at once. For example the 
‘4get’ mouse, reporting IL-4 as GFP, has been crossed to the ‘YETI’ mouse, where 
yellow fluorescent protein (YFP) has been incorporated into the Ifng locus (Stetson et 
al., 2003). Thus these mice can report IL-4 (GFP) and IFNγ (YFP) simultaneously. The 
major benefit of this system is that using this mouse one can track cells that are 
expressing certain cytokines without having to disrupt the cells with techniques such as 
fixation or permeablisation that may reduce mRNA quality. However, there are several 
caveats to this system. Firstly, reporter mice have only been developed for a handful of 
cytokines, and therefore we would have to generate new reporter mice for any cytokines 
that do not currently have corresponding reporter mice. Secondly, as we want to look at 
IL-10 alongside the hallmark cytokines we would have to cross multiple reporter mice 
strains. Furthermore, if in the future we want to look at the cytokine secreting Th cell 
subpopulations in gene knockout mice we would have to again cross our reporter mice 
strains with these knockout stains, and this method could never be used on human cells. 
All of which would be very costly and time-consuming. Simultaneously, another facet 
of separating Th cells based on this method is that fluorescent reporters do not fully 
correlate to intracellular protein production (Kamanaka et al., 2006; Mohrs et al., 2005). 
The fluorescent reporter is transcribed alongside the cytokine’s mRNA, however, as 
previously discussed, cytokines have many checkpoints of post-transcriptional 




fluorescence is reporting all cells that are transcribing the cytokine, some of which may 
not produce the protein.  
 
Single cell RNA-Seq is a technique by which individual cells from within a 
heterogeneous population of cells can be analysed at the mRNA level (Tang et al., 
2010a; Tang et al., 2010b; Tang et al., 2009). Using this technique it is possible to 
differentiate Th cells and then process multiple individual cells from within the 
population for their mRNA expression profiles to establish what cytokines they were 
expressing, and what genes are associated with these expression profiles. This can be 
performed on cells from any organism including humans and knockout mice, and the 
cells are not disrupted in any way prior to mRNA extraction. However, there are many 
limitations at both the processing and analysis stages with this technique (Saliba et al., 
2014; Tang et al., 2011). As this technique selects individual cells, there is often a bias 
towards more highly expressed genes in the processing of the samples with low-
expression genes showing higher inter-sample variability (Wu et al., 2014). 
Furthermore, the selection of cells taken for the single cell RNA-Seq is effectively 
random and therefore many samples are required for representative coverage – there is 
always a risk that certain cytokine expressing subpopulations will not be selected. 
Finally, and primarily for our study, we want to be able to perform a comparison 
between protein production and mRNA expression. Single cell RNA-Seq does not allow 
us to do this as it only assesses cells at the mRNA level, and as we are aware cells can 
express high levels of a certain mRNA without actually producing detectable amounts 
of the protein (Powell et al., 2000), this technique is not well suited for this project. 
 
We want to tie IL-10 and hallmark cytokine protein production to mRNA expression, 
and to transcription factors and other genes associated with Il10 regulation, and we want 
to be able to do this with cells from any mouse stain or from humans. Therefore, we 
decided to investigate if we could use ICS and fluorescence assisted cell sorting (FACS) 
to separate Th cell subpopulations for RNA-Sea analysis. ICS and flow cytometric 
techniques for analysis of CD4+ T cells are well developed within the O’Garra lab 
(Barrat et al., 2002; Gabrysova et al., 2011; Murphy et al., 1996; Openshaw et al., 1995; 
Saraiva et al., 2009; Vieira et al., 2004). However a major obstacle is that for ICS the 
cells must be fixed and permeablised, to enable the cytokine staining antibodies to enter 
the cells. Once fixed and permeablised there is very little further analysis one can 




intracellular stained samples is that fixation is known to fragment mRNA (Opitz et al., 
2010), and this may hinder RNA-Seq analysis. However, there is literature suggesting 
that microarray can be performed on fragmented mRNA (Haller et al., 2006; Hodgin et 
al., 2010), but it may be a concern for RNA-Seq analysis. To overcome this a recent 
publication implemented a technique that enables RNA-Seq analysis of different cell 
subpopulations based on protein as seen by intracellular protein staining by 
incorporating RNase inhibitors throughout the protocol (Hrvatin et al., 2014a). Though 
this technique was developed on human stem cells, and was not performed on cytokines, 
practices of this protocol could be used to aid us in developing a method for separating 







4.2 Separating T helper cells into different cytokine expressing 
populations for analysis by RNA-Seq: Study Aims 
We want to establish a method for separating Th cell subset subpopulations based on 
their intracellular cytokine protein profiles for analysis by RNA-Seq. However, when 
starting this project there was no literature on performing RNA-Seq on ICS samples and 
fixation is thought to fragment mRNA. Therefore we set out to fulfil the following aims, 
with the overall aim of designing an optimised protocol for performing RNA-Seq on 
ICS samples.  
 
1. Establish a protocol in which mRNA, which is suitable for RNA-Seq analysis, 
can be extracted from ICS samples. 
2. Establish if mRNA from ICS samples is comparable to mRNA from non-ICS 
samples. 
3. To validate this technique: when performing RNA-Seq on ICS Th1 and Th2 






4.3.1 Investigating the quality of mRNA extracted from intracellular cytokine stained 
samples 
We were interested in separating Th cell subpopulations based on their intracellular 
cytokine profiles for analysis by RNA-Seq. However, the literature suggested that 
standard the protocol for ICS (Figure 4.1 A) may result in low quality degraded mRNA 
(Opitz et al., 2010). Cells prepared for ICS (Figure 4.1 A) or mRNA extraction (Figure 
4.1 B) are both restimulated after in vitro differentiation, however after this step bulk 
populations of cells for mRNA are normally immediately lysed and frozen, while cells 
for ICS are stained, fixed and permeablised. We wanted to find a way to combine these 
two protocols; to isolate mRNA from samples after flow cytometric sorting of the Th 
cell subpopulations. From now on mRNA isolated from ICS samples (Figure 4.1 A) 
will be referred to as ‘fixed’ while mRNA isolated using the standard mRNA 
preparation protocol (Figure 4.1 B) will be referred to as ‘unfixed’. Therefore we set 
out to investigate the quality of mRNA extracted from ICS ‘fixed’ samples to ascertain 
whether it could be used for RNA-Seq analysis. 
 
4.3.1.1 mRNA from fixed samples is comparable to mRNA from unfixed samples 
when analysed by qPCR 
Th1 and Th2 cells were cultured in vitro as described in Chapter 3. These samples were 
then split in half, with one portion being prepared for ICS (Figure 4.1 A) and, as a 
comparison, the other portion being prepared for standard mRNA extraction (Figure 
4.1 B). mRNA from these samples was analysed by qPCR. We found that the fixed and 
unfixed Th1 samples had equivalent levels of Ifng mRNA and undetectable amounts of 
Il4 mRNA (Figure 4.2 A). Fixed Th2 cells were shown to express slightly more Il4 
mRNA than unfixed Th2 cells. Both fixed and unfixed Th2 samples expressed 
undetectable amounts of Ifng mRNA (Figure 4.2 A). Therefore mRNA from fixed Th 
samples could be analysed by qPCR and the levels of hallmark cytokine mRNA were 





4.3.1.2 mRNA from fixed samples is of low quality 
Th1 and Th2 cells were cultured in vitro as described in Chapter 3. These samples were 
then split in half, with one portion being prepared for ICS (Figure 4.1 A) and the other 
portion being prepared for standard mRNA extraction (Figure 4.1 B). The integrity of 
the mRNA from these samples was analysed by electropherogram (Figure 4.2 B). 
mRNA from unfixed samples had high RNA integrity numbers (RINs), reflective of 
good RNA quality, with clear 18S and 28S rRNA peaks, the 28S peak being larger than 
the 18S peak and with little noise between the peaks or before the 18S peak. However, 
mRNA from the fixed samples had low RINs, having lost both peaks and there was 
increased noise throughout the electropherogram. Furthermore, there was significantly 
less material in the fixed samples (Figure 4.2 B). This showed mRNA from fixed 
samples is fragmented or degraded.  
 
4.3.1.3 mRNA from fixed samples is degraded when cells are permeablised 
Th2 cells were cultured in vitro as described in Chapter 3. These samples were then 
prepared for ICS (Figure 4.1 A), with samples for mRNA extraction being taken at 
each step of the ICS process. Samples were taken: 1) straight after restimulation, as with 
standard mRNA preparation, 2) after restimulation and formaldehyde fixation, 3) after 
restimulation, formaldehyde fixation and permeablisation, 4) after restimulation, 
formaldehyde fixation, permeablisation and intracellular cytokine staining. The integrity 
of these mRNA samples was analysed by electropherogram (Figure 4.3 A). mRNA 
from unfixed samples in condition 1) had high RINs, with clear 18S and 28S rRNA 
peaks and little noise between the peaks or before the 18S peak. The same was true for 
fixed samples that had not been permeablised in condition 2). However, after 
permeablisation, in conditions 3) and 4), the samples had low RINs, having lost both 
peaks and there was increased noise throughout the electropherogram (Figure 4.3 A). 
Having confirmed that permeablisation, rather than fixation, led to reduced RINs, we 
wanted to establish if the RNA was fragmented or degraded. If the samples were 
fragmented then RNA-Seq should be possible and previous publications have shown 
that microarray can be performed on fragmented samples (Haller et al., 2006; Hodgin et 
al., 2010). However, if the samples were degraded then information would be lost and 




samples prepared in conditions 1) which were not fixed and had high RINs (referred to 
as unfixed), or 4) which were fixed, permeablised and stained and had low RINs 
(referred to a fixed). We wanted to establish if permeablisation led to alterations in the 
representation of individual transcripts by looking for bias in gene coverage (Figure 4.3 
B). We found that fixed samples had an increased detection of transcripts at the 3’ end 
relative to the 5’ end, demonstrating a 3’-coverage bias (Figure 4.3 B). This is 
indicative of mRNA degradation by ribonucleases (Auer et al., 2003), rather than 
fragmentation. 
 
4.3.2 Investigating whether the addition of RNase inhibitors prevents RNA 
degradation in fixed samples 
Our data suggested that ribonucleases, also known as RNases, may have caused the 
mRNA degradation we saw upon permeablisation of samples. This is supported by a 
recent publication, which performed microarray and RNA-Seq analysis on fixed 
intracellular protein stained human cells, and showed that if the staining protocol was 
performed in the presence of high concentrations of RNase inhibitors, then high quality 
RNA can be extracted from the samples (Hrvatin et al., 2014a). Therefore we wanted to 
establish whether the RNase inhibitors would prevent the degradation of mRNA we see 
after preparing samples for ICS. To do this we added RNase inhibitors from the fixation 
step onwards (Figure 4.4). We wanted to ensure that mRNA extracted from these 
samples was of high quality and comparable to mRNA from unfixed samples, and 
without the loss of detection of particular transcripts. Therefore we set up a study in 
which Th1 and Th2 cells were differentiated in vitro and then the whole population of 
Th cells was split into two and restimulated, as optimised in Chapter 3 and described in 
Materials and Methods. One portion of the cells was immediately transferred into RLT 
buffer and RNA was extracted using the RNeasy Micro kit (Figure 4.5 A). The other 
portion of cells was prepared using the ICS protocol shown in Figure 4.4 with the 
addition of RNase inhibitors, and cells were sorted on the flow cytometer for live CD4+ 
cells and RNA was extracted using the FFPE RNeasy kit (Figure 4.5 A). 
 
The integrity of the mRNA extracted from these samples was analysed by 
electropherogram (Figure 4.5 B). mRNA from the unfixed Th1 and Th2 samples had 




mRNA from the fixed Th1 and Th2 samples also had high RINs of 9, with clear rRNA 
peaks and little noise throughout the electropherogram (Figure 4.5 B). To further assess 
the quality of the samples we ran RNA-Seq on the RNA and assessed the representation 
of individual transcripts by looking for bias in the gene coverage (Figure 4.5 C). We 
found that though the fixed samples had a very slight increase in the detection of 
transcripts at the 3’ end relative to the 5’ end, it was not sufficient to be regarded as a 
3’-coverage bias. In fact, there was a more even coverage of the gene bodies in the fixed 
samples, as the unfixed samples had a slight 5’-coverage bias (Figure 4.5 C). This 
indicates that the addition of RNase inhibitors throughout the ICS protocol prevents the 
degradation of mRNA from fixed samples, allowing for RNA-Seq analysis to fully 
cover the 3’ to 5’ of genes. 
 
4.3.3 Investigating the similarity between fixed and unfixed Th1 and Th2 samples 
4.3.3.1 Comparison of fixed and unfixed Th1 and Th2 samples at the whole gene 
expression level by RNA-Seq 
Having established that we could extract high quality mRNA from ICS samples when in 
the presence of RNase inhibitors, we set out to further establish the similarities between 
the fixed and unfixed samples. We wanted to conclusively determine whether fixed 
samples were equivalent to unfixed samples. The samples were processed for RNA-Seq 
and analysed as described in the Materials and Methods. 
 
The first test we ran to compare the unfixed and fixed samples involved calculating the 
Pearson’s coefficient between the fixed and unfixed samples within each replicate 
experiment for Th1 cells and Th2 cells (Figure 4.6). In the coefficient, an R2=1 means 
that the samples are identical. For each of the three experiments, comparing fixed and 
unfixed Th1 or Th2 cells, the R2 was consistently greater than 0.96 (Figure 4.6). 
Therefore, the interpretation from the Pearson’s Coefficients was that the fixed and 
unfixed samples were reliably almost indistinguishable. However, as the R2 were not 
equal to 1, it was considered that some differences might exist between the samples. 
Therefore we further analysed these samples to try to establish what these differences 





For the Th1 cells we averaged the number of genes expressed in each of the six 
samples: three unfixed samples, and three fixed samples (11,848 genes). 93% of these 
genes were expressed in all six samples, both in the fixed and unfixed samples (Figure 
4.7 A). Therefore, on average, 7% of genes did not overlap between the fixed and 
unfixed samples; 6% of these genes were expressed in only the fixed samples, and 1% 
of the genes were expressed in only the unfixed samples (Figure 4.7 A). It is possible 
that the ICS protocol may lead to the loss or overrepresentation of certain mRNA 
molecules. Consequently we looked at greater depth into whether these genes were 
consistently differentially expressed between the two conditions. Looking at each repeat 
individually, we compiled a list of the genes that were expressed in unfixed samples but 
not expressed in the fixed samples. For repeat 1, this list consisted of 101 genes, which 
was 0.9% of the total number of genes expressed by that sample (Figure 4.7 B). For 
repeat 2, there were 50 genes, which was 0.4% of the total, and for repeat 3 there were 
274 genes, which was 2.3% of the total (Figure 4.7 B). Of these genes, only 27 were 
present in any two of the three repeats. None of the genes were present in all three of 
the repeats (Figure 4.7 B). Therefore, though there were some genes that were only 
expressed in the unfixed samples, no genes were repeatably overrepresented in the 
unfixed samples. Next, we compiled a list of the genes that were expressed in fixed 
samples but not expressed in the unfixed samples. For repeat 1, this list consisted of 
1035 genes, which was 8.8% of the total number of genes expressed by that sample 
(Figure 4.7 C). For repeat 2, there were 684 genes, which was 5.7% of the total, and for 
repeat 3 there were 323 genes, which was 2.8% of the total (Figure 4.7 C). Of these 
genes, 344 were present in any two of the three repeats. 97 of the genes were present in 
all three of the repeats (Figure 4.7 C), which was 0.8% of the 11,848 average total 
number of genes expressed in the samples. Therefore, though there were some genes 
that were only expressed in the fixed samples, very few were repeatably 
overrepresented in the fixed samples, indicating these may be random differences. 
 
We performed a similar analysis with the Th2 cells. For the Th2 cells we averaged the 
number of genes expressed in each of the six samples: three unfixed samples, and three 
fixed samples (12,357 genes). 92% of these genes were expressed in all six samples, 
both in the fixed and unfixed samples (Figure 4.8 A). Therefore, on average, 8% of 
genes did not overlap between the fixed and unfixed samples; 2% of these genes were 
expressed in only the fixed samples, and 6% of the genes were expressed in only the 




of the genes that were expressed in unfixed samples but not expressed in the fixed 
samples. For repeat 1, this list consisted of 145 genes, which was 2.0% of the total 
number of genes expressed by that sample (Figure 4.8 B). For repeat 2, there were 400 
genes, which was 3.4% of the total, and for repeat 3 there were 1408 genes, which was 
10.7% of the total (Figure 4.8 B). Of these genes, only 203 were present in any two of 
the three repeats. 53 of the genes were present in all three of the repeats (Figure 4.8 C), 
which was 0.4% of the 12.357 average total number of genes expressed in the samples. 
We also compiled a list of the genes that were expressed in fixed samples but not 
expressed in the unfixed samples. For repeat 1, this list consisted of 364 genes, which 
was 3.0% of the total number of genes expressed by that sample (Figure 4.8 C). For 
repeat 2, there were 184 genes, which was 1.6% of the total, and for repeat 3 there were 
134 genes, which was 1.0% of the total (Figure 4.8 C). Of these genes, 106 were 
present in any two of the three repeats. 13 of the genes were present in all three of the 
repeats (Figure 4.8 C), which was 0.1% of the 12,357 average total number of genes 
expressed in the samples. Therefore, though there were some genes that were only 
expressed in the fixed or unfixed samples, very few were repeatably overrepresented in 
the either condition.  
 
To further establish the similarity between the fixed and unfixed samples we analysed 
the differential gene expression, pooling the results from the three repeats to enable 
statistical power. The magnitude of differential gene expression between fixed and 
unfixed Th1 cells and fixed and unfixed Th2 cells was analysed and represented as 
volcano plots (Figure 4.9 A). Each dot represents a gene transcript that was detectable 
in both the fixed and unfixed samples. Volcano plots report significance of differential 
expression (concentrated P value) as a function of fold change. Genes that were 
differentially expressed between fixed and unfixed samples at P < 0.05 are indicated by 
coloring. Blue indicates > 2.0 fold change in expression, red indicates < 2.0 fold change 
in expression (Figure 4.9 A). The actually number of differentially expressed genes at P 
< 0.05 and different fold changes for Th1 and Th2 cells are shown in Figure 4.9 B. In 
Th1 cells there were no significantly differentially expressed genes. Therefore, from a 
statistical standpoint the Th1 fixed and unfixed samples over three repeat experiments 
could be considered identical (Figure 4.9 B). In the Th2 cells, 21 genes (0.17% of total 
12,652 genes) were significantly differentially expressed between the fixed and unfixed 
samples. At a cut-off of FC > 2.0, 8 genes (0.06% of total) were significantly 




Therefore, though there were 0.06% of the 12,652 genes that were significantly 
differentially expressed between Th2 fixed and unfixed samples, this was negligible in 
comparison to the similarities between the samples. Consequently, we concluded that 
the fixed and unfixed Th1 and Th2 samples were comparable at the RNA expression 
level. 
4.3.3.2 Comparing fixed and unfixed Th1 and Th2 samples at the individual gene 
expression level 
To further determine if the fixed and unfixed Th1 and Th2 samples are comparable, and 
that these samples are expressing the genes we would expect, we examined the gene 
expression profiles of the samples. To do this we chose to look at the relative expression 
of seven key genes that are known to be highly expressed by either Th1 or Th2 cells or 
both. The Th1 associated genes we chose were Ifng and Tbx21, the Th2 associated 
genes were Il4, Il5, Il13 and Gata3. Il10 was chosen as a gene that should be expressed 
in both subsets. The relative expression of these genes is shown as a bar graph (Figure 
4.10). The error bars represent the relative expression across the three repeat 
experiments. The error bars were found to be almost negligible, supporting the previous 
result that there is little variation between the repeats. Furthermore, there was no 
significant difference between the fixed and unfixed samples for any of the genes 
analysed, further supporting that the fixed and unfixed samples, as prepared using novel 
protocols described in this chapter, were comparable. Finally, as expected the Th1 
samples expressed considerably more Ifng and Tbx21 than the Th2 cells, while the Th2 
cells expressed considerably more Il4, Il5 and Il13 (Figure 4.10). Though Gata3 was 
more highly expressed in the Th2 cells than the Th1 cells, this was not as noticeably 
different as it is for the other genes (Figure 4.10), which may be expected as discussed 
earlier GATA3 is required for CD4+ T cell development. Il10 was expressed to almost 
equal amounts in both the Th1 and Th2 cells (Figure 4.10). 
 
Finally, to validate this technique we determined whether the fixed and unfixed Th1 and 
Th2 samples had the gene expression profiles we would expect from the literature. We 
performed an unpaired T test comparing the fixed Th1 cells to the fixed Th2 cells, and 
compared the unfixed Th1 cells to the unfixed Th2 cells. The p-value cut-off was set at 
0.05. We then looked at the top 20 most highly expressed genes in each cell type: fixed 




16 of the top 20 genes expressed in the fixed sample were also in the top 20 genes in the 
unfixed samples (Figure 4.11 A). Furthermore, Ifng was the most highly expressed 
gene in both the fixed and unfixed Th1 cells. Three of the genes that were found in the 
fixed Th1 top 20 were not present in the unfixed Th1 top 20 (ligp1, Klrb1f, Twist1). 
These genes were however present in the unfixed top 33. Three of the genes that were 
found in the unfixed Th1 top 20 were not present in the fixed Th1 top 20 (Cldnd2, Cd86, 
Nkg7). These genes were however present in the fixed top 31. Therefore, there was a 
large amount of overlap between the fixed and unfixed Th1 cells at the gene expression 
level, and many of the genes that were highly expressed by these cells are associated 
with Th1 gene expression profiles.  
 
In the Th2 cells, 14 of the top 20 genes expressed in the fixed sample were also in the 
top 20 genes in the unfixed samples (Figure 4.11 B). Il5, Il13 and Il4 were all within 
the top 16 most highly expressed genes for both fixed and unfixed Th2 cells. 
Furthermore, the 3 most highly expressed genes were the same in both the fixed and 
unfixed Th2 cells (Adamtsl3, Akr1c18, Il5). Six genes that were found in the fixed Th2 
top 20 were not present in the unfixed Th2 top 20 (Rnf152, Nrgn, Il24, Mnp10, Mei4, 
Epas1). These were however present in the unfixed top 35. Five of the genes that were 
found in the unfixed Th2 top 20 were not present in the fixed Th2 top 20 (Dgkk, Gpr83, 
Prkcdbp, Hap1, Pdzrn3), but these were present in the fixed top 52. Therefore, the fixed 
and unfixed Th2 cells were very similar at the gene expression level, and many of the 
genes that were highly expressed by these cells are associated with Th2 gene expression 





T helper cells secrete their hallmark cytokines, to regulate the proinflammatory 
responses of the immune system (Zhu et al., 2010), alongside IL-10 (Maynard and 
Weaver, 2008; Saraiva and O'Garra, 2010), which feeds back to reduce 
proinflammatory cytokine secretion and proliferation (Ouyang et al., 2011). However, 
each T helper cell subset does not form a homogeneous population of cells, in fact with 
regard to cytokine secretion the Th cell subsets are very heterogeneous. Therefore, to 
better understand the mechanisms involved in regulating Il10 gene expression and 
hallmark cytokine gene expression, we wanted to set up a system to separate the Th 
subsets into subpopulations based on cytokine production and analyse the differential 
gene expression patterns within these populations using RNA-Seq.  
 
We decided not to use reporter mice as a system for isolating different cytokine 
secreting Th cell subpopulation. This was because, to look at all the different Th cell 
subsets and their different cytokine secreting subpopulations, we would need to 
generate multiple dual reporter mice strains, which would need to be crossed to 
knockout mouse strains for future studies. These would require much time and money 
to generate, and this system could not be used on human samples. Furthermore, we 
discounted using single cell RNA-Seq for this study as, aside from the limitations of 
this newly developing technique, we want to be able to perform a comparison between 
protein production and mRNA expression. Single cell RNA-Seq only assesses cells at 
the mRNA level, and consequently this technique is not well suited for this project. 
Therefore, to separate Th cell subset subpopulations based on their protein profiles for 
analysis by RNA-Seq, we have designed and optimised a system for extracting viable 
mRNA for RNA-Seq analysis from intracellular cytokine stained samples.  
 
4.4.1 Preparing samples for intracellular cytokine staining results in mRNA 
degradation 
4.4.1.1 qPCR, but not RNA-Seq, can be performed on degraded samples 
Using qPCR we found that the expression of hallmark cytokine genes in Th1 and Th2 




However, as suggested in the literature (Opitz et al., 2010), we found that mRNA from 
ICS samples was of low quality. This low quality did not have an affect on the result 
when analysing these samples by qPCR. Furthermore, other studies have found that this 
low quality does not seem to have an affect on the result when analysing these samples 
by microarray (Haller et al., 2006; Hodgin et al., 2010). However, this low quality 
dramatically affected the RNA-Seq results, as compared to high quality unfixed mRNA, 
and data from these fixed samples could not be analysed.  
 
The ability to analyse low quality mRNA samples with qPCR or microarray may be a 
result of the way in which qPCR and microarray detect mRNA. qPCR and microarray 
work on a probe-based system. Probes for specific short sequences within a known 
molecule of mRNA are used to detect the presence of that mRNA molecule. Most of 
these probes are designed to detect sequences at the 3’ end of mRNA molecules (Opitz 
et al., 2010). Therefore, even if an mRNA molecule is degraded, as long as the 3’ end is 
intact then qPCR and microarray will be able to detect that molecule. As ribonucleases 
tend to degrade from the 5’ end, it is possible to sidestep this issue by analysis of fixed 
samples with microarray. RNA-Seq however, works on a system that aligns all mRNA 
transcripts to the genome. If the mRNA molecules are degraded then material will be 
absent and cannot be aligned, the resulting under- and over- representation of genes will 
lead to unreliable and biased results (Sigurgeirsson et al., 2014). Therefore it is possible 
that qPCR and microarray can be performed on fixed samples because they work using 
a probe based system. However, if the mRNA is degraded then RNA-Seq cannot be 
performed on ICS samples. 
 
4.4.1.2 Permeablisation of cells for intracellular cytokine staining leads to 
degradation of mRNA 
To elucidate at which stage mRNA damage was occurring during the preparation of 
cells for ICS, we took mRNA samples for electropherogram analysis at each step. We 
found that, contrary to our expectation, it was the permeablisation stage rather than the 
fixation stage that resulted in the majority of damage to the mRNA samples. Although 
our samples did have slightly a lower RIN after fixation, and therefore extended periods 




and unfixed samples revealed that the mRNA was being degraded, rather than 
fragmented, during the ICS protocol.  
 
Therefore, permeablisation of the cell membranes during ICS resulted in the 
degradation of mRNA within the samples. Analysis of gene coverage revealed that the 
genes were being overrepresented at the 3’ end and underrepresented at the 5’ end. This 
suggested that the mRNA molecules were being degraded by 5’ exonucleases upon 
permeablisation (Houseley and Tollervey, 2009). Where these RNases were coming 
from though is unknown; RNases are important in many physiological processes and 
are ubiquitous (Opitz et al., 2010). However, it is likely that the 5’ exonucleases 
performing this degradation are of eukaryotic origins, as it is widely accepted that 
bacteria cannot degrade RNA in the 5’ to 3’ direction (Mathy et al., 2007). The 
permeablisation of the cells may allow RNases to access the cellular mRNA via two 
mechanisms. First, the permeablisation of the cellular membrane may allow enzymes 
from the extracellular environment to enter the cells and degrade the mRNA. Second, 
the permeablisation may lead to the lysis of intracellular compartments such as P bodies, 
mitochondria or the nucleus; all of which contain enzymes that are specialised in the 
degradation of RNA (Houseley and Tollervey, 2009). Either way, upon permeablisation 
of the cells, mRNA is rapidly and extremely degraded in a 3’ biased manner, resulting 
in samples that were not viable for RNA-Seq analysis. 
 
4.4.2 The addition of RNase inhibitors prevents mRNA degradation in intracellular 
cytokine stained samples 
As RNases appeared to be causing mRNA degradation within our ICS samples, we 
aimed to find a way to prevent the activity of these enzymes. Ribonuclease inhibitor 
(RI) is a mammalian 50KDa protein that forms extremely strong protein-protein 
interactions with certain RNases and renders these enzymes inactive (Dickson et al., 
2005). RI binds to RNases non-covalently at a 1:1 ratio. Therefore, RI can be used to 
prevent the degradation of RNA by RNases. Furthermore, a series of recent publications 
that have successfully prepared human intracellularly stained samples for microarray or 
RNA-Seq, used RNase inhibitors (Hrvatin et al., 2014a; Hrvatin et al., 2014b; Kenty 
and Melton, 2015). To test if RNases were the cause of the mRNA degradation we 




we added RNase inhibitors throughout the ICS protocol. We found that the use of 
RNase inhibitors resulted in high RINs when assessed by electropherogram, and when 
analysed by RNA-Seq, the gene coverage in the fixed samples was equivalent to that 
seen in unfixed samples. Therefore, we can prevent RNA degradation during ICS by 
adding RNase inhibitors.  
 
4.4.3 Fixed and unfixed Th1 and Th2 cells are equivalent and have characteristic gene 
expression profiles 
Having established a protocol for extracting viable mRNA from fixed (ICS) samples, 
we wanted to ensure that the mRNA profiles from these samples were comparable to 
samples that had not undergone ICS. Therefore we performed RNA-Seq on fixed and 
unfixed Th1 and Th2 cells to assess the similarities and differences between these 
samples.  
 
4.4.3.1 There is no significant difference between fixed and unfixed Th1 cells at 
the global gene expression level 
A correlation between all the genes expressed in fixed Th1 cells and unfixed Th1 cells 
showed that there was almost no difference between the samples. This highly positive 
correlation was reproducibly seen across three biological replicate experiments. This is 
in keeping with Hrvatin et al., who showed gene expression between fixed and unfixed 
samples was very similar when preparing cells in the presence of RNase inhibitors 
(Hrvatin et al., 2014a). We consistently got high R2 values when comparing fixed and 
unfixed Th1 cells. To further elucidate any differences between the three repeats, we 
looked at genes that were only present in the fixed samples (6%), or only present in the 
unfixed samples (1%). We then assessed whether any genes were consistently ‘lost’ or 
‘gained’ upon fixation of the samples. We found little consistency in the repeats with 
regard to the loss or gain of genes, and that mostly these genes appeared to be random. 
This suggested, as one would expect (Marioni et al., 2008), that there were insignificant 
random differences between each of the samples prepared for RNA-Seq, but that this 




that revealed there was no significant difference between the fixed and unfixed Th1 
cells.  
 
4.4.3.2 There is very little difference between fixed and unfixed Th2 cells at the 
global gene expression level 
A correlation between all the genes expressed in fixed Th2 cells and unfixed Th2 cells 
showed that there was very little difference between the samples. As with the Th1 cells, 
this highly positive correlation was reproducibly seen across three biological replicate 
experiments, and consistently high R2 values were found when comparing fixed and 
unfixed Th2 cells. To further elucidate any differences between the three repeats, we 
assessed genes that were only present in the fixed samples (2%), or only present in the 
unfixed samples (6%). When comparing these genes to see if any genes were 
consistently ‘lost’ or ‘gained’ upon fixation of the samples, we found that there were 
only a few genes consistently gained or lost, and that mostly these genes seemed to be 
random. This was supported by an unpaired T test that revealed that only 0.17% of the 
total genes expressed in the samples was significantly different between the fixed and 
unfixed Th2 cells. Furthermore, when looking at genes that had a greater than two fold-
change difference, the number dropped to below 0.1%. Therefore there was obviously a 
minor difference between the fixed and unfixed Th2 cells, however at the expression 
level this difference was only marginally significant and no genes seemed to be 
consistently lost or gained.  
 
4.4.3.3 Fixed and unfixed Th1 and Th2 cells are comparable in expression for 
highly represented genes  
After establishing that there was little difference between the fixed and unfixed Th1 and 
Th2 cells at the whole gene expression level we wanted to ascertain that the samples 
were comparable at the single gene level. Furthermore we wanted to ensure that our in 
vitro cultured Th cells were expressing the genes one would expect from the literature. 
Therefore we decided to look at the expression level of seven key cytokine and 




To define Th1 cells we chose to look at the expression of Ifng and Tbx21, and to define 
Th2 cells we chose Il4, Il5, Il13 and Gata3, alongside Il10. Looking at the expression of 
these genes, we firstly noted that the there was very little difference in normalised 
expression levels between the three repeats (as shown by the error bars). Secondly, we 
saw that the expression levels between the fixed and unfixed samples was almost 
identical, and finally we observed the gene expression profiles we would expect. Both 
fixed and unfixed Th1 cells expressed high levels of the hallmark cytokine Ifng and the 
master transcription factor Tbx21, while both fixed and unfixed Th2 cells expressed 
high levels of the hallmark cytokines Il4, Il5 and Il13 and the hallmark transcription 
factor Gata3. Gata3 was more highly expressed in the Th2 cells than the Th1 cells, but 
this was not as noticeably different as it was for Tbx21. The relatively high levels of 
Gata3 expression in Th1 cells may be due to the important role GATA3 plays in CD4+ 
T cell development (Wei et al., 2011) and as a pioneer transcription factor (Wei et al., 
2011; Zhang et al., 2012). Il10 was expressed to almost equal amounts in both the Th1 
and Th2 cells, matching what we saw at the protein level. Therefore we concluded that 
the fixed and unfixed Th1 and Th2 cells were repeatable and comparable, and they 
expressed the genes we would expect from the literature.  
 
4.4.3.4 Fixed and unfixed Th1 and Th2 cells express subset specific genes 
Finally, we took an unbiased approach to look at the differences between the fixed and 
unfixed samples at the single gene level. Performing an unpaired T test between the 
fixed Th1 and Th2 cells and the unfixed Th1 and Th2 cells, we looked at the top 20 
most highly expressed genes in each cell type. We found a large amount of overlap in 
these genes between the fixed and unfixed Th1 cells and also between the fixed and 
unfixed Th2 cells. Furthermore, we found that many of the most highly expressed genes 
have been reported to be expressed in the corresponding cell type.  
 
In both the fixed and unfixed Th1 samples, Ifng, which is the Th1 hallmark cytokine, 
was the most highly expressed gene. In the Th1 samples several members of the 
CD94/Natural Killer cell surface protein family (Killer cell lectin-like receptors) were 
present in both the fixed and unfixed top 20, namely Klrc1, Klrk1 and Klrd1. Klrb1f, 
which was in the fixed Th1 sample top 20, is the 25th most highly expressed in the 




the surface of Th1 cells (Graham et al., 2007), and it has been suggested that they are 
involved in the costimulation of these cells (Meyers et al., 2002). Two members of the 
membrane spanning 4A family (Ms4a4b and Ms4a4c) were found in both Th1 samples. 
Chandra/MS4a4B is reportedly expressed on Th1 cells but not Th2 cells (Venkataraman 
et al., 2000), and overexpression of MS4a4B results in TCR-induced Th1 cytokine 
expression in primary CD4+ T cells (Xu et al., 2006). MS4a4C is closely related to 4B, 
and though it has more widely distributed cellular expression, it has a similar expression 
pattern to 4B in T cells (Xu et al., 2006). Furthermore, the interferon-inducible gene 
Ifi204 was present in both Th1 samples, which has been associated with differentiated 
Th1 cells. This gene is found in resting naive CD4+ T cells, its expression is 
downregulated as cells are TCR stimulated and driven in Th1 and Th2 conditions, 
however high expression returns as the Th1 cells but not Th2 cells differentiate (Lu et 
al., 2004). Other Th1 related factors found in the fixed Th1 top 20 included Ligp1 and 
Twist1. Ligp1 encodes an IFN-stimulated GTPase that is part of the p47 family, the 
expression of which is dramatically upregulated by IFNγ (Stockinger, 2000-). NFAT 
and IL-12 signalling via STAT4 has been shown to upregulate Twist1 expression in Th1 
cells (Niesner et al., 2008; Pham et al., 2012), and the levels of this factor are increased 
upon repeated TCR stimulation (Niesner et al., 2008). Therefore this factor is thought to 
be associated with chronic Th1 inflammation (Haftmann et al., 2015), and acts as a 
negative feedback to T-bet binding at the Ifng locus (Pham et al., 2012) resulting in 
reduced IFNγ production (Niesner et al., 2008; Pham et al., 2012).  
 
In both the fixed and unfixed Th2 cells, all three of the hallmark cytokine genes, Il4, Il5 
and Il13, were highly expressed. Furthermore, Il24, which is a member of the IL-20 
subfamily of the IL-10 family of cytokines (Ouyang et al., 2011), and is located 
upstream of Il10 on chromosome 1, was also highly expressed in these cells. IL-24, also 
known as FISP or IL-4-induced secreted protein, is selectively expressed in 
differentiated Th2 cells, and its expression requires both TCR signalling and STAT6-
dependent IL-4 signalling (Schaefer et al., 2001). Another IL-4 and IL-13 regulated 
gene that is expressed in both the Th2 samples was Hs3st1. This sulphotransferase has 
been shown to be upregulated in epithelium-derived cells by IL-4/IL-13 (Takeda et al., 
2010), though its expression in Th2 cells themselves has not been reported. However, as 
Th2 cells respond to IL-4 it is possible that this gene is upregulated upon Th2 cell 
differentiation. Cxcl3 was highly expressed in both Th2 samples, which is in keeping 




2013). Finally, Eaps1, which was the 20th most highly expressed gene in the fixed Th2 
cells, and 25th most highly expressed gene in the unfixed Th2 cells, has also been 
associated with Th2 cells in the literature. GATA3 binds the Epas1 gene (Horiuchi et al., 
2011), and it is also a direct target of STAT6 (O'Shea et al., 2011). Furthermore, as Th2 
cells differentiate, the levels of Epas1 have been shown to increase (Lu et al., 2004). 
 
4.4.4 Conclusions and future plans for separating T helper cells into different cytokine 
expressing populations for analysis by RNA-Seq 
We have established a method for separating Th cell subset subpopulations based on 
their intracellular cytokine protein profiles for analysis by RNA-Seq. We have designed 
a protocol in which viable mRNA for RNA-Seq analysis can be extracted from ICS 
samples when prepared in the presence of RNase inhibitors. RNA-Seq analysis reveals 
that the gene expression profiles of fixed ICS Th1 and Th2 samples were as expected 
from the literature. For future experiments we want to separate different T helper cell 
subpopulations based on intracellular cytokine staining, and then analyse these samples 






Figure 4.1 The standard protocols for intracellular cytokine staining and for 
mRNA extraction 
A. Polarised T helper cells were restimulated for 4 hours (with BfA for the second 2 
hours). They were then stained for dead cells and surface markers, fixed, permeablised 
and intracellular cytokine stained. Samples were then separated into different cytokine 
producing populations using FACS. B. Polarised T helper cells were restimulated for 4 
hours. They were then washed and transferred to RLT buffer, which lysed the cells, and 





























Figure 4.2 mRNA extracted from Th1 and Th2 cells before and after fixation and 
permeablisation for intracellular cytokine staining  
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-
CD3 and soluble anti-CD28, and polarised to Th2 cells with IL-4, IL-2, anti-IL-12 and 
anti-IFNγ, Th1 cells with IL-12, anti-IL-4 and IL-27. After 7 days of polarisation in 
vitro cells were harvested and restimulated for 4 hours, and either lysed and stored in 
RLT buffer for RNA extraction with Qiagen RNeasy Kit or fixed with formaldehyde, 
washed and stored for RNA extraction with Qiagen FFPE RNA extraction Kit. A. 
Graphs of cytokine mRNA measured by qPCR relative to HPRT. B. Isolated RNA 
quality assessed using 2100 Biolanalyser (Agilent Technologies, Inc.). Simulated 
electropherogram suggests minimal degradation of total RNA based on 10S and 28S 






Figure 4.3 Permeablisation degrades RNA in samples prepared using the standard 
intracellular cytokine staining protocol 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-
CD3 and soluble anti-CD28, and polarised to Th2 cells with IL-4, IL-2, anti-IL-12 and 
anti-IFNγ. After 7 days of polarization in vitro cells were restimulated as described in 
Materials and Methods. A. Cells were taken at different times throughout the ICS 
protocol and stored for RNA extraction with the Qiagen FFPE RNA extraction kit. 
Isolated RNA quality assessed using 2100 Biolanalyser (Agilent Technologies, Inc.). B. 
RNA samples from the first group (Washed, Frozen) and from the last group (ICS 
Fixed) were single-end sequenced using TruSeq chemistry on a HiSeq 2500 (Illumina). 
Graph shows relative RNA-Seq coverage of all annotated transcripts. Representative of 






Figure 4.4 The addition of RNase inhibitors during the intracellular cytokine 
staining protocol to ensure high quality mRNA for RNA-Seq 
Polarised Th cells were restimulated for 4 hours (with BfA for the second 2 hours). 
Cells were then stained for dead cells and surface markers. Fixation, permeablisation 
and intracellular cytokine staining were performed in the presence of RNase inhibitors. 
Samples were then separated into different cytokine producing populations using FACS 
in the presence of RNase inhibitors. The samples were then lysed and proteinase K 




























Figure 4.5 The addition of RNase inhibitors prevents mRNA degradation caused 
by permeablisation when staining for intracellular cytokines 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-CD3 
and soluble anti-CD28, and polarised to Th2 cells with IL-4, IL-2, anti-IL-12 and anti-IFNγ 
or Th1 cells with IL-12, IL-27 and anti-IL-4. Cells were assessed after 7 days of 
polarization in vitro. A. Plots of flow cytometric analysis of intracellular cytokine staining, 
cells restimulated as described in Materials and Methods. Numbers show percentage of 
live CD4+ cells. B. mRNA isolated and analysed by electropherogram from Th1 and Th2 
cells using standard protocol (Unfixed) or following fixation, staining and sorting (Fixed). 
C. Samples were prepared and single-end sequenced using TruSeq chemistry on a HiSeq 






Figure 4.6 Quantitative comparison between fixed and unfixed Th1 and Th2 
samples  
Using Strand NGS software reads were aligned to the transcriptome & Genome (mm10, 
RefSeq annotation, 95% identity, max 5% gaps, 1 read only if duplicate) and normalisation 
with DeSeq and no Baseline. The correlation coefficients of the per-gene expression 
values in fixed and unfixed samples were reported for three biological replicate 
experiments in the respective graphs. The high correlations demonstrated the similarity 
between the fixed and unfixed samples. Grey dots represent genes that are 2-fold 





Figure 4.7 Differential gene expression of fixed and unfixed Th1 samples  
Analysed using Strand NGS software as described in Materials and Methods. Upper cut 
off 983409, lower cut off 10 12,652 genes). A. The doughnut plot represents an average 
of the total number of genes expressed over the three Th1 repeat experiments. Black – the 
number of genes that were expressed in both the fixed and unfixed samples. White - the 
proportion of genes expressed in the fixed samples that were not present in the unfixed 
samples. Grey - the proportion of genes expressed in the unfixed samples that were not 
present in the fixed samples. B & C. For each repeat a list of genes that were present in the 
unfixed samples but not in the fixed samples (B) or in the fixed samples but not in the 
unfixed samples (C) were created. These three lists were then overlapped for form a Venn. 
The number in the centre of the Venn represents the number of genes that were always 
present in the unfixed samples and not in the fixed samples (B) or always present in the 
fixed samples and not in the unfixed samples (C). The percentages represent the portion this 





Figure 4.8 Differential gene expression of fixed and unfixed Th2 samples  
Analysed using Strand NGS software as described in Materials and Methods. Upper cut 
off 983409, lower cut off 10 (12,652 genes). A. The doughnut plot represents an average 
of the total number of genes expressed over the three Th2 repeat experiments. Black – the 
number of genes that were expressed in both the fixed and unfixed samples. White - the 
proportion of genes expressed in the fixed samples that were not present in the unfixed 
samples. Grey - the proportion of genes expressed in the unfixed samples that were not 
present in the fixed samples. B & C. For each repeat a list of genes that were present in the 
unfixed samples but not in the fixed samples (B) or in the fixed samples but not in the 
unfixed samples (C) were created. These three lists were then overlapped for form a Venn. 
The number in the centre of the Venn represents the number of genes that were always 
present in the unfixed samples and not in the fixed samples (B) or always present in the 
fixed samples and not in the unfixed samples (C). The percentages represent the portion this 





Figure 4.9 Differential gene expression between fixed and unfixed Th1 and Th2 
samples  
Analysed using Strand NGS software as described in Materials and Methods. Upper cut 
off 983409, lower cut off 10 (12,652 genes). A. The volcano plot shows the magnitude 
of differential expression between fixed and unfixed Th1 cells, or fixed and unfixed Th2 
cells. Each dot represents gene transcripts that had detectable expression in both tissues. 
Genes that were differentially expressed between fixed and unfixed samples at P < 0.05 
were indicated by coloring. Blue indicates > 2.0 fold change in expression, red indicated < 
2.0 fold change in expression. B. The tables show the actual number of genes differently 
expressed, as illustrated in the volcano plots. Unpaired T test, asymptomatic P-value 








Figure 4.10 Hallmark cytokine and IL-10 gene expression in Th1 and Th2 cells, 
between fixed and unfixed samples  
Analysed using Strand NGS software as described in Materials and Methods. Upper cut 
off 983409, lower cut off 10 (12,652 genes). Relative expression was averaged across 





Figure 4.11 The top 20 genes most highly expressed in fixed and unfixed Th1 and 
Th2 cells 
Analysed using Strand NGS software as described in Materials and Methods. Upper cut 
off 983409, lower cut off 10 (12,652 genes). Log fold change of gene expression was 
calculated by comparing the fixed or unfixed Th1 cells to the Th2 cells. The top 20 
genes that were most differentially expressed in one cell type over the other are 
displayed here. Grey boxes highlights genes that overlap in the top 20 for that cell type 







Chapter 5. RNA-Seq analysis of differential 
gene expression in Th1 cells driven in the 
presence or absence of IL-27, and, in depth 
analysis of the different intracellular cytokine 
producing subpopulations within these Th1 





Chapter 5 (A) RNA-Seq analysis of differential gene 
expression in bulk populations of Th1 cells driven in the 
presence or absence of IL-27 
 
5.1 (A) Background 
Cytokines play a central role in determining and driving Th cell differentiation, and in 
controlling IL-10 production (O'Garra, 1998). Downstream of multiple cytokine 
receptors STAT and SMAD proteins have been shown to affect IL-10 expression 
(Batten et al., 2008; Blokzijl et al., 2002; Fitzgerald et al., 2007; Kitani et al., 2003; 
Saraiva et al., 2009; Stumhofer et al., 2007). In vitro differentiated Th2 cells make IL-
10 (Fiorentino et al., 1989) and the factors that drive Th2 differentiation, namely IL-2 
and IL-4, are required for IL-10 expression. Th1 cells, however, require alternative or 
additional cytokine signals alongside their differentiating cytokine IL-12 to initiate 
maximal IL-10 expression. We describe here mechanisms to induce reliable and robust 
IL-10 production by Th1 cells in vitro.  
 
IL-12, which is predominantly produced by macrophages and DCs, is the main factor in 
driving Th1 cell differentiation and IFNγ production (Hsieh et al., 1993b). However, IL-
27, the dominant source of which is myeloid populations (Yoshida and Hunter, 2015), 
can also activate STAT1 and T-bet to stimulate responsiveness to IL-12 and promote 
IFNγ production (Chen et al., 2000a; Lucas et al., 2003; Takeda et al., 2003). However, 
IL-12 and IL-27 have differential effects on Th1 cells. IL-27 not only promotes Th1 
immunity, but also has a role in limiting overactive immune responses (reviewed in 
(Yoshida and Hunter, 2015)). IL-27 receptor KO mice develop lethal immune 
pathology associated with elevated IFNγ from CD4+ T cells (Villarino et al., 2003). It is 
now understood that IL-27 suppresses pathogenic Th1 responses by promoting CD4+ T 
cell IL-10 production (Anderson et al., 2009; Awasthi et al., 2007; Batten et al., 2008; 
Fitzgerald et al., 2007; Freitas do Rosario et al., 2012; Stumhofer et al., 2007; Torrado 
et al., 2015). The mechanisms by which IL-27 drives IL-10 production by CD4+ T cells 
are complex and not fully understood. Alongside STAT1 and STAT3 signalling 
(Stumhofer et al., 2007), costimulation of ICOS has been proposed to be involved in 




expression of c-Maf and IL-21 (Pot et al., 2009), both of which have been suggested to 
induce IL-10 (Spolski et al., 2009; Xu et al., 2009). Additionally, IL-27 has been shown 
to induce interaction of c-Maf with AhR to promote IL-10 production from type 1 
regulatory (Tr1) cells (Apetoh et al., 2010). However, the mechanisms that 
transcriptionally regulate IL-10 and IFNγ remain unclear. 
 
Alongside promoting Th1 responses and IL-10 production, IL-27 also has inhibitory 
effects on other subsets of CD4+ T cells and cytokine production. In the setting of 
infections that drive Type 2 immunity, IL-27 negatively regulates Th2 cells; IL-27 
receptor KO mice have enhanced Th2 responses (Bancroft et al., 2004; Lucas et al., 
2003). Furthermore, it has become clear that IL-27 is a potent inhibitor of IL-17 
production (Anderson et al., 2009; Murugaiyan et al., 2009) and Th17 cell 
differentiation (Diveu et al., 2009; Stumhofer et al., 2006), in part due to 
STAT1/STAT3 and T-bet signalling reducing the expression of RORγt. The anti-
inflammatory properties of IL-27 also involve the suppression of IL-2 expression by 
Th1 cells, which in turn reduces T cell growth and survival (Owaki et al., 2006; 
Villarino et al., 2006; Wojno et al., 2011). Therefore, alongside promoting Th1 
development and IFNγ production, IL-27 limits production of IL-2, inhibits Th2 and 
Th17 responses and induces IL-10, which can feedback to limit Th1 cells. IL-27 has 
been shown to induce a robust subset of Th1 cells that produce increased levels of IFNγ 
and IL-10. However, the mechanisms resulting in enhanced IL-10 production are not 
fully understood and therefore we were interested in comparing Th1 cells driven in the 
absence or presence of IL-27 by RNA-Seq to investigate the potential transcriptional 
mechanisms and factors that regulate IL-10 in Th1 cells. 
 
We want to apply the method devised in Chapter 4 to perform RNA-Seq analysis on 
Th1 cells cultured in the presence or absence of IL-27. By analysing the transcriptional 
profiles of the bulk Th1 and Th1 + IL-27 cells using RNA-Seq, we hope to address the 






5.2 (A) Results 
5.2.1 IL-10 and IFNγ production by Th1 cells increases upon culture with IL-27 
In Th1 cells, IL-12, alongside high antigen dose presented by APCs, is required for 
maximal IL-10 expression (Saraiva et al., 2009). Evidence also highlights a role for IL-
27 in driving high levels of IL-10 expression in Th1 cells (Batten et al., 2008; 
Stumhofer et al., 2007; Zhu et al., 2015). Therefore we investigated the role of IL-27 in 
driving IL-10 production during in vitro differentiation of Th1 cells, cultured with IL-12 
in the absence of APCs in the presence or absence of IL-27. Naïve 
CD4+CD62L+CD44loCD25- T cells were stimulated with anti-CD3 and anti-CD28, 
and cultured for 7 days in the presence of IL-12 and anti-IL-4 (referred to as ‘Th1’), or 
in the presence of IL-12, anti-IL-4 and IL-27 (referred to as ‘Th1 + IL-27’). The 
addition of IL-27 did not affect the minimal production of IL-2, and the production of 
IL-4 or IL-17 remained undetectable (Figure 5A.1 A), however IL-27 led to a 
significant increase in both IL-10 and IFNγ protein concentrations (Figure 5A.1 A&B).  
 
5.2.2 Quality control analysis of bulk Th1 and Th1 + IL-27 RNA-Seq samples 
5.2.2.1 Determining the optimal lower cut-off of reads 
Prior to the identification of significantly differentially expressed genes between the 
bulk Th1 and Th1 + IL-27 samples, noise removal and quality control were carried out 
to ensure the integrity of the replicates. Once the RNA-Seq was performed, the 
transcripts were aligned, noise was removed (Figure 5A.2 A) and a quality control 
analysis was conducted to ensure the robustness of the experiments (Figure 5A.2 B). 
All the bulk Th1 and Th1 + IL-27 samples were pooled and the upper cut-off of reads 
for expression threshold was set at 1027711.75 reads (where at least 1 out of 6 samples 
had values within the cut-off), which was the maximal number of reads found for any 
gene. The number of entities passing expression thresholds with different lower-cut offs 
was assessed to determine where to set the lower cut-off (Figure 5A.2 A). The curve 
began to flatten at around 20 reads. With lower cut-offs greater than 20 the number of 
entities removed was minimal, suggesting background noise was mostly removed with a 




important data, the lower cut-off was set at 20 reads. Next we pooled the data from the 
three biological replicates, and if any one gene in the three had a read count of above 20 
then the entity would be included in analysis. With the lower cut-off set at 20, the 
number of entities passing through each repeat was calculated (Figure 5A.2 B). The 
results revealed that each of the replicates expressed around 12,000 entities. This 
showed that all of the replicates were comparable and were robust. Furthermore, as 
expected, we found that the mRNA expression profile of the cytokines Il10 and Ifng 
mirrored the protein production profiles of the cells (Figure 5A.2 C). The Th1 + IL-27 
cells expressed considerably more Il10 and Ifng mRNA as compared to the Th1 cells.  
 
5.2.2.2 PCA and cluster analysis of bulk Th1 and Th1 + IL-27 cells 
We performed a principle component analysis (PCA) on the bulk Th1 and Th1 + IL-27 
samples to further understand the variations in gene expression between the samples 
(Figure 5A.3 A). PCA is a technique that reduces the number of dimensions in the 
dataset to identify patterns. The biological replicates of the bulk Th1 and Th1 + IL-27 
subsets clustered away from each other. There was greater inter-repeat variability in the 
bulk Th1 + IL-27 subset than between the bulk Th1 subset replicates, however there 
were no obvious outliers in the data with the three replicates of each subpopulation 
clustering together. 
 
To further determine the robustness of the samples and understand the variations in 
gene expression between the samples we performed unsupervised hierarchical 
clustering on the conditions. Hierarchical clustering constructs a dendrogram in which 
entities are represented in a relationship tree that allows the visualisation of the data 
within one heat map. This groups the samples based on their similarity, and therefore 
similar samples should cluster together within the heat map. Gene expression is shown 
as a red-blue heat map, with red indicating upregulation, blue indicating downregulation 
and yellow no change. This clustering was performed on all 12,502 genes found within 
the samples (Figure 5A.3 B). As with the PCA, the dendrogram showed that the Th1 
and Th1 + IL-27 subset replicates clustered away from each other, suggesting that IL-27 
has a distinct impact on the gene expression of Th1 cells. From this analysis we were 
assured that the replicates were robust and there were no outliers. Therefore from this 




replicates we ran unsupervised hierarchical clustering on conditions and found that the 
bulk Th1 and bulk Th1 + IL-27 subsets had visible differences in expression (Figure 
5A.3 C), however, overall their gene expression profiles looked very similar (as seen by 
the predominance of yellow). 
 
5.2.3 Hierarchical clustering separates the genes within the bulk Th1 and Th2 + IL-27 
cells into groups based on their expression profiles 
Our data thus far demonstrates that culture of Th1 cells with IL-27 alters the 
transcriptional profile of Th1 cells. To further investigate the differential gene 
expression between the samples we applied statistical filtering to retain genes that were 
at least 3-fold up- or downregulated in at least one of the samples (repeat data pooled) 
vs. the baseline (median of all the samples). This resulted in a list of 307 genes that we 
then subjected to hierarchical clustering on entities and conditions (Figure 5A.4.1 A). 
The 307 gene set separated into two branches; 284 that were downregulated in the Th1 
cells cultured in the presence of IL-27 (Table 5A.4.1), and 23 that were upregulated in 
the Th1 cells cultured in the presence of IL-27 (Table 5A.4.2). Therefore, culture with 
IL-27 seemed to predominantly result in the downregulation of gene expression (Figure 
5A.4.1 A). 
 
To further investigate the genes in these two groups we assessed if they were 
significantly associated with any GO terms or IPA pathways. The genes in Group 1 
(Table 5A.4.1) were related to binding, T cell differentiation, CD28 signalling in Th 
cells and NFAT signalling (Figure 5A.4.1. B). Genes of interest included the steroid 
metabolism (Th2 associated) gene Cyp11a1 (Mahata et al., 2014); the glutamate 
receptor Gria3; the cell surface signalling molecule Cd80; Dgkk, which encodes the 
diacylglycerol kinase kappa, which is involved in the metabolism of the TCR signalling 
molecule DAG; Gzmc, which encodes the serine protease granzyme C; and the IFNγ 
receptor 2 (Ifngr2) (Figure 5A.4.1. B). Network analysis of these genes suggested they 
fall into two major interaction groups, with genes of interest falling into both groups 
(Figure 5A.4.2).  
 
The genes in Group 2 (Table 5A.4.2) were revealed to have no significant GO terms 




signalling pathways within the gene set (Figure 5A.4.1 C). The presence of the 
chemokine Ccl9 and the interferon inducible gene Ifit1 support these two pathways, 
respectively. However, of interest, the AhR signalling molecule Arnt2 was also 
upregulated in Th1 cells cultured in the presence of IL-27 (Figure 5A.4.1 C). No 
interaction networks were found between the genes in this set.  
 
In conclusion, though there were significant differences between Th1 cells cultured in 
the presence or absence of IL-27, these were not dramatic. The upregulation of 
interferon signalling pathways is in conjunction with IL-27 increasing IFNγ production 
by these cells, and furthermore IFNγ is known to feedback on the IFNγR2 to 
downregulate its expression (Bach et al., 1995). However, this analysis revealed no 
other substantial effects of IL-27 on networks and pathways within Th1 cells. We were 
aware that many factors involved in IL-27 driven Th1 cell differentiation and IL-10 
production may be undetectable due to masking by the large IFNγ- IL-10- 
subpopulation of cells within the bulk cultures. Therefore we wanted to assess whether 
the separation of different intracellular cytokine producing subpopulations with the 
heterogeneous Th1 and Th1 + IL-27 bulk populations could reveal additional novel 









Chapter 5 (B) In depth analysis of the different intracellular 
cytokine producing subpopulations within these Th1 and Th1 
+ IL-27 subsets 
 
We next asked the question whether the separation of subpopulations within the 
heterogeneous Th1 and Th1 + IL-27 bulk populations could reveal additional novel 
factors involved in IL-27 driven Th1 cell differentiation and IL-10 production; which 
may be undetectable due to the potential masking by the large IFNγ- IL-10- 
subpopulation of cells within the bulk cultures. 
 
5.3 (B) Background 
Throughout this investigation, and in the literature, it has been shown that high levels of 
heterogeneity exist within all Th cell subsets (O'Garra et al., 2011; Zhu et al., 2010). 
Even in very similar cell types, gene expression has been shown to be very 
heterogeneous and suggested to be stochastic (Huang, 2009). Within an individual Th 
subset, there are multiple subpopulations of cells that can be distinguished by their 
patterns of intracellular cytokine production. In vitro differentiated Th1 cells can 
produce IFNγ alone, or IFNγ together with IL-10, but also maintain a population of cells 
that do not express either IFNγ or IL-10. It is increasingly understood that genes 
associated with subpopulations of cells within a heterogeneous population may not be 
revealed unless these cells are separated from the bulk population (Mahata et al., 2014) 
(Kuchroo VK, International Congress of Immunology, 2013). Therefore, it is hard to 
draw conclusions about the regulation of an individual cytokine within these 
heterogeneous populations, as not all cells within that subset will express that cytokine. 
Furthermore, in our bulk Th1 and Th1 + IL-27 populations at least half of the cells do 
not express IFNγ or IL-10 and therefore the RNA-Seq results may be biased by this 
major IFNγ- IL-10- subpopulation over the IFNγ+ IL-10- and IFNγ+ IL-10+ 
subpopulations.  
 
With the protocol developed in Chapter 4 we can now perform RNA-Seq analysis on 




27 subsets, to try and shed light on the mechanisms behind IL-10 regulation in these 
cells. By comparing these results to those obtained from analysis of bulk Th1 
populations driven similarly we hope to determine additional information that may be 
gleaned from analysis of the separated cytokine producing subpopulations. Therefore 
our question was, could separation of different subpopulations within heterogeneous 
Th1 bulk populations reveal additional novel factors involved in IL-27 driven Th1 





5.4 (B) Results 
5.4.1 Separating different intracellular cytokine producing subpopulations of Th1 cells  
As highlighted in Figure 5A.1, the Th1 and Th1 + IL-27 subsets are heterogeneous 
populations of cells with regard to protein production. Therefore we were interested in 
applying the technique developed in Chapter 4 to separate the different intracellular 
cytokine producing subpopulations within the Th1 and Th1 + IL-27 subsets. We elected 
to carry out RNA-Seq analysis on the Th1 and Th1 + IL-27 subsets as we were 
interested in genes affected by IL-27 and genes associated with the different 
intracellular cytokine producing subpopulations. We separated these subsets into 
different intracellular cytokine producing subpopulations based on the production of 
IFNγ and IL-10 (Figure 5B.1). mRNA from three different subpopulations: IFNγ- IL-
10-, IFNγ+ IL-10- and IFNγ+ IL-10+, was extracted for RNA-Seq analysis. 
 
The separated subpopulations represented similar percentages of the bulk live CD4+ 
Th1 and Th1 + IL-27 populations in the three repeat experiments (Figure 5B.1). In the 
Th1 subset, the IFNγ- IL-10- subpopulations represented on average 62% of the bulk, 
the IFNγ+ IL-10- subpopulations 27.4%, and the IFNγ+ IL-10+ subpopulations 3.9%. 
Therefore the cytokine producing subpopulations consisted of about 32% of the bulk 
population (Figure 5B.1 A), although the IL-10 producing subpopulation was the 
lowest. In the Th1 + IL-27 subset, the IFNγ- IL-10- subpopulations represented on 
average 44.5% of the bulk, the IFNγ+ IL-10- subpopulations 33.4%, and the IFNγ+ IL-
10+ subpopulations 11.4%. Therefore the cytokine producing subpopulations consisted 
of about 45% of the bulk population (Figure 5B.1 B). The IFNγ+ IL-10- and IFNγ+ IL-






5.4.2 Quality control analysis of Th1 and Th1 + IL-27 subpopulation RNA-Seq 
samples 
5.4.2.1 Determining the optimal lower cut-off of reads 
As with the analysis of the bulk Th1 and Th1 + IL-27 samples we performed noise 
removal and quality control to ensure the integrity of the replicates. Once the RNA-Seq 
was performed, the transcripts were aligned, noise was removed (Figure 5B.2 A) and a 
quality control analysis was conducted to ensure the robustness of the experiments 
(Figure 5B.2 B). All the Th1 and Th1 + IL-27 samples were pooled and the upper cut-
off of reads for expression threshold was set at 1165880.5 reads (where at least 1 out of 
24 samples had values within the cut-off), which was the maximal number of reads 
found for any gene. The number of entities passing expression thresholds with different 
lower-cut offs was assessed to determine where to set the lower cut-off (Figure 5B.2 A). 
Again, the curve began to flatten at around 20 reads and the lower cut-off was set at 20 
reads. Next we pooled the data from the three biological replicates of each 
subpopulation, and if any one gene in the three had a read count of above 20 then the 
entity would be included in the analysis. With the lower cut-off set at 20, the number of 
entities passing through each repeat was calculated (Figure 5B.2 B). The results 
revealed that each of the replicates expressed between 10,000 – 12,000 entities. This 
showed that all of the replicates are comparable and are robust.  
 
5.4.2.2 PCA and cluster analysis of Th1 and Th1 + IL-27 subpopulations 
We performed PCA on the Th1 and Th1 + IL-27 subpopulations to further understand 
the variations in gene expression between the samples (Figure 5B.3 A). As with the 
analysis of the bulk unseparated populations earlier, the Th1 and Th1 + IL-27 subsets 
clustered away from each other. Within both subsets, the cytokine producing 
subpopulations, IFNγ+ IL-10- and IFNγ+ IL-10+, clustered separately from the non-
cytokine producing subpopulation, IFNγ- IL-10-. As expected the bulk Th1 and Th1 + 
IL-27 cells fell between the cytokine producing and non-producing subpopulations 
(Figure 5B.3 A). Again there was greater inter-repeat variability between the samples 




were no obvious outliers in the data with the three replicates of each subpopulation 
clustering together.  
 
To further determine the robustness of the samples and understand the variations in 
gene expression between the samples we performed unsupervised hierarchical 
clustering on the conditions. This clustering was performed on all 12,114 genes found 
within the samples (Figure 5B.3 B). As with the PCA, the dendrogram showed that the 
Th1 and Th1 + IL-27 subsets clustered away from each other, suggesting that IL-27 has 
a distinct impact on the gene expression of Th1 cells. The cytokine producing 
subpopulations, IFNγ+ IL-10- and IFNγ+ IL-10+, cluster separately from the bulk cells 
and non-cytokine producing subpopulations, IFNγ- IL-10- (Figure 5B.3 B), suggesting 
the production of cytokines also has distinct effects on gene expression. From this 
analysis we were assured that the replicates were robust and there were no outliers. 
Therefore from this point forward, data from the three replicates was pooled.  
 
5.4.2.3 Different intracellular cytokine producing subpopulations within the Th1 
and Th1 + IL-27 have different transcriptional profiles 
After pooling the data from the replicates we again ran unsupervised hierarchical 
clustering on conditions, and found that the major factor separating the subpopulations 
was the presence or absence of IL-27 in the culture (Figure 5B.4 A). Furthermore, these 
differences could not be attributed to differences in the expression of the Th1 master 
regulator Tbx21; as all of the subpopulations in both the Th1 and Th1 + IL-27 subsets 
expressed similar levels of this gene (Figure 5B.4 B). Again, within the Th1 and Th1 + 
IL-27 subsets the IFNγ+ IL-10- and IFNγ+ IL-10+ subpopulations clustered together, 
and separately from the bulk and IFNγ- IL-10- subpopulations. This suggested, that 
even though in the Th1 + IL-27 subset, where the cytokine producing and non-cytokine 
producing subpopulations represented equal proportions of the bulk cells, the gene 
expression profile of the bulk population mirrored that of the IFNγ- IL-10- 
subpopulation. This further suggests that the detection of genes expressed at a lower 





5.4.3 Hierarchical clustering separates the Th1 and Th1 + IL-27 samples into groups 
based on their gene expression profiles 
Our data thus far demonstrates that culture of Th1 cells with IL-27, or the production of 
cytokines within our Th1 or Th1 + IL-27 cultured cells, alters the transcriptional profile 
of Th1 cells. To further investigate the differential gene expression between the samples 
we applied statistical filtering to retain genes that were at least 3-fold up- or 
downregulated in at least one of the samples (repeat data pooled) vs. the baseline 
(median of all the samples). This resulted in a list of 1944 genes that we then subjected 
to hierarchical clustering on entities and conditions (Figure 5B.5). This was 
dramatically more genes than the 307 genes found in the analysis of the bulk 
unseparated populations (Figure 5A.4.1). 
 
The 1944 gene set separated into two branches; the cytokine producers clustered into 
one group and the IFNγ- IL-10- subpopulations clustered with the bulk un-separated 
cells. Within these two clusters, the Th1 subpopulations clustered together and the Th1 
+ IL-27 subpopulations clustered together. However, there were clear groups of genes 
with different transcriptional profiles within this 1944 set of genes. Genes within this set 
could be separated into 6 groups. Groups of genes were manually curated based on the 
dendrogram and experimental hypotheses. Four groups of genes had altered expression 
resulting from the presence or absence of IL-27; three groups of genes had altered 
expression in the different cytokine producing subpopulations. 
 
Groups of genes that are affected by the presence of IL-27 in the culture:  
• Group 1: 146 genes downregulated in Th1 cells cultured with IL-27, regardless 
of cytokine production. 
• Group 2: 349 genes downregulated in Th1 cells cultured with IL-27. Most 
pronounced in the IFNγ- IL-10- subpopulation. 
• Group 3: 299 genes downregulated in Th1 cells cultured with IL-27. More 
pronounced in the cytokine producing subpopulations. 





Groups of genes that correlated with the production of cytokines: 
• Group 5: 586 genes downregulated in cytokine producing subpopulations.  
• Group 6: 37 genes upregulated in cytokine producing subpopulations. More 
pronounced in the IFNγ+ IL-10- subpopulation 
• Group 7: 124 genes upregulated in cytokine producing subpopulations. More 
pronounced in the IFNγ+ IL-10+ subpopulations.  
 
5.4.3.1 Groups of genes that are affected by the presence of IL-27 in the culture 
5.4.3.1.1 Three groups of genes were downregulated in Th1 cells cultured with IL-27 
Group 1 consisted of 146 genes (Table 5B.6.1) that were downregulated in Th1 cells 
cultured with IL-27, regardless of cytokine production (Figure 5B.6.1 A&B). Pathways 
and terms related to this list of genes included cell projection, tryptophan degradation 
and glutathione redox reactions (Figure 5B.6.1 C). The genes for two glutamate 
receptors were included in this list, Gria3 and Grin1. The list also contained Dgkk, 
which encodes the diacylglycerol kinase kappa, which is involved in the metabolism of 
the TCR signalling molecule DAG. Furthermore, Aldh3a1, which encodes the aldehyde 
dehydrogenase 3 family member A1 and is involved in the AhR pathway and 
metabolism, was present in this group of genes. The actual read number of most of the 
genes within this group were relatively low, as highlighted by the raw read number of 
the genes Gria3, Grin1 and Dgkk, which are all below 80 (Figure 5B.6.1 D). The 
expression of Gria3 and Grin1 followed a similar pattern, being more highly expressed 
in the bulk and all of the subpopulations within the Th1 subset compared to the Th1 + 
IL-27 subset. However, Dgkk had a more complex pattern of expression. It was highly 
downregulated in the bulk Th1 subset compared to Th1 + IL-27, and in the IFNγ- IL-
10- and IFNγ+ IL-10- subpopulations within the Th1 subset compared to Th1 + IL-27. 
However, both the Th1 and Th1 + IL-27 IFNγ+ IL-10+ subpopulations had very low 
levels of Dgkk expression regardless of the presence of IL-27. This suggests Dgkk was 
downregulated in cells cultured in the presence of IL-27 and in cells that produce IL-10 
regardless of the presence of IL-27. To further elucidate the interaction of genes within 
this group we performed network analysis, and found that most of the genes did not 




involved the two glutamate receptors GRIA3 and GRIN1 (Figure 5B.6.2). MAPK13, 
the p38 MAP kinase 13, which is a positive regulator of Il10 expression in macrophages 
(Chi et al., 2006; Hammer et al., 2006), and LTBR, the lymphotoxin β receptor, were 
also involved in a small signalling network within this group of genes (Figure 5B.6.2). 
95 of the genes in this list (Table 5B.6.1 highlighted in blue) were also seen to be 
downregulated by IL-27 in the analysis of the bulk unseparated Th1 and Th1 + IL-27 
cells (Group 1, Table 5A.4.1). 
 
Group 2 consisted of 349 genes (Table 5B.7.1) that were downregulated in Th1 cells 
cultured with IL-27. This downregulation was most pronounced in the IFNγ- IL-10- 
subpopulation (Figure 5B.7.1 A&B), showing that even though these cells did not 
upregulated cytokine production they had received signals from IL-27. Pathways and 
terms related to this list of genes included cell-substrate junction assembly, positive 
regulation of metabolism, FXR/RXR activation and RhoGDI signalling (Figure 5B.7.1 
C). The FXR/RXR signalling pathway is involved in lipid metabolism, and 
heterodimers of retinoid X receptors (RXR) with PPARγ act together to regulate gene 
expression (Keller et al., 1993). Supporting this was the presence of the gene Pparg in 
this group, suggesting certain forms of metabolism are downregulated by IL-27 in Th1 
cells. Genes in this group included the cytokine Il6, the transcription factors Eomes and 
Pparg, the enzyme Cyp11a1, the chemokine ligand Cxcl3 and the cell surface signalling 
molecule Cd80 (Figure 5B.7.1 C) Pparg and Cd80 were both downregulated by IL-27, 
and this was seen in the analysis of the bulk unseparated Th1 and Th1 + IL-27 cells and 
in all of the Th1 subpopulations. Cyp11a1 and Eomes, the downregulation of which was 
not seen in the analysis of the bulk unseparated Th1 and Th1 + IL-27 cells, were more 
highly expressed in the cytokine producing subpopulations in the Th1 subset compared 
to the IFNγ- IL-10- subpopulation (Figure 5B.7.1 D).  
 
Of note the raw read numbers of the genes within Group 2 were much higher than 
those in Group 1 (Figure 5B.6.1 D & 5B.7.1 D). Network analysis of the genes in 
Group 2 revealed that Il6 was a core node in the signalling interactions within this 
group of genes (Figure 5B.7.2). As seen in Figure 5B.7.2 IL-6 interacts directly with 
PPARγ, which is upstream of CYP11a1. IL-6 and CD80 also formed a triangle of direct 
and indirect interactions (Figure 5B.7.2). However, the raw reads of Il6 expression 




findings is uncertain. 53 of the genes in this list (Table 5B.7.1 highlighted in blue) were 
also downregulated by IL-27 in the analysis of the bulk unseparated Th1 and Th1 + IL-
27 cells (Group 1, Table 5A.4.1). 
 
Group 3 consisted of 299 (Table 5B.8.1) genes that were downregulated in Th1 cells 
cultured with IL-27. This was more pronounced in the IFNγ+ IL-10- and IFNγ+ IL-10+ 
subpopulations (Figure 5B.8.1 A&B). There were no significant GO terms associated 
with this set of genes. Pathways related to this list of genes included NFAT signalling, 
AhR signalling and tryptophan degradation (Figure 5B.8.1 C). NFAT signalling was 
also found to be downregulated by IL-27 in the bulk Th1 and Th1 + IL-27 comparison. 
We showed earlier that the culture of Th1 cells with IL-27 resulted in the 
downregulation of Ifngr2 in the analysis of the bulk unseparated Th1 and Th1 + IL-27 
cells (Figure 5A.4.1). This downregulation of Ifngr2 was also seen in all of the Th1 + 
IL-27 subpopulations (Figure 5B.8.1 D). However, regardless of IL-27 the IFNγ+ IL-
10- and IFNγ+ IL-10+ subpopulations showed markedly reduced Ifngr2 expression as 
compared to the IFNγ- IL-10- subpopulations (Figure 5B.8.1 D). This suggests that 
both IL-27 and cytokine production can result in the downregulation of Ifngr2 
expression, although it is unclear whether the latter is via a cell intrinsic mechanism.  
 
Other genes in this Group 3 included the aldehyde dehydrogenases Aldh1l1 and 
Aldh5a1, the induction of which may be related to AhR signalling (Elizondo et al., 
2000), the Indoleamine-pyrrole 2,3-dioxygenase gene Ido1 that is involved in 
tryptophan degradation and the androgen receptor Ar (Figure 5B.8.1 C). Analysis of 
the raw read number of Aldh5a1 revealed that the Th1 and Th1 + IL-27 subpopulations 
express similar amounts of this gene, and IL-27 only results in its downregulation in the 
cytokine producing subpopulations (Figure 5B.8.1 D). However, the raw read number 
of Aldh5a1 also highlight that it is expressed to a very low level and these minor 
changes in expression may not be physiologically relevant. The only significant 
interaction network within this set of genes stemmed from the androgen receptor 
(Figure 5B.8.2). Only 32 of the genes in this list (Table 5B.8.1 highlighted in blue) 
were also downregulated by IL-27 in the analysis of the bulk unseparated Th1 and Th1 





5.4.3.1.2 One group of genes was upregulated in Th1 cells cultured with IL-27 
Group 4 consisted of 86 genes (Figure 5B.9.1) that were upregulated in Th1 cells 
cultured with IL-27. Some of these genes were upregulated in all of the subpopulations; 
IFNγ- IL-10-, IFNγ+ IL-10- and IFNγ+ IL-10+, within the Th1 + IL-27 subset, whereas 
genes were only upregulated in the cytokine producing subpopulations; IFNγ+ IL-10- 
and IFNγ+ IL-10+, within the Th1 + IL-27 subset (Figure 5B.9.1). We showed earlier 
that the culture of Th1 cells with IL-27 resulted in the upregulation of Arnt2 in the 
analysis of the bulk unseparated Th1 and Th1 + IL-27 cells (Figure 5A.4.1). This 
downregulation of Arnt2 was also seen in all of the Th1 + IL-27 subpopulations (Figure 
5B.9.1 A). However, other genes of interest not revealed in the analysis of the bulk 
unseparated Th1 and Th1 + IL-27 cells included: Maf, which encodes the transcription 
factor c-Maf, Nfkbid, which encodes the NFκB inhibitor delta and Tnf. Maf and Arnt2 
were by IL-27 upregulated in all of the subpopulations; IFNγ- IL-10-, IFNγ+ IL-10- and 
IFNγ+ IL-10+ (Figure 5B.9.1 A&D). Nfkbid and Tnf were only upregulated by IL-27 in 
the cytokine producing subpopulations; IFNγ+ IL-10- and IFNγ+ IL-10+ (Figure 
5B.9.1 A&D). TNF, which can be produced by Th1 cells (Cherwinski et al., 1987), and 
is generally associated with negative regulation of IL-10 (Evans et al., 2014), was a 
central node in the interactions between MAF, ARNT2 and other genes within this 
group (Figure 5B.9.2). Therefore, alongside IL-10 and IFNγ, IL-27 appears to drive 
increased expression of Tnf in Th1 cells. ID3 was involved in many chemokine-
signalling pathways and interacted with Maf (Figure 5B.9.2). 13 of the genes in this list 
(Table 5B.9.1 highlighted in red) were also found to be upregulated by IL-27 in the 
analysis of the bulk unseparated Th1 and Th1 + IL-27 cells (Group 2, Table 5A.4.2). 
 
5.4.3.2 Groups of genes that correlated with the production of cytokines 
5.4.3.2.1 One group of genes was downregulated in cytokine producing 
subpopulations 
Group 5 consisted of 586 genes (Table 5B.10.1) that were downregulated in cytokine 
producing subpopulations. However this was not irrespective of IL-27. The genes in this 
group were most highly downregulated in the Th1 + IL-27 cytokine producing 




Th1 + IL-27 non-cytokine producing subpopulation; IFNγ- IL-10- (Figure 5B.10.1 
A&B). Therefore the difference in expression of these genes between the cytokine 
producing and non-cytokine producing subpopulations was more pronounced in the 
presence of IL-27. 6 of the genes in this list (Table 5B.10.1 highlighted in red) were 
also upregulated by IL-27 in the analysis of the bulk unseparated Th1 and Th1 + IL-27 
cells (Group 2, Table 5A.4.2), this is in conjunction with the observation that the 
upregulation of these genes was not irrespective of IL-27. 
 
Pathways and terms related to Group 5 of genes were mostly related to interferon 
signalling (Figure 5B.10.1 C), and additionally many interferon related genes were 
present in this group (Table 5B.10.1). STAT1, which regulates genes downstream of 
the interferon receptors including IFNγR1 (Darnell et al., 1994), was present in this list. 
Multiple Gbp genes, which are known to be IFNγ responsive (Shenoy et al., 2007), were 
also present, as well as Irf7 and Ifit2, which are also interferon inducible (Levy et al., 
1986; Nguyen et al., 1997) (Figure 5B.10.1 C). This downregulation of interferon 
signalling in the different cytokine producing subpopulations seemed to be unaffected 
by the presence of IL-27, and upon analysis of the bulk populations there was little 
difference in the raw read values of Ifngr1 and Stat1 (Figure 5B.10.1 D). However, 
Ifngr1 and Stat1 expression may have been slightly upregulated in the Th1 + IL-27 
IFNγ- IL-10- subpopulation compared to the Th1 IFNγ- IL-10- subpopulation (Figure 
5B.10.1 D). Again, as seen in the heat map and profile plot, the raw read values of 
Ifngr1 and Stat1 were highly downregulated in the IFNγ+ IL-10- and IFNγ+ IL-10+ 
cytokine producing subpopulations of both the Th1 and Th1 + IL-27 subsets compared 
to the IFNγ- IL-10- subpopulations (Figure 5B.10.1 D). This suggests that intrinsic 
downregulation of the Ifngr1 is occurring in cytokine producing cells. The central role 
of interferon signalling in this group of genes was highlighted by the core nodes that 
STAT1, IFNγR1 and IRF7 formed in the interactions between the genes in this group 
(Figure 5B.10.2). This demonstrates that analysis of heterogeneous cell populations 
may present apparent upregulation of genes in the bulk population, which is actually 





5.4.3.2.2 Two groups of genes were upregulated in cytokine producing subpopulations 
Group 6 consisted of 37 genes (Figure 5B.11 A) that were upregulated in cytokine 
producing subpopulations except surprisingly in the Th1 + IL-27 IFNγ+ IL-10+ 
subpopulation, suggesting an inverse correlation with IL-10 (Figure 5B.11 A&B). This 
group of genes were highly related to glutamate receptor signalling, PPAR signalling 
and TGFβ signalling (Figure 5B.11 C). Dusp9 was present in this list of genes, which 
encodes the phosphatase DUSP9 that is involved in the suppression of ERK signalling 
(Keyse, 2000). Dusp9 appeared to be downregulated by IL-27 in the bulk Th1 + IL-27 
subset, however when looking at the individual subpopulations this was not always the 
case (Figure 5B.11 D). The read number of Dusp9 highlighted that this gene was 
upregulated in the Th1 and Th1 + IL-27 cytokine producing subpopulations, and was 
associated with high IFNγ production but was downregulated in IL-27 driven IFNγ+ IL-
10+ cells (Figure 5B.11 D). 
 
Network analysis of Group 6 revealed two glutamate receptors, Grm1 and Gria1, were 
present in this gene list, and the interaction between these genes was the only significant 
interaction found between genes in this list (Figure 5B.11 E). Grm1 encodes the 
mGlu1R glutamine receptor that is coupled to the ERK signalling pathway (Pacheco et 
al., 2004) and the stimulation of this receptor has been correlated to IL-10 secretion by 
Th1 cells (Pacheco et al., 2006). However, the read number of Grm1 transcripts were 
very low, even in the groups with increased expression. There was no overlap with 
genes in this list and those found to be affected by IL-27 in the analysis of the bulk 
unseparated Th1 and Th1 + IL-27 cells (Group 1 & 2, Table 5A.4.1 & 2). Therefore, 
we highlight many novel factors correlating with cytokine production that would not 
have been revealed without separating the different subpopulations.  
 
Group 7 consisted of 124 genes (Table 5B.12.1) that were more highly expressed in 
the cytokine producing subpopulations. This was more pronounced in the IFNγ+ IL-10+ 
subpopulations, suggesting these genes more closely correlated with IL-10 expression 
than IFNγ expression (Figure 5B.12.1 A&B). The pathways and terms related to this 
group were mostly involved in immune processes including the regulation and 
signalling of cytokines, communication between immune cells and inflammatory 
responses (Figure 5B.12.1 C). However, genes within this list are also known to 




Wnt9b, Wnt11, Cav1 and Foxl2 (GO annotations). As expected genes within this list 
encoded many cytokines and chemokines, including Il10, Ifng, Il3, Il1a, Il23a, Il17f, 
Il22, Csf2, Ccl1, Ccl3 and Cxcl13 (Figure 5B.12.1 C). Of note, the expression of Il10 
and Ifng mRNA followed the same pattern as intracellular IL-10 and IFNγ protein 
production seen in the FACS plots (Figure 5B.12.1 D). These genes were all 
upregulated in the cytokine producing subpopulations compared to the IFNγ- IL-10- 
subpopulations, however, the patterns of expression at the raw read number varied 
(Figure 5B.12.1 D). As expected Il10 was only upregulated in the IFNγ+ IL-10+ 
subpopulations, and to a greater extent in the Th1 + IL-27 cells, while Ifng was 
expressed in both the IFNγ+ IL-10- and IFNγ+ IL-10+ subpopulations; corroborating 
the protein levels seen by intracellular cytokine staining. Csf2, which encodes the 
cytokine GM-CSF, was upregulated in both cytokine producing subpopulations but to a 
greater extent in the Th1 subset, but this was not reflected when comparing the whole 
populations, where Csf2 expression appeared to be comparable between the Th1 and 
Th1 + IL-27 subsets. Gzma, which encodes the serine protease granzyme A, was mostly 
upregulated in the Th1 IFNγ+ IL-10- subpopulation, whereas in the whole populations 
the Th1 + IL-27 subset appeared to express higher Gzma expression. Therefore, 
although all of these genes were associated with the cytokine producing subpopulations, 
they had different expression profiles. Network analysis revealed many of these 
cytokines at the centre of interactions between these genes (Figure 5B.12.2). Again was 
no overlap with genes in this list and those found to be affected by IL-27 in the analysis 
of the bulk unseparated Th1 and Th1 + IL-27 cells (Group 1 & 2, Table 5A.4.1 & 2). 
 
Within these final gene lists it is possible there are genes that are associated with Il10 
regulation. Genes in Group 6 were downregulated in IL-10 producing subpopulations, 
and therefore may have regulatory roles in repressing Il10 expression. Genes in Group 
7 were upregulated in IL-10 producing subpopulations, and therefore may have 
regulatory roles in promoting Il10 expression. However, in isolation we have little 
information with which to select viable candidates that may be novel factors involved in 
the regulation of Il10. Therefore it would be of use to set up a screen using RNAi or 
CRISPR-Cas to determine the effects on Il10 gene expression. Comparison of these 
gene sets to genes up- or downregulated in the IL-10+ subpopulations of other Th cell 






IL-27 has been shown to upregulate IL-10 production by Th1 cells (Batten et al., 2008; 
Stumhofer et al., 2007; Zhu et al., 2015). However, the effects of IL-27 on these cells at 
a transcriptional level are still poorly understood. Furthermore, cytokine production by 
Th1 cells is heterogeneous and the effects of IL-27 on these different intracellular 
cytokine producing subpopulations may vary. Therefore not only did we want to 
characterise the transcriptional changes IL-27 drives in Th1 cells, but also how the 
different intracellular cytokine producing subpopulations differ transcriptionally and 
how they respond to IL-27. In this Chapter we carried out RNA-Seq analysis on Th1 
cells and Th1 cells cultured with IL-27, and on the intracellular cytokine producing 
subpopulations within these two subsets.  
 
5.5.1 IL-27 drives increased IL-10 and IFNγ production by Th1 cells 
Previous studies have shown that IL-27 drives increased IFNγ (Chen et al., 2000a; 
Lucas et al., 2003; Takeda et al., 2003) and IL-10 (Awasthi et al., 2007; Batten et al., 
2008; Fitzgerald et al., 2007; Stumhofer et al., 2007) production from Th1 cells. When 
culturing Th1 cells in vitro, as optimised in Chapter 3, alongside IL-27 we also saw an 
increase in IFNγ and IL-10 protein production from Th1 cells. Interestingly, as 
discussed in Chapter 3, in the presence or absence of IL-27 it was the cells that produce 
high levels of IFNγ that also produce IL-10. None of the Th1 cells that were negative 
for IFNγ produced IL-10. Therefore IL-27 does not drive IL-10 production in the 
absence of IFNγ production. The expression of Ifng and Il10 mRNA matched that of 
IFNγ and IL-10 protein production, in the bulk Th1 and Th1 + IL-27 subsets and in the 
different subpopulations.  
 
We continue to consistently see an IFNγ- IL-10- subpopulation. This does not appear to 
be due to different levels of activation of the cells, as all of the subpopulations express 
similar high levels of the IL-2 receptor CD25. Therefore, is it possible this population is 
maintained due to homeostatic regulation within the heterogeneous subset. Evidence 
from cytokine secretion assays suggests that upon re-culture, IL-10 non-producing cells 




2007). Furthermore, it has been proposed that individual Th1 cells have a quantitative 
cytokine memory and that within a heterogeneous population there are stable cytokine-
producing and –nonproducing subpopulations (Helmstetter et al., 2015). However, we 
do not know if these IFNγ- IL-10- cells are stable or would start to produce cytokines if 
separated from the cytokine-producing cells and re-cultured. To separate these cells and 
re-culture them, ICS could not be used; an IFNγ reporter or secretion assay would have 
to be employed instead. This analysis has however revealed many transcriptional 
differences between this cytokine-nonproducing subpopulation and the cytokine-
producing subpopulations. 
 
5.5.2 Culture with IL-27 results in changes in the transcriptional profile of bulk 
populations of Th1 cells 
Analysis of the transcriptional profiles of the bulk Th1 and Th1 + IL-27 subsets, 
revealed that the cells within each subset were transcriptionally very different. 
Clustering analysis revealed that the majority of genes whose expression was altered by 
IL-27 were downregulated. These predominantly repressive effects of IL-27 on Th1 
gene expression have not previously been shown. Within this group of 284 genes, the 
expression of Ifngr2, which encodes the IFNγ receptor 2, was downregulated. This is 
supported by the literature, which proposes that Ifngr2 is downregulated by IFNγ 
feeding back upon the Th1 cells (Bach et al., 1995). Other genes within this group are 
associated with lipid metabolism (Cyp11a1), glutamate signalling (Gria3) and TCR 
signalling (Dgkk), however these pathways were not reflected in the GO and IPA 
analysis. The decreased expression of Cd80 and multiple HLA genes resulted in the IPA 
analysis associating multiple T cell signalling pathways to this group of IL-27 
downregulated genes. A minority of genes, 23, were upregulated by IL-27. IPA analysis 
revealed the upregulation of Interferon signalling by IL-27. This is as expected, owing 
to the increased levels of IFNγ produced by Th1 + IL-27 cells. Other genes within this 
group are associated with AhR signalling (Arnt2), however this pathway was not 
reflected in the GO and IPA analysis. Overall the analysis of bulk Th1 and Th1 + IL-27 
subsets revealed little about the results of IL-27 on the transcriptional profiles of Th1 
cells. Therefore, it was hard to elucidate any mechanisms that may regulate Il10 gene 
expression. It is possible that dominant subpopulations of cells within these 




gene expression. Furthermore, work on single-cell transcriptomics have highlighted 
how looking at covariance between transcripts in individual cells can reveal regulatory 
circuits that may not be obvious at the population level (Shalek et al., 2014). Therefore, 
our question was, could we improve this analysis and reveal more about the effects of 
IL-27 on Th1 cells and mechanisms that may regulate Il10 gene expression by 
separating the different intracellular cytokine producing subpopulations within the Th1 
and Th1 + IL-27 subsets? 
 
5.5.3 Different intracellular cytokine producing Th1 and Th1 + IL-27 subpopulations 
have different transcriptional profiles 
Analysis of the transcriptional profiles of the bulk Th1 and Th1 + IL-27 subsets, and the 
different intracellular cytokine producing subpopulations within the Th1 and Th1 + IL-
27 subsets, revealed that the bulk and the three different subpopulations within each 
subset were transcriptionally very different. We found earlier that the analysis of bulk 
unseparated Th1 and Th1 + IL-27 subsets revealed that the expression of 307 genes was 
altered by the presence of IL-27, 284 of these being downregulated by IL-27. When 
analysing the different subpopulations within the Th1 and Th1 + IL-27 subsets we 
revealed that the expression of 880 genes was altered by the presence of IL-27, 794 of 
these being downregulated by IL-27. Therefore by separating the heterogeneous bulk 
Th1 and Th1 + IL-27 subsets we have revealed many more genes affected by IL-27. 
 
Clustering and correlative analysis suggested that the cytokine producing 
subpopulations within each subset were very closely related to one another, but were 
very different from the IFNγ- IL-10- subpopulation. Furthermore, the bulk Th1 or Th1 + 
IL-27 subset transcriptional signature was most similar to the IFNγ- IL-10- 
subpopulation. Therefore, when analysing these samples by RNA-Seq the IFNγ- IL-10- 
subpopulation biased the transcriptional profile of the bulk population. In the Th1 
subset, the IFNγ- IL-10- subpopulation represented 62% of the culture, while the 
cytokine producing subpopulations represented 32%, and therefore it is not unexpected 
that the bulk mRNA is dominated by the IFNγ- IL-10- signature. However, in the Th1 + 
IL-27 subset, the IFNγ- IL-10- subpopulation represented 45% of the culture, while the 




the bulk mRNA to have a transcriptional profile half way between the IFNγ- IL-10- and 
cytokine producing subpopulations. Consequently, we can conclude that the 
transcriptional profile of a heterogeneous population of cells is not equally 
representative of all the subpopulations within it. Therefore, by separating the different 
intracellular cytokine producing subpopulations from within a Th subset we may obtain 
more accurate gene expression profiling of different subpopulations and additional 
information regarding differential gene expression. 
 
5.5.4 IL-27 drives transcriptional changes in the different intracellular cytokine 
producing subpopulations within Th1 cells 
Culturing Th1 cells in vitro with IL-27 resulted in distinct changes in both up- and 
downregulation of genes compared to Th1 cells cultured in the absence of IL-27. The 
majority, but not all, of these changes were only seen when analysing the different 
intracellular producing subpopulations, rather than the bulk un-separated subsets.  
 
5.5.4.1 IL-27 alters glutamate signalling in Th1 cells  
In Group 1, the expression of two iGluRs was downregulated by IL-27; Gria3 encodes 
the APMA receptor iGlu3R, and Grin1 encodes the NMDA receptor 1 (Discussion 
Figure 5.1). Much evidence suggests glutamate receptors play an important role in T 
cell immunity and development (Pacheco et al., 2007). Glutamate can interact with 
different types of receptors, which are separated into two main groups; the ionotropic 
glutamate receptors (iGluRs) and the metabotropic glutamate receptors (mGluRs). As 
found in the associated GO terms, iGlu3R has been shown to be involved in T cell 
adhesion and migration.  Furthermore, it has been postulated that upon TCR stimulation, 
iGlu3R may impair IL-10 production (Pacheco et al., 2006). This is supported by 
evidence that IL-10 impairs T cell adhesion and migration (Jinquan et al., 1995; Tan et 
al., 1995), and iGlu3R may promote these processes by inhibiting IL-10. Therefore, a 
possible mechanism by which IL-27 increases Il10 expression in Th1 cells is by 






5.5.4.2 IL-27 alters signalling associated with lipid & cholesterol metabolism 
Multiple genes involved in metabolic processes were downregulated in Th1 cells 
cultured with IL-27, including Cyp11a1 and Pparg (Discussion Figure 5.1). In Group 
2 the expression of the enzyme Cyp11a1 was downregulated by IL-27. Cyp11a1 is 
involved in steroid metabolism and is a key enzyme in the conversion of cholesterol to 
the steroid hormone pregnenolone. Steroids are immunoregulators and have suppressive 
effects on inflammation (Sakiani et al., 2013). Recent publications have highlighted the 
specific upregulation of Cyp11a1 in Th2 cells (Mahata et al., 2014). Therefore IL-27 
appears to downregulate the expression of genes associated with Th2 cells, and genes 
that drive immune-suppressive pathways.  
 
Moreover, in Group 2 the expression of the peroxisome proliferator-activated receptor 
γ (PPARγ) was downregulated by IL-27. PPARγ is a nuclear hormone receptor that 
regulates lipid metabolism and glucose homeostasis (Waickman and Powell, 2012; Xu 
et al., 1999), and has also been shown to decrease IFNγ secretion in CD4+ T cells 
(Cunard et al., 2004). Therefore, a novel pathway by which IL-27 may regulate the 
increased production of IFNγ by Th1 cells may be via the downregulation of PPARγ. 
Furthermore, the homologue of PPARγ, PPARα has been shown to repress the 
transcription factors AP-1 and NF-κB (Delerive et al., 1999). It is possible that PPARγ 
may have similar repressive effects on these pro-inflammatory transcription factors, and 
therefore IL-27 may reduce this repression and in turn promote inflammatory responses 
along with IFNγ.  
 
5.5.4.3 TCR signalling is altered in IL-27 driven Th1 cells 
The gene Dgkk, which encodes diacylglycerol kinase (DGK) kappa, was downregulated 
by IL-27 in Th1 cells (Group 1 & Discussion Figure 5.1). DGKs are intracellular lipid 
kinases that phosphorylate diacylglycerol (DAG), enabling it to be converted to 
phosphatidic acid (Merida et al., 2008). This reduces DAG signalling and in turn 
regulates intracellular signalling. DAG is a fundamental molecule in the TCR signalling 
cascade, and is key in antigen receptor triggering (Cantrell, 2002). Therefore, this data 
suggests that IL-27 may indirectly augment TCR signalling via the downregulation of 




it has been shown that increased antigen dose increases IL-10 expression by Th1 cells 
(Saraiva et al., 2009).  
 
Model	  for	  postulated	  mechanism	  
 
 
The possibility that IL-27 promotes greater TCR triggering in Th1 cells is supported by 
the increased expression of Nfkbid in Th1 + IL-27 cells (Discussion Figure 5.2). Nfkbid, 
which encodes the NF-κB inhibitor IκBNS, was upregulated by IL-27 in Group 3. 
Induction of IκBNS expression has been correlated with TCR signal strength, with 
weak TCR ligands failing to trigger IκBNS expression (Fiorini et al., 2002). 
Furthermore, IκBNS has been associated with T cell cytokine regulation and that 
IκBNS deficient thymocytes and CD8+ T cells produce significantly reduced amounts 
of IFNγ (Touma et al., 2007). Therefore, the culture of Th1 cells with IL-27 potentially 
could result in increased TCR signalling, which drives Il10 expression, and Nfkbid 
expression that in turn drives increased IFNγ production.  
 
5.5.4.4 Molecules involved in the AhR signalling pathway are highly upregulated 
in the IFNγ- IL-10- subpopulation within the Th1 + IL-27 subset 
Upon analysis of the bulk unseparated Th1 and Th1 + IL-27 subsets we saw a dramatic 
increase in the expression of Arnt2 (Discussion Figure 5.2). Furthermore, analysis of 
the separate intracellular cytokine producing subpopulations revealed a dramatic 
increase in the expression of Maf in Group 4 (Discussion Figure 5.2). Arnt2 is part of 
a group of proteins that are important in translocating AhR into the nucleus, where it 
can then act as a transcription factor (Rowlands and Gustafsson, 1997). c-Maf has been 
shown to promote the activation of Il10 expression in IL-27 driven Tr1 cells (Pot et al., 
2009), and IL-27 has been shown to activate AhR, which upon interaction with c-Maf 













been shown to regulate the metabolic programme that supports IL-10 producing, IL-27 
driven, Tr1 cells (Mascanfroni et al., 2015). However, this has not been reported in Th1 
cells. Therefore our findings are in conjunction with previous reports that IL-27 
promotes c-Maf and AhR signalling. 
 
When we characterised the expression of Maf and Arnt2 in the different intracellular 
cytokine producing subpopulations within the Th1 + IL-27 subset we found that these 
factors were differentially expressed.  Maf and Arnt2 were most upregulated by IL-27 in 
the IFNγ- IL-10- subpopulation, and were expressed to a lower level in the cytokine 
producing subpopulations. Maf expression has been shown to be maximal at 72 – 96 
hours of differentiation from naïve CD4+ T cells under Th1 driving conditions, after 
which point its expression is downregulated (Neumann et al., 2014). We show that in 
this heterogeneous population of Th1 cells, Maf expression remains high in the IFNγ- 
IL-10- subpopulation, and is downregulated as cytokines are produced. This perhaps 
points to the role of c-Maf in the regulation of cytokine expression and in turn its 
mechanism of action. 
 
This data shows that IL-27 drives increased Maf and Arnt2 expression, which is then 
downregulated upon cytokine production by the Th1 cells. It is possible that there is a 
cell intrinsic feedback mechanism that initiates once the cells have started to make the 
cytokines, which acts to reduce the induction of c-Maf and AhR. Interestingly, when 
returning to the raw read data, the expression of the Il27ra follows a similar expression 
profile to Maf and Arnt2 (Discussion Figure 5.2). Therefore our data shows that in the 
presence of IL-27 the expression of Maf and Arnt2 is upregulated in the IFNγ- IL-10- 
subpopulations, but upon cytokine production Maf and Arnt2 expression is decreased, 
and this coincides with a decreased expression of Il27ra. Therefore, it is possible that 
upon the production of cytokines cells downregulate the expression of the IL-27 
receptor, and therefore cannot respond further to IL-27, resulting in the signalling 
pathways and transcriptional networks driven by IL-27 being reduced, and in turn 
reducing the expression of Maf and Arnt2.  
 
In Group 4 the expression of Tnf follows the reverse expression profile to Maf and 
Arnt2 in Th1 + IL-27 cells (Discussion Figure 5.2). It is under expressed in IFNγ- IL-




IFNγ+ IL-10- and IFNγ+ IL-10+. Corresponding with its immune effector function. It 
has been shown in microglia that IL-27 can downregulate TNF-α expression (Baker et 
al., 2010) and lymph node cells from IL-27 receptor knockout mice express 
significantly more TNF (Batten et al., 2006). Therefore the increase in Tnf expression 
seen in our data in the cytokine producing subpopulations of the Th1 + IL-27 subset 
may be because of the downregulation of the Il27ra.  
 
5.5.5 Different intracellular producing subpopulations from the Th1 and Th1 + IL-27 
subsets have different transcriptional profiles 
Separating the Th1 and Th1 + IL-27 subsets into different intracellular cytokine 
producing subpopulations highlighted dramatic differences in gene expression.  
 
5.5.5.1 Interferon signalling is downregulated in cytokine producing 
subpopulations 
Our data shows that in Th1 cells cultured in the presence of IL-27 the expression of 
Ifngr1 and Ifngr2 was downregulated (Discussion Figure 5.1). However, irrespective of 
the presence of IL-27, the expression of Ifngr1 and Ifngr2 was also downregulated in 
the cytokine producing subpopulations (Discussion Figure 5.1). Previous publications 
reveal that upon activation, Th1 cells downregulate the expression of IFNγ receptors. 
The expression of Ifngr1 is downregulated in Th1 cells upon TCR engagement and 
signalling (Skrenta et al., 2000), while the expression of Ifngr2 is downregulated by 
IFNγ feeding back upon the Th1 cells (Bach et al., 1995). Therefore in our in vitro 
culture system, we would expect all of the subpopulations within the Th1 + IL-27 
subset to have downregulated the expression of both IFNγ receptors; as IL-27 drives 
increased IFNγ production, and as all the cells received the same dose of antigen and 
were in their own supernatant containing IFNγ. However, this was not that case. 
Therefore, these data suggest that, rather than IFNγ acting in an autocrine manner to 
feedback on all Th1 cells in the culture and reduce IFNγ receptor expression, there is in 
fact either; a cell intrinsic mechanism that results in the downregulation of IFNγ 




the IFNγ+ cells acts in a highly local manner to mediate negative feedback only on Th1 
cells producing IFNγ. 
 
To further characterise our findings, analysis of the expression of the IFNγ receptor and 
interferon responsive genes in naïve CD4+ T cells and Th0 cells would be of interest. 
Neither naïve CD4+ T cells nor Th0 cells produce IFNγ. Naïve CD4+ T cells, which 
have not received TCR or IFNγ signalling, should according to the literature have 
maximal Ifngr1 and Ifngr2 expression. Th0 cells, which receive TCR signalling but are 
cultured in the presence of anti-IFNγ to prevent IFNγ signalling, should according to the 
literature have maximal Ifngr2 but reduced Ifngr1 expression. By comparing the naïve 
CD4+ T cells and Th0 cells to the Th1 subpopulations we can establish if the expression 
if the IFNγ receptors is downregulated by TCR or IFNγ signalling in the absence of Ifng 
expression.  
 
5.5.5.2 DUSP9  expression is decreased in the IFNγ+ IL-10+ subpopulation within 
the Th1 + IL-27 subset 
 
Dusp9 encodes the dual specificity phosphatase 9 (also known as MKP-4) (Niedzielska 
et al., 2015). This gene is upregulated in both the Th1 and Th1 + IL-27 IFNγ+ IL-10- 
subpopulations, and downregulated in the IFNγ+ IL-10+ subpopulation of the Th1 + IL-
27 subset (Group 6, Discussion Figure 5.1). DUSP9 is a phosphatase that has an 
important role in the attenuation of ERK, JNK and p38 via dephosphorylation of these 
proteins (Muda et al., 1997). ERK signalling is also important for positive regulation of 
IL-10 (Saraiva et al., 2009). Furthermore, pDCs (which do not make IL-10) selectively 
express high levels of DUSP9 compared to cDCs (which do express IL-10) (Niedzielska 
et al., 2015). Therefore this recent finding, alongside our data, suggests that DUSP9 
may be a negative regulator of IL-10 production via the repression of ERK signalling. 







We propose that in IFNγ+ IL-10- cells Dusp9 expression is high to enable IFNγ 
production in the absence of IL-10, and in IFNγ+ IL-10+ cells Dusp9 expression is 
reduced to enable IFNγ and IL-10 production. The greater reduction of Dusp9 
expression in the IFNγ+ IL-10+ Th1 + IL-27 cells compared to the IFNγ+ IL-10+ Th1 
cells may define one mechanism by which IL-27 drives increased IL-10 production. 
 
5.5.5.3 Multiple genes involved in cytokine signalling are upregulated in the 
cytokine producing subpopulations within the Th1 and Th1 + IL-27 
subsets 
Group 5 was a cluster of genes that were upregulated in the cytokine producing 
subpopulations within the Th1 and Th1 + IL-27 subsets. Therefore, as expected Il10 
was upregulated in the IFNγ+ IL-10+ subpopulations and Ifng was upregulated in both 
the IFNγ+ IL-10- and IFNγ+ IL-10+ subpopulations. However, many other cytokines 
and chemokines were also upregulated in these subpopulations alongside IL-10 and 
IFNγ. Some of the cytokines that were upregulated alongside IL-10 and IFNγ are known 
to be associated with Th1 cells. The initial studies that phenotyped Th1 and Th2 clones 
found Th1 cells produce IL-3 and GM-CSF (Cherwinski et al., 1987). GM-CSF is made 
by Th1 cells in a STAT4 dependent manner (McWilliams et al., 2015) and is important 
in the initiation of autoimmune inflammation, particularly during EAE (Codarri et al., 
2011; Herndler-Brandstetter and Flavell, 2014; Marusic et al., 2002). In support of 
recent publications that show IL-27 suppresses T cell GM-CSF expression (Young et al., 
2012), in our data Csf2 expression was downregulated in the Th1 + IL-27 cytokine 
producing subpopulations compared to the Th1 cytokine producing subpopulations. 
Interestingly some of the cytokines that were upregulated are not generally considered 
to be associated with Th1 cells, such as IL-1α and IL-23α. Furthermore, IL-22 and IL-
17F, cytokines associated with Th17 cells (Awasthi and Kuchroo, 2009; Harrington et 
al., 2005), were upregulated in the cytokine producing subpopulations of the Th1 and 
Th1 + IL-27 subsets. Therefore, alongside the upregulation of IL-10 and IFNγ 
production in the cytokine producing subpopulations of the Th1 and Th1 + IL-27 
subsets, the expression of multiple other cytokines was upregulated. It is likely that the 
factors and pathways driving the upregulation of Il10 and Ifng expression are also 





5.5.6 The identification of mechanisms that may regulate the expression of Il10 
The analysis of the bulk unseparated Th1 and Th1 + IL-27 subsets revealed some genes 
and processes that were affected by IL-27, however this analysis could not be used to 
expose any novel genes or mechanisms that may be involved in the regulation of Il10 
gene expression, as discussed above with examples. By separating the different 
intracellular cytokine producing subpopulations within the Th1 and Th1 + IL-27 subsets, 
however, we did reveal groups of genes that were specifically downregulated or 
upregulated alongside IL-10. Therefore these genes could be negative or positive 
regulators of Il10 expression, respectively. Nevertheless, it is difficult to be sure that 
these genes within these lists are involved in Il10 regulation. These genes could have no 
relation of IL-10, could be regulated in parallel with IL-10, or could be regulated by IL-
10. Therefore, these targets will be knocked out by CRISPR-Cas or RNAi by the 






Figure 5A.1 IL-10 and IFNγ  production by Th1 cells increased upon culture with 
IL-27 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-CD3 
and soluble anti-CD28, and polarised to Th1 cells with IL-12 and anti-IL-4 in the presence 
or absence of IL-27. A. Plots of flow cytometric analysis of intracellular cytokine staining. 
Numbers show percentage of live CD4+ cells. Gating strategy described in Materials and 
Methods. B. Graphs represent cytokines in supernatants of cells determined by ELISA. 
Cells restimulated as described in Materials and Methods, assessed after 7 days of 
polarization in vitro. Graphs show means ± SD of triplicates, **p < 0.01, ***p < 0.001, 
****p<0.0001 determined by students T-test. Representative of six experiments. 





Figure 5A.2 Determining the optimal lower cut-off of reads for expression 
threshold of bulk Th1 and Th1 + IL-27 RNA-Seq samples 
mRNA extracted and prepared for RNA-Seq as described in Materials and Methods. 
Using Strand NGS software reads were aligned to the transcriptome & Genome (mm10, 
RefSeq annotation, 95% identity, max 5% gaps, 1 read only if duplicate) and 
normalisation with DeSeq and no Baseline. Upper cut-off 1027711.75 (where at least 1 
out of 6 samples have values within cut-off). A. The number of entities passing 
expression thresholds with indicated lower cut-offs. All bulk Th1 and Th1 + IL-27 
samples were pooled for this test. B. Using an expression threshold with a lower cut-off 
of 20 reads, the number of entities in each repeat of the bulk Th1 and Th1 + IL-27 







Figure 5A.3 PCA and cluster analysis demonstrates that bulk Th1 and Th1 + IL-
27 cells have different gene expression profiles 
mRNA extracted and prepared for RNA-Seq as described in the Materials and Methods. 
A. PCA plots of the bulk Th1 and Th1 + IL-27 samples analysed by RNA-Seq. B. 
Unsupervised hierarchical clustering on conditions, of all individual replicates within 
the bulk Th1 and Th1 + IL-27 subsets. C. Unsupervised hierarchical clustering on 
conditions, of the bulk Th1 and Th1 + IL-27 subsets (repeat data pooled). Unsupervised 
hierarchical clustering was carried out on the normalised intensity values with a 
Pearson’s centred similarity measure and an Average linkage rule. Colour ranges 







Figure 5A.4.1 There are dramatic transcriptional differences between the bulk 
Th1 and Th1 + IL-27 subsets 
mRNA extracted and prepared for RNA-Seq as described in the Materials and Methods. 
Data from the three biological replicates were pooled. Differentially regulated genes 
were obtained by taking those that were at least 3-fold up- or downregulated in at least 1 
of the 2 samples vs. the baseline (median of all the samples). A. This left 307 genes that 
were subjected to hierarchical clustering on entities and conditions with a Pearson’s 
centred similarity measure and an Average linkage rule. Colour ranges indicate 
normalised intensity. The dendrogram represents the relatedness of the samples. Genes 
were separated into 2 groups based on the hierarchical dendrogram. B. Group 1 GO 
terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, and examples of 
genes within the group. C. Group 2 IPA pathways (p<0.01) with significant overlap, 
and examples of genes within the group. There were no significant GO terms for Group 





Figure 5A.4.2 Group 1: Network analysis of 284 genes downregulated in Th1 cells 
cultured with IL-27 
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 













































































































































































































































































































































Figure 5B.1 Subpopulations of Th1 and Th1 + IL-27 subsets 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-
CD3 and soluble anti-CD28. Th1 cells were polarised with IL-12 and anti-IL-4 in the 
presence or absence of IL-27, and were assessed after 7 days of polarization in vitro. 
Cells were restimulated for ICS as described in the Materials and Methods. Plots of 
sorted populations by flow cytometric analysis of intracellular cytokine staining. Tables 
showing the percentage of the total number of cells that each cytokine producing 
subpopulation represented for each of the three repeat experiments. The bulk is 100% of 
all CD4+ live cells as described in the Materials and Methods. A. Subpopulations 






Figure 5B.2 Determining the optimal lower cut-off of reads for expression 
threshold of Th1 and Th1 + IL-27 RNA-Seq samples 
Cell populations are described in Figure 5B.1, mRNA extracted and prepared for RNA-
Seq as described in Materials and Methods. Using Strand NGS software reads were 
aligned to the transcriptome & Genome (mm10, RefSeq annotation, 95% identity, max 
5% gaps, 1 read only if duplicate) and normalisation with DeSeq and no Baseline. 
Upper cut-off 1165880.5 (where at least 1 out of 24 samples have values within cut-off). 
A. The number of entities passing expression thresholds with indicated lower cut-offs. 
All the Th1 and Th1 + IL-27 samples were pooled for this test. B. Using an expression 
threshold with a lower cut-off of 20 reads, the number of entities in each repeat of each 






Figure 5B.3 PCA and cluster analysis demonstrates that Th1 and Th1 + IL-27 cells 
have different gene expression profiles 
Cell populations are described in Figure 5B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. A. PCA plots of different intracellular 
cytokine producing subpopulations within the Th1 and Th1 + IL-27 samples analysed 
by RNA-Seq. B. Unsupervised hierarchical clustering on conditions, of all individual 
replicates within the Th1 and Th1 + IL-27 subsets, was carried out on the normalised 
intensity values with a Pearson’s centred similarity measure and an Average linkage 
rule. Colour ranges indicate normalised intensity. The dendrogram represents the 






Figure 5B.4 Clustering analysis demonstrates that Th1 cells and Th1 + IL-27 cells 
are distinct and have transcriptional differences 
Cell populations are described in Figure 5B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. Data from the three biological replicates 
were pooled. A. Unsupervised hierarchical clustering on conditions, of each 
subpopulations within the Th1 and Th1 + IL-27 subsets, was carried out on the 
normalised intensity values with a Pearson’s centred similarity measure and an Average 
linkage rule. Colour ranges indicate normalised intensity. The dendrogram represents 






Figure 5B.5 There are dramatic transcriptional differences between the different 
intracellular cytokine producing subpopulations within the Th1 and Th1 + IL-27 
subsets 
Cell populations are described in Figure 5B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. Data from the three biological replicates 
were pooled. Differentially regulated genes were obtained by taking those that were at 
least 3-fold up- or downregulated in at least 1 of the 8 samples vs. the baseline (median 
of all the samples). This left 1944 genes that were subjected to hierarchical clustering 
on entities and conditions with a Pearson’s centred similarity measure and an Average 
linkage rule. Colour ranges indicate normalised intensity. The dendrogram represents 
the relatedness of the samples. Genes were separated into 7 groups based on the 






Figure 5B.6.1 Group 1: 146 genes downregulated in Th1 cells cultured with IL-27, 
regardless of cytokine production 
A. Genes in Group 1 from hierarchical clustering in Figure 5B.5. B. Expression profile 
of group. C. GO terms (p<0.05) and IPA pathways (p<0.01) with significant overlap, 







Figure 5B.6.2 Group 1: Network analysis of 146 genes downregulated in Th1 cells 
cultured with IL-27, regardless of cytokine production 
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 





Table 5B.6.1 Group 1: List of 146 genes downregulated in Th1 cells cultured with 
IL-27, regardless of cytokine production 

























































































































































Figure 5B.7.1 Group 2: 349 genes downregulated in Th1 cells cultured with IL-27. 
More pronounced in Th1 + IL-27 IFNγ- IL-10- subpopulation 
A. Genes in Group 2 from hierarchical clustering in Figure 5B.5. B. Expression profile 
of group. C. GO terms (p<0.05) and IPA pathways (p<0.01) with significant overlap, 







Figure 5B.7.2 Group 2: Network analysis of 349 genes downregulated in Th1 cells 
cultured with IL-27. More pronounced in Th1 + IL-27 IFNγ- IL-10- subpopulation 
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 





Table 5B.7.1 Group 2: List of 349 genes downregulated in Th1 cells cultured with 
IL-27. More pronounced in Th1 + IL-27 IFNγ- IL-10- subpopulation 







































































































































































































































































































































































Figure 5B.8.1 Group 3: 299 genes downregulated in Th1 cells cultured with IL-27. 
More pronounced in Th1 + IL-27 cytokine producing subpopulations 
A. Genes in Group 3 from hierarchical clustering in Figure 5B.5. B. Expression profile 
of group. C. IPA pathways (p<0.01) with significant overlap, and examples of genes 
within the group (no significant GO terms). D. The read number of selected genes in 





Figure 5B.8.2 Group 3: Network analysis of 299 genes downregulated in Th1 cells 
cultured with IL-27. More pronounced in Th1 + IL-27 cytokine producing 
subpopulations 






Table 5B.8.1 Group 3: List of 299 genes downregulated in Th1 cells cultured with 
IL-27. More pronounced in Th1 + IL-27 cytokine producing subpopulations 



























































































































































































































































































































Figure 5B.9.1 Group 4: 86 genes upregulated in Th1 cells cultured with IL-27.  
A. Genes in Group 4 from hierarchical clustering in Figure 5B.5. B. Expression profile 
of group. C. GO terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, 








Figure 5B.9.2 Group 4: Network analysis of 86 genes upregulated in Th1 cells 
cultured with IL-27.  
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 





Table 5B.9.1 Group 4: List of 86 genes upregulated in Th1 cells cultured with IL-
27.  





























































































Figure 5B.10.1 Group 5: 586 genes downregulated in cytokine producing 
subpopulations.  
A. Genes in Group 5 from hierarchical clustering in Figure 5B.5. B. Expression profile 
of group. C. GO terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, 







Figure 5B.10.2 Group 5: Network analysis of 586 genes downregulated in cytokine 
producing subpopulations.  
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 





Table 5B.10.1 Group 5: List of 586 genes downregulated in cytokine producing 
subpopulations.  





























































































































































































































































































































































































































































































































































































































Figure 5B.11 Group 6: 37 genes upregulated in cytokine producing 
subpopulations. More pronounced in IFNγ+ IL-10- subpopulation 
A. Genes in Group 6 from hierarchical clustering in Figure 5B.5, with gene names 
alongside. B. Expression profile of group. C. GO terms (p<0.3) and IPA pathways 
(p<0.01) with significant overlap, and examples of genes within the group. D. The read 
number of selected genes in each subpopulation. E. IPA network analysis of direct and 
indirect interactions between genes. Solid lines indicate direct interactions, the dashed 






Figure 5B.12.1 Group 7: 124 genes upregulated in cytokine producing 
subpopulations. More pronounced in IFNγ+ IL-10+ subpopulation 
A. Genes in Group 7 from hierarchical clustering in Figure 5B.5. B. Expression profile 
of group. C. GO terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, 







Figure 5B.12.2 Group 7: Network analysis of 124 genes upregulated in cytokine 
producing subpopulations. More pronounced in IFNγ+ IL-10+ subpopulation 
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 





Table 5B.12.1 Group 7: List of 124 genes upregulated in cytokine producing 



































































































































Discussion Figure 5.1 Genes of interest downregulated by IL-27 
A. Table highlighting genes of interest found to be downregulated by IL-27 in Th1 cells. 
The first column highlights genes revealed in the analysis of the bulk unseparated Th1 
and Th1 + IL-27 subsets. The second column highlights genes revealed in the analysis 
of different intracellular cytokine producing subpopulations within the Th1 and Th1 + 






Discussion Figure 5.2 Genes of interest upregulated by IL-27 
A. Table highlighting genes of interest found to be upregulated by IL-27 in Th1 cells. 
The first column highlights genes revealed in the analysis of the bulk unseparated Th1 
and Th1 + IL-27 subsets. The second column highlights genes revealed in the analysis 
of different intracellular cytokine producing subpopulations within the Th1 and Th1 + 







Chapter 6. RNA-Seq analysis of differential 
gene expression in Th17 cells driven in the 
presence or absence of IL-2, and, in depth 
analysis of the different intracellular cytokine 
producing subpopulations within these Th17 + 






Chapter 6 (A) RNA-Seq analysis of differential gene 
expression in Th17 cells driven in the presence or absence of 
IL-2 
 
6.1 (A) Background 
The mechanisms that regulate IL-10 production by Th17 cells are complex and remain 
unresolved. Th17 cells driven with TGFβ, rather than IL-1β, IL-6 and IL-23 have been 
shown to express higher levels of IL-10, and when driven with TGFβ and IL-6 alone 
Th17 cells express IL-17 and IL-10 but do not upregulate proinflammatory cytokines 
(Ghoreschi et al., 2010). However, the effects are variable and the cells in these 
conditions are highly heterogeneous (Kuchroo VK, International Congress of 
Immunology, 2013). When stimulated with IL-23 the cells express IL-17 and 
proinflammatory cytokines, including IFNγ, and no IL-10, leading to a pathogenic 
function (Ghoreschi et al., 2010; Lee et al., 2009b; McGeachy et al., 2007). As in Th1 
cells, IL-27 can drive IL-10 from Th17 cells. IL-27 and IL-6 synergise with TGFβ to 
drive increased IL-10, but decreased IL-17, in Th17 cells, without affecting FoxP3 
expression. The synergy of IL-27 and TGFβ has been suggested to drive IL-10 
production via c-Maf, although this remains unclear (Xu et al., 2009). IL-27 driven IL-
10 expression depends on STAT1 and STAT3 signalling, IL-6 driven IL-10 depends 
only on STAT3 signalling (Fitzgerald et al., 2007; Stumhofer et al., 2007). 
 
There is a complicated and dynamic balancing process between Th17 and Treg 
differentiation, which is crucially regulated by the dose of TGFβ (Bettelli et al., 2006; 
Veldhoen et al., 2006). Low doses of TGFβ can synergise with IL-6 and IL-21 to 
initiate the development of Th17 responses, whereas high doses of TGFβ lead to the 
inhibition of IL-23 receptor expression and the induction of the Treg transcription factor 
FoxP3 (Awasthi and Kuchroo, 2009; Bettelli et al., 2006). IL-2, in conjunction with 
high levels of TGFβ, is thought to be essential for the differentiation of Treg cells in 
vitro (Davidson et al., 2007; Yamane and Paul, 2012) and the maintenance of Treg 
homeostasis in vivo (Fontenot et al., 2005). When culturing Th17 cells with IL-2 in 




phosphorylation is increased (Zielinski et al., 2012), and the generation of Th17 cells 
and IL-17 expression is impaired. This is supported by findings that STAT5 represses 
RORγt and IL-17 upregulation (Laurence et al., 2007), and the inhibition of STAT5 or 
IL-2 results in greater IL-17 production (Zielinski et al., 2012). Furthermore, it has been 
demonstrated that IL-6, via STAT3, and IL-2, via STAT5, act reciprocally at the Il17 
locus to promote Th17 or Treg differentiation, respectively (Yang et al., 2011). 
However, alongside the role of IL-2 in suppressing Th17 cells, there is some evidence 
to suggest that IL-2 can drive transient IL-10 production by Th17 cells. It has been 
shown that during S. aureus infection IL-10 expression is transiently increased and IL-
17 expression is decreased in Th17 cells, via what was postulated to be a STAT5 
dependent, FoxP3 independent, mechanism (Zielinski et al., 2012).  
 
IL-10 production by Th17 cells is variable and transient and the factors dominantly 
inducing IL-10 in Th17 cells are unclear; therefore we wanted to investigate the factors 
involved in driving IL-10 production from Th17 cells. We have found that IL-2 levels 
are crucial in driving two distinct forms of Th17 cell; addition of IL-2 results in 
increased IL-10, albeit alongside decreased IL-17, and blockade of IL-2 results in the 
disappearance of IL-10 alongside increased IL-17. We want to apply the method 
devised in Chapter 4 to perform RNA-Seq analysis on bulk cell populations of these 
‘IL-10-’ or ‘IL-10+’ Th17 cells to address the effect of IL-2 on the transcriptional 
profile of Th17 cells and to illuminate some of the mechanisms behind IL-10 






6.2 (A) Results 
6.2.1 IL-10 production by Th17 cells increases, and IL-17 production decreases, upon 
culture with IL-2 
IL-2 has been reported to repress Th17 cell generation and to promote Treg 
differentiation (Davidson et al., 2007; Laurence et al., 2007). Thus, IL-2 is thought to be 
important in balancing between the generation of RORγt+ Th17 cells and FoxP3+ Treg 
cells. Therefore, we wanted to investigate the role of IL-2 on Th17 differentiation and 
IL-10 production in our in vitro culture system. To test this, naïve 
CD4+CD62L+CD44loCD25- T cells were stimulated with anti-CD3 and anti-CD28, 
and cultured with TGFβ and IL-6 for the optimal 3 days (Chapter 3) (Figure 6A.1 A) in 
the presence of IL-2 (referred to as Th17 + IL-2 Figure 6A.1 A) or in the presence of 
anti-IL-2 (referred to as Th17 + anti-IL-2 Figure 6A.1 A); to neutralise any autocrine 
IL-2 produced by the Th17 cells.  The presence of IL-2 did not effect the undetectable 
expression of IL-4 or IFNγ by the Th17 cells (Figure 6A.1 A), since cells were cultured 
in the presence of anti-IL-4 and anti-IFNγ. Treatment with anti-IL-2 lead to a slight 
increase in intracellular IL-2, which was also seen at the mRNA level, possibly due to 
the cells trying to compensate for the blocked IL-2 signalling in the extracellular 
environment. In keeping with the literature, treatment with anti-IL-2 significantly 
enhanced the production of IL-17 from Th17 cells (from 18.5% to 56%), although IL-
17 was still produced by Th17 cells treated with IL-2 (21%) (Figure 6A.1 A&B). In 
addition, Th17 cells cultured in the presence of IL-2 produced increased amounts of IL-
10 compared to the Th17 cells that only had endogenous IL-2 (from 4% to 14%) and 
from Th17 + anti-IL-2 cells as IL-10 was not observed in anti-IL-2 treated Th17 cells 
(Figure 6A.1 A&B). Furthermore, IL-10 was not only expressed by the subpopulations 
of cells that did not produce IL-17, but also by cells that did produce IL-17 (Figure 
6A.1 A). None of the cells in either of the Th17 populations expressed FoxP3 and 
therefore were not IL-10 expressing Treg cells (data not shown). Therefore, the Th17 + 
IL-2 subset consisted of four subpopulations: IL-17- IL-10-, IL-17+ IL-10-, IL-17- IL-
10+ and IL-17+ IL-10+. The Th17 + anti-IL-2 subset consisted of only two 





6.2.2 Quality control analysis of bulk Th17 + IL-2 and Th17 + anti-IL-2 RNA-Seq 
samples 
6.2.2.1 Determining the optimal lower cut-off of reads 
Prior to the identification of significantly differentially expressed genes in the Th17 + 
IL-2 and Th17 + anti-IL-2 samples, noise removal and quality control were carried out 
to ensure the integrity of the repeats. Once the RNA-Seq was performed, the transcripts 
were aligned, noise was removed (Figure 6A.2 A) and a quality control analysis was 
conducted to ensure the robustness of the experiments (Figure 6A.2 B). All the Th17 + 
IL-2 and Th17 + anti-IL-2 samples were pooled and the upper cut-off of reads for 
expression threshold was set at 253033.02 reads (where at least 1 out of 6 samples have 
values within cut-off), which was the maximal number of reads found for any gene. The 
number of entities passing expression thresholds with different lower-cut offs was 
assessed to determine where to set the lower cut-off (Figure 6A.2 A). As with in 
Chapter 5 the curve began to flatten at around 20 reads and the lower cut-off was set at 
20 reads. Next we pooled the data from the three biological repeats of each 
subpopulation, and if any one gene in the three had a read count of above 20 then the 
entity would be included in the analysis. With the lower cut-off set at 20, the number of 
entities passing through each repeat was calculated (Figure 6A.2 B). The results 
revealed that each of the repeats had very tight error bars with all expressing between 
11,200 – 11,500 entities. This showed that all of the repeats are comparable and are 
robust. Furthermore, as expected, we found that the mRNA expression profile of the 
cytokines Il10 and Il17a mirrored the protein production profiles of the cells (Figure 
6A.2 C). The Th17 + IL-2 cells expressed considerably more Il10, while the Th17 + 
anti-IL-2 cells expressed considerably more Il17a.  
 
6.2.2.2 PCA and cluster analysis of bulk Th17 + IL-2 and Th17 + anti-IL-2 
We performed a PCA on the bulk Th17 + IL-2 and Th17 + anti-IL-2 samples to further 
understand the variations in gene expression between the samples (Figure 6A.3 A). The 
repeats of the bulk Th17 + IL-2 and Th17 + anti-IL-2 subsets clustered away from each 
other. There was slightly more inter-repeat variability in the bulk Th17 + anti-IL-2 




there were no obvious outliers in the data with the three repeats of each subpopulation 
clustering together. 
 
To further determine the robustness of the samples and understand the variations in 
gene expression between the samples we performed unsupervised hierarchical 
clustering on the conditions. This clustering was performed on all 12,114 genes found 
within the samples (Figure 6A.3 B). As with the PCA, the dendrogram showed that the 
Th17 + IL-2 and Th17 + anti-IL-2 subsets clustered away from each other, suggesting 
that IL-2 has a distinct impact on the gene expression of Th17 cells. From this analysis 
we were assured that the repeats were robust and there were no outliers. Therefore, from 
this point forward, data from the three repeats was pooled. After pooling the data from 
the repeats we ran unsupervised hierarchical clustering on conditions and found that the 
bulk Th17 + IL-2 and bulk Th17 + anti-IL-2 subsets had visible differences in 
expression (Figure 6A.3 C), however, overall their gene expression profiles looked 
very similar (as seen by the predominance of yellow on the heat map). 
 
6.2.3 Hierarchical clustering separates the genes within the bulk Th17 + IL-2 and 
Th17 + anti-IL-2 cells into groups based on their expression profiles 
Our data thus far demonstrates that culture of Th17 cells with IL-2 alters the 
transcriptional profile of Th17 cells. To further investigate the differential gene 
expression between the samples we applied statistical filtering to retain genes that were 
at least 3-fold up- or downregulated in at least one of the samples (repeat data pooled) 
vs. the baseline (median of all the samples). This resulted in a list of 861 genes that we 
then subjected to hierarchical clustering on entities and conditions (Figure 6A.4.1 A). 
The 861 gene set separated into two branches, 606 that were downregulated by IL-2 in 
Th17 cells (Table 6A.4.1), and 256 that were upregulated by IL-2 in Th17 cells (Table 
6A.4.2). Therefore, the absence of IL-2 in Th17 cultures predominantly resulted in 
increased gene expression and the presence of IL-2 predominantly resulted in the 
downregulation of gene expression (Figure 6A.4.1 A). 
 
To further investigate the genes in these two groups we assessed if they were 
significantly associated with any GO terms or IPA pathways. The genes in Group 1 




retinoic acid metabolic process, cell adhesion, regulation of phosphate metabolic 
process, FXR/RXR activation, P2Y purigenic receptor signalling and MIF regulation of 
innate immunity (JNK/AP1 signalling) (Figure 6A.4.1 B). Genes of interest included 
Cyp26a1 and Cyp26b1, which encode enzymes that degrade retinoic acid (Rhinn and 
Dolle, 2012), and also various factors associated with ERK / AP-1 signalling were 
present, including Egr1, Egr3, Fos, Fosb and Twist1, and the cytokines Il2, Il17a and 
Il23a (Figure 6A.4.1 B). Network analysis revealed that many of these genes directly 
interact with one another, with FOS, TWIST1 and EGR1 playing central roles in this 
network (Figure 6A.4.2). 
 
The genes in Group 2 (Table 6A.4.2), which were upregulated by IL-2 in Th17 cells, 
were related to cytokine receptor activity, immune system effector process, cell 
migration, inflammatory and immune responses, CTLA4, IL-12 & IL-10 signalling, T 
helper cell differentiation and CD28 signalling in T helper cells (Figure 6A.4.1 C). 
Genes of interest included the cytokine receptors Il10ra, IL12rb1 and Il12rb2, the 
chemokine receptors Cxcr1, Ccr2, Ccr4 and Ccr5, the cell surface molecules Cd80 and 
Cd86, the transcription factors Maf and Prdm1, and as expected Il10 (Figure 6A.4.1 C); 
showing the dependence of these genes on IL-2. Most of these genes are interrelated at 
the network level, stemming from the core nodes of MAF and PRDM1 (Figure 6A.4.3). 
 
This analysis revealed many interesting differences between Th17 cells cultured in the 
presence of IL-2 or anti-IL-2. Of particular interest is the finding that IL-2 may 
downregulate the expression of molecules involved in retinoic acid metabolism and the 
expression of genes involved in ERK / AP-1 signalling. Prdm1 and Maf have been 
associated with IL-10 regulation in Th1 cells (Neumann et al., 2014), and therefore IL-2 
may drive Il10 expression in Th17 cells via this pathway. However, as analysis of the 
different cytokine producing Th1 cell subpopulations revealed many more pathways 
involved in IL-27 driven Th1 cell differentiation and IL-10 production, we wanted to 
perform a similar analysis on the different intracellular producing subpopulations within 
the Th17 + IL-2 and Th17 + anti-IL-2 subsets to investigate in greater depth the effect 
of IL-2 on Il10 gene expression and the transcriptional profiles of Th17 cells, and 






Chapter 6 (B) In depth analysis of the different intracellular 
cytokine producing subpopulations within these Th17 + IL-2 
and Th17 + anti-IL-2 subsets 
 
We next asked the question whether the separation of subpopulations within the 
heterogeneous Th17 + IL-2 and Th17 + anti-IL-2 bulk populations could reveal 
additional novel factors involved in IL-2 driven Th17 cell differentiation and IL-10 
production; which may be undetectable due to the potential masking by the large IL-17- 
IL-10- subpopulation of cells within the bulk cultures. 
 
6.3 (B) Background 
As with other Th subsets, Th17 cultures are heterogeneous and contain distinct 
subpopulations, those that don’t make cytokines and those that do produce cytokines. In 
support of this, it has been found that only single cell RNA-Seq can reveal regulatory 
factors involved in the ‘non-pathogenic’ IL-10+ phenotype of Th17 cells, and single 
cell RNA-Seq of Th17 cells has highlighted the vast amount of heterogeneity within the 
Th17 population (Kuchroo VK, International Congress of Immunology, 2013). Our 
work separating different intracellular cytokine producing subpopulations within Th1 
and Th1 + IL-27 subsets has highlighted significant transcriptional differences between 
these subpopulations. In the first section of this chapter we optimised a system for 
culturing IL-10- and IL-10+ Th17 cells in vitro with anti-IL-2 and IL-2, respectively, 
and analysed the bulk population of these cells. Now, to determine the transcriptional 
profiles of the different intracellular cytokine producing cells from within the 
heterogeneous populations of Th17 + IL-2 and Th17 + anti-IL-2 cells, we again used 
the approach of analysing different intracellular cytokine producing subpopulations by 









6.4 (B) Results 
6.4.1 Separating different intracellular cytokine producing subpopulations of Th17 
cells  
As highlighted in Figure 6A.1, the Th17 + IL-2 and Th17 + anti-IL-2 subsets are 
heterogeneous populations of cells with regard to protein production. Therefore, we 
were interested in applying the technique developed in Chapter 4 to separate the 
different intracellular cytokine producing subpopulations within the Th17 + IL-2 and 
Th17 + anti-IL-2 subsets. We elected to carry out RNA-Seq analysis on the Th17 + IL-2 
and Th17 + anti-IL-2 subsets as we were interested in genes affected by IL-2 and genes 
associated with the different intracellular cytokine producing subpopulations. We 
separated these subsets into different intracellular cytokine producing subpopulations 
based on the production of IL-17 and IL-10 (Figure 6B.1). The mRNA from the four 
different subpopulations within the Th17 + IL-2 subset was extracted for RNA-Seq 
analysis: IL-17- IL-10-, IL-17+ IL-10-, IL-17- IL-10+ and IL-17+ IL-10+. Alongside 
the mRNA was isolated from the two different subpopulations within the Th17 + anti-
IL-2 subset: IL-17- IL-10- and IL-17+ IL-10-. 
 
The separated subpopulations represented similar percentages of the bulk Th17 + IL-2 
and Th17 + anti-IL-2 populations in the three repeat experiments (Figure 6B.1). In the 
Th17 + anti-IL-2 subset, the IL-17- IL-10- subpopulation represented on average of 
36% of the bulk, the IL-17+ IL-10- subpopulation 50.5%. Therefore the major 
proportion of this subset was the IL-17 producing cells (Figure 6B.1 A). In the Th17 + 
IL-2 subset, the IL-17- IL-10- subpopulation represented on average 55.3% of the bulk, 
the IL-17+ IL-10- subpopulation 14.8%, the IL-17+ IL-10+ subpopulation 7.8%, and 
the IL-17- IL-10+ subpopulation 13.1% (Figure 6B.1 B). The IL-17+ IL-10- 
subpopulation showed a decrease as a result of IL-2 signalling, while the IL-17- IL-10+ 
and IL-17+ IL-10+ subpopulations were only detected as a result of IL-2. The total 
cytokine producing subpopulations consisted of about 35.7% of the bulk population 





6.4.2 Quality control analysis of Th17 + IL-2 and Th17 + anti-IL-2 subpopulation 
RNA-Seq samples 
6.4.2.1 Determining the optimal lower cut-off of reads 
As with the analysis of the bulk Th17 + IL-2 and Th17 + anti-IL-2 samples we 
performed noise removal and quality control to ensure the integrity of the repeats. Once 
the RNA-Seq was performed, the transcripts were aligned, noise was removed (Figure 
6B.2 A) and a quality control analysis was conducted to ensure the robustness of the 
experiments (Figure 6B.2 B). All the Th17 + IL-2 and Th17 + anti-IL-2 samples were 
pooled and the upper cut-off of reads for expression threshold was set at 323885.938 
reads (where at least 1 out of 24 samples had values within the cut-off), which was the 
maximal number of reads found for any gene. The number of entities passing 
expression thresholds with different lower-cut offs was assessed to determine where to 
set the lower cut-off (Figure 6B.2 A). As with the bulk Th17 + IL-2 and Th17 + anti-
IL-2 samples, the curve began to flatten at around 20 reads and the lower cut-off was set 
at 20 reads. Next, we pooled the data from the three biological repeats of each 
subpopulation, and with the lower cut-off set at 20, the number of entities passing 
through each repeat was calculated (Figure 6B.2 B). The results revealed that each of 
the repeats expressed between 11,000 – 12,000 entities. This showed that all of the 
repeats are comparable and are robust.  
 
6.4.2.2 PCA and cluster analysis of Th17 + IL-2 and Th17 + anti-IL-2 
subpopulations 
We performed PCA on the Th17 + IL-2 and Th17 + anti-IL-2 samples to further 
understand the variations in gene expression between the samples (Figure 6B.3 A). For 
the Th17 + IL-2 and Th17 + anti-IL-2 samples, the PCA showed that the greatest 
variation in the data was due to the presence or absence of IL-2 in the culture. The 
second component split the Th17 + IL-2 cells based on the production of IL-10; the IL-
10 producing subpopulations within the Th17 + IL-2 subset clustered close to one 
another and away from the bulk, IL-17+ IL-10- and IL-17- IL-10- subpopulations 
(Figure 6B.3 A). The bulk Th17 + IL-2 and Th17 + anti-IL-2 cells fell between the IL-




experimental variability between the samples of the Th17 + anti-IL-2 subset, however 
there were no obvious outliers in the data (Figure 6B.3 A).  
 
To further determine the robustness of the samples and understand the variations in 
gene expression between the subpopulations we performed unsupervised hierarchical 
clustering on the conditions. This clustering was performed on all 12,536 genes found 
within the samples (Figure 6B.3 B). As with the PCA, the dendrogram showed the 
Th17 + IL-2 and Th17 + anti-IL-2 subsets cluster away from each other. Suggesting that 
IL-2 has a distinct impact on the gene expression of Th17 cells. The branch lengths of 
the dendrogram are representative of similarity, and compactness of the branches 
between the subpopulations within the Th17 + anti-IL-2 subset suggested that all the 
subpopulations within this subset were very similar. This may be due to the inter-group 
variability between the repeats, seen in the PCA (Figure 6B.3 A), causing overlap 
between the expression profiles of these samples. The Th17 + anti-IL-2 bulk, IL-17+ 
IL-10- and IL-17- IL-10- subpopulations were interspersed, further suggesting there 
were only minor differences between the subpopulations in this subset driven in the 
absence of IL-2. Within the Th17 + IL-2 subset the subpopulations separated into two 
main groups; repeats of the two IL-10+ subpopulations clustered together, repeats of the 
bulk and IL-17- IL-10- subpopulations clustered together, and the IL-17+ IL-10- repeats 
were interspersed between these two groups (Figure 6B.3 B). These data show that the 
presence or absence of IL-2, and the production of cytokines, both have distinct effects 
on gene expression. 
 
6.4.2.3 Different intracellular cytokine producing subpopulations within the Th17 
+ IL-2 and Th17 + anti-IL-2 have different transcriptional profiles 
After pooling data from the three repeats we ran unsupervised hierarchical clustering on 
conditions. Again, we found that the major factor separating the subpopulations was the 
presence or absence of IL-2 in the culture (Figure 6B.4 A). Furthermore, these 
differences cannot be attributed to differences in the expression of the Th17 master 
regulator Rorc; as all of the subpopulations in both the Th17 + IL-2 and Th17 + anti-IL-
2 subsets expressed similar levels of this gene (Figure 6B.4 B).  Moreover, the 
compactness of the branches between the subpopulations within the Th17 + anti-IL-2 




though the bulk and IL-17+ IL-10- subpopulations looked to be slightly more closely 
related (Figure 6B.4 A). Within the Th17 + IL-2 subset, the IL-10 producing 
subpopulations clustered together and separately from the other subpopulations, the 
bulk and IL-17- IL-10- subpopulations clustered together. The IL-17+ IL-10- 
subpopulation was more closely related to the bulk and IL-17- IL-10- subpopulations, 
but lay between the two groups. This suggested that a major factor separating the Th17 
+ IL-2 subpopulations was the production of IL-10 (Figure 6B.4). 
 
6.4.3 Hierarchical clustering separates the Th17 + IL-2 and Th17 + anti-IL-2 
subpopulations into groups based on their gene expression profiles 
Our data thus far demonstrates that culture of Th17 cells with IL-2, or the production of 
cytokines, alters the transcriptional profile of Th17 cells. To further investigate the 
differential gene expression between the samples we applied statistical filtering to retain 
genes that were at least 3-fold up- or downregulated in at least one of the samples 
(repeat data pooled) vs. the baseline (median of all the samples). This resulted in a list 
of 1098 genes that we then subjected to hierarchical clustering on entities and 
conditions (Figure 6B.5).  
 
The 1098 gene set separated into two branches; the Th17 + IL-2 subpopulations 
clustered into one group and the Th17 + anti-IL-2 subpopulations clustered to a 
different group. There were two clear groups of genes with different transcriptional 
profiles within this 1098 set of genes: 
• Group 1: 749 genes downregulated by IL-2 in Th17 cells. 
• Group 2: 349 genes upregulated by IL-2 in Th17 cells. 
 
6.4.3.1 Genes downregulated by IL-2 in Th17 cells 
Group 1 consisted of 749 genes (Table 6B.6.1) that were downregulated in Th17 cells 
cultured in the presence of IL-2 (Figure 6B.6.1 A&B). The results from this group were 
similar to those seen for Group 1 in the analysis of the bulk unseparated Th17 + IL-2 
and Th17 + anti-IL-2 cells (Figure 6A.4.1). Pathways and terms related to this list of 




signalling (Figure 6B.6.1 C). Cyp26a1 and Cyp26b1, are again in this list, alongside 
various factors associated with ERK and AP-1 signalling, including Egr3, Fos, Fosb 
and Twist1. Furthermore, factors not seen in the analysis of the bulk unseparated Th17 + 
IL-2 and Th17 + anti-IL-2 cells were revealed, including the ERK associated factors 
Twist2 and Mapk10, which encodes the c-Jun N-terminal Kinase JNK3 (Figure 6B.6.1 
C). Though we see similar results to the analysis of the bulk unseparated Th17 + IL-2 
and Th17 + anti-IL-2 cells, by performing analysis on the different subpopulations we 
gain greater insight into the expression profiles of these genes. Fos, Fosb and Egr3 
follow a similar expression pattern to each other; the bulk Th17 + anti-IL-2 and IL-17+ 
IL-10- subpopulation express similar levels while the number of reads in the IL-17- IL-
10- subpopulation was much higher (Figure 6B.6.1 D). None of the Th17 + IL-2 
subpopulations expressed significant amounts of these genes (Figure 6B.6.1 D), 
suggesting that IL-2 suppresses their expression. Network analysis of the genes in this 
list revealed a close interaction with FOS, FOSB and FOSL1 (Figure 6B.6.2). 
Furthermore, MAPK10 interacts with two genes, MAPK8IP1 & 2, that are known to 
interact with another c-Jun N-terminal Kinase: JNK1 (Figure 6B.6.2). 512 of the genes 
in this list (Table 6B.6.1 highlighted in red) were also seen to be downregulated in the 
analysis of the bulk unseparated Th17 + IL-2 and Th17 + anti-IL-2 cells (Group 1, 
Table 6A.4.1). However, a further 237 genes in this list were not seen to be 
downregulated by IL-2 in the analysis of the bulk unseparated Th17 + IL-2 and Th17 + 
anti-IL-2 cells, showing that analysis of the separated subpopulations reveals more 
factors. 
 
6.4.3.2 Genes upregulated by IL-2 in Th17 cells 
Group 2 consisted of 349 genes (Table 6B.71) that were upregulated in Th17 cells 
cultured in the presence of IL-2 (Figure 6B.7.1 A&B). Again, the results from this 
group were similar to those seen for Group 2 in the analysis of the bulk unseparated 
Th17 + IL-2 and Th17 + anti-IL-2 cells (Figure 6A.4.1). Multiple pathways involved in 
cytokine signalling, immune responses and T cell signalling were associated with this 
list of genes (Figure 6B.7.1 C). However, additional cytokine, cytokine receptor and 
chemokine receptor genes were revealed, including Il10, Ifng, Il24, Il1a, Csf2, Il12rb1, 
Il12rb2, Il10r, Il7r, Ccr2, Ccr4 and Ccr5 (Figure 6B.7.1 C). Furthermore, expression 




keeping with the literature that has shown that IL-2 upregulates CD86 expression in 
human CD4+ T cells (Paine et al., 2012). 
 
The expression profile of Il10 matched the protein production profile of the cells, with 
undetectable Il10 expression in the Th17 + anti-IL-2 subpopulations and very little 
expression of Il10 in the non-IL-10 producing subpopulations of the Th17 + IL-2 subset 
(Figure 6B.7.1 D). Il10 was highly expressed in the Th17 + IL-2 IL-17- IL-10+ and IL-
17+ IL-10+ subpopulations: to the greatest extent in the IL-17+ IL-10+ subpopulation 
(Figure 6B.7.1 D). The amount of Il10 expressed in the bulk Th17 + IL-2 subset was 
dwarfed by the amounts seen in the IL-17- IL-10+ and IL-17+ IL-10+ subpopulations. 
However, Il10ra expression was upregulated in all of the Th17 + IL-2 subpopulations, 
suggesting the IL-10 produced by only 21% of the cells could feedback on all of the 
subpopulations (Figure 6B.7.1 D). 
 
Maf was also highly expressed in the Th17 + IL-2 subset compared to the Th17 + anti-
IL-2 subset (Figure 6B.7.1 D). c-Maf clearly required IL-2 for its expression since this 
was abrogated when anti-IL-2 had been added to the cultures. Network analysis of this 
list of genes highlighted two core node genes, EGFR and ESR1. MAF, IL10 and the 
IL10RA interacted with one another and MAF also interacted with IL12RB1. IL12RB2 
and IFNγ were also found within this netwrok. Furthermore, two AhR targets, AHRR 
and CYP1B1 were found within this network, which was not seen in the bulk 
comparison (Figure 6B.7.2). 1 of the genes in this list (Table 6B.7.1 highlighted in red) 
was also seen to be downregulated by IL-2 in the analysis of the bulk unseparated Th17 
+ IL-2 and Th17 + anti-IL-2 cells (Group 1, Table 6A.4.1). 210 of the genes in this list 
(Table 6B.7.1 highlighted in blue) were also seen to be upregulated by IL-2 in the 
analysis of the bulk unseparated Th17 + IL-2 and Th17 + anti-IL-2 cells (Group 2, 
Table 6A.4.2). However, a further 138 genes in this list were not seen to be upregulated 
by IL-2 in the analysis of the bulk unseparated Th17 + IL-2 and Th17 + anti-IL-2 cells, 





6.4.4 Hierarchical clustering separates the Th17 + IL-2 intracellular cytokine 
producing subpopulations into 2 major groups based on their gene expression 
profiles 
The dramatic difference in the gene expression profiles of the Th17 + IL-2 and Th17 + 
anti-IL-2 subsets meant that there was little difference between the results of analysis of 
the bulk subsets (Figure 6A.4.1) and analysis of the different subpopulations (Figure 
6B.5, 6B.6 & 6B.7). Therefore we saw a loss of resolution of the transcriptional 
differences between the subpopulations within the subsets. Consequently, to investigate 
transcriptional differences between the subpopulations of the Th17 + IL-2 and Th17 + 
anti-IL-2 subsets, we chose to analyse each of them in more depth separately. 
 
To further investigate the differential gene expression between the subpopulations 
within the Th17 + IL-2 subset we applied statistical filtering to retain genes that were at 
least 2-fold up- or downregulated in at least one of the samples (repeat data pooled) vs. 
the baseline (median of all the samples). This resulted in a list of 483 genes that we then 
subjected to hierarchical clustering on entities and conditions (Figure 6B.8). The 483 
gene set separated into two major branches; the IL-17+ IL-10-, IL-17- IL-10+ and IL-
17+ IL-10+ cytokine producing subpopulations clustered into one group and the IL-17- 
IL-10- subpopulation clustered with the bulk Th17 + IL-2 cells. There were two clear 
groups of genes with different transcriptional profiles within this 483 set of genes: 
• Group 1: 313 genes downregulated in the cytokine producing subpopulations of 
the Th17 + IL-2 cells. 
• Group 2: 170 genes upregulated in the cytokine producing subpopulations of the 
Th17 + IL-2 cells. 
 
6.4.4.1 Genes that are downregulated in the cytokine producing subpopulations 
of the Th17 + IL-2 subset 
Group 1 consisted of 313 genes that were downregulated in the cytokine producing 
subpopulations of the Th17 + IL-2 cells (Figure 6B.9.1 A&B). Some of these genes 




6B.9.1 A, List 1, Table 6B.9.1). Some of these genes were downregulated in the IL-17- 
IL-10+ and IL-17+ IL-10+ subpopulations (Figure 6B.9.1 A, List 2, Table 6B.9.2). 
Some of these genes were only downregulated in the IL-17- IL-10+ subpopulation 
(Figure 6B.9.1 A, List 3, Table 6B.9.3). Further analysis of List 1 (Table 6B.9.1) and 
List 3 (Table 6B.9.3) revealed no significant GO terms or IPA pathways associated 
with these gene sets. However, further analysis of List 2 (Table 6B.9.2) revealed 
pathways and terms including cellular metabolic processes and cell cycle (Figure 
6B.9.2 A).  
 
Genes in List 2 (Table 6B.9.2) included Bard1, Cdkn1, Ccnb1 and FoxM1 (Figure 
6B.9.2 A). BARD1 and FoxM1 have both been associated with cell cycle. CDK1 and 
CCNB1 are downstream of FoxM1. In particular, FoxM1 has been suggested to be a 
master cell cycle regulator in T cells (Xue et al., 2010). The expression of Foxm1 was 
highly downregulated in the IL-17- IL-10+ and IL-17+ IL-10+ subpopulations of the 
Th17 + IL-2 subset. However, its expression was high in the bulk, IL-17- IL-10- and IL-
17+ IL-10- subpopulations (Figure 6B.9.2 B). The expression of Cdkn1 and Ccnb1 
mirrored the Foxm1 expression profile (Figure 6B.9.2 B). This suggests cell cycle 
regulators were specifically downregulated in the IL-10 producing subpopulations of 
the Th17 + IL-2 subset. Network analysis further revealed the central role FOXM1 
played in the interaction of genes within this list (Figure 6B.9.3), which also contained 
many cell cycle regulating genes; including the cyclins CCNA2 and CCNB2, and the 
cell division cycle associated genes CDCA2, CDCA5 and CDC25C. 
 
6.4.4.2 Genes that are upregulated in the cytokine producing subpopulations of 
the Th17 + IL-2 subset 
Group 2 consists of 170 genes (Table 6B.10.1) that were upregulated in the cytokine 
producing subpopulations of the Th17 + IL-2 cells (Figure 6B.10.1 A&B). Most of the 
genes were upregulated in the IL-17+ IL-10+ subpopulation of cells. However, only 
some of the genes are upregulated in the IL-17+ IL-10- subpopulation (Figure 6B.10.1 
A, List 1 & 3) or the IL-17- IL-10+ subpopulation (Figure 6B.10.1 A, List 2). Terms 
and pathways associated with this list included cytokine signalling, immune cell 
communication and the upregulation of some metabolic processes (Figure 6B.10.1 C). 




Il17f, Il17a, Il10, Il1a, Il3, Il24, Ccl3, Ccl4, Ccl5 (Figure 6B.10.1 C). Il17a and Il10 
were both found within this list and their mRNA expression profiles mirror the protein 
production profiles seen by ICS (Figure 6B.10.1 D). Of note, the levels of Il17a and 
Il10 expression seen in the bulk populations are relatively low and seem to be masked 
by the IL-17- and IL-10- subpopulations, respectively. 
 
As mentioned, the genes in this group were not all upregulated in all the cytokine 
producing subpopulations. The heat map reveals three clusters of genes that had 
obvious differences in their expression profiles (Figure 6B.10.1 A). The genes within 
these three lists are displayed in Figure 6B.10.2. Lists 1 and 3 were genes that were 
upregulated in both IL-17 producing subpopulations. List 2 was genes that were 
upregulated in both IL-10 producing subpopulations.  
 
In List 1, the most highly upregulated gene in the IL-17+ IL-10- and IL-17+ IL-10+ 
subpopulations was Il17a (Figure 6B.10.2, List 1). Therefore the expression of genes in 
this cluster are likely to be regulated in parallel with Il17a. Additionally, Nos2 is 
upregulated specifically in the IL-17 producing subpopulations, which is known to be 
produced by Th17 cells (Jianjun et al., 2013; Obermajer et al., 2013).  
 
In List 2, one of the most highly upregulated genes in the IL-17- IL-10+ and IL-17+ IL-
10+ subpopulations was Il10 (Figure 6B.10.2, List 2). The most highly upregulated 
genes in the IL-17- IL-10+ and IL-17+ IL-10+ subpopulations were 1700094J05Rik and 
Dnahc11, suggesting the expression of genes in this list are regulated in parallel with 
Il10. Dnahc11 alongside Klrc1, Klrc2 and Klrc3 (Figure 6B.10.2, List 2 in bold) were 
all also found in Group 7 of the Th1 cell analysis in Chapter 5; these were genes most 
highly upregulated in the IFNγ+ IL-10+ subpopulations (Figure 5B.12.1). Therefore, 
these genes are associated with Il10 expression in both Th1 cells and Th17 cells. 
 
In List 3, many of the genes are highly upregulated in the IL-17+ IL-10- and IL-17+ IL-
10+ subpopulations (Figure 6B.10.2, List 3). Overlap of this cluster with those genes 
found in Group 6 of the Th1 cell analysis in Chapter 5; these genes were upregulated in 
cytokine producing subpopulations except in the Th1 + IL-27 IFNγ+ IL-10+ 
subpopulation, suggesting an inverse correlation with IL-10  (Figure 5B.11.1), revealed 
many similar genes (Figure 6B.10.2, List 3 in bold): Kcna5, Ebf1, Igf2as, Sdk1, 




with Ifng expression than Il10 expression in Th1 cells, and more associated with Il17a 
expression than Il10 expression in Th17 cells, suggesting these genes are inversely 
correlated with Il10 and could be potential repressors of Il10 gene expression. 
 
IL10 and IL17F played a central role in the interactions between these genes (Figure 
6B.10.3). Interestingly, again, (as seen in Figure 6B.7.3) ESR1 is also a core node 
(Figure 6B.10.3). 
 
6.4.5 Hierarchical clustering separates the Th17 + anti-IL-2 intracellular cytokine 
producing subpopulations into 2 groups based on their gene expression profiles 
To further investigate the differential gene expression between the subpopulations 
within the Th17 + anti-IL-2 subset we applied statistical filtering to retain genes that 
were at least 2-fold up- or downregulated in at least one of the samples (repeat data 
pooled) vs. the baseline (median of all the samples). This resulted in a list of 106 genes 
that we then subjected to hierarchical clustering on entities and conditions (Figure 
6B.11). The 106 gene set separated into two major branches; the bulk and IL-17+ IL-
10- clustered separately from the IL-17- IL-10- subpopulation. There were two clear 
groups of genes with different transcriptional profiles within this 106 set of genes: 
• Group 1: 58 genes decreased in the IL-17+ IL-10- subpopulation of the Th17 
cells cultured in the absence of IL-2. 
• Group 2: 48 genes increased in the IL-17+ IL-10- subpopulation of the Th17 
cells cultured in the absence of IL-2. 	  
6.4.5.1 Genes that are decreased in the IL-17+ IL-10- subpopulation of the Th17 
cells cultured in the absence of IL-2 
Group 1 consisted of 58 genes (Figure 6B.12 A) with decreased expression in the IL-
17+ IL-10- subpopulation of the Th17 + anti-IL-2 cells (Figure 6B.12 A&B). Pathways 
and terms associated with this group included cellular responses to mechanical stimulus, 




suppressor of cytokine signalling gene Socs3, the MCHII family member H2-Ob, Il17c, 
Foxp3 and Smad6 (Figure 6B.12 C). SOCS3, which is known to be involved in the 
downregulation of IL-17 production and Th17 development, was dramatically 
downregulated in the IL-17+ IL-10- subpopulation compared to the IL-17- IL-10- 
subpopulation of the Th17 + anti-IL-2 subset (Figure 6B.12 D). Furthermore, Foxp3, 
which suppresses Th17 development and promotes Tregs, was downregulated in the IL-
17+ IL-10- subpopulation (Figure 6B.12 D), though the actual read numbers of Foxp3 
were very low and the inter-repeat variability resulted in large error bars. Therefore this 
decrease may not be physiologically relevant. There were few interactions between 
these genes (Figure 6B.12 E). 
 
6.4.5.2 Genes that are increased in the IL-17+ IL-10- subpopulation of the Th17 
cells cultured in the absence of IL-2 
Group 2 consisted of 48 genes (Figure 6B.13.1 A) with increased expression in the IL-
17+ IL-10- subpopulation of the Th17 + anti-IL-2 cells (Figure 6B.13.1 A&B). 
Pathways associated with these genes included immune cell communication, antigen 
presentation and iNOS signalling (Figure 6B.13.1 C). Genes in this list included Batf3, 
Tgfbi that encodes TGFβ induced protein, Nos2 that encodes NOS2 / iNOS, and Ifng 
(Figure 6B.13.1 C). The read number of these genes was relatively low; nevertheless 
Nos2, Ifng and Tgfbi were all upregulated in the IL-17+ IL-10- subpopulation compared 
to the IL-17- IL-10- subpopulation (Figure 6B.13.1 D). The expression of Nos2 was 
highest in the bulk and intermediate in the IL-17+ IL-10- subpopulation. The expression 
of Ifng was lower in the bulk Th17 + anti-IL-2 subset compared to the IL-17+ IL-10- 
subpopulation. The expression of Tgfbi in the bulk was about mid-way between the IL-
17+ IL-10- and IL-17- IL-10- subpopulations (Figure 6B.13.1 D). Network analysis 
revealed IFNγ as a central node in the interactions of these genes, and there were 






IL-10 production by Th17 cells is variable and transient, and the mechanisms that are 
involved in driving robust IL-10 from Th17 cells are unknown. IL-2 is thought to be a 
Treg promoting cytokine (Davidson et al., 2007; Fontenot et al., 2005; Yamane and 
Paul, 2012) that suppresses Th17 cell differentiation and IL-17 production (Laurence et 
al., 2007). After investigating many factors that may have been involved in the 
upregulation of IL-10 production in Th17 cells we have found that IL-2 levels are 
crucial in driving two distinct forms of Th17 cell; addition of IL-2 results in increased 
IL-10, albeit alongside decreased IL-17, and blockade of IL-2 results in the 
disappearance of IL-10 alongside increased IL-17. Therefore, we wanted to characterise 
the transcriptional changes IL-2 drives in Th17 cells, and also to determine the effects 
of IL-2, and the process of cytokine production, had on these different intracellular 
cytokine producing subpopulations. Consequently we carried out RNA-Seq analysis on 
Th17 cells cultured with IL-2 or anti-IL-2, and on the intracellular cytokine producing 
subpopulations within these two subsets. 
 
6.5.1 IL-2 drives increased IL-10 production, and decreased IL-17 production, from 
Th17 cells 
In the absence of IL-2, achieved by the addition of anti-IL-2 antibody, Th17 cells 
produced substantial amounts of IL-17 and very little IL-10. In the presence of IL-2 
Th17 cells produced significant amounts of IL-10, and a reduced amount of IL-17. 
However, these IL-10 producing Th17 cells did not have detectable amounts of FoxP3. 
The expression of Il17a and Il10 mRNA matched that of IL-17 and IL-10 protein 
production, in the bulk Th17 + IL-2 and Th17 + anti-IL-2 subsets and in the different 
subpopulations. This suggests that IL-2 can drive IL-10 expression in Th17 cells in a 
FoxP3 independent and possibly STAT5 dependent manner. There is little mention in 
the literature of a role for IL-2 in driving IL-10 production by Th17 cells; however, this 
finding may explain other observations that have solely been attributed to the role of IL-
2 on Tregs. IL-2 deficient mice suffer from unlimited inflammatory bowel disease 
(IBD) (Sadlack et al., 1993), the loss of lymphocyte homeostasis and autoimmunity 
(Suzuki et al., 1995). Therefore, it was concluded that IL-2 must have paradoxical roles 




response. The important role for IL-2 in maintaining Tregs offered a possible solution – 
when IL-2 is removed, Treg homeostasis is lost and therefore immune regulation is lost. 
However, our data suggests that IL-2 may also have a direct role in maintaining Th17 
regulation by promoting IL-10 production from these cells, which could then act in an 
autocrine manner to prevent Th17 driven pathology (Huber et al., 2011). This theory is 
supported by the important role Th17 cells play in autoimmunity (Miossec et al., 2009) 
and colitis (Elson et al., 2007; Lee et al., 2009b), and the absolute requirement for IL-10 
in gut homeostasis (Kuhn et al., 1993). Therefore, IL-2 may not only drive Treg 
homeostasis but also IL-10 producing Th17 cells, which together could act to prevent 
immune dysregulation and gut pathology. However, this phenotype is likely to be 
highly dose dependent and greater concentrations of IL-2 may enable competition 
between STAT5 and STAT3, which would prevent Th17 differentiation. In this context, 
we have optimised a system in which we can consistently drive IL-10 production from 
Th17 cells without compromising the stability of their differentiation.  
 
6.5.2 Culture in the presence or absence of IL-2 results in changes in the 
transcriptional profile of bulk populations of Th17 cells 
Analysis of the transcriptional profiles of the bulk unseparated Th17 + IL-2 and Th17 + 
anti-IL-2 subsets, revealed that the cells within each subset were transcriptionally very 
different. Unlike what we saw with the analysis of the Th1 and Th1 + IL-27 cells in 
Chapter 5, analysis of the different intracellular cytokine producing subpopulations 
within the Th17 + IL-2 and Th17 + anti-IL-2 subsets revealed very similar results to the 
analysis of the bulk unseparated subsets. This may be explained by the IL-2 or anti-IL-2 
conditions resulting in opposite transcriptional profiles in the Th17 cells. Therefore, the 
majority of the genes were revealed in the analysis of bulk unseparated Th17 + IL-2 and 
Th17 + anti-IL-2 subsets. Nevertheless some genes, including Il10, Il17a, Socs3 and 
Foxm1, were revealed by separating the heterogeneous bulk Th17 + IL-2 and Th17 + 
anti-IL-2 subsets (Discussion figure 6.1). 
 
In Th17 cells cultured in the presence of IL-2 or anti-IL-2 we see an increase in the 
expression of Socs3 in the IL-17- IL-10- subpopulations compared to the cytokine 
producing subpopulations (Discussion Figure 6.1). However, in the absence of IL-2 




IL-2 did not affect the expression of Socs3 in the cytokine producing subpopulations. 
Therefore, our data suggests that one of the major differences between the IL-17- IL-10- 
subpopulation and cytokine producing subpopulations is the expression of Socs3, and 
that IL-2 may downregulate Socs3. Suppressor of cytokine signalling (SOCS) proteins 
are associated with the suppression of cytokine production and there is much evidence 
that SOCS3 downregulates Th17 cell differentiation, and IL-17 and IL-6 production 
(reviewed in (Tamiya et al., 2011)). SOCS proteins are classical negative feedback 
regulators; cytokine ligation results in JAK-STAT signalling that induces SOCS 
transcription, which in turn blocks cytokine receptor signalling and JAK-STAT 
phosphorylation. SOCS3 has been shown to prevent phosphorylation of STAT3 (Li et 
al., 2012b) and in doing so inhibit downstream STAT3 signalling. One mechanism by 
which it has been proposed to do this is via the inhibition of IL-23 signalling, which in 
turn phosphorylates STAT3 to promote IL-17 production (Chen et al., 2006). 
Furthermore, SOCS3 can block JAK2’s ability to phosphorylate substrates (Babon et al., 
2012). In summary, the increased levels of SOCS3 in the IL-17- IL-10- subpopulations 
of Th17 + IL-2 and Th17 + anti-IL-2 cells may be a major factor in preventing cytokine 
production by these cells.  
 
Our data shows that in the bulk, IL-17- IL-10- and IL-17+ IL-10- subpopulations, IL-2 
results in an upregulation of Foxm1 expression (Discussion Figure 6.1). However, the 
IL-10 producing subpopulations of the Th17 + IL-2 subset have dramatically reduced 
Foxm1 expression. FoxM1 is a master regulator of cell cycle and has been shown to be 
important for the proliferation of early thymocytes and activated CD4+ T cells (Xue et 
al., 2010). IL-2 is known to promote Th cell proliferation (Yamane and Paul, 2012) and 
therefore the upregulation of Foxm1 expression by IL-2 seen in our results is in keeping 
with the literature. Therefore our data suggests that IL-2 upregulates Foxm1 expression 
to drive the proliferation of the Th17 cells, but this expression is subsequently 
downregulated in the IL-10 producing subpopulations. 
 
6.5.2.1 Maf and Prdm1 are upregulated in the presence of IL-2 
c-Maf clearly required IL-2 for its expression since its expression was abrogated when 
anti-IL-2 was added to the cultures (Discussion Figure 6.2). In Th17 cells c-Maf, 




such as Il10 (Ciofani et al., 2012). Furthermore, in Th17 cells c-Maf has been shown to 
bind the Il10 promoter and transactivate it, and thus regulate IL-10 expression (Xu et al., 
2009). Furthermore, c-Maf has also been associated with AhR signalling: the interaction 
between the two has been shown to drive Il10 transcription (Apetoh et al., 2010). We 
have shown here that in Th17 cells cultured in the presence of IL-2, Maf expression and 
Il10 expression are upregulated, as in the presence of anti-IL-2 their expression is 
abrogated. Therefore it is possible that this increase in c-Maf, resulting from IL-2 
signalling, may be driving the upregulation of Il10.  
 
Our data also suggested that Blimp-1 (Prdm1) required IL-2 for its expression, as its 
expression was decreased in Th17 cells cultured in the absence of IL-2 (Discussion 
Figure 6.2 A). The Prdm1 gene encodes Blimp-1, which has been shown to positively 
regulate IL-10 expression in Th cells; conditional deletion of Prdm1 in T cells leads to 
pathology and inflammation in vivo and decreased IL-10 production by CD4+ T cells 
(Martins et al., 2006). It has been shown that IL-12 can induce Blimp-1 regulation of 
IL-10 via STAT4 in Th1 cells (Neumann et al., 2014) and that IL-10 expression in IL-
12 driven Th1 cells was dependent on Blimp-1. This IL-10 production was enhanced by 
Blimp-1 synergising with c-Maf (Neumann et al., 2014). 
 
IL-2 has been shown to induce Maf expression in human bulk CD4+ T cells via STAT5, 
which directly binds to the Maf locus (Rani et al., 2011). Also in CD8+ T cells IL-2 has 
been shown to promote IL-10 production via a Blimp-1 dependent mechanism (Sun et 
al., 2011). Therefore, it is possible that in Th17 cells IL-2 promotes the expression of c-
Maf and Blimp-1, which then cooperate to drive Il10 expression; it may be via this 
mechanism that IL-2 drives IL-10 production in Th17 cells.  
 
6.5.2.2 AhR signalling is upregulated in the presence of IL-2 
Our data shows that in presence of IL-2 there is upregulation in the expression of 
molecules involved the repression of in AhR signalling, namely Ahrr and Cyp1b1 
(Discussion Figure 6.2 B). The AhR has important physiological functions in cellular 
development and immunity, however the effects of AhR on immune responses are 
multidimensional and variable. It can induce both immunosuppressive functions, and 




(Hao and Whitelaw, 2013) and upregulation of these genes by IL-2 within our data 
suggests that IL-2 induces AhR signalling. The ligation of AhR with its classical ligand 
TCDD leads to the suppression of EAE via the induction of Treg cell differentiation 
(Zhang et al., 2010). In a graft-versus-host model, TCDD has been shown to promote 
the development of Treg cells that produced significant amounts of IL-10 (Marshall et 
al., 2008). Therefore in certain scenarios AhR signalling is known to skew CD4+ T 
cells towards a Treg phenotype and to promote the production of IL-10 by Tregs in 
various ways. Our data suggests that can IL-2 promote AhR signalling, and that via this 
pathway IL-2 may be promoting the IL-10 producing phenotype of Th17 cells that we 
observe.  
 
6.5.2.3 Culture of Th17 cells with IL-2 results in the increase in Il10ra, Ifng and 
Nos2 expression 
In our system, the addition of anti-IL-2 to Th17 cell cultures abolished the expression of 
the Il10ra (Discussion Figure 6.2 C). This increase in expression of the IL-10 receptor 
by IL-2 is likely to result in Th17 cells being more responsive to IL-10, which in turn 
has been shown to negatively regulate IL-17 production by Th17 cells (Huber et al., 
2011). 
  
We show that low levels of Ifng expression were induced by IL-2 signalling 
(Discussion Figure 6.2 C), supporting the idea that Th17 cells can take on a more 
‘regulatory’ Th1 like phenotype, expressing IL-10 and trace amounts of IFNγ (Gagliani 
et al., 2015). In this paper they suggest that Th17 cells can transdifferentiate into IL-10+ 
(Tr1) regulatory cells (Gagliani et al., 2015), and we propose a mechanism by which 
this might occur, via IL-2 signalling. In vitro and in vivo analysis of IL-2 receptor 
deficient Th17 cells could be used to address this and to further investigate the role of 
IL-2 in driving the conversion of Th17 cells into IL-10+ regulatory cells. However, 
owing to the importance of IL-2 signalling in multiple pathways of Th cell proliferation 
and differentiation, conditional deletion of the IL-2R in a temporally controlled manner 





In our samples we see that IL-2 leads to an upregulation of Nos2 expression in Th17 
cells (Discussion Figure 6.2 C). Furthermore, we see an increase in NOS2 expression 
in the IL-17+ subpopulations of both the Th17 + IL-2 and Th17 + anti-IL-2 subsets 
compared to the IL-17- IL-10- subpopulations (Discussion Figure 6.2 C), although the 
actual amount of NOS2 mRNA we see in our samples are very low. It has been shown 
that human and mouse Th17 cells can produce NOS2 (Jianjun et al., 2013; Obermajer et 
al., 2013), though the functional role of this enzyme is still unresolved, with both 
positive and negative effects on Th17 cell cytokine production having been proposed. In 
mouse Th17 cells NOS2 has been shown to hinder Th17 cell differentiation via the 
inactivation of RORγt (Jianjun et al., 2013). While in human Th17 cells endogenous 
NOS2 and NO-induced cGMP signalling have been shown to maintain Th17 cell Il17 
and Il23r expression (Obermajer et al., 2013). Therefore, we cannot know the actions of 
the endogenous expression of NOS2 seen in our Th17 cells. However, as it is more 
highly expressed in the IL-17+ subpopulations our data supports the theory that NOS2 
is promoting Il17 expression as suggested by Obermajer et al. 
 
6.5.2.4 IL-2 downregulates the expression of molecules involved in retinoic acid 
metabolism 
We show that the expression of Cyp26a1 and Cyp26b1, two proteins fundamental to the 
degradation of retinoic acid, were downregulated in the presence of IL-2 since they 
were increased by the presence of anti-IL-2 in the cultures (Discussion Figure 6.3 A). 
Retinoic acid (RA) is derived from vitamin A and ligates nuclear RA receptors (RARs) 
and retinoid X receptors (RXRs). The distribution and levels of RA are tightly 
controlled by synthesis and degradation by specific cytochrome P450s (Cyp26) (Rhinn 
and Dolle, 2012). In CD4+ T cells Cyp26b1 has been identified as the primary negative 
regulator of RA, and Cyp26b1 deficiency is associated with reduced intestinal 
inflammation and the reduced development of IFNγ producing ‘pathological’ Th17 cells 
(Chenery et al., 2013). In fact RA alters the balance between Th17 cells and Tregs, in 
favour of Tregs. RA enhances the expression and phosphorylation of SMAD3, which 
enables enhanced TGFβ signalling, resulting in increased expression of FoxP3 (Xiao et 
al., 2008). To further promote Treg development and prevent Th17s, RA also inhibits 




IL-10 production by Th17 cells and promote ‘pathogenic’ Th17 cells (Ghoreschi et al., 
2010; McGeachy et al., 2007). Therefore, this data suggests that by repressing the 
metabolism of RA in Th17 cells, IL-2 promotes IL-10 production and the differentiation 
of Th17 cells in the absence of FoxP3.  
 
6.5.2.5 The expression of genes involved in ERK / AP-1 signalling is altered by 
IL-2 
Il2 expression was dramatically increased in Th17 cells cultured in the absence of IL-2, 
suggesting that the lack of IL-2 drives Il2 expression, and that the presence of IL-2 
represses Il2 expression  (Discussion Figure 6.3 B). IL-2 negatively regulates Th17 cell 
differentiation (Laurence et al., 2007), but Th17 cells are likely to need low levels of IL-
2 early in differentiation to promote proliferation. These data suggest that IL-2 
signalling results in a negative feedback loop to maintain low levels Il2 expression, 
possibly to allow Th17 differentiation. 
 
In the list of genes that were downregulated by IL-2, and thus increased by the addition 
anti-IL-2, there were various factors that have been associated with AP-1 signalling, 
namely Twist1, Egr1 and Egr3 and Fos/Fosb (Discussion Figure 6.3 B). AP-1 is 
downstream of the MAP kinase ERK, which is activated via RAS downstream of the 
TCR. AP-1 is a heterodimeric transcription factor composed of dimers of the FOS, JUN, 
JUN dimerising protein (JDP) and activating transcription factor (ATF) family members 
(Karin et al., 1997). AP-1 signalling is highly complex and incompletely understood; 
there are many different types of AP-1 dimers, all with different functional roles. 
However, many of the ERK and AP-1 family members present in our gene list have 
been associated in the regulation of IL-2 (Macian et al., 2002; Whitehurst and Geppert, 
1996). 
 
AP-1 has been shown to interact with NFAT, which results in the integration of 
Calcium and Ras signals and the expression of genes important for T cell activation 
including IL-2 (Macian et al., 2002). There are two AP-1 sites within the Il2 promoter at 
which various combinations of Fos and Jun are thought to bind (Jain et al., 1992). In 
CD4+ T cell lines c-Jun, JunD, JunB and FosB are thought to interact with Oct proteins 




(an AP-1 inhibitor) and in doing so promotes AP-1 activation and IL-2 production in 
CD4+ T cells (Li et al., 2012b).  In the absence of IL-2, Th17 cells increase the 
expression of these ERK / AP-1 genes. Therefore it is possible that this is a feedback 
mechanism; in the presence of IL-2 the Th17 cells downregulate pathways that promote 
Il2 expression, and thus maintain Th17 differentiation, which is downregulated by IL-2. 
However, further investigation would be needed to address the precise function of these 








Figure 6A.1 IL-2 is essential for IL-10 production, but inhibits IL-17 production, 
by Th17 cells 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-CD3 
and soluble anti-CD28, and polarised to Th17 cells with IL-6, TGFβ, anti-IL-12, anti-IFNγ 
and anti-IL-4 in the presence or absence of IL-2 (Th17 + IL-2) or anti-IL-2 (Th17 + anti-IL-
2), or neither (Th17). A. Plots of flow cytometric analysis of intracellular cytokine staining. 
Numbers show percentage of live CD4+ cells. Gating strategy described in Materials and 
Methods. B. Graphs represent cytokines in supernatants determined by ELISA. Cells 
restimulated as described in Materials and Methods, assessed after 3 days of polarization in 
vitro. Graphs show means ± SD of triplicates, **p < 0.01, ***p < 0.001, ****p<0.0001 






Figure 6A.2 Determining the optimal lower cut-off of reads for expression 
threshold of bulk Th17 + IL-2 and Th17 + anti-IL-2 RNA-Seq samples 
mRNA extracted and prepared for RNA-Seq as described in Materials and Methods. 
Using Strand NGS software reads were aligned to the transcriptome & Genome (mm10, 
RefSeq annotation, 95% identity, max 5% gaps, 1 read only if duplicate) and 
normalisation with DeSeq and no Baseline. Upper cut-off 253033.02 (where at least 1 
out of 6 samples have values within cut-off). A. The number of entities passing 
expression thresholds with indicated lower cut-offs. All bulk Th17 + IL-2 and Th17 + 
anti-IL-2 samples were pooled for this test. B. Using an expression threshold with a 
lower cut-off of 20 reads, the number of entities in each repeat within the bulk Th17 + 
IL-2 and Th17 + anti-IL-2 subsets was determined. C. Graphs of Il10 and Il17a read 






Figure 6A.3 PCA and cluster analysis demonstrates that bulk Th17 + IL-2 and 
Th17 + anti-IL-2 cells have different gene expression profiles 
mRNA extracted and prepared for RNA-Seq as described in the Materials and Methods. 
A. PCA plots of each repeat of the bulk Th17 + IL-2 and Th17 + anti-IL-2 samples 
analysed by RNA-Seq. B. Unsupervised hierarchical clustering on conditions, of all 
individual repeats within the bulk Th17 + IL-2 and Th17 + anti-IL-2 subsets. C. 
Unsupervised hierarchical clustering on conditions, the bulk Th17 + IL-2 and Th17 + 
anti-IL-2 subsets (repeat data pooled). Unsupervised hierarchical clustering was carried 
out on the normalised intensity values with a Pearson’s centred similarity measure and 
an Average linkage rule. Colour ranges indicate normalised intensity. The dendrogram 






Figure 6A.4.1 There are dramatic transcriptional differences between the bulk 
Th17 + IL-2 and Th17 + anti-IL-2 subsets 
mRNA extracted and prepared for RNA-Seq as described in the Materials and Methods. 
Data from the three biological repeats were pooled. Differentially regulated genes were 
obtained by taking those that were at least 3-fold up- or downregulated in at least 1 of 
the 2 samples vs. the baseline (median of all the samples). A. This left 861 genes that 
were subjected to hierarchical clustering on entities and conditions with a Pearson’s 
centred similarity measure and an Average linkage rule. Colour ranges indicate 
normalised intensity. The dendrogram represents the relatedness of the samples. Genes 
were separated into 2 groups based on the hierarchical dendrogram. B. Group 1 GO 
terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, and examples of 
genes within the group. C. Group 2 GO terms (p<0.01) and IPA pathways (p<0.01) with 





Figure 6A.4.2 Group 1: Network analysis of 606 genes downregulated by IL-2 in 
Th17 cells 
IPA network analysis of direct interactions between genes within group 1 from Figure 






Figure 6A.4.3 Group 2: Network analysis of 256 genes upregulated by IL-2 in 
Th17 cells 
IPA network analysis of direct interactions between genes within group 2 from Figure 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6B.1 Subpopulations of Th17 + IL-2 and Th17 + anti-IL-2 subsets 
C57BL/6 naive CD4+CD62L+CD44loCD25- cells were driven with plate-bound anti-CD3 
and soluble anti-CD28, and polarised to Th17 cells with IL-6, TGFβ, anti-IL-12, anti-IFNγ 
and anti-IL-4 in the presence or absence of IL-2 or anti-IL-2. Plots of sorted populations 
by flow cytometric analysis of intracellular cytokine staining. Tables showing the 
percentage of the total number of cells that each cytokine producing subpopulation 
represented for each of the three repeat experiments. The bulk is 100% of all CD4+ live 
cells as described in the Materials and Methods. A. Subpopulations within the Th17 + 






Figure 6B.2 Determining the optimal lower cut-off of reads for expression 
threshold of Th17 + IL-2 and Th17 + anti-IL-2 RNA-Seq samples 
Cell populations are described in Figure 6B.1, mRNA extracted and prepared for RNA-
Seq as described in Materials and Methods. Using Strand NGS software reads were 
aligned to the transcriptome & Genome (mm10, RefSeq annotation, 95% identity, max 
5% gaps, 1 read only if duplicate) and normalisation with DeSeq and no Baseline. 
Upper cut-off 323885.938 (where at least 1 out of 24 samples have values within cut-
off). A. The number of entities passing expression thresholds with indicated lower cut-
offs. All the Th17 samples were pooled for this test. B. Using an expression threshold 
with a lower cut-off of 20 reads, the number of entities in each repeat of each 







Figure 6B.3 PCA and cluster analysis demonstrates that Th17 + IL-2 and Th17 + 
anti-IL-2 cells have different gene expression profiles 
Cell populations are described in Figure 6B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. A. PCA plots of intracellular cytokine 
producing subpopulations within the Th17 + IL-2 and Th17 + anti-IL-2 samples 
analysed by RNA-Seq. B. Unsupervised hierarchical clustering on conditions, of all 
individual repeats within the Th17 + IL-2 and Th17 + anti-IL-2 subsets, was carried out 
on the normalised intensity values with a Pearson’s centred similarity measure and an 
Average linkage rule. Colour ranges indicate normalised intensity. The dendrogram 






Figure 6B.4 Clustering demonstrates that Th17 + IL-2 and Th17 + anti-IL-2 cells 
are distinct and have transcriptional differences 
Cell populations are described in Figure 6B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. Data from the three biological repeats 
were pooled. A. Unsupervised hierarchical clustering on conditions, of each 
subpopulations within the Th17 + IL-2 and Th17 + anti-IL-2 subsets, was carried out on 
the normalised intensity values with a Pearson’s centred similarity measure and an 
Average linkage rule. Colour ranges indicate normalised intensity. The dendrogram 







Figure 6B.5 There are dramatic transcriptional differences between the Th17 + IL-
2 and Th17 + anti-IL-2 subsets 
Cell populations are described in Figure 6B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. Data from the three biological repeats 
were pooled. Differentially regulated genes were obtained by taking those that were at 
least 3-fold up- or downregulated in at least 1 of the 8 samples vs. the baseline (median 
of all the samples). This left 1098 genes that were subjected to hierarchical clustering 
on entities and conditions with a Pearson’s centred similarity measure and an Average 
linkage rule. Colour ranges indicate normalised intensity. The dendrogram represents 
the relatedness of the samples. Genes were separated into 2 groups based on the 






Figure 6B.6.1 Group 1: 749 genes downregulated by IL-2 in Th17 cells 
A. Genes in Group 1 from hierarchical clustering in Figure 6B.5. B. Expression profile 
of group. C. GO terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, 
and examples of genes within the group. D. The read number of selected genes in each 





Figure 6B.6.2 Group 1: Network analysis of 749 genes downregulated by IL-2 in 
Th17 cells 






Table 6B.6.1 Group 1: List of 749 genes downregulated by IL-2 in Th17 cells 





























































































































































































































































































































































































































































































































































































































































































































































































Figure 6B.7.1 Group 2: 349 genes upregulated by IL-2 in Th17 cells 
A. Genes in Group 2 from hierarchical clustering in Figure 6B.5. B. Expression profile 
of group. C. GO terms (p<0.05) and IPA pathways (p<0.01) with significant overlap, 
and examples of genes within the group. D. The read number of selected genes in each 





Figure 6B.7.2 Group 2: Network analysis of 349 genes upregulated by IL-2 in Th17 
cells 






Table 6B.7.1 Group 2: List of 349 genes upregulated by IL-2 in Th17 cells 
Genes highlighted in red are those also found in Group 1 of Table 6A.4.1. Genes 







































































































































































































































































































































































Figure 6B.8 There are dramatic transcriptional differences between the 
subpopulations within the Th17 + IL-2 subset 
Cell populations are described in Figure 6B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. Data from the three biological repeats 
within the Th17 + IL-2 subset were pooled. Differentially regulated genes were 
obtained by taking those that were at least 2-fold up- or downregulated in at least 1 of 
the 5 samples vs. the baseline (median of all the samples). This left 483 genes that were 
subjected to hierarchical clustering on entities and conditions with a Pearson’s centred 
similarity measure and an Average linkage rule. Colour ranges indicate normalised 
intensity. The dendrogram represents the relatedness of the samples. Genes were 







Figure 6B.9.1 Group 1: 313 genes downregulated in the cytokine producing 
subpopulations of the Th17 + IL-2 cells  
A. Genes in Group 1 from hierarchical clustering in Figure 6B.8. B. Expression profile 





Table 6B.9.1 Group 1, List 1: 36 genes downregulated in the IL-17+ IL-10- and IL-













































Figure 6B.9.2 Group 1, List 2: 255 genes downregulated in the IL-17- IL-10+ and 
IL-17+ IL-10+ subpopulations of the Th17 + IL-2 cells  
A. GO terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, and 







Figure 6B.9.3 Group 1, List 2: Network analysis 255 genes downregulated in the 
IL-17- IL-10+ and IL-17+ IL-10+ subpopulations of the Th17 + IL-2 cells  






Table 6B.9.2 Group 1, List 2: 255 genes downregulated in the IL-17- IL-10+ and 















































































































































































































































































Table 6B.9.3 Group 1, List 3: 22 genes downregulated in the IL-17- IL-10+ 






























Figure 6B.10.1 Group 2: 170 genes upregulated in the cytokine producing 
subpopulations of the Th17 + IL-2 cells  
A. Genes in Group 2 from hierarchical clustering in Figure 6B.8. B. Expression profile 
of group. C. GO terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, 
and examples of genes within the group. D. The read number of selected genes in each 





Figure 6B.10.2 Group 2: Further analysis of clusters of genes within the 170 genes 
upregulated in the cytokine producing subpopulations of the Th17 + IL-2 cells  
3 lists of genes that form distinctive clusters within Group 2 from hierarchical clustering 
in Figure 6B.8. Genes were separated into 3 lists based on the hierarchical dendrogram 





Figure 6B.10.3 Group 2: Network analysis of 170 genes upregulated in the cytokine 
producing subpopulations of the Th17 + IL-2 cells  
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 





Table 6B.10.1 Group 2: List of 170 genes upregulated in the cytokine producing 

















































































































































































Figure 6B.11 There are dramatic transcriptional differences between the 
subpopulations within the Th17 + anti-IL-2 subset 
Cell populations are described in Figure 6B.1, mRNA extracted and prepared for RNA-
Seq as described in the Materials and Methods. Data from the three biological repeats 
within the Th17 + anti-IL-2 subset were pooled. Differentially regulated genes were 
obtained by taking those that were at least 2-fold up- or downregulated in at least 1 of 
the 3 samples vs. the baseline (median of all the samples). This left 106 genes that were 
subjected to hierarchical clustering on entities and conditions with a Pearson’s centred 
similarity measure and an Average linkage rule. Colour ranges indicate normalised 
intensity. The dendrogram represents the relatedness of the samples. Genes were 












Figure 6B.12 Group 1: 58 genes decreased in the IL-17+ IL-10- subpopulations of 
Th17 cells cultured in the absence of IL-2 
A. Genes in Group 1 from hierarchical clustering in Figure 6B.13. B. Expression profile 
of group. C. GO terms (p<0.05) and IPA pathways (p<0.01) with significant overlap, 
and examples of genes within the group. D. The read number of selected genes in each 
subpopulation. E. IPA network analysis of direct and indirect interactions between 
genes. Solid lines indicate direct interactions, the dashed lines indicate indirect 











Figure 6B.13.1 Group 2: 48 genes increased in the IL-17+ IL-10- subpopulations of 
Th17 cells cultured in the absence of IL-2 
A. Genes in Group 2 from hierarchical clustering in Figure 6B.13. B. Expression profile 
of group. C. GO terms (p<0.01) and IPA pathways (p<0.01) with significant overlap, 






Figure 6B.13.2 Group 2: Network analysis of 48 genes increased in the IL-17+ IL-
10- subpopulations of Th17 cells cultured in the absence of IL-2 
IPA network analysis of direct and indirect interactions between genes. Solid lines 
indicate direct interactions, the dashed lines indicate indirect interactions. Genes in red 






Discussion Figure 6.1 Genes of interest only revealed by analysis of the different 
intracellular cytokine producing subpopulations within the Th17 + IL-2 and Th17 
+ anti-IL-2 subsets 






Discussion Figure 6.2 Genes of interest upregulated by IL-2, revealed by analysis 
of the bulk unseparated Th17 + IL-2 and Th17 + anti-IL-2 subsets 
The read number of selected genes in each subpopulation. A. Genes associated with 
discussion about Blimp-1 and c-Maf. B. Genes associated with discussion about AhR 






Discussion Figure 6.3 Genes of interest downregulated by IL-2, revealed by 
analysis of the bulk unseparated Th17 + IL-2 and Th17 + anti-IL-2 subsets 
The read number of selected genes in each subpopulation. A. Genes associated with 













IL-10 has a vital role in maintaining a balanced and appropriate immune response 
(Jankovic et al., 2010; Saraiva and O'Garra, 2010). CD4+ T helper cells are important in 
regulating effective immune responses, and are a dominant source of IL-10 (Roers et al., 
2004). However, owing to the complex nature of Th cell differentiation, a full 
understanding of the factors that regulate hallmark cytokine and IL-10 expression are 
incomplete. Thus, the conditions under which naïve CD4+ T cells are polarised in vitro 
into different Th subsets have a fundamental impact on cytokine expression. The type of 
TCR stimulation, the cocktail and dose of polarising cytokines, the length of culture, 
and the duration of restimulation all play an important role in determining IL-10 and 
hallmark cytokine production (O'Garra et al., 2011). Therefore, in Chapter 3 we found 
the optimal in vitro differentiation conditions for Th1, Th2 and Th17 cell hallmark 
cytokine and IL-10 production, with regard to TCR stimuli, culture durations, 
restimulation kinetics, and cytokine stimuli. 
 
The T helper cell subset populations are phenotypically heterogeneous, particularly with 
respect the IL-10 protein production. Each Th subset secretes a repertoire of different 
cytokines, but within that Th population the cells are heterogeneous – with cells having 
different cytokine secretion profiles. This confounds the ability to draw conclusions 
about the regulation of an individual cytokine within these heterogeneous populations 
as not all cells within that subset will express that cytokine. To better understand the 
common and disparate mechanisms involved in regulating Il10 gene expression and 
hallmark cytokine gene expression, we wanted to separate the Th subsets into 
subpopulations and analyse the differential gene expression patterns within these 
populations using RNA-Seq. Therefore, in Chapter 4 we designed and optimised a 
system for extracting viable mRNA from intracellular cytokine stained samples. Using 
this protocol we separated different intracellular cytokine producing subpopulations 





7.1.1 Major conclusions from studying the transcriptional profiles of Th1 and Th1 + 
IL-27 subsets, and Th17 + IL-2 and Th17 + anti-IL-2 subsets 
Th1 cell differentiation is driven by IL-12, which alongside strong TCR ligation is 
required to initiate IL-10 expression in this cell type (Saraiva et al., 2009). Additionally, 
IL-27 has been shown to boost IL-10 expression in Th1 cells (Stumhofer and Hunter, 
2008). Therefore in Chapter 5 we cultured Th1 cells in the presence or absence of IL-27 
to see how this cytokine differentially affected gene expression in these cells. Of note, 
the Ifng and Il10 mRNA expression profiles matched the IFNγ and IL-10 protein 
production profiles of these cells. 
 
Th17 cells, primarily driven by TGFβ and IL-6, express IL-10 transiently and 
heterogeneously, via mechanisms that are still not understood. IL-23 has been shown to 
suppress IL-10 expression (Ghoreschi et al., 2010; McGeachy et al., 2007) and promote 
a ‘pathogenic’ phenotype of Th17 cells that produce proinflammatory cytokines 
including IFNγ. IL-2 with high levels of TGFβ is thought to be essential for Treg 
differentiation in vitro (Davidson et al., 2007; Yamane and Paul, 2012). We have found 
that IL-2 levels are crucial in driving two distinct forms of Th17 cell; addition of IL-2 
results in increased IL-10, albeit alongside decreased IL-17, and blockade of IL-2 
results in the disappearance of IL-10 alongside increased IL-17. Therefore in Chapter 6 
we cultured Th17 cells in the presence of IL-2 or presence of anti-IL-2 to see how this 
cytokine differentially affected gene expression in these cells. Of note, the Il17a and 
Il10 mRNA expression profiles matched the IL-17 and IL-10 protein production 
profiles of these cells. 
 
Our results highlight that the Th1 and Th1 + IL-27 subsets are not only heterogeneous 
in cytokine production but also at the level of gene expression. Overall the analysis of 
the bulk unseparated Th1 and Th1 + IL-27 subsets exposed little about the effect of IL-
27 on the transcriptional profiles of Th1 cells and it was hard to elucidate any 
mechanisms that may regulate Il10 gene expression. By separating the different 
intracellular cytokine producing subpopulations we have gained a much greater 
understanding of the transcriptional changes that occur in Th1 cells in the presence or 
absence of IL-27, and of the transcriptional changes that occur upon cytokine 





Analysis of the transcriptional profiles of the bulk unseparated Th17 + IL-2 and Th17 + 
anti-IL-2 subsets, revealed that the cells within each subset were transcriptionally very 
different. Unlike what we saw with the analysis of the Th1 and Th1 + IL-27 cells, 
analysis of the different intracellular cytokine producing subpopulations within the 
Th17 + IL-2 and Th17 + anti-IL-2 subsets revealed very similar results to the analysis 
of the bulk unseparated subsets. This is not in keeping with suggestions that Th17 cell 
populations are highly heterogeneous and that only by analysis at the single cell level 
can regulatory networks be established (Kuchroo VK, International Congress of 
Immunology, 2013). However, this may be explained by the IL-2 or anti-IL-2 
conditions in this study resulting in considerably more homogeneous Th17 cell 
populations with very distinct transcriptional profiles.  
 
This project has revealed that IL-27 predominantly results in the downregulation of 
gene expression in Th1 cells. The expression of certain glutamate receptors, which have 
been proposed to be involved in the inhibition of IL-10 production (Pacheco et al., 
2006), was downregulated by IL-27. Furthermore, in this study IL-27 downregulated 
genes involved in metabolic processes, that are known to suppress the transcription of 
inflammatory responses (Cunard et al., 2004; Sakiani et al., 2013). Finally, our data 
shows that IL-27 appears to downregulate genes associated in AhR signalling in IFNγ+ 
IL-10- and IFNγ+ IL-10+ subpopulations. 
 
We found that the expression of Maf was significantly upregulated by IL-27 in Th1 
cells and IL-2 in Th17 cells (Maf expression was abolished when IL-2 signalling was 
blocked by anti-IL-2). We have shown that IL-27 (in Th1 cells) and IL-2 (in Th17 cells) 
drive IL-10 production in these cells, and therefore c-Maf could be a common factor 
used by IL-27 and IL-2 to drive Il10 expression. Therefore, as alluded to in the 
literature, c-Maf seems to be associated with IL-10 production in Th cells, although the 
role of c-Maf in different Th subsets and the production of proinflammatory cytokines 
is unclear. c-Maf has been shown to have a role in the differentiation of many different 
Th subsets (Th1 (Neumann et al., 2014; Saraiva et al., 2009)) (Th2 (Hodge et al., 1996; 
Li et al., 1999a; Rengarajan et al., 2002)) (Th17 (Ciofani et al., 2012; Li et al., 2012a; 
O'Shea et al., 2011)) and therefore the mechanism by which it may regulate IL-10 
(Apetoh et al., 2010; Kim et al., 1999; Neumann et al., 2014; Saraiva et al., 2009; Xu et 




c-Maf in the differentiation and production of IL-10 in various Th cell subsets would be 
required to resolve the mechanisms by which this transcription factor regulates immune 
responses.  
 
Additionally, we found that multiple molecules involved in AhR signalling were 
increased by IL-27 in Th1 cells and by IL-2 in Th17 cells, suggesting a role for this 
pathway in regulating IL-10 production. However, the AhR signalling molecules that 
were upregulated by IL-27 in Th1 cells were different from the molecules upregulated 
by IL-2 in Th17 cells. IL-27, in Th1 cells, resulted in the upregulation of Arnt2. IL-2, in 
Th17 cells, resulted in the upregulation of Cyp1a1 and Ahrr. Therefore, our data 
suggests that though the AhR signalling pathway may have a role in regulating Il10 
expression in Th cells, it is highly complex. 
 
7.2 Future Perspectives 
IL-27 upregulates Il10 expression in Th1 cells and we have shown that IL-2 upregulates 
Il10 expression in Th17 cells. This study has revealed several factors that are 
upregulated by IL-27 in Th1 cells and are dependent on IL-2 in Th17 cells, such as Maf 
or Prdm1. Therefore these factors are possible targets that may be associated with the 
regulation of Il10 gene expression. To ascertain the role of these factors in the 
regulation of Il10 gene expression the O’Garra laboratory will utilise CRISPR-cas to 
knock out these genes in vitro and in vivo.  Furthermore, using retroviral transfection of 
Th17 cells cultured in the presence of anti-IL-2 with these target genes, we could 
ascertain the role of these genes in the regulation of Il10 gene expression; to see if 
reconstitution can result in the induction of Il10 expression in Th17 + anti-IL-2 cells.  
 
In particular we have revealed that the expression of Maf was significantly upregulated 
by IL-27 in Th1 cells and IL-2 in Th17 cells By using c-Maf deficient mice we can 
further address the role of c-Maf in Th cell differentiation and IL-10 production. 
Different Th subsets can be cultured in vitro to establish a system in which c-Maf may 
affect IL-10 production. Furthermore, in vivo infection models, which drive specific Th 
cell immune responses, can be assessed to determine the role of c-Maf in CD4+ T cell 
differentiation and IL-10 production. For instance, Malaria or Toxoplasma gondii can 




in Th2 responses, and fungal infection results in the differentiation of Th17 cells. 
Alongside phenotypic analysis of these animals during infection, cells can also be 
extracted for analysis ex vivo. Moreover, using the techniques optimised in this thesis, 
cells from these infections can be extracted and separated based on their intracellular 
cytokine profiles for further analysis by RNA- and ChIP-Seq. This would enable a 
comprehensive and in depth analyses of the role of c-Maf in Th cell differentiation and 
cytokine production, to resolve the mechanisms this transcription factor regulates in 
immune responses.  
 
In the presence of anti-IL-2 many genes were increased in Th17 cells, alongside Il17a. 
Therefore these genes may be targets involved in inflammatory pathways within Th17 
cells that drive pathogenesis. Again, to ascertain the role of these factors in the 
regulation of the expression of inflammatory factors the O’Garra laboratory will utilise 
CRISPR-cas to knock out these genes in vitro and in vivo.   
 
7.3 Conclusion  
In this thesis we have devised and optimised a technique that has never been applied to 
immune cells and will be greatly beneficial within the field for both in vitro and in vivo 
studies. We have shown that it is possible to extract high quality RNA from in vitro 
differentiated Th1 cells cultured in the presence or absence of IL-27 and Th17 cells 
cultured with IL-2 or anti-IL-2, even though they are fixed and stained for intracellular 
cytokines. By separating the different intracellular cytokine producing subpopulations 
from these different Th cell subsets according to their hallmark cytokine and IL-10 
production we have revealed possible mechanisms by which IL-27 alters Th1 cells and 
IL-2 alters Th17 cells, and we have elucidated factors and pathways that may be 
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